Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-10-24
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| 0610007P14Rik | -0.0392645 |
| 0610009B22Rik | -0.0028689 |
| 0610009E02Rik | -0.2454686 |
| 0610009L18Rik | 0.9803795 |
| 0610009O20Rik | -0.3821166 |
| 0610010F05Rik | 0.5840653 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10586 |
| num_genes_in_profile | 15245 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 11907 |
| num_profile_genes_not_in_sets | 3338 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10586 |
| num_genesets_excluded | 4121 |
| num_genesets_included | 6465 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOMF MHC PROTEIN COMPLEX BINDING | 11 | 4.96e-06 | -0.795 | 1.08e-04 |
| GOCC MHC PROTEIN COMPLEX | 17 | 6.53e-07 | -0.697 | 1.92e-05 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 11 | 1.00e-04 | -0.677 | 1.51e-03 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 10 | 2.16e-04 | -0.676 | 2.75e-03 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 10 | 3.02e-04 | -0.660 | 3.66e-03 |
| GOCC GOLGI LUMEN | 14 | 2.16e-05 | -0.656 | 3.91e-04 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 18 | 1.60e-06 | -0.653 | 4.02e-05 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 12 | 1.01e-04 | -0.648 | 1.51e-03 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 12 | 1.05e-04 | -0.647 | 1.56e-03 |
| GOMF PEPTIDE ANTIGEN BINDING | 21 | 5.76e-07 | -0.630 | 1.73e-05 |
| GOMF PROFILIN BINDING | 12 | 1.74e-04 | -0.626 | 2.34e-03 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 20 | 1.28e-06 | -0.626 | 3.38e-05 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 10 | 6.32e-04 | -0.624 | 6.81e-03 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 11 | 3.67e-04 | -0.620 | 4.28e-03 |
| GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING | 12 | 3.69e-04 | -0.594 | 4.29e-03 |
| GOMF MHC PROTEIN BINDING | 22 | 2.26e-06 | -0.582 | 5.43e-05 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 1.40e-06 | -0.581 | 3.62e-05 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 2.48e-05 | -0.574 | 4.38e-04 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 2.76e-03 | -0.547 | 2.20e-02 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 10 | 2.85e-03 | -0.545 | 2.26e-02 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY | 10 | 3.00e-03 | 0.542 | 2.34e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 23 | 6.87e-06 | -0.542 | 1.44e-04 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 11 | 1.97e-03 | -0.539 | 1.68e-02 |
| GOBP GOLGI RIBBON FORMATION | 11 | 2.55e-03 | -0.525 | 2.07e-02 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 4.07e-03 | -0.525 | 2.94e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 12 | 1.97e-03 | -0.516 | 1.68e-02 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 4.92e-03 | -0.514 | 3.41e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 29 | 1.70e-06 | -0.513 | 4.25e-05 |
| GOBP FAT CELL PROLIFERATION | 12 | 2.07e-03 | -0.513 | 1.76e-02 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 16 | 3.95e-04 | -0.512 | 4.55e-03 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 12 | 2.15e-03 | -0.512 | 1.82e-02 |
| GOBP PEPTIDE CROSS LINKING | 11 | 3.41e-03 | -0.510 | 2.57e-02 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 17 | 2.94e-04 | -0.507 | 3.59e-03 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 12 | 2.35e-03 | -0.507 | 1.96e-02 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 13 | 1.74e-03 | -0.502 | 1.54e-02 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 11 | 4.27e-03 | -0.498 | 3.07e-02 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 10 | 6.73e-03 | -0.495 | 4.30e-02 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 6.91e-03 | -0.493 | 4.36e-02 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 15 | 1.08e-03 | 0.487 | 1.06e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 13 | 2.39e-03 | -0.486 | 1.97e-02 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 11 | 5.22e-03 | 0.486 | 3.57e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 29 | 6.03e-06 | -0.486 | 1.29e-04 |
| GOMF T CELL RECEPTOR BINDING | 16 | 7.85e-04 | -0.485 | 8.12e-03 |
| GOCC TRAPPIII PROTEIN COMPLEX | 11 | 5.61e-03 | -0.482 | 3.74e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 15 | 1.26e-03 | -0.481 | 1.20e-02 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 13 | 2.70e-03 | -0.481 | 2.17e-02 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 13 | 2.72e-03 | -0.480 | 2.18e-02 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 20 | 2.08e-04 | -0.479 | 2.67e-03 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 15 | 1.33e-03 | 0.479 | 1.25e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 15 | 1.38e-03 | -0.477 | 1.28e-02 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOMF MHC PROTEIN COMPLEX BINDING | 11 | 4.96e-06 | -7.95e-01 | 1.08e-04 |
| GOCC MHC PROTEIN COMPLEX | 17 | 6.53e-07 | -6.97e-01 | 1.92e-05 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 11 | 1.00e-04 | -6.77e-01 | 1.51e-03 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 10 | 2.16e-04 | -6.76e-01 | 2.75e-03 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 10 | 3.02e-04 | -6.60e-01 | 3.66e-03 |
| GOCC GOLGI LUMEN | 14 | 2.16e-05 | -6.56e-01 | 3.91e-04 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 18 | 1.60e-06 | -6.53e-01 | 4.02e-05 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 12 | 1.01e-04 | -6.48e-01 | 1.51e-03 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 12 | 1.05e-04 | -6.47e-01 | 1.56e-03 |
| GOMF PEPTIDE ANTIGEN BINDING | 21 | 5.76e-07 | -6.30e-01 | 1.73e-05 |
| GOMF PROFILIN BINDING | 12 | 1.74e-04 | -6.26e-01 | 2.34e-03 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 20 | 1.28e-06 | -6.26e-01 | 3.38e-05 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 10 | 6.32e-04 | -6.24e-01 | 6.81e-03 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 11 | 3.67e-04 | -6.20e-01 | 4.28e-03 |
| GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING | 12 | 3.69e-04 | -5.94e-01 | 4.29e-03 |
| GOMF MHC PROTEIN BINDING | 22 | 2.26e-06 | -5.82e-01 | 5.43e-05 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 1.40e-06 | -5.81e-01 | 3.62e-05 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 2.48e-05 | -5.74e-01 | 4.38e-04 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 2.76e-03 | -5.47e-01 | 2.20e-02 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 10 | 2.85e-03 | -5.45e-01 | 2.26e-02 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY | 10 | 3.00e-03 | 5.42e-01 | 2.34e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 23 | 6.87e-06 | -5.42e-01 | 1.44e-04 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 11 | 1.97e-03 | -5.39e-01 | 1.68e-02 |
| GOBP GOLGI RIBBON FORMATION | 11 | 2.55e-03 | -5.25e-01 | 2.07e-02 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 4.07e-03 | -5.25e-01 | 2.94e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 12 | 1.97e-03 | -5.16e-01 | 1.68e-02 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 4.92e-03 | -5.14e-01 | 3.41e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 29 | 1.70e-06 | -5.13e-01 | 4.25e-05 |
| GOBP FAT CELL PROLIFERATION | 12 | 2.07e-03 | -5.13e-01 | 1.76e-02 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 16 | 3.95e-04 | -5.12e-01 | 4.55e-03 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 12 | 2.15e-03 | -5.12e-01 | 1.82e-02 |
| GOBP PEPTIDE CROSS LINKING | 11 | 3.41e-03 | -5.10e-01 | 2.57e-02 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 17 | 2.94e-04 | -5.07e-01 | 3.59e-03 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 12 | 2.35e-03 | -5.07e-01 | 1.96e-02 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 13 | 1.74e-03 | -5.02e-01 | 1.54e-02 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 11 | 4.27e-03 | -4.98e-01 | 3.07e-02 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 10 | 6.73e-03 | -4.95e-01 | 4.30e-02 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 6.91e-03 | -4.93e-01 | 4.36e-02 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 15 | 1.08e-03 | 4.87e-01 | 1.06e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 13 | 2.39e-03 | -4.86e-01 | 1.97e-02 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 11 | 5.22e-03 | 4.86e-01 | 3.57e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 29 | 6.03e-06 | -4.86e-01 | 1.29e-04 |
| GOMF T CELL RECEPTOR BINDING | 16 | 7.85e-04 | -4.85e-01 | 8.12e-03 |
| GOCC TRAPPIII PROTEIN COMPLEX | 11 | 5.61e-03 | -4.82e-01 | 3.74e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 15 | 1.26e-03 | -4.81e-01 | 1.20e-02 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 13 | 2.70e-03 | -4.81e-01 | 2.17e-02 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 13 | 2.72e-03 | -4.80e-01 | 2.18e-02 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 20 | 2.08e-04 | -4.79e-01 | 2.67e-03 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 15 | 1.33e-03 | 4.79e-01 | 1.25e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 15 | 1.38e-03 | -4.77e-01 | 1.28e-02 |
| GOBP PEPTIDYL ARGININE METHYLATION | 10 | 8.99e-03 | -4.77e-01 | 5.28e-02 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 14 | 2.02e-03 | 4.77e-01 | 1.72e-02 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 10 | 9.41e-03 | -4.74e-01 | 5.46e-02 |
| GOCC CYTOCHROME COMPLEX | 33 | 2.42e-06 | 4.74e-01 | 5.78e-05 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 45 | 3.72e-08 | -4.74e-01 | 1.59e-06 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 13 | 3.15e-03 | -4.73e-01 | 2.42e-02 |
| GOCC PSEUDOPODIUM | 10 | 9.74e-03 | -4.72e-01 | 5.60e-02 |
| GOBP PYROPTOSIS | 26 | 3.19e-05 | -4.71e-01 | 5.46e-04 |
| GOBP MACROPHAGE PROLIFERATION | 10 | 9.87e-03 | -4.71e-01 | 5.67e-02 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 4.79e-03 | 4.70e-01 | 3.35e-02 |
| GOCC CILIARY ROOTLET | 12 | 4.82e-03 | -4.70e-01 | 3.37e-02 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 12 | 4.88e-03 | 4.69e-01 | 3.39e-02 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 19 | 4.09e-04 | -4.68e-01 | 4.67e-03 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 12 | 4.97e-03 | -4.68e-01 | 3.44e-02 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 23 | 1.05e-04 | -4.67e-01 | 1.56e-03 |
| GOCC TRAPP COMPLEX | 14 | 2.61e-03 | -4.65e-01 | 2.10e-02 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 11 | 7.65e-03 | -4.64e-01 | 4.74e-02 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 11 | 7.72e-03 | -4.64e-01 | 4.78e-02 |
| GOBP PROTEIN AUTOPROCESSING | 16 | 1.32e-03 | -4.64e-01 | 1.25e-02 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 19 | 4.74e-04 | -4.63e-01 | 5.28e-03 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 22 | 1.73e-04 | 4.63e-01 | 2.33e-03 |
| GOBP XENOPHAGY | 16 | 1.38e-03 | -4.62e-01 | 1.28e-02 |
| GOBP PIGMENT ACCUMULATION | 10 | 1.15e-02 | -4.61e-01 | 6.32e-02 |
| GOMF PRE MRNA INTRONIC BINDING | 13 | 4.04e-03 | 4.61e-01 | 2.93e-02 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 10 | 1.18e-02 | -4.60e-01 | 6.44e-02 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 11 | 8.41e-03 | -4.59e-01 | 5.02e-02 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 19 | 5.37e-04 | -4.59e-01 | 5.91e-03 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 15 | 2.16e-03 | -4.57e-01 | 1.82e-02 |
| GOCC CELL TIP | 11 | 8.82e-03 | -4.56e-01 | 5.20e-02 |
| GOBP RESPONSE TO PROTOZOAN | 31 | 1.27e-05 | -4.53e-01 | 2.49e-04 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 15 | 2.38e-03 | -4.53e-01 | 1.97e-02 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 10 | 1.33e-02 | -4.52e-01 | 6.97e-02 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 11 | 9.44e-03 | -4.52e-01 | 5.47e-02 |
| GOBP EOSINOPHIL MIGRATION | 15 | 2.48e-03 | -4.51e-01 | 2.03e-02 |
| GOCC TRAPPII PROTEIN COMPLEX | 10 | 1.37e-02 | -4.50e-01 | 7.15e-02 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 14 | 3.74e-03 | -4.48e-01 | 2.75e-02 |
| GOMF ANTIGEN BINDING | 39 | 1.40e-06 | -4.46e-01 | 3.62e-05 |
| GOBP MONOCYTE CHEMOTAXIS | 28 | 4.78e-05 | -4.44e-01 | 7.86e-04 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 15 | 2.98e-03 | -4.43e-01 | 2.34e-02 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.11e-02 | 4.42e-01 | 6.16e-02 |
| GOBP MICROGLIA DIFFERENTIATION | 15 | 3.13e-03 | -4.41e-01 | 2.41e-02 |
| GOCC BLOC 1 COMPLEX | 12 | 8.23e-03 | -4.41e-01 | 4.96e-02 |
| GOBP RESPONSE TO SALT | 16 | 2.31e-03 | -4.40e-01 | 1.94e-02 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 11 | 1.19e-02 | -4.38e-01 | 6.46e-02 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 20 | 6.97e-04 | 4.38e-01 | 7.39e-03 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 12 | 8.99e-03 | 4.36e-01 | 5.28e-02 |
| GOBP REGULATION OF MYOBLAST FUSION | 17 | 1.93e-03 | -4.34e-01 | 1.66e-02 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 13 | 6.80e-03 | -4.34e-01 | 4.32e-02 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 16 | 2.86e-03 | -4.31e-01 | 2.26e-02 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 1.34e-02 | -4.31e-01 | 7.02e-02 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 16 | 2.90e-03 | -4.30e-01 | 2.28e-02 |
| GOBP ELASTIC FIBER ASSEMBLY | 11 | 1.36e-02 | -4.30e-01 | 7.12e-02 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 14 | 5.43e-03 | -4.29e-01 | 3.65e-02 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 11 | 1.41e-02 | -4.27e-01 | 7.29e-02 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 10 | 1.95e-02 | -4.27e-01 | 9.15e-02 |
| GOCC CONTRACTILE RING | 11 | 1.44e-02 | -4.26e-01 | 7.39e-02 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 27 | 1.32e-04 | -4.25e-01 | 1.88e-03 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 49 | 2.68e-07 | -4.25e-01 | 8.88e-06 |
| GOBP REGULATION OF XENOPHAGY | 12 | 1.09e-02 | -4.25e-01 | 6.07e-02 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 10 | 2.04e-02 | -4.24e-01 | 9.42e-02 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 11 | 1.54e-02 | -4.22e-01 | 7.73e-02 |
| GOMF HYALURONIC ACID BINDING | 16 | 3.55e-03 | -4.21e-01 | 2.65e-02 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE BIOSYNTHETIC PROCESS | 12 | 1.18e-02 | -4.20e-01 | 6.44e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 11 | 1.60e-02 | -4.19e-01 | 7.98e-02 |
| GOBP PARENTAL BEHAVIOR | 10 | 2.17e-02 | 4.19e-01 | 9.89e-02 |
| GOCC PODOSOME | 29 | 9.61e-05 | -4.18e-01 | 1.45e-03 |
| GOCC RNA CAP BINDING COMPLEX | 12 | 1.23e-02 | -4.17e-01 | 6.65e-02 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 11 | 1.68e-02 | -4.16e-01 | 8.24e-02 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 15 | 5.33e-03 | -4.16e-01 | 3.62e-02 |
| GOCC CORNIFIED ENVELOPE | 14 | 7.21e-03 | -4.15e-01 | 4.52e-02 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 46 | 1.19e-06 | -4.14e-01 | 3.16e-05 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 15 | 5.58e-03 | -4.13e-01 | 3.72e-02 |
| GOBP RESPONSE TO FUNGUS | 38 | 1.05e-05 | -4.13e-01 | 2.11e-04 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 20 | 1.39e-03 | -4.13e-01 | 1.29e-02 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 15 | 5.63e-03 | -4.13e-01 | 3.74e-02 |
| GOMF ADENYLATE CYCLASE BINDING | 12 | 1.33e-02 | -4.13e-01 | 6.97e-02 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 27 | 2.11e-04 | -4.12e-01 | 2.69e-03 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 10 | 2.41e-02 | -4.12e-01 | 1.07e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 10 | 2.43e-02 | -4.11e-01 | 1.07e-01 |
| GOMF S100 PROTEIN BINDING | 13 | 1.06e-02 | -4.10e-01 | 5.95e-02 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 14 | 7.96e-03 | -4.10e-01 | 4.87e-02 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 19 | 2.05e-03 | -4.08e-01 | 1.74e-02 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 27 | 2.45e-04 | -4.08e-01 | 3.06e-03 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 10 | 2.57e-02 | -4.07e-01 | 1.11e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 18 | 2.81e-03 | -4.07e-01 | 2.23e-02 |
| GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE | 12 | 1.47e-02 | -4.07e-01 | 7.52e-02 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 27 | 2.55e-04 | -4.07e-01 | 3.19e-03 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 28 | 1.98e-04 | -4.06e-01 | 2.59e-03 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 15 | 6.48e-03 | -4.06e-01 | 4.17e-02 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 12 | 1.56e-02 | -4.03e-01 | 7.81e-02 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 23 | 8.19e-04 | -4.03e-01 | 8.38e-03 |
| GOBP FIBROBLAST ACTIVATION | 19 | 2.36e-03 | -4.03e-01 | 1.96e-02 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 10 | 2.74e-02 | -4.03e-01 | 1.17e-01 |
| GOBP MIDBODY ABSCISSION | 15 | 6.95e-03 | -4.03e-01 | 4.38e-02 |
| GOBP REGULATION OF PIGMENTATION | 13 | 1.21e-02 | -4.02e-01 | 6.54e-02 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 15 | 7.08e-03 | -4.02e-01 | 4.45e-02 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 14 | 9.71e-03 | -3.99e-01 | 5.59e-02 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 2.89e-02 | -3.99e-01 | 1.21e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 23 | 9.42e-04 | -3.98e-01 | 9.47e-03 |
| GOBP EOSINOPHIL CHEMOTAXIS | 12 | 1.69e-02 | -3.98e-01 | 8.28e-02 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 10 | 2.92e-02 | -3.98e-01 | 1.22e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 19 | 2.67e-03 | -3.98e-01 | 2.16e-02 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 29 | 2.09e-04 | -3.98e-01 | 2.68e-03 |
| GOBP RESPONSE TO STILBENOID | 12 | 1.71e-02 | -3.98e-01 | 8.33e-02 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 13 | 1.32e-02 | -3.97e-01 | 6.95e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 2.97e-02 | -3.97e-01 | 1.23e-01 |
| GOCC U1 SNRNP | 18 | 3.56e-03 | 3.97e-01 | 2.65e-02 |
| GOBP CHONDROCYTE PROLIFERATION | 19 | 2.77e-03 | -3.97e-01 | 2.21e-02 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 13 | 1.33e-02 | -3.96e-01 | 7.00e-02 |
| GOMF SNRNP BINDING | 14 | 1.03e-02 | 3.96e-01 | 5.85e-02 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 31 | 1.36e-04 | -3.96e-01 | 1.92e-03 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 16 | 6.20e-03 | -3.95e-01 | 4.04e-02 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 17 | 4.86e-03 | -3.95e-01 | 3.39e-02 |
| GOBP UBIQUINONE METABOLIC PROCESS | 17 | 4.86e-03 | -3.95e-01 | 3.39e-02 |
| GOCC CELL TRAILING EDGE | 12 | 1.81e-02 | -3.94e-01 | 8.68e-02 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 20 | 2.36e-03 | 3.93e-01 | 1.96e-02 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 11 | 2.42e-02 | -3.93e-01 | 1.07e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 19 | 3.07e-03 | -3.92e-01 | 2.38e-02 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 12 | 1.88e-02 | -3.92e-01 | 8.93e-02 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 10 | 3.20e-02 | -3.92e-01 | 1.30e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 31 | 1.61e-04 | -3.92e-01 | 2.20e-03 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 12 | 1.91e-02 | -3.91e-01 | 9.02e-02 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 10 | 3.27e-02 | -3.90e-01 | 1.32e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 3.29e-02 | 3.90e-01 | 1.32e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 36 | 5.53e-05 | -3.88e-01 | 8.82e-04 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 11 | 2.61e-02 | -3.87e-01 | 1.13e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 12 | 2.02e-02 | -3.87e-01 | 9.36e-02 |
| GOBP RESPONSE TO GLUCAGON | 11 | 2.67e-02 | 3.86e-01 | 1.15e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 81 | 2.10e-09 | -3.85e-01 | 1.21e-07 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 14 | 1.28e-02 | -3.84e-01 | 6.82e-02 |
| GOCC PROTEASOME CORE COMPLEX | 17 | 6.09e-03 | -3.84e-01 | 4.00e-02 |
| GOBP SYNAPSE PRUNING | 14 | 1.30e-02 | -3.83e-01 | 6.90e-02 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 16 | 7.97e-03 | -3.83e-01 | 4.87e-02 |
| GOBP PODOSOME ASSEMBLY | 22 | 1.88e-03 | -3.83e-01 | 1.64e-02 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 22 | 1.91e-03 | -3.82e-01 | 1.65e-02 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 17 | 6.41e-03 | 3.82e-01 | 4.14e-02 |
| GOMF FATTY ACID BINDING | 34 | 1.25e-04 | -3.80e-01 | 1.78e-03 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 12 | 2.27e-02 | -3.80e-01 | 1.02e-01 |
| GOCC U4 SNRNP | 10 | 3.76e-02 | 3.80e-01 | 1.44e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 14 | 1.40e-02 | -3.79e-01 | 7.24e-02 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 14 | 1.43e-02 | -3.78e-01 | 7.35e-02 |
| GOBP NAD CATABOLIC PROCESS | 18 | 5.60e-03 | -3.77e-01 | 3.73e-02 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 17 | 7.26e-03 | -3.76e-01 | 4.54e-02 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 14 | 1.49e-02 | 3.76e-01 | 7.61e-02 |
| GOMF DEATH DOMAIN BINDING | 12 | 2.47e-02 | -3.75e-01 | 1.08e-01 |
| GOBP T CELL CHEMOTAXIS | 14 | 1.57e-02 | -3.73e-01 | 7.88e-02 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 14 | 1.59e-02 | -3.72e-01 | 7.93e-02 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 27 | 8.19e-04 | -3.72e-01 | 8.38e-03 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 11 | 3.27e-02 | -3.72e-01 | 1.32e-01 |
| GOMF BH DOMAIN BINDING | 14 | 1.61e-02 | -3.72e-01 | 7.99e-02 |
| GOMF CARGO ADAPTOR ACTIVITY | 19 | 5.11e-03 | -3.71e-01 | 3.52e-02 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 12 | 2.62e-02 | -3.71e-01 | 1.13e-01 |
| GOCC SPERM PLASMA MEMBRANE | 10 | 4.25e-02 | 3.71e-01 | 1.56e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 19 | 5.23e-03 | -3.70e-01 | 3.58e-02 |
| GOBP PROSTANOID METABOLIC PROCESS | 39 | 6.42e-05 | -3.70e-01 | 1.01e-03 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 15 | 1.34e-02 | -3.69e-01 | 7.00e-02 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 11 | 3.41e-02 | -3.69e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE INVAGINATION | 16 | 1.07e-02 | -3.69e-01 | 6.00e-02 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 14 | 1.74e-02 | -3.67e-01 | 8.47e-02 |
| GOBP COMPLEMENT ACTIVATION | 31 | 4.08e-04 | -3.67e-01 | 4.67e-03 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS | 11 | 3.52e-02 | -3.67e-01 | 1.39e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 16 | 1.12e-02 | -3.66e-01 | 6.17e-02 |
| GOBP ACTIN FILAMENT SEVERING | 17 | 9.03e-03 | -3.66e-01 | 5.29e-02 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 14 | 1.79e-02 | -3.66e-01 | 8.60e-02 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 35 | 1.82e-04 | -3.66e-01 | 2.42e-03 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 26 | 1.26e-03 | -3.65e-01 | 1.20e-02 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 11 | 3.60e-02 | -3.65e-01 | 1.41e-01 |
| GOCC GOLGI CIS CISTERNA | 12 | 2.88e-02 | -3.64e-01 | 1.21e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 13 | 2.29e-02 | -3.64e-01 | 1.03e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 13 | 2.31e-02 | -3.64e-01 | 1.04e-01 |
| GOCC PROTEASOME COMPLEX | 59 | 1.38e-06 | -3.64e-01 | 3.61e-05 |
| GOCC CELL POLE | 14 | 1.86e-02 | -3.63e-01 | 8.85e-02 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 12 | 2.96e-02 | -3.63e-01 | 1.23e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 18 | 7.98e-03 | -3.61e-01 | 4.87e-02 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 12 | 3.03e-02 | -3.61e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 11 | 3.84e-02 | -3.61e-01 | 1.46e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 16 | 1.25e-02 | -3.61e-01 | 6.72e-02 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 13 | 2.47e-02 | 3.60e-01 | 1.09e-01 |
| GOBP VESICLE COATING | 31 | 5.29e-04 | -3.60e-01 | 5.85e-03 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 13 | 2.50e-02 | -3.59e-01 | 1.09e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 45 | 3.14e-05 | -3.59e-01 | 5.39e-04 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 6.88e-03 | -3.58e-01 | 4.35e-02 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 10 | 5.01e-02 | 3.58e-01 | 1.75e-01 |
| GOCC PARASPECKLES | 10 | 5.02e-02 | 3.58e-01 | 1.75e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 11 | 4.01e-02 | -3.57e-01 | 1.50e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 12 | 3.21e-02 | -3.57e-01 | 1.30e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 18 | 8.66e-03 | -3.57e-01 | 5.15e-02 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 19 | 7.04e-03 | 3.57e-01 | 4.44e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 14 | 2.07e-02 | -3.57e-01 | 9.53e-02 |
| GOMF DNA BINDING BENDING | 11 | 4.06e-02 | -3.56e-01 | 1.51e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 31 | 6.01e-04 | -3.56e-01 | 6.53e-03 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 21 | 4.75e-03 | -3.56e-01 | 3.33e-02 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 47 | 2.49e-05 | -3.56e-01 | 4.38e-04 |
| GOMF PROTEIN RNA ADAPTOR ACTIVITY | 18 | 9.03e-03 | 3.56e-01 | 5.29e-02 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 16 | 1.38e-02 | -3.55e-01 | 7.18e-02 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 22 | 3.97e-03 | -3.55e-01 | 2.89e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 27 | 1.42e-03 | -3.55e-01 | 1.32e-02 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 10 | 5.26e-02 | -3.54e-01 | 1.81e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 11 | 4.24e-02 | -3.54e-01 | 1.56e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 24 | 2.76e-03 | -3.53e-01 | 2.20e-02 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 5.18e-03 | -3.52e-01 | 3.55e-02 |
| GOBP INTEGRIN ACTIVATION | 23 | 3.50e-03 | -3.52e-01 | 2.62e-02 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 8.06e-03 | -3.51e-01 | 4.90e-02 |
| GOMF OPSONIN BINDING | 12 | 3.52e-02 | -3.51e-01 | 1.39e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 11 | 4.40e-02 | -3.51e-01 | 1.60e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 44 | 5.93e-05 | -3.50e-01 | 9.35e-04 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 29 | 1.11e-03 | -3.50e-01 | 1.08e-02 |
| GOCC RESPIRASOME | 80 | 6.46e-08 | 3.50e-01 | 2.55e-06 |
| GOMF PROTEOGLYCAN BINDING | 30 | 9.26e-04 | -3.49e-01 | 9.36e-03 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 13 | 2.92e-02 | -3.49e-01 | 1.22e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 32 | 6.39e-04 | -3.49e-01 | 6.86e-03 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 15 | 1.97e-02 | 3.48e-01 | 9.23e-02 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 13 | 3.02e-02 | -3.47e-01 | 1.25e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 11 | 4.65e-02 | -3.47e-01 | 1.66e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 14 | 2.49e-02 | -3.46e-01 | 1.09e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 19 | 9.09e-03 | -3.46e-01 | 5.31e-02 |
| GOBP CRISTAE FORMATION | 16 | 1.67e-02 | -3.46e-01 | 8.21e-02 |
| GOBP INTERLEUKIN 18 PRODUCTION | 10 | 5.89e-02 | -3.45e-01 | 1.95e-01 |
| GOBP RESPIRATORY BURST | 21 | 6.25e-03 | -3.45e-01 | 4.06e-02 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 11 | 4.91e-02 | -3.43e-01 | 1.73e-01 |
| GOBP AEROBIC ELECTRON TRANSPORT CHAIN | 59 | 5.35e-06 | 3.43e-01 | 1.15e-04 |
| GOCC FILOPODIUM MEMBRANE | 16 | 1.77e-02 | -3.43e-01 | 8.58e-02 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 25 | 3.04e-03 | -3.42e-01 | 2.36e-02 |
| GOBP COPPER ION HOMEOSTASIS | 16 | 1.78e-02 | -3.42e-01 | 8.58e-02 |
| GOBP KERATINOCYTE MIGRATION | 15 | 2.17e-02 | -3.42e-01 | 9.90e-02 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 29 | 1.43e-03 | -3.42e-01 | 1.32e-02 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 17 | 1.46e-02 | -3.42e-01 | 7.48e-02 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 13 | 3.28e-02 | -3.42e-01 | 1.32e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 24 | 3.75e-03 | 3.42e-01 | 2.76e-02 |
| GOBP RESPONSE TO MERCURY ION | 10 | 6.17e-02 | -3.41e-01 | 2.00e-01 |
| GOMF CHEMOKINE ACTIVITY | 20 | 8.42e-03 | -3.40e-01 | 5.02e-02 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 46 | 6.54e-05 | -3.40e-01 | 1.02e-03 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 5.07e-02 | -3.40e-01 | 1.76e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 13 | 3.38e-02 | -3.40e-01 | 1.35e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 11 | 5.17e-02 | -3.39e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 11 | 5.21e-02 | -3.38e-01 | 1.80e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 1.59e-02 | 3.38e-01 | 7.93e-02 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 11 | 5.25e-02 | -3.38e-01 | 1.80e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 1.60e-02 | -3.38e-01 | 7.95e-02 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 14 | 2.89e-02 | 3.37e-01 | 1.21e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 12 | 4.31e-02 | -3.37e-01 | 1.57e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 16 | 1.95e-02 | -3.37e-01 | 9.18e-02 |
| GOMF U1 SNRNP BINDING | 10 | 6.52e-02 | 3.37e-01 | 2.08e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 10 | 6.55e-02 | -3.36e-01 | 2.08e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 16 | 1.99e-02 | -3.36e-01 | 9.29e-02 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 20 | 9.31e-03 | -3.36e-01 | 5.41e-02 |
| GOMF GLUCOSE BINDING | 10 | 6.64e-02 | -3.35e-01 | 2.10e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 34 | 7.18e-04 | -3.35e-01 | 7.57e-03 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 15 | 2.46e-02 | 3.35e-01 | 1.08e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 20 | 9.53e-03 | -3.35e-01 | 5.51e-02 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 15 | 2.49e-02 | -3.35e-01 | 1.09e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 15 | 2.49e-02 | -3.35e-01 | 1.09e-01 |
| GOBP ZINC ION TRANSPORT | 21 | 8.01e-03 | -3.34e-01 | 4.87e-02 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 18 | 1.41e-02 | 3.34e-01 | 7.27e-02 |
| GOCC MEIOTIC SPINDLE | 11 | 5.50e-02 | -3.34e-01 | 1.86e-01 |
| GOBP ACTIN NUCLEATION | 47 | 7.48e-05 | -3.34e-01 | 1.15e-03 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 22 | 6.71e-03 | -3.34e-01 | 4.29e-02 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 24 | 4.67e-03 | -3.34e-01 | 3.29e-02 |
| GOCC COLLAGEN TRIMER | 57 | 1.46e-05 | -3.32e-01 | 2.85e-04 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 13 | 3.83e-02 | -3.32e-01 | 1.46e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 10 | 6.93e-02 | -3.32e-01 | 2.16e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 13 | 3.86e-02 | -3.31e-01 | 1.46e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 22 | 7.24e-03 | -3.31e-01 | 4.53e-02 |
| GOBP PLATELET MORPHOGENESIS | 21 | 8.73e-03 | -3.31e-01 | 5.17e-02 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 1.52e-02 | -3.31e-01 | 7.68e-02 |
| GOBP SEX CHROMOSOME DOSAGE COMPENSATION | 18 | 1.52e-02 | 3.31e-01 | 7.68e-02 |
| GOBP RENAL SODIUM ION TRANSPORT | 13 | 3.91e-02 | 3.30e-01 | 1.48e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 19 | 1.27e-02 | -3.30e-01 | 6.78e-02 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 16 | 2.24e-02 | -3.30e-01 | 1.01e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 20 | 1.07e-02 | -3.30e-01 | 6.02e-02 |
| GOBP PINOCYTOSIS | 20 | 1.07e-02 | -3.30e-01 | 6.02e-02 |
| GOBP KILLING OF CELLS OF ANOTHER ORGANISM | 40 | 3.11e-04 | -3.30e-01 | 3.74e-03 |
| GOCC MLL3 4 COMPLEX | 11 | 5.86e-02 | 3.29e-01 | 1.94e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 20 | 1.09e-02 | -3.29e-01 | 6.07e-02 |
| GOBP FIBRINOLYSIS | 12 | 4.86e-02 | -3.29e-01 | 1.71e-01 |
| GOMF CARD DOMAIN BINDING | 12 | 4.87e-02 | -3.29e-01 | 1.71e-01 |
| GOBP GERMINAL CENTER FORMATION | 14 | 3.33e-02 | -3.29e-01 | 1.33e-01 |
| GOBP MYOBLAST FUSION | 34 | 9.16e-04 | -3.29e-01 | 9.28e-03 |
| GOCC ENDOLYSOSOME | 12 | 4.89e-02 | -3.28e-01 | 1.72e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 18 | 1.59e-02 | -3.28e-01 | 7.93e-02 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 2.30e-02 | -3.28e-01 | 1.04e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 24 | 5.39e-03 | -3.28e-01 | 3.64e-02 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 16 | 2.32e-02 | -3.28e-01 | 1.04e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 14 | 3.42e-02 | -3.27e-01 | 1.36e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 18 | 1.65e-02 | -3.26e-01 | 8.16e-02 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 17 | 1.98e-02 | -3.26e-01 | 9.26e-02 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 10 | 7.45e-02 | -3.26e-01 | 2.27e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 11 | 6.14e-02 | 3.26e-01 | 2.00e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 15 | 2.90e-02 | -3.26e-01 | 1.21e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 72 | 1.80e-06 | -3.26e-01 | 4.44e-05 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 14 | 3.54e-02 | -3.25e-01 | 1.39e-01 |
| GOBP CAMP METABOLIC PROCESS | 12 | 5.16e-02 | -3.25e-01 | 1.79e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 12 | 5.21e-02 | -3.24e-01 | 1.80e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 10 | 7.66e-02 | -3.23e-01 | 2.31e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 17 | 2.10e-02 | -3.23e-01 | 9.63e-02 |
| GOBP RESPONSE TO ETHER | 12 | 5.25e-02 | -3.23e-01 | 1.80e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 69 | 3.56e-06 | 3.23e-01 | 8.13e-05 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 11 | 6.38e-02 | 3.23e-01 | 2.05e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 39 | 4.87e-04 | -3.23e-01 | 5.41e-03 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 14 | 3.67e-02 | 3.23e-01 | 1.42e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 12 | 5.32e-02 | -3.22e-01 | 1.82e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 14 | 3.68e-02 | -3.22e-01 | 1.42e-01 |
| GOBP NEPHRON TUBULE FORMATION | 12 | 5.33e-02 | 3.22e-01 | 1.82e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 18 | 1.80e-02 | -3.22e-01 | 8.62e-02 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 2.17e-02 | -3.22e-01 | 9.88e-02 |
| GOBP QUINONE BIOSYNTHETIC PROCESS | 14 | 3.72e-02 | -3.22e-01 | 1.43e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 26 | 4.59e-03 | -3.21e-01 | 3.25e-02 |
| GOBP GENITALIA MORPHOGENESIS | 13 | 4.51e-02 | 3.21e-01 | 1.62e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 123 | 8.09e-10 | -3.21e-01 | 5.23e-08 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 20 | 1.30e-02 | -3.21e-01 | 6.90e-02 |
| GOBP REGULATION OF SYNAPSE MATURATION | 23 | 7.78e-03 | -3.21e-01 | 4.80e-02 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 12 | 5.47e-02 | 3.20e-01 | 1.85e-01 |
| GOMF NADH DEHYDROGENASE ACTIVITY | 11 | 6.59e-02 | 3.20e-01 | 2.09e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 17 | 2.23e-02 | -3.20e-01 | 1.01e-01 |
| GOBP ECTODERM DEVELOPMENT | 12 | 5.50e-02 | -3.20e-01 | 1.86e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 22 | 9.48e-03 | -3.20e-01 | 5.48e-02 |
| GOBP RESPONSE TO INTERFERON BETA | 49 | 1.12e-04 | -3.19e-01 | 1.63e-03 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 14 | 3.87e-02 | 3.19e-01 | 1.47e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 11 | 6.71e-02 | -3.19e-01 | 2.12e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 23 | 8.19e-03 | -3.19e-01 | 4.95e-02 |
| GOBP PROTEIN DEGLYCOSYLATION | 13 | 4.68e-02 | -3.18e-01 | 1.67e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 13 | 4.72e-02 | -3.18e-01 | 1.67e-01 |
| GOBP LEUKOCYTE AGGREGATION | 15 | 3.31e-02 | -3.18e-01 | 1.33e-01 |
| GOCC GBAF COMPLEX | 11 | 6.81e-02 | -3.18e-01 | 2.14e-01 |
| GOBP INTERNEURON MIGRATION | 10 | 8.24e-02 | 3.17e-01 | 2.41e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 53 | 6.52e-05 | -3.17e-01 | 1.02e-03 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 16 | 2.82e-02 | -3.17e-01 | 1.19e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 87 | 3.41e-07 | -3.16e-01 | 1.08e-05 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 71 | 4.10e-06 | -3.16e-01 | 9.17e-05 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 55 | 5.12e-05 | -3.16e-01 | 8.30e-04 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 17 | 2.42e-02 | 3.16e-01 | 1.07e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 15 | 3.44e-02 | -3.16e-01 | 1.36e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 12 | 5.85e-02 | -3.15e-01 | 1.94e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 26 | 5.40e-03 | -3.15e-01 | 3.64e-02 |
| GOMF CHEMOKINE RECEPTOR BINDING | 30 | 2.84e-03 | -3.15e-01 | 2.25e-02 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 10 | 8.48e-02 | -3.15e-01 | 2.45e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 50 | 1.19e-04 | -3.15e-01 | 1.72e-03 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 11 | 7.10e-02 | -3.14e-01 | 2.19e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 39 | 6.85e-04 | -3.14e-01 | 7.28e-03 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 11 | 7.13e-02 | -3.14e-01 | 2.20e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 92 | 1.94e-07 | -3.14e-01 | 6.83e-06 |
| GOBP EPITHELIAL CELL CELL ADHESION | 14 | 4.21e-02 | -3.14e-01 | 1.55e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 92 | 2.00e-07 | -3.14e-01 | 6.94e-06 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 19 | 1.79e-02 | -3.14e-01 | 8.61e-02 |
| GOCC RETROMER COMPLEX | 19 | 1.80e-02 | -3.13e-01 | 8.64e-02 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 29 | 3.49e-03 | -3.13e-01 | 2.62e-02 |
| GOBP MEMBRANE INVAGINATION | 63 | 1.71e-05 | -3.13e-01 | 3.22e-04 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 11 | 7.20e-02 | -3.13e-01 | 2.21e-01 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 16 | 3.03e-02 | -3.13e-01 | 1.25e-01 |
| GOBP PROTEIN IMPORT | 10 | 8.69e-02 | -3.13e-01 | 2.49e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 10 | 8.73e-02 | 3.12e-01 | 2.49e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 32 | 2.24e-03 | -3.12e-01 | 1.88e-02 |
| GOCC NADH DEHYDROGENASE COMPLEX | 43 | 4.00e-04 | 3.12e-01 | 4.60e-03 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 43 | 4.16e-04 | -3.11e-01 | 4.74e-03 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 35 | 1.45e-03 | -3.11e-01 | 1.34e-02 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 11 | 7.41e-02 | -3.11e-01 | 2.26e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 28 | 4.40e-03 | -3.11e-01 | 3.15e-02 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 14 | 4.43e-02 | -3.11e-01 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 21 | 1.39e-02 | -3.10e-01 | 7.20e-02 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 15 | 3.77e-02 | 3.10e-01 | 1.44e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 12 | 6.33e-02 | -3.10e-01 | 2.04e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 34 | 1.81e-03 | -3.09e-01 | 1.59e-02 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 20 | 1.67e-02 | -3.09e-01 | 8.20e-02 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 13 | 5.36e-02 | -3.09e-01 | 1.83e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 38 | 9.78e-04 | -3.09e-01 | 9.77e-03 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 13 | 5.39e-02 | -3.09e-01 | 1.84e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 6.41e-02 | 3.09e-01 | 2.06e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 17 | 2.76e-02 | -3.09e-01 | 1.17e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 11 | 7.68e-02 | -3.08e-01 | 2.32e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 47 | 2.60e-04 | -3.08e-01 | 3.23e-03 |
| GOBP T CELL CYTOKINE PRODUCTION | 29 | 4.10e-03 | -3.08e-01 | 2.96e-02 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 47 | 2.66e-04 | -3.08e-01 | 3.29e-03 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 85 | 9.97e-07 | -3.07e-01 | 2.73e-05 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 23 | 1.09e-02 | 3.07e-01 | 6.07e-02 |
| GOBP MELANOCYTE DIFFERENTIATION | 22 | 1.28e-02 | -3.07e-01 | 6.82e-02 |
| GOBP ICOSANOID METABOLIC PROCESS | 72 | 7.01e-06 | -3.06e-01 | 1.47e-04 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 18 | 2.46e-02 | -3.06e-01 | 1.08e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 12 | 6.65e-02 | -3.06e-01 | 2.10e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 104 | 7.14e-08 | -3.06e-01 | 2.76e-06 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 15 | 4.03e-02 | -3.06e-01 | 1.50e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 28 | 5.10e-03 | -3.06e-01 | 3.52e-02 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 65 | 2.03e-05 | -3.06e-01 | 3.70e-04 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 5.63e-02 | -3.06e-01 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 46 | 3.37e-04 | -3.06e-01 | 3.98e-03 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 14 | 4.80e-02 | -3.05e-01 | 1.69e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 59 | 5.02e-05 | -3.05e-01 | 8.17e-04 |
| GOBP UBIQUITIN RECYCLING | 11 | 7.97e-02 | 3.05e-01 | 2.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 10 | 9.48e-02 | -3.05e-01 | 2.63e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 12 | 6.74e-02 | -3.05e-01 | 2.12e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 13 | 5.79e-02 | -3.04e-01 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS | 11 | 8.14e-02 | -3.04e-01 | 2.39e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 24 | 1.01e-02 | -3.03e-01 | 5.75e-02 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 22 | 1.38e-02 | -3.03e-01 | 7.18e-02 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 23 | 1.19e-02 | -3.03e-01 | 6.47e-02 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.21e-02 | -3.03e-01 | 2.40e-01 |
| GOCC PCG PROTEIN COMPLEX | 43 | 5.96e-04 | 3.03e-01 | 6.50e-03 |
| GOBP QUINONE METABOLIC PROCESS | 20 | 1.91e-02 | -3.03e-01 | 9.05e-02 |
| GOBP PIGMENT CELL DIFFERENTIATION | 32 | 3.05e-03 | -3.03e-01 | 2.37e-02 |
| GOCC BLOC COMPLEX | 17 | 3.08e-02 | -3.03e-01 | 1.26e-01 |
| GOCC PROTEIN LIPID COMPLEX | 24 | 1.03e-02 | -3.02e-01 | 5.86e-02 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 13 | 5.93e-02 | -3.02e-01 | 1.96e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 9.81e-02 | -3.02e-01 | 2.69e-01 |
| GOBP REGULATION OF T CELL CYTOKINE PRODUCTION | 23 | 1.22e-02 | -3.02e-01 | 6.58e-02 |
| GOCC ENDOPEPTIDASE COMPLEX | 75 | 6.44e-06 | -3.01e-01 | 1.36e-04 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 13 | 6.02e-02 | -3.01e-01 | 1.98e-01 |
| GOBP SYNCYTIUM FORMATION | 49 | 2.71e-04 | -3.01e-01 | 3.34e-03 |
| GOBP RESPONSE TO CHEMOKINE | 51 | 2.07e-04 | -3.00e-01 | 2.66e-03 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 31 | 3.80e-03 | -3.00e-01 | 2.79e-02 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 13 | 6.11e-02 | -3.00e-01 | 2.00e-01 |
| GOCC ACTOMYOSIN | 89 | 1.02e-06 | -3.00e-01 | 2.75e-05 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 8.51e-02 | 3.00e-01 | 2.45e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 161 | 5.63e-11 | -3.00e-01 | 4.61e-09 |
| GOMF POTASSIUM ION BINDING | 11 | 8.54e-02 | -3.00e-01 | 2.46e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 42 | 7.87e-04 | -2.99e-01 | 8.12e-03 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 98 | 3.07e-07 | -2.99e-01 | 9.84e-06 |
| GOBP GRANULOCYTE MIGRATION | 107 | 8.92e-08 | -2.99e-01 | 3.31e-06 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 11 | 8.56e-02 | 2.99e-01 | 2.46e-01 |
| GOBP CERAMIDE TRANSPORT | 13 | 6.17e-02 | -2.99e-01 | 2.00e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 7.27e-02 | -2.99e-01 | 2.23e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 22 | 1.53e-02 | -2.99e-01 | 7.71e-02 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 58 | 8.37e-05 | -2.99e-01 | 1.28e-03 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 10 | 1.02e-01 | -2.99e-01 | 2.76e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 38 | 1.45e-03 | -2.99e-01 | 1.34e-02 |
| GOBP VIRAL BUDDING VIA HOST ESCRT COMPLEX | 14 | 5.32e-02 | -2.98e-01 | 1.82e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 30 | 4.69e-03 | -2.98e-01 | 3.31e-02 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 52 | 2.01e-04 | -2.98e-01 | 2.62e-03 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 180 | 5.71e-12 | -2.98e-01 | 6.15e-10 |
| GOBP SYNAPSE MATURATION | 37 | 1.74e-03 | -2.98e-01 | 1.54e-02 |
| GOMF COMPLEMENT BINDING | 16 | 3.97e-02 | -2.97e-01 | 1.49e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 31 | 4.24e-03 | -2.97e-01 | 3.04e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 7.52e-02 | 2.97e-01 | 2.28e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 16 | 4.02e-02 | -2.96e-01 | 1.50e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 43 | 7.83e-04 | -2.96e-01 | 8.12e-03 |
| GOBP REGULATION OF CELL KILLING | 71 | 1.63e-05 | -2.96e-01 | 3.11e-04 |
| GOBP RESPONSE TO OXYGEN RADICAL | 22 | 1.63e-02 | -2.96e-01 | 8.08e-02 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 10 | 1.05e-01 | -2.96e-01 | 2.83e-01 |
| GOMF VINCULIN BINDING | 13 | 6.49e-02 | -2.96e-01 | 2.07e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 22 | 1.64e-02 | -2.96e-01 | 8.10e-02 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 104 | 1.96e-07 | -2.95e-01 | 6.84e-06 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 42 | 9.29e-04 | -2.95e-01 | 9.37e-03 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 172 | 2.54e-11 | -2.95e-01 | 2.25e-09 |
| GOBP REGULATION OF GTP BINDING | 10 | 1.06e-01 | -2.95e-01 | 2.86e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 10 | 1.07e-01 | -2.95e-01 | 2.86e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 11 | 9.10e-02 | 2.94e-01 | 2.56e-01 |
| GOMF 1 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 10 | 1.08e-01 | 2.94e-01 | 2.88e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 9.17e-02 | -2.94e-01 | 2.57e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 12 | 7.92e-02 | -2.93e-01 | 2.35e-01 |
| GOBP GROWTH HORMONE SECRETION | 13 | 6.77e-02 | 2.93e-01 | 2.13e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 35 | 2.74e-03 | -2.93e-01 | 2.19e-02 |
| GOBP GLYCINE METABOLIC PROCESS | 11 | 9.29e-02 | -2.93e-01 | 2.60e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 86 | 2.80e-06 | -2.92e-01 | 6.56e-05 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 11 | 9.36e-02 | 2.92e-01 | 2.61e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 20 | 2.38e-02 | -2.92e-01 | 1.06e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 5.86e-02 | -2.92e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 43 | 9.30e-04 | -2.92e-01 | 9.37e-03 |
| GOBP PHAGOCYTOSIS RECOGNITION | 18 | 3.21e-02 | -2.92e-01 | 1.30e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 10 | 1.10e-01 | -2.92e-01 | 2.91e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 73 | 1.64e-05 | -2.92e-01 | 3.11e-04 |
| GOMF DIPEPTIDASE ACTIVITY | 15 | 5.05e-02 | -2.92e-01 | 1.76e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 47 | 5.42e-04 | 2.92e-01 | 5.96e-03 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 38 | 1.91e-03 | -2.91e-01 | 1.65e-02 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 16 | 4.40e-02 | -2.91e-01 | 1.60e-01 |
| GOCC ACTIN FILAMENT | 118 | 4.94e-08 | -2.91e-01 | 2.07e-06 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 8.12e-02 | -2.91e-01 | 2.39e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 46 | 6.52e-04 | -2.91e-01 | 6.97e-03 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 9.57e-02 | -2.90e-01 | 2.65e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 21 | 2.14e-02 | -2.90e-01 | 9.77e-02 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 10 | 1.12e-01 | -2.90e-01 | 2.94e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 34 | 3.43e-03 | -2.90e-01 | 2.58e-02 |
| GOBP RENAL SODIUM ION ABSORPTION | 12 | 8.21e-02 | 2.90e-01 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 24 | 1.41e-02 | -2.90e-01 | 7.26e-02 |
| GOBP EPIBOLY | 26 | 1.06e-02 | -2.89e-01 | 5.99e-02 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 12 | 8.30e-02 | -2.89e-01 | 2.42e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 10 | 1.14e-01 | -2.89e-01 | 2.98e-01 |
| GOBP BASIC AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 9.73e-02 | 2.89e-01 | 2.68e-01 |
| GOBP CELL KILLING | 128 | 1.75e-08 | -2.89e-01 | 8.39e-07 |
| GOMF IMMUNOGLOBULIN BINDING | 12 | 8.36e-02 | -2.89e-01 | 2.43e-01 |
| GOBP DIOL METABOLIC PROCESS | 24 | 1.45e-02 | -2.88e-01 | 7.42e-02 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 10 | 1.15e-01 | -2.88e-01 | 2.99e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 52 | 3.30e-04 | -2.88e-01 | 3.92e-03 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 47 | 6.60e-04 | -2.87e-01 | 7.04e-03 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 22 | 1.97e-02 | -2.87e-01 | 9.23e-02 |
| GOBP CYTOKINETIC PROCESS | 43 | 1.13e-03 | -2.87e-01 | 1.09e-02 |
| GOCC PRC1 COMPLEX | 16 | 4.68e-02 | 2.87e-01 | 1.67e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 42 | 1.29e-03 | -2.87e-01 | 1.22e-02 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 16 | 4.69e-02 | -2.87e-01 | 1.67e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 35 | 3.31e-03 | -2.87e-01 | 2.52e-02 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 15 | 5.47e-02 | -2.87e-01 | 1.85e-01 |
| GOCC TOR COMPLEX | 12 | 8.59e-02 | -2.86e-01 | 2.47e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 12 | 8.59e-02 | -2.86e-01 | 2.47e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 13 | 7.39e-02 | -2.86e-01 | 2.26e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 11 | 1.01e-01 | 2.86e-01 | 2.74e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 20 | 2.69e-02 | 2.86e-01 | 1.15e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 15 | 5.55e-02 | 2.86e-01 | 1.87e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 28 | 8.92e-03 | -2.86e-01 | 5.25e-02 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 11 | 1.01e-01 | -2.85e-01 | 2.76e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 1.18e-01 | -2.85e-01 | 3.06e-01 |
| GOCC CLATHRIN VESICLE COAT | 29 | 7.98e-03 | -2.85e-01 | 4.87e-02 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 45 | 9.71e-04 | -2.84e-01 | 9.73e-03 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 54 | 3.04e-04 | -2.84e-01 | 3.67e-03 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 17 | 4.26e-02 | -2.84e-01 | 1.56e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 26 | 1.22e-02 | -2.84e-01 | 6.60e-02 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 10 | 1.20e-01 | 2.84e-01 | 3.09e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 40 | 1.93e-03 | -2.83e-01 | 1.66e-02 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 36 | 3.26e-03 | -2.83e-01 | 2.49e-02 |
| GOBP CELL CHEMOTAXIS | 225 | 2.64e-13 | -2.83e-01 | 4.06e-11 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 15 | 5.75e-02 | 2.83e-01 | 1.92e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 49 | 6.06e-04 | -2.83e-01 | 6.56e-03 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 115 | 1.61e-07 | -2.83e-01 | 5.85e-06 |
| GOCC AMPHISOME MEMBRANE | 10 | 1.22e-01 | -2.83e-01 | 3.11e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 10 | 1.22e-01 | 2.83e-01 | 3.11e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 15 | 5.82e-02 | -2.83e-01 | 1.93e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 26 | 1.28e-02 | -2.82e-01 | 6.84e-02 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 10 | 1.23e-01 | -2.82e-01 | 3.12e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 23 | 1.93e-02 | -2.82e-01 | 9.09e-02 |
| GOMF 5 NUCLEOTIDASE ACTIVITY | 10 | 1.23e-01 | 2.82e-01 | 3.13e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 51 | 5.19e-04 | -2.81e-01 | 5.75e-03 |
| GOBP VACUOLE FUSION | 11 | 1.07e-01 | -2.81e-01 | 2.86e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 26 | 1.33e-02 | -2.81e-01 | 6.97e-02 |
| GOMF ALKALI METAL ION BINDING | 15 | 5.99e-02 | -2.81e-01 | 1.97e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 45 | 1.14e-03 | -2.80e-01 | 1.10e-02 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 23 | 2.00e-02 | -2.80e-01 | 9.30e-02 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 20 | 3.00e-02 | -2.80e-01 | 1.24e-01 |
| GOBP CELLULAR EXTRAVASATION | 60 | 1.75e-04 | -2.80e-01 | 2.34e-03 |
| GOBP RESPONSE TO TYPE II INTERFERON | 103 | 9.08e-07 | -2.80e-01 | 2.50e-05 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 14 | 6.96e-02 | -2.80e-01 | 2.17e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 12 | 9.30e-02 | 2.80e-01 | 2.60e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 18 | 3.97e-02 | 2.80e-01 | 1.49e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 13 | 8.05e-02 | 2.80e-01 | 2.38e-01 |
| GOCC NEURONAL RIBONUCLEOPROTEIN GRANULE | 10 | 1.25e-01 | -2.80e-01 | 3.17e-01 |
| GOMF FOLIC ACID BINDING | 12 | 9.33e-02 | 2.80e-01 | 2.61e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 23 | 2.03e-02 | -2.80e-01 | 9.38e-02 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 37 | 3.25e-03 | -2.80e-01 | 2.48e-02 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 12 | 9.36e-02 | 2.80e-01 | 2.61e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 10 | 1.26e-01 | -2.80e-01 | 3.17e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 22 | 2.33e-02 | -2.79e-01 | 1.04e-01 |
| GOMF COLLAGEN BINDING | 60 | 1.85e-04 | -2.79e-01 | 2.44e-03 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 42 | 1.75e-03 | -2.79e-01 | 1.55e-02 |
| GOCC GOLGI MEDIAL CISTERNA | 21 | 2.69e-02 | -2.79e-01 | 1.15e-01 |
| GOBP RUFFLE ASSEMBLY | 39 | 2.58e-03 | -2.79e-01 | 2.09e-02 |
| GOBP REGULATION OF CHEMOTAXIS | 159 | 1.35e-09 | -2.79e-01 | 8.17e-08 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 37 | 3.38e-03 | -2.78e-01 | 2.56e-02 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 11 | 1.10e-01 | -2.78e-01 | 2.92e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 11 | 1.10e-01 | -2.78e-01 | 2.92e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 19 | 3.61e-02 | -2.78e-01 | 1.41e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 21 | 2.76e-02 | -2.78e-01 | 1.17e-01 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 10 | 1.28e-01 | 2.78e-01 | 3.21e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 18 | 4.14e-02 | 2.78e-01 | 1.53e-01 |
| GOMF TAU PROTEIN BINDING | 21 | 2.78e-02 | -2.77e-01 | 1.18e-01 |
| GOMF KINESIN BINDING | 44 | 1.46e-03 | -2.77e-01 | 1.34e-02 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 8.34e-02 | -2.77e-01 | 2.43e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 19 | 3.64e-02 | -2.77e-01 | 1.41e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 22 | 2.46e-02 | -2.77e-01 | 1.08e-01 |
| GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 8.39e-02 | -2.77e-01 | 2.43e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 87 | 8.16e-06 | -2.77e-01 | 1.69e-04 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 11 | 1.12e-01 | -2.77e-01 | 2.94e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 165 | 9.91e-10 | -2.76e-01 | 6.22e-08 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 28 | 1.15e-02 | -2.76e-01 | 6.32e-02 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 25 | 1.70e-02 | -2.76e-01 | 8.32e-02 |
| GOMF LONG CHAIN FATTY ACID BINDING | 14 | 7.43e-02 | -2.76e-01 | 2.26e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 12 | 9.84e-02 | -2.76e-01 | 2.70e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 16 | 5.66e-02 | -2.75e-01 | 1.89e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 19 | 3.78e-02 | -2.75e-01 | 1.44e-01 |
| GOBP RANDOM INACTIVATION OF X CHROMOSOME | 10 | 1.32e-01 | 2.75e-01 | 3.28e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 53 | 5.34e-04 | -2.75e-01 | 5.89e-03 |
| GOBP RUFFLE ORGANIZATION | 48 | 9.98e-04 | -2.75e-01 | 9.94e-03 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 12 | 9.96e-02 | -2.75e-01 | 2.72e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 23 | 2.28e-02 | -2.74e-01 | 1.03e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 11 | 1.16e-01 | -2.74e-01 | 3.01e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 12 | 1.01e-01 | 2.74e-01 | 2.74e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 44 | 1.69e-03 | -2.74e-01 | 1.52e-02 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 8.79e-02 | -2.73e-01 | 2.50e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 22 | 2.67e-02 | -2.73e-01 | 1.15e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 20 | 3.46e-02 | -2.73e-01 | 1.37e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 16 | 5.88e-02 | -2.73e-01 | 1.95e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 26 | 1.62e-02 | 2.73e-01 | 8.02e-02 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 24 | 2.08e-02 | -2.73e-01 | 9.58e-02 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 7.77e-02 | -2.72e-01 | 2.33e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 27 | 1.44e-02 | -2.72e-01 | 7.39e-02 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 12 | 1.03e-01 | -2.72e-01 | 2.78e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 14 | 7.81e-02 | -2.72e-01 | 2.34e-01 |
| GOCC 90S PRERIBOSOME | 25 | 1.88e-02 | -2.71e-01 | 8.95e-02 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 28 | 1.30e-02 | -2.71e-01 | 6.90e-02 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 14 | 7.95e-02 | 2.71e-01 | 2.36e-01 |
| GOCC FLEMMING BODY | 17 | 5.36e-02 | -2.70e-01 | 1.83e-01 |
| GOBP AXONAL FASCICULATION | 20 | 3.63e-02 | 2.70e-01 | 1.41e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 29 | 1.18e-02 | -2.70e-01 | 6.44e-02 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 13 | 9.17e-02 | -2.70e-01 | 2.57e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 12 | 1.05e-01 | -2.70e-01 | 2.83e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 12 | 1.05e-01 | -2.70e-01 | 2.83e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 15 | 7.02e-02 | -2.70e-01 | 2.18e-01 |
| GOCC CLEAVAGE FURROW | 32 | 8.21e-03 | -2.70e-01 | 4.96e-02 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 47 | 1.37e-03 | -2.70e-01 | 1.28e-02 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 65 | 1.69e-04 | -2.70e-01 | 2.29e-03 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 20 | 3.70e-02 | -2.69e-01 | 1.43e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 13 | 9.34e-02 | -2.69e-01 | 2.61e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 3.77e-02 | -2.68e-01 | 1.44e-01 |
| GOBP TOLERANCE INDUCTION | 17 | 5.54e-02 | -2.68e-01 | 1.87e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 36 | 5.39e-03 | -2.68e-01 | 3.64e-02 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 34 | 6.85e-03 | -2.68e-01 | 4.34e-02 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 10 | 1.42e-01 | 2.68e-01 | 3.44e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 10 | 1.42e-01 | -2.68e-01 | 3.44e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 4.92e-02 | -2.68e-01 | 1.73e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 2.33e-02 | -2.68e-01 | 1.04e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 31 | 9.97e-03 | -2.67e-01 | 5.70e-02 |
| GOBP GLYCOPHAGY | 12 | 1.09e-01 | -2.67e-01 | 2.89e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 60 | 3.48e-04 | -2.67e-01 | 4.09e-03 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 33 | 8.01e-03 | -2.67e-01 | 4.87e-02 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 53 | 7.84e-04 | -2.67e-01 | 8.12e-03 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 11 | 1.26e-01 | -2.67e-01 | 3.17e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 12 | 1.10e-01 | -2.67e-01 | 2.91e-01 |
| GOCC REPLISOME | 22 | 3.06e-02 | 2.66e-01 | 1.26e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 11 | 1.26e-01 | 2.66e-01 | 3.18e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 10 | 1.45e-01 | -2.66e-01 | 3.48e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 87 | 1.82e-05 | -2.66e-01 | 3.38e-04 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 14 | 8.49e-02 | -2.66e-01 | 2.45e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 148 | 2.50e-08 | -2.66e-01 | 1.13e-06 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 35 | 6.61e-03 | -2.65e-01 | 4.24e-02 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 10 | 1.47e-01 | 2.65e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 23 | 2.79e-02 | -2.65e-01 | 1.18e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 15 | 7.58e-02 | -2.65e-01 | 2.29e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 10 | 1.47e-01 | -2.65e-01 | 3.51e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 87 | 2.00e-05 | -2.65e-01 | 3.64e-04 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 62 | 3.14e-04 | -2.65e-01 | 3.76e-03 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 185 | 5.60e-10 | -2.65e-01 | 3.72e-08 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 69 | 1.45e-04 | -2.65e-01 | 2.00e-03 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 19 | 4.59e-02 | -2.65e-01 | 1.65e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 43 | 2.72e-03 | -2.64e-01 | 2.18e-02 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 22 | 3.20e-02 | -2.64e-01 | 1.30e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 12 | 1.13e-01 | -2.64e-01 | 2.96e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 29 | 1.39e-02 | -2.64e-01 | 7.21e-02 |
| GOBP NUCLEOSIDE CATABOLIC PROCESS | 16 | 6.77e-02 | -2.64e-01 | 2.13e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 25 | 2.26e-02 | -2.63e-01 | 1.02e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 27 | 1.78e-02 | -2.63e-01 | 8.59e-02 |
| GOBP REGULATION OF PINOCYTOSIS | 12 | 1.14e-01 | -2.63e-01 | 2.98e-01 |
| GOBP AGGREPHAGY | 15 | 7.75e-02 | -2.63e-01 | 2.33e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 11 | 1.31e-01 | -2.63e-01 | 3.25e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 8.81e-02 | -2.63e-01 | 2.50e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 42 | 3.18e-03 | -2.63e-01 | 2.44e-02 |
| GOCC PHAGOCYTIC VESICLE | 101 | 5.01e-06 | -2.63e-01 | 1.09e-04 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 41 | 3.58e-03 | -2.63e-01 | 2.67e-02 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 36 | 6.34e-03 | -2.63e-01 | 4.11e-02 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 15 | 7.83e-02 | -2.63e-01 | 2.34e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 14 | 8.91e-02 | -2.62e-01 | 2.52e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 15 | 7.86e-02 | -2.62e-01 | 2.34e-01 |
| GOCC AMPHISOME | 12 | 1.16e-01 | -2.62e-01 | 3.02e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 15 | 7.91e-02 | 2.62e-01 | 2.35e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 30 | 1.31e-02 | -2.62e-01 | 6.92e-02 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 1.33e-01 | -2.61e-01 | 3.29e-01 |
| GOBP FUCOSYLATION | 11 | 1.33e-01 | -2.61e-01 | 3.29e-01 |
| GOBP NEUTROPHIL MIGRATION | 80 | 5.41e-05 | -2.61e-01 | 8.67e-04 |
| GOBP ERYTHROCYTE MATURATION | 17 | 6.22e-02 | -2.61e-01 | 2.02e-01 |
| GOBP REGULATION OF COAGULATION | 50 | 1.40e-03 | -2.61e-01 | 1.30e-02 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 17 | 6.25e-02 | -2.61e-01 | 2.02e-01 |
| GOBP TRANSPORT OF VIRUS | 12 | 1.18e-01 | -2.61e-01 | 3.04e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 23 | 3.05e-02 | -2.61e-01 | 1.26e-01 |
| GOCC ATAC COMPLEX | 13 | 1.04e-01 | 2.61e-01 | 2.80e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 52 | 1.16e-03 | -2.60e-01 | 1.12e-02 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 16 | 7.14e-02 | -2.60e-01 | 2.20e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 27 | 1.93e-02 | 2.60e-01 | 9.08e-02 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 20 | 4.39e-02 | -2.60e-01 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 25 | 2.43e-02 | -2.60e-01 | 1.08e-01 |
| GOMF MONOSACCHARIDE BINDING | 68 | 2.09e-04 | -2.60e-01 | 2.67e-03 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 26 | 2.17e-02 | -2.60e-01 | 9.89e-02 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 28 | 1.74e-02 | -2.60e-01 | 8.47e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 34 | 8.83e-03 | -2.60e-01 | 5.21e-02 |
| GOBP RESPONSE TO ISCHEMIA | 42 | 3.64e-03 | -2.59e-01 | 2.70e-02 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 56 | 7.92e-04 | -2.59e-01 | 8.15e-03 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 1.56e-01 | -2.59e-01 | 3.65e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 12 | 1.21e-01 | -2.59e-01 | 3.10e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 30 | 1.42e-02 | -2.59e-01 | 7.32e-02 |
| GOCC NSL COMPLEX | 11 | 1.38e-01 | 2.59e-01 | 3.37e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 23 | 3.19e-02 | -2.59e-01 | 1.30e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 48 | 1.97e-03 | -2.58e-01 | 1.68e-02 |
| GOBP LEUKOCYTE MIGRATION | 279 | 1.29e-13 | -2.58e-01 | 2.08e-11 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 16 | 7.40e-02 | -2.58e-01 | 2.26e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 15 | 8.40e-02 | -2.58e-01 | 2.44e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 10 | 1.59e-01 | -2.58e-01 | 3.68e-01 |
| GOBP NADH METABOLIC PROCESS | 37 | 6.74e-03 | -2.57e-01 | 4.30e-02 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 11 | 1.40e-01 | -2.57e-01 | 3.40e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 12 | 1.23e-01 | -2.57e-01 | 3.13e-01 |
| GOBP CHEMOKINE PRODUCTION | 84 | 4.84e-05 | -2.57e-01 | 7.94e-04 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 232 | 1.94e-11 | -2.56e-01 | 1.80e-09 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 25 | 2.71e-02 | -2.55e-01 | 1.16e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 25 | 2.72e-02 | -2.55e-01 | 1.16e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 89 | 3.20e-05 | -2.55e-01 | 5.46e-04 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 87 | 3.93e-05 | -2.55e-01 | 6.60e-04 |
| GOMF MANNOSIDASE ACTIVITY | 14 | 9.88e-02 | -2.55e-01 | 2.71e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 15 | 8.76e-02 | -2.55e-01 | 2.50e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 10 | 1.63e-01 | 2.55e-01 | 3.75e-01 |
| GOBP GLYCEROL METABOLIC PROCESS | 16 | 7.77e-02 | -2.55e-01 | 2.33e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 1.44e-01 | 2.55e-01 | 3.46e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 12 | 1.27e-01 | -2.54e-01 | 3.20e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 21 | 4.39e-02 | -2.54e-01 | 1.60e-01 |
| GOBP PERISTALSIS | 11 | 1.45e-01 | 2.54e-01 | 3.48e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 19 | 5.54e-02 | -2.54e-01 | 1.87e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 18 | 6.25e-02 | -2.54e-01 | 2.02e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 19 | 5.57e-02 | 2.54e-01 | 1.87e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 37 | 7.63e-03 | -2.54e-01 | 4.74e-02 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 10 | 1.65e-01 | -2.53e-01 | 3.78e-01 |
| GOBP SPINDLE LOCALIZATION | 49 | 2.15e-03 | -2.53e-01 | 1.82e-02 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 26 | 2.54e-02 | -2.53e-01 | 1.11e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 24 | 3.18e-02 | -2.53e-01 | 1.29e-01 |
| GOMF SIRNA BINDING | 10 | 1.66e-01 | 2.53e-01 | 3.78e-01 |
| GOCC KERATIN FILAMENT | 10 | 1.66e-01 | -2.53e-01 | 3.78e-01 |
| GOBP PROSTATE GLAND GROWTH | 10 | 1.66e-01 | 2.53e-01 | 3.78e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 15 | 8.98e-02 | -2.53e-01 | 2.53e-01 |
| GOCC ESC E Z COMPLEX | 14 | 1.01e-01 | 2.53e-01 | 2.75e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 25 | 2.87e-02 | -2.53e-01 | 1.21e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 24 | 3.21e-02 | -2.53e-01 | 1.30e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 36 | 8.70e-03 | -2.53e-01 | 5.16e-02 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 14 | 1.02e-01 | -2.53e-01 | 2.76e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 28 | 2.07e-02 | 2.53e-01 | 9.53e-02 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 11 | 1.47e-01 | 2.53e-01 | 3.51e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 36 | 8.77e-03 | -2.52e-01 | 5.18e-02 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 22 | 4.05e-02 | -2.52e-01 | 1.51e-01 |
| GOMF CHEMOKINE BINDING | 20 | 5.08e-02 | -2.52e-01 | 1.76e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 18 | 6.40e-02 | -2.52e-01 | 2.06e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 26 | 2.61e-02 | -2.52e-01 | 1.13e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 84 | 6.58e-05 | -2.52e-01 | 1.02e-03 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 48 | 2.54e-03 | -2.52e-01 | 2.07e-02 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 33 | 1.23e-02 | -2.52e-01 | 6.64e-02 |
| GOBP AUTOPHAGOSOME MATURATION | 56 | 1.12e-03 | -2.52e-01 | 1.09e-02 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 11 | 1.48e-01 | -2.52e-01 | 3.53e-01 |
| GOMF DEATH RECEPTOR BINDING | 15 | 9.14e-02 | -2.52e-01 | 2.57e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 19 | 5.75e-02 | -2.52e-01 | 1.92e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 39 | 6.57e-03 | -2.52e-01 | 4.22e-02 |
| GOMF LAMIN BINDING | 16 | 8.17e-02 | -2.51e-01 | 2.39e-01 |
| GOBP MITOTIC RECOMBINATION | 22 | 4.15e-02 | 2.51e-01 | 1.53e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 20 | 5.19e-02 | -2.51e-01 | 1.79e-01 |
| GOBP VASCULAR TRANSPORT | 17 | 7.31e-02 | -2.51e-01 | 2.24e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 26 | 2.67e-02 | -2.51e-01 | 1.15e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 14 | 1.04e-01 | -2.51e-01 | 2.80e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 31 | 1.57e-02 | -2.51e-01 | 7.85e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 33 | 1.28e-02 | -2.51e-01 | 6.82e-02 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 16 | 8.27e-02 | -2.51e-01 | 2.41e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 31 | 1.58e-02 | -2.50e-01 | 7.91e-02 |
| GOBP T CELL MEDIATED IMMUNITY | 88 | 4.96e-05 | -2.50e-01 | 8.10e-04 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 46 | 3.35e-03 | -2.50e-01 | 2.55e-02 |
| GOBP T CELL MIGRATION | 48 | 2.73e-03 | -2.50e-01 | 2.19e-02 |
| GOMF DNA REPLICATION ORIGIN BINDING | 14 | 1.05e-01 | 2.50e-01 | 2.83e-01 |
| GOMF UNMETHYLATED CPG BINDING | 10 | 1.72e-01 | 2.50e-01 | 3.87e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 30 | 1.80e-02 | -2.50e-01 | 8.62e-02 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 12 | 1.34e-01 | -2.50e-01 | 3.31e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 22 | 4.27e-02 | -2.50e-01 | 1.56e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 1.72e-01 | -2.49e-01 | 3.87e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 19 | 5.99e-02 | -2.49e-01 | 1.97e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 26 | 2.78e-02 | -2.49e-01 | 1.18e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 34 | 1.19e-02 | -2.49e-01 | 6.46e-02 |
| GOBP HAIR FOLLICLE MATURATION | 18 | 6.74e-02 | -2.49e-01 | 2.12e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 24 | 3.48e-02 | -2.49e-01 | 1.37e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 28 | 2.27e-02 | -2.49e-01 | 1.02e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 13 | 1.21e-01 | 2.49e-01 | 3.09e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 16 | 8.53e-02 | 2.48e-01 | 2.46e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 33 | 1.35e-02 | -2.48e-01 | 7.07e-02 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 99 | 1.97e-05 | -2.48e-01 | 3.62e-04 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 134 | 7.08e-07 | -2.48e-01 | 2.04e-05 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 19 | 6.10e-02 | -2.48e-01 | 2.00e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 20 | 5.46e-02 | 2.48e-01 | 1.85e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 45 | 3.98e-03 | -2.48e-01 | 2.90e-02 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 14 | 1.08e-01 | 2.48e-01 | 2.88e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 112 | 5.82e-06 | 2.48e-01 | 1.25e-04 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.54e-01 | -2.48e-01 | 3.62e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 10 | 1.74e-01 | -2.48e-01 | 3.90e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 235 | 6.24e-11 | -2.48e-01 | 4.92e-09 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 33 | 1.37e-02 | -2.48e-01 | 7.15e-02 |
| GOBP TAXIS | 314 | 4.85e-14 | -2.48e-01 | 9.50e-12 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 35 | 1.12e-02 | -2.48e-01 | 6.17e-02 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 90 | 4.90e-05 | -2.48e-01 | 8.02e-04 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 53 | 1.82e-03 | -2.48e-01 | 1.60e-02 |
| GOBP DETOXIFICATION | 58 | 1.11e-03 | -2.48e-01 | 1.08e-02 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 55 | 1.49e-03 | -2.48e-01 | 1.36e-02 |
| GOBP LYMPH VESSEL DEVELOPMENT | 31 | 1.71e-02 | -2.48e-01 | 8.33e-02 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 12 | 1.38e-01 | 2.47e-01 | 3.37e-01 |
| GOMF CYTOKINE BINDING | 96 | 2.86e-05 | -2.47e-01 | 4.95e-04 |
| GOBP SLEEP | 19 | 6.21e-02 | -2.47e-01 | 2.01e-01 |
| GOBP SUCKLING BEHAVIOR | 12 | 1.38e-01 | -2.47e-01 | 3.37e-01 |
| GOCC CORTICAL CYTOSKELETON | 103 | 1.49e-05 | -2.47e-01 | 2.89e-04 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 18 | 7.00e-02 | -2.47e-01 | 2.17e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 1.57e-01 | 2.47e-01 | 3.65e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 18 | 7.00e-02 | 2.47e-01 | 2.17e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 10 | 1.77e-01 | 2.47e-01 | 3.94e-01 |
| GOBP RETINOIC ACID BIOSYNTHETIC PROCESS | 10 | 1.77e-01 | -2.47e-01 | 3.94e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 17 | 7.85e-02 | -2.47e-01 | 2.34e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 43 | 5.17e-03 | -2.47e-01 | 3.55e-02 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 14 | 1.10e-01 | -2.46e-01 | 2.92e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 11 | 1.57e-01 | -2.46e-01 | 3.66e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 42 | 5.75e-03 | -2.46e-01 | 3.80e-02 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 44 | 4.71e-03 | -2.46e-01 | 3.31e-02 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 23 | 4.09e-02 | -2.46e-01 | 1.52e-01 |
| GOBP COPII COATED VESICLE BUDDING | 36 | 1.06e-02 | -2.46e-01 | 5.97e-02 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 45 | 4.28e-03 | -2.46e-01 | 3.07e-02 |
| GOBP DETECTION OF VISIBLE LIGHT | 12 | 1.40e-01 | -2.46e-01 | 3.40e-01 |
| GOBP SYMBIONT ENTRY INTO HOST | 70 | 3.80e-04 | -2.46e-01 | 4.40e-03 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 22 | 4.61e-02 | -2.46e-01 | 1.65e-01 |
| GOCC CLATHRIN COAT OF TRANS GOLGI NETWORK VESICLE | 11 | 1.58e-01 | -2.46e-01 | 3.68e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 43 | 5.33e-03 | -2.46e-01 | 3.62e-02 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 20 | 5.73e-02 | -2.46e-01 | 1.91e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 5.14e-02 | -2.46e-01 | 1.78e-01 |
| GOCC CIS GOLGI NETWORK | 51 | 2.45e-03 | -2.45e-01 | 2.01e-02 |
| GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 14 | 1.12e-01 | 2.45e-01 | 2.94e-01 |
| GOCC BRUSH BORDER | 109 | 9.86e-06 | -2.45e-01 | 1.99e-04 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 17 | 8.05e-02 | -2.45e-01 | 2.38e-01 |
| GOBP RETINAL METABOLIC PROCESS | 11 | 1.60e-01 | -2.45e-01 | 3.70e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 32 | 1.66e-02 | -2.45e-01 | 8.19e-02 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 16 | 9.03e-02 | -2.45e-01 | 2.54e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 133 | 1.16e-06 | -2.44e-01 | 3.10e-05 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 10 | 1.81e-01 | -2.44e-01 | 4.00e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 17 | 8.12e-02 | -2.44e-01 | 2.39e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 15 | 1.02e-01 | -2.44e-01 | 2.76e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 31 | 1.87e-02 | -2.44e-01 | 8.90e-02 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 16 | 9.12e-02 | -2.44e-01 | 2.56e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 15 | 1.02e-01 | -2.44e-01 | 2.76e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 199 | 3.15e-09 | -2.44e-01 | 1.73e-07 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 25 | 3.48e-02 | -2.44e-01 | 1.37e-01 |
| GOCC PEPTIDASE COMPLEX | 107 | 1.33e-05 | -2.44e-01 | 2.60e-04 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 19 | 6.59e-02 | 2.44e-01 | 2.09e-01 |
| GOBP BLEB ASSEMBLY | 13 | 1.29e-01 | -2.43e-01 | 3.22e-01 |
| GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY | 10 | 1.83e-01 | -2.43e-01 | 4.02e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 272 | 5.64e-12 | -2.43e-01 | 6.15e-10 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 10 | 1.83e-01 | 2.43e-01 | 4.02e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 27 | 2.88e-02 | -2.43e-01 | 1.21e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 95 | 4.32e-05 | 2.43e-01 | 7.18e-04 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 2.89e-02 | -2.43e-01 | 1.21e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 1.83e-01 | 2.43e-01 | 4.02e-01 |
| GOBP SNRNA METABOLIC PROCESS | 46 | 4.41e-03 | 2.43e-01 | 3.15e-02 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 30 | 2.15e-02 | 2.43e-01 | 9.80e-02 |
| GOBP CELLULAR RESPONSE TO VIRUS | 37 | 1.08e-02 | -2.42e-01 | 6.02e-02 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 139 | 8.37e-07 | -2.42e-01 | 2.33e-05 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 10 | 1.85e-01 | 2.42e-01 | 4.04e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 18 | 7.53e-02 | -2.42e-01 | 2.28e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 56 | 1.73e-03 | -2.42e-01 | 1.54e-02 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 3.62e-02 | -2.42e-01 | 1.41e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 14 | 1.17e-01 | 2.42e-01 | 3.04e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 16 | 9.40e-02 | 2.42e-01 | 2.62e-01 |
| GOBP HYPERSENSITIVITY | 11 | 1.65e-01 | -2.42e-01 | 3.78e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 1.65e-01 | -2.42e-01 | 3.78e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 27 | 2.97e-02 | -2.42e-01 | 1.23e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 25 | 3.65e-02 | -2.42e-01 | 1.42e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 17 | 8.46e-02 | -2.42e-01 | 2.44e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 47 | 4.18e-03 | -2.42e-01 | 3.01e-02 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 53 | 2.36e-03 | -2.42e-01 | 1.96e-02 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 14 | 1.18e-01 | -2.42e-01 | 3.04e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 40 | 8.25e-03 | -2.41e-01 | 4.96e-02 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 11 | 1.66e-01 | -2.41e-01 | 3.78e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 17 | 8.50e-02 | -2.41e-01 | 2.45e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 78 | 2.33e-04 | -2.41e-01 | 2.92e-03 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 12 | 1.48e-01 | -2.41e-01 | 3.53e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 22 | 5.03e-02 | -2.41e-01 | 1.75e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 22 | 5.03e-02 | -2.41e-01 | 1.75e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 34 | 1.50e-02 | -2.41e-01 | 7.63e-02 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 11 | 1.67e-01 | -2.41e-01 | 3.79e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 13 | 1.33e-01 | -2.41e-01 | 3.29e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 158 | 1.86e-07 | -2.41e-01 | 6.56e-06 |
| GOMF INTEGRIN BINDING | 126 | 3.22e-06 | -2.40e-01 | 7.40e-05 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 24 | 4.15e-02 | 2.40e-01 | 1.54e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 12 | 1.50e-01 | -2.40e-01 | 3.55e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 72 | 4.33e-04 | -2.40e-01 | 4.90e-03 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 1.89e-01 | -2.40e-01 | 4.09e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 36 | 1.28e-02 | -2.40e-01 | 6.82e-02 |
| GOBP NEUTROPHIL DEGRANULATION | 11 | 1.68e-01 | -2.40e-01 | 3.82e-01 |
| GOBP LACTATE METABOLIC PROCESS | 19 | 7.04e-02 | -2.40e-01 | 2.18e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 17 | 8.71e-02 | -2.40e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 22 | 5.18e-02 | -2.40e-01 | 1.79e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 32 | 1.90e-02 | -2.40e-01 | 9.02e-02 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 11 | 1.69e-01 | 2.39e-01 | 3.83e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 54 | 2.35e-03 | -2.39e-01 | 1.96e-02 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 29 | 2.58e-02 | -2.39e-01 | 1.12e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 95 | 5.64e-05 | -2.39e-01 | 8.93e-04 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 26 | 3.48e-02 | -2.39e-01 | 1.37e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 16 | 9.79e-02 | 2.39e-01 | 2.69e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 13 | 1.36e-01 | -2.39e-01 | 3.34e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 11 | 1.70e-01 | -2.39e-01 | 3.84e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 16 | 9.81e-02 | -2.39e-01 | 2.69e-01 |
| GOBP PHAGOCYTOSIS | 177 | 4.37e-08 | -2.39e-01 | 1.86e-06 |
| GOBP HEART FIELD SPECIFICATION | 12 | 1.52e-01 | 2.39e-01 | 3.59e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 39 | 9.92e-03 | -2.39e-01 | 5.68e-02 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 14 | 1.22e-01 | 2.39e-01 | 3.12e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 18 | 7.98e-02 | 2.39e-01 | 2.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 27 | 3.22e-02 | -2.38e-01 | 1.30e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 13 | 1.37e-01 | -2.38e-01 | 3.36e-01 |
| GOBP ADULT WALKING BEHAVIOR | 38 | 1.11e-02 | 2.38e-01 | 6.15e-02 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 17 | 8.93e-02 | -2.38e-01 | 2.52e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 15 | 1.11e-01 | -2.38e-01 | 2.92e-01 |
| GOBP LYMPHOCYTE MIGRATION | 68 | 7.02e-04 | -2.38e-01 | 7.42e-03 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 11 | 1.73e-01 | -2.37e-01 | 3.88e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 51 | 3.39e-03 | -2.37e-01 | 2.56e-02 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 57 | 1.96e-03 | -2.37e-01 | 1.68e-02 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 15 | 1.12e-01 | -2.37e-01 | 2.94e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 42 | 7.88e-03 | -2.37e-01 | 4.85e-02 |
| GOBP RESPONSE TO COPPER ION | 17 | 9.11e-02 | -2.37e-01 | 2.56e-01 |
| GOCC PORE COMPLEX | 20 | 6.69e-02 | -2.37e-01 | 2.11e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 13 | 1.40e-01 | 2.36e-01 | 3.40e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 45 | 6.12e-03 | -2.36e-01 | 4.01e-02 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 11 | 1.75e-01 | 2.36e-01 | 3.91e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 24 | 4.55e-02 | 2.36e-01 | 1.64e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 21 | 6.13e-02 | -2.36e-01 | 2.00e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 112 | 1.65e-05 | -2.36e-01 | 3.12e-04 |
| GOCC FILOPODIUM | 80 | 2.69e-04 | -2.36e-01 | 3.32e-03 |
| GOBP AUDITORY RECEPTOR CELL STEREOCILIUM ORGANIZATION | 13 | 1.41e-01 | 2.36e-01 | 3.42e-01 |
| GOCC RUFFLE | 141 | 1.40e-06 | -2.36e-01 | 3.62e-05 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 22 | 5.59e-02 | -2.35e-01 | 1.88e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 36 | 1.46e-02 | -2.35e-01 | 7.48e-02 |
| GOBP TONGUE MORPHOGENESIS | 10 | 1.98e-01 | 2.35e-01 | 4.21e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 20 | 6.88e-02 | -2.35e-01 | 2.15e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 61 | 1.51e-03 | -2.35e-01 | 1.38e-02 |
| GOBP COLLAGEN CATABOLIC PROCESS | 25 | 4.21e-02 | -2.35e-01 | 1.55e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 22 | 5.66e-02 | -2.35e-01 | 1.89e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 14 | 1.28e-01 | -2.35e-01 | 3.21e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 103 | 3.99e-05 | -2.34e-01 | 6.68e-04 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 31 | 2.39e-02 | -2.34e-01 | 1.07e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 16 | 1.05e-01 | -2.34e-01 | 2.82e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 299 | 3.84e-12 | -2.34e-01 | 4.36e-10 |
| GOCC PRONUCLEUS | 19 | 7.76e-02 | 2.34e-01 | 2.33e-01 |
| GOMF PEPTIDE BINDING | 169 | 1.65e-07 | -2.34e-01 | 5.91e-06 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE PROCESS | 18 | 8.61e-02 | -2.34e-01 | 2.47e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 55 | 2.76e-03 | -2.33e-01 | 2.20e-02 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 19 | 7.84e-02 | -2.33e-01 | 2.34e-01 |
| GOBP SPHINGOID BIOSYNTHETIC PROCESS | 10 | 2.01e-01 | -2.33e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 114 | 1.73e-05 | -2.33e-01 | 3.24e-04 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 32 | 2.26e-02 | -2.33e-01 | 1.02e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 31 | 2.51e-02 | -2.33e-01 | 1.10e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 15 | 1.19e-01 | -2.32e-01 | 3.07e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 17 | 9.73e-02 | -2.32e-01 | 2.68e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 10 | 2.03e-01 | -2.32e-01 | 4.27e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 15 | 1.20e-01 | 2.32e-01 | 3.08e-01 |
| GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY | 16 | 1.08e-01 | 2.32e-01 | 2.89e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 13 | 1.48e-01 | -2.32e-01 | 3.53e-01 |
| GOBP MACROPHAGE ACTIVATION | 84 | 2.45e-04 | -2.32e-01 | 3.06e-03 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 18 | 8.89e-02 | -2.32e-01 | 2.52e-01 |
| GOMF SPHINGOLIPID BINDING | 23 | 5.46e-02 | -2.32e-01 | 1.85e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 37 | 1.49e-02 | -2.31e-01 | 7.60e-02 |
| GOBP THYMIC T CELL SELECTION | 18 | 8.94e-02 | -2.31e-01 | 2.53e-01 |
| GOCC INTERMEDIATE FILAMENT | 49 | 5.12e-03 | -2.31e-01 | 3.52e-02 |
| GOCC EXTRACELLULAR ORGANELLE | 89 | 1.65e-04 | -2.31e-01 | 2.25e-03 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 22 | 6.07e-02 | -2.31e-01 | 1.99e-01 |
| GOCC PRESPLICEOSOME | 16 | 1.10e-01 | 2.31e-01 | 2.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 10 | 2.06e-01 | -2.31e-01 | 4.31e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 21 | 6.71e-02 | -2.31e-01 | 2.12e-01 |
| GOBP ENDODERM FORMATION | 30 | 2.87e-02 | -2.31e-01 | 1.21e-01 |
| GOMF MISMATCHED DNA BINDING | 10 | 2.06e-01 | -2.31e-01 | 4.31e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 54 | 3.38e-03 | -2.31e-01 | 2.56e-02 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 32 | 2.40e-02 | -2.31e-01 | 1.07e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 15 | 1.22e-01 | 2.31e-01 | 3.12e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 21 | 6.77e-02 | -2.30e-01 | 2.13e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 10 | 2.08e-01 | -2.30e-01 | 4.33e-01 |
| GOMF ADP BINDING | 36 | 1.70e-02 | -2.30e-01 | 8.33e-02 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 39 | 1.31e-02 | -2.30e-01 | 6.92e-02 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 188 | 6.06e-08 | -2.29e-01 | 2.47e-06 |
| GOMF FIBRONECTIN BINDING | 31 | 2.72e-02 | -2.29e-01 | 1.16e-01 |
| GOBP ASTROCYTE ACTIVATION | 18 | 9.24e-02 | -2.29e-01 | 2.59e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 22 | 6.30e-02 | -2.29e-01 | 2.03e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 19 | 8.41e-02 | -2.29e-01 | 2.44e-01 |
| GOBP REGULATION OF WOUND HEALING | 94 | 1.29e-04 | -2.29e-01 | 1.84e-03 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 21 | 6.98e-02 | -2.29e-01 | 2.17e-01 |
| GOBP REGULATION OF CELL SHAPE | 126 | 9.63e-06 | -2.29e-01 | 1.95e-04 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 13 | 1.54e-01 | -2.28e-01 | 3.62e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 31 | 2.79e-02 | -2.28e-01 | 1.18e-01 |
| GOMF CYCLASE ACTIVITY | 15 | 1.26e-01 | -2.28e-01 | 3.17e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 104 | 5.91e-05 | -2.28e-01 | 9.35e-04 |
| GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 10 | 2.12e-01 | 2.28e-01 | 4.38e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 11 | 1.90e-01 | 2.28e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 22 | 6.42e-02 | -2.28e-01 | 2.06e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 23 | 5.85e-02 | -2.28e-01 | 1.94e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 51 | 4.88e-03 | -2.28e-01 | 3.39e-02 |
| GOBP SPHINGOID METABOLIC PROCESS | 16 | 1.15e-01 | -2.28e-01 | 2.99e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 12 | 1.72e-01 | -2.28e-01 | 3.87e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 23 | 5.87e-02 | -2.28e-01 | 1.94e-01 |
| GOCC PHAGOCYTIC CUP | 21 | 7.09e-02 | -2.28e-01 | 2.19e-01 |
| GOBP RIBOSOME DISASSEMBLY | 29 | 3.39e-02 | -2.28e-01 | 1.35e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 27 | 4.08e-02 | -2.27e-01 | 1.52e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 76 | 6.12e-04 | -2.27e-01 | 6.62e-03 |
| GOBP PLASMA MEMBRANE TUBULATION | 18 | 9.50e-02 | -2.27e-01 | 2.63e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 14 | 1.41e-01 | -2.27e-01 | 3.42e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 31 | 2.90e-02 | -2.27e-01 | 1.21e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 11 | 1.93e-01 | -2.27e-01 | 4.15e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 46 | 7.89e-03 | -2.27e-01 | 4.85e-02 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 122 | 1.58e-05 | -2.26e-01 | 3.04e-04 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 10 | 2.15e-01 | -2.26e-01 | 4.42e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 23 | 6.01e-02 | -2.26e-01 | 1.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 27 | 4.18e-02 | -2.26e-01 | 1.54e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 19 | 8.78e-02 | -2.26e-01 | 2.50e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 22 | 6.64e-02 | -2.26e-01 | 2.10e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 12 | 1.75e-01 | -2.26e-01 | 3.91e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 163 | 6.73e-07 | -2.26e-01 | 1.96e-05 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 26 | 4.64e-02 | -2.26e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 31 | 2.97e-02 | -2.26e-01 | 1.23e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 1.07e-01 | -2.26e-01 | 2.87e-01 |
| GOCC MICROTUBULE PLUS END | 23 | 6.11e-02 | -2.26e-01 | 2.00e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 48 | 6.85e-03 | -2.26e-01 | 4.34e-02 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 49 | 6.31e-03 | -2.26e-01 | 4.09e-02 |
| GOCC RSC TYPE COMPLEX | 14 | 1.44e-01 | -2.26e-01 | 3.46e-01 |
| GOMF SPECTRIN BINDING | 27 | 4.25e-02 | -2.26e-01 | 1.56e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 11 | 1.96e-01 | -2.25e-01 | 4.18e-01 |
| GOCC MULTIVESICULAR BODY | 38 | 1.63e-02 | -2.25e-01 | 8.08e-02 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 36 | 1.94e-02 | -2.25e-01 | 9.14e-02 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 17 | 1.08e-01 | -2.25e-01 | 2.88e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 59 | 2.82e-03 | -2.25e-01 | 2.23e-02 |
| GOBP INNATE IMMUNE RESPONSE | 641 | 4.17e-22 | -2.25e-01 | 5.39e-19 |
| GOBP LEUKOCYTE HOMEOSTASIS | 111 | 4.35e-05 | -2.25e-01 | 7.21e-04 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 19 | 8.99e-02 | -2.25e-01 | 2.54e-01 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 11 | 1.97e-01 | 2.25e-01 | 4.19e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 21 | 7.48e-02 | -2.25e-01 | 2.27e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 28 | 3.97e-02 | 2.25e-01 | 1.49e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 55 | 3.99e-03 | -2.25e-01 | 2.90e-02 |
| GOMF R SMAD BINDING | 24 | 5.72e-02 | -2.24e-01 | 1.91e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 20 | 8.27e-02 | -2.24e-01 | 2.41e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 390 | 3.64e-14 | -2.24e-01 | 7.84e-12 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 13 | 1.62e-01 | -2.24e-01 | 3.74e-01 |
| GOCC EUCHROMATIN | 57 | 3.45e-03 | 2.24e-01 | 2.60e-02 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 21 | 7.56e-02 | 2.24e-01 | 2.29e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 1.21e-01 | -2.24e-01 | 3.10e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 154 | 1.67e-06 | -2.24e-01 | 4.18e-05 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 85 | 3.63e-04 | -2.24e-01 | 4.25e-03 |
| GOCC CELL SUBSTRATE JUNCTION | 169 | 5.48e-07 | -2.24e-01 | 1.66e-05 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 11 | 1.99e-01 | -2.24e-01 | 4.22e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 810 | 6.83e-27 | -2.23e-01 | 1.47e-23 |
| GOCC VESICLE COAT | 56 | 3.86e-03 | -2.23e-01 | 2.82e-02 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 72 | 1.06e-03 | -2.23e-01 | 1.04e-02 |
| GOBP SEGMENT SPECIFICATION | 16 | 1.22e-01 | 2.23e-01 | 3.12e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 169 | 5.96e-07 | -2.23e-01 | 1.78e-05 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 38 | 1.75e-02 | 2.23e-01 | 8.49e-02 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 23 | 6.44e-02 | -2.23e-01 | 2.06e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 10 | 2.23e-01 | 2.23e-01 | 4.50e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 67 | 1.66e-03 | -2.22e-01 | 1.49e-02 |
| GOBP NEUTROPHIL CHEMOTAXIS | 62 | 2.49e-03 | -2.22e-01 | 2.04e-02 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 2.97e-02 | -2.22e-01 | 1.23e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 60 | 2.97e-03 | -2.22e-01 | 2.33e-02 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 43 | 1.19e-02 | -2.22e-01 | 6.46e-02 |
| GOCC SPINDLE MIDZONE | 36 | 2.14e-02 | -2.22e-01 | 9.77e-02 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 50 | 6.72e-03 | -2.22e-01 | 4.30e-02 |
| GOMF MANNOSE BINDING | 19 | 9.45e-02 | -2.22e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 25 | 5.53e-02 | -2.22e-01 | 1.87e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 95 | 1.93e-04 | -2.21e-01 | 2.53e-03 |
| GOBP BLASTODERM SEGMENTATION | 21 | 7.90e-02 | 2.21e-01 | 2.35e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 10 | 2.26e-01 | 2.21e-01 | 4.53e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 42 | 1.32e-02 | -2.21e-01 | 6.94e-02 |
| GOCC NPBAF COMPLEX | 14 | 1.52e-01 | -2.21e-01 | 3.59e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 13 | 1.68e-01 | -2.21e-01 | 3.81e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 19 | 9.57e-02 | -2.21e-01 | 2.65e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 12 | 1.86e-01 | -2.21e-01 | 4.05e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF CELL POLARITY | 17 | 1.15e-01 | -2.21e-01 | 3.01e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 14 | 1.53e-01 | -2.20e-01 | 3.61e-01 |
| GOCC BASEMENT MEMBRANE | 96 | 1.92e-04 | -2.20e-01 | 2.51e-03 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 11 | 2.06e-01 | -2.20e-01 | 4.31e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 25 | 5.65e-02 | 2.20e-01 | 1.89e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 33 | 2.85e-02 | -2.20e-01 | 1.20e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 12 | 1.86e-01 | -2.20e-01 | 4.05e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 11 | 2.06e-01 | -2.20e-01 | 4.31e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 243 | 3.62e-09 | -2.20e-01 | 1.94e-07 |
| GOBP DECIDUALIZATION | 21 | 8.08e-02 | -2.20e-01 | 2.38e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 11 | 2.06e-01 | -2.20e-01 | 4.31e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 21 | 8.09e-02 | -2.20e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 3.40e-02 | -2.20e-01 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 41 | 1.48e-02 | -2.20e-01 | 7.58e-02 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 36 | 2.26e-02 | -2.20e-01 | 1.02e-01 |
| GOCC VESICLE TETHERING COMPLEX | 63 | 2.58e-03 | -2.20e-01 | 2.10e-02 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 13 | 1.71e-01 | 2.20e-01 | 3.85e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 16 | 1.29e-01 | -2.20e-01 | 3.21e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 14 | 1.55e-01 | -2.19e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 39 | 1.78e-02 | -2.19e-01 | 8.58e-02 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 157 | 2.16e-06 | -2.19e-01 | 5.22e-05 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 17 | 1.17e-01 | -2.19e-01 | 3.04e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 13 | 1.71e-01 | -2.19e-01 | 3.86e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 134 | 1.20e-05 | -2.19e-01 | 2.37e-04 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 30 | 3.79e-02 | -2.19e-01 | 1.44e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 43 | 1.31e-02 | -2.19e-01 | 6.91e-02 |
| GOBP MACROPHAGE MIGRATION | 51 | 6.88e-03 | -2.19e-01 | 4.35e-02 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 31 | 3.51e-02 | -2.19e-01 | 1.38e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 170 | 8.98e-07 | -2.19e-01 | 2.48e-05 |
| GOMF ACETYLATION DEPENDENT PROTEIN BINDING | 25 | 5.84e-02 | 2.19e-01 | 1.94e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 14 | 1.57e-01 | -2.19e-01 | 3.66e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 13 | 1.73e-01 | 2.18e-01 | 3.88e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 59 | 3.72e-03 | -2.18e-01 | 2.74e-02 |
| GOBP AORTA MORPHOGENESIS | 34 | 2.76e-02 | -2.18e-01 | 1.17e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 19 | 9.96e-02 | -2.18e-01 | 2.72e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 13 | 1.74e-01 | -2.18e-01 | 3.89e-01 |
| GOCC EMC COMPLEX | 11 | 2.11e-01 | -2.18e-01 | 4.37e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 40 | 1.72e-02 | -2.18e-01 | 8.37e-02 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 156 | 2.74e-06 | -2.18e-01 | 6.44e-05 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 24 | 6.48e-02 | -2.18e-01 | 2.07e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 45 | 1.15e-02 | -2.18e-01 | 6.32e-02 |
| GOCC ENZYME ACTIVATOR COMPLEX | 15 | 1.44e-01 | 2.18e-01 | 3.47e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 483 | 3.27e-16 | -2.18e-01 | 1.11e-13 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 35 | 2.61e-02 | -2.17e-01 | 1.13e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 24 | 6.54e-02 | -2.17e-01 | 2.08e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 103 | 1.43e-04 | -2.17e-01 | 1.98e-03 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 2.35e-01 | -2.17e-01 | 4.63e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 10 | 2.35e-01 | 2.17e-01 | 4.64e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 13 | 1.76e-01 | -2.17e-01 | 3.92e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 1.60e-01 | -2.17e-01 | 3.71e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 71 | 1.60e-03 | -2.17e-01 | 1.44e-02 |
| GOBP REGULATION OF ACTIN NUCLEATION | 26 | 5.59e-02 | -2.17e-01 | 1.88e-01 |
| GOMF TRANSPORTER INHIBITOR ACTIVITY | 34 | 2.88e-02 | -2.17e-01 | 1.21e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 30 | 4.01e-02 | -2.17e-01 | 1.50e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 11 | 2.14e-01 | -2.17e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 15 | 1.46e-01 | -2.17e-01 | 3.51e-01 |
| GOMF HISTONE READER ACTIVITY | 16 | 1.34e-01 | 2.17e-01 | 3.30e-01 |
| GOBP PROTEIN DESTABILIZATION | 53 | 6.44e-03 | -2.16e-01 | 4.15e-02 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 14 | 1.61e-01 | 2.16e-01 | 3.73e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 10 | 2.37e-01 | -2.16e-01 | 4.64e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 21 | 8.64e-02 | -2.16e-01 | 2.48e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 24 | 6.72e-02 | -2.16e-01 | 2.12e-01 |
| GOMF G PROTEIN ACTIVITY | 54 | 6.16e-03 | -2.16e-01 | 4.03e-02 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 52 | 7.19e-03 | -2.16e-01 | 4.51e-02 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 196 | 2.07e-07 | -2.15e-01 | 7.14e-06 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 14 | 1.63e-01 | -2.15e-01 | 3.75e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 379 | 7.02e-13 | -2.15e-01 | 9.65e-11 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 35 | 2.75e-02 | -2.15e-01 | 1.17e-01 |
| GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 10 | 2.38e-01 | 2.15e-01 | 4.66e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 179 | 6.95e-07 | -2.15e-01 | 2.01e-05 |
| GOBP TRNA DECAY | 16 | 1.36e-01 | -2.15e-01 | 3.34e-01 |
| GOBP FIBROBLAST MIGRATION | 63 | 3.14e-03 | -2.15e-01 | 2.42e-02 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 118 | 5.54e-05 | -2.15e-01 | 8.82e-04 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 73 | 1.50e-03 | -2.15e-01 | 1.37e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 1.37e-01 | 2.15e-01 | 3.35e-01 |
| GOMF C C CHEMOKINE BINDING | 11 | 2.17e-01 | -2.15e-01 | 4.44e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 11 | 2.17e-01 | 2.15e-01 | 4.44e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 39 | 2.03e-02 | -2.15e-01 | 9.38e-02 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 38 | 2.20e-02 | -2.15e-01 | 9.99e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 10 | 2.40e-01 | 2.15e-01 | 4.67e-01 |
| GOBP REPLICATIVE SENESCENCE | 10 | 2.40e-01 | 2.15e-01 | 4.68e-01 |
| GOBP INTESTINAL ABSORPTION | 23 | 7.49e-02 | 2.15e-01 | 2.28e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 89 | 4.72e-04 | -2.15e-01 | 5.26e-03 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 20 | 9.69e-02 | -2.14e-01 | 2.67e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 18 | 1.15e-01 | -2.14e-01 | 3.01e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 29 | 4.58e-02 | -2.14e-01 | 1.64e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 79 | 1.00e-03 | -2.14e-01 | 9.96e-03 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 9.75e-02 | -2.14e-01 | 2.68e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 40 | 1.92e-02 | -2.14e-01 | 9.06e-02 |
| GOBP OLIGOPEPTIDE TRANSPORT | 11 | 2.19e-01 | 2.14e-01 | 4.46e-01 |
| GOBP HEAT GENERATION | 15 | 1.52e-01 | -2.14e-01 | 3.58e-01 |
| GOCC INTEGRATOR COMPLEX | 13 | 1.82e-01 | 2.14e-01 | 4.01e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 29 | 4.64e-02 | -2.14e-01 | 1.66e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 23 | 7.61e-02 | -2.14e-01 | 2.30e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 1.27e-01 | -2.14e-01 | 3.20e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 28 | 5.05e-02 | -2.14e-01 | 1.76e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 23 | 7.65e-02 | -2.13e-01 | 2.31e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 13 | 1.83e-01 | -2.13e-01 | 4.02e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 103 | 1.85e-04 | -2.13e-01 | 2.44e-03 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 17 | 1.28e-01 | 2.13e-01 | 3.21e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 12 | 2.01e-01 | -2.13e-01 | 4.24e-01 |
| GOCC ACTIN CYTOSKELETON | 426 | 5.39e-14 | -2.13e-01 | 9.97e-12 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 24 | 7.07e-02 | 2.13e-01 | 2.19e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 46 | 1.24e-02 | 2.13e-01 | 6.69e-02 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 27 | 5.54e-02 | -2.13e-01 | 1.87e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 22 | 8.39e-02 | -2.13e-01 | 2.43e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 121 | 5.31e-05 | -2.13e-01 | 8.56e-04 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 14 | 1.68e-01 | -2.13e-01 | 3.81e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 77 | 1.25e-03 | -2.13e-01 | 1.19e-02 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 26 | 6.05e-02 | -2.13e-01 | 1.99e-01 |
| GOCC GTPASE COMPLEX | 30 | 4.39e-02 | -2.13e-01 | 1.60e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 61 | 4.11e-03 | -2.13e-01 | 2.96e-02 |
| GOMF DNA POLYMERASE ACTIVITY | 27 | 5.61e-02 | 2.12e-01 | 1.88e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 18 | 1.19e-01 | -2.12e-01 | 3.07e-01 |
| GOBP V D J RECOMBINATION | 15 | 1.55e-01 | 2.12e-01 | 3.63e-01 |
| GOCC ENDOCYTIC VESICLE | 188 | 5.35e-07 | -2.12e-01 | 1.63e-05 |
| GOBP CHROMOSOME LOCALIZATION | 91 | 4.72e-04 | -2.12e-01 | 5.26e-03 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 40 | 2.03e-02 | -2.12e-01 | 9.38e-02 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 18 | 1.20e-01 | -2.12e-01 | 3.08e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 32 | 3.81e-02 | -2.12e-01 | 1.45e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 23 | 7.87e-02 | -2.12e-01 | 2.34e-01 |
| GOBP VOCALIZATION BEHAVIOR | 15 | 1.56e-01 | -2.12e-01 | 3.65e-01 |
| GOMF NOTCH BINDING | 20 | 1.01e-01 | -2.12e-01 | 2.75e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 18 | 1.20e-01 | -2.12e-01 | 3.09e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS | 31 | 4.16e-02 | -2.11e-01 | 1.54e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 10 | 2.47e-01 | -2.11e-01 | 4.76e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 1.87e-01 | -2.11e-01 | 4.06e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 16 | 1.44e-01 | -2.11e-01 | 3.46e-01 |
| GOBP VESICLE TARGETING | 57 | 5.88e-03 | -2.11e-01 | 3.88e-02 |
| GOMF I SMAD BINDING | 16 | 1.44e-01 | -2.11e-01 | 3.46e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 31 | 4.21e-02 | -2.11e-01 | 1.55e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 23 | 8.00e-02 | -2.11e-01 | 2.37e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 33 | 3.61e-02 | -2.11e-01 | 1.41e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 13 | 1.88e-01 | -2.11e-01 | 4.07e-01 |
| GOCC COATED VESICLE MEMBRANE | 80 | 1.12e-03 | -2.11e-01 | 1.09e-02 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 14 | 1.72e-01 | -2.11e-01 | 3.87e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 22 | 8.76e-02 | -2.10e-01 | 2.50e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 11 | 2.27e-01 | -2.10e-01 | 4.54e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 23 | 8.07e-02 | 2.10e-01 | 2.38e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 15 | 1.58e-01 | 2.10e-01 | 3.68e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 10 | 2.50e-01 | -2.10e-01 | 4.80e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 11 | 2.27e-01 | 2.10e-01 | 4.55e-01 |
| GOCC LAMELLAR BODY | 10 | 2.50e-01 | 2.10e-01 | 4.80e-01 |
| GOBP RESPONSE TO BACTERIUM | 459 | 1.55e-14 | -2.10e-01 | 3.72e-12 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 23 | 8.13e-02 | -2.10e-01 | 2.39e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 669 | 3.22e-20 | -2.10e-01 | 2.98e-17 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 78 | 1.35e-03 | -2.10e-01 | 1.27e-02 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 70 | 2.41e-03 | -2.10e-01 | 1.98e-02 |
| GOBP HEART FORMATION | 29 | 5.05e-02 | 2.10e-01 | 1.76e-01 |
| GOMF CLATHRIN BINDING | 41 | 2.01e-02 | -2.10e-01 | 9.35e-02 |
| GOBP IMMUNE EFFECTOR PROCESS | 441 | 5.40e-14 | -2.10e-01 | 9.97e-12 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 24 | 7.57e-02 | -2.09e-01 | 2.29e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 76 | 1.61e-03 | -2.09e-01 | 1.45e-02 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 33 | 3.75e-02 | -2.09e-01 | 1.44e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 25 | 7.01e-02 | -2.09e-01 | 2.17e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 31 | 4.38e-02 | -2.09e-01 | 1.59e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 38 | 2.56e-02 | -2.09e-01 | 1.11e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 33 | 3.75e-02 | 2.09e-01 | 1.44e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 1.91e-01 | -2.09e-01 | 4.13e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 14 | 1.75e-01 | -2.09e-01 | 3.91e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 16 | 1.47e-01 | -2.09e-01 | 3.52e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 10 | 2.53e-01 | 2.09e-01 | 4.83e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 73 | 2.03e-03 | -2.09e-01 | 1.73e-02 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 13 | 1.92e-01 | -2.09e-01 | 4.14e-01 |
| GOBP AMINO ACID ACTIVATION | 26 | 6.54e-02 | -2.09e-01 | 2.08e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 12 | 2.11e-01 | -2.09e-01 | 4.37e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 10 | 2.53e-01 | -2.09e-01 | 4.83e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 22 | 9.04e-02 | -2.09e-01 | 2.55e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 112 | 1.40e-04 | -2.09e-01 | 1.96e-03 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 67 | 3.18e-03 | -2.08e-01 | 2.44e-02 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 101 | 2.98e-04 | -2.08e-01 | 3.64e-03 |
| GOBP REGULATION OF URINE VOLUME | 20 | 1.07e-01 | -2.08e-01 | 2.86e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 13 | 1.94e-01 | 2.08e-01 | 4.16e-01 |
| GOBP MANNOSYLATION | 17 | 1.37e-01 | 2.08e-01 | 3.36e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 23 | 8.43e-02 | -2.08e-01 | 2.44e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 10 | 2.55e-01 | 2.08e-01 | 4.85e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 20 | 1.08e-01 | -2.08e-01 | 2.88e-01 |
| GOBP AEROBIC RESPIRATION | 154 | 9.03e-06 | 2.08e-01 | 1.85e-04 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 132 | 3.92e-05 | -2.08e-01 | 6.60e-04 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 109 | 1.87e-04 | -2.07e-01 | 2.46e-03 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 13 | 1.96e-01 | -2.07e-01 | 4.18e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 89 | 7.32e-04 | -2.07e-01 | 7.64e-03 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 16 | 1.51e-01 | -2.07e-01 | 3.58e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 13 | 1.96e-01 | -2.07e-01 | 4.19e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 73 | 2.24e-03 | -2.07e-01 | 1.88e-02 |
| GOCC NUCLEAR ENVELOPE LUMEN | 11 | 2.35e-01 | 2.07e-01 | 4.63e-01 |
| GOMF LAMININ BINDING | 27 | 6.28e-02 | -2.07e-01 | 2.03e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 66 | 3.67e-03 | -2.07e-01 | 2.71e-02 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 15 | 1.65e-01 | 2.07e-01 | 3.78e-01 |
| GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 24 | 7.95e-02 | -2.07e-01 | 2.36e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 92 | 6.13e-04 | -2.07e-01 | 6.62e-03 |
| GOBP PLASMINOGEN ACTIVATION | 17 | 1.40e-01 | -2.07e-01 | 3.40e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 15 | 1.66e-01 | -2.07e-01 | 3.78e-01 |
| GOMF NADPH BINDING | 18 | 1.30e-01 | -2.06e-01 | 3.23e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 20 | 1.10e-01 | -2.06e-01 | 2.92e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 38 | 2.79e-02 | 2.06e-01 | 1.18e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 175 | 2.69e-06 | -2.06e-01 | 6.35e-05 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 23 | 8.74e-02 | -2.06e-01 | 2.50e-01 |
| GOCC MICROVILLUS MEMBRANE | 18 | 1.31e-01 | -2.06e-01 | 3.25e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 40 | 2.44e-02 | -2.06e-01 | 1.08e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 32 | 4.43e-02 | -2.05e-01 | 1.61e-01 |
| GOBP PROTEIN PALMITOYLATION | 26 | 7.01e-02 | 2.05e-01 | 2.17e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 281 | 3.46e-09 | -2.05e-01 | 1.86e-07 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 47 | 1.50e-02 | -2.05e-01 | 7.61e-02 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 33 | 4.14e-02 | -2.05e-01 | 1.53e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 142 | 2.48e-05 | -2.05e-01 | 4.38e-04 |
| GOMF SNORNA BINDING | 30 | 5.19e-02 | -2.05e-01 | 1.79e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 43 | 2.00e-02 | -2.05e-01 | 9.31e-02 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 1.56e-01 | -2.05e-01 | 3.65e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 54 | 9.24e-03 | -2.05e-01 | 5.38e-02 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 16 | 1.56e-01 | -2.05e-01 | 3.65e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 22 | 9.64e-02 | -2.05e-01 | 2.66e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 74 | 2.33e-03 | -2.05e-01 | 1.95e-02 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 10 | 2.62e-01 | -2.05e-01 | 4.94e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 18 | 1.33e-01 | -2.05e-01 | 3.29e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 116 | 1.42e-04 | -2.05e-01 | 1.98e-03 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 12 | 2.20e-01 | -2.05e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 19 | 1.23e-01 | -2.05e-01 | 3.12e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 10 | 2.63e-01 | -2.05e-01 | 4.95e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 10 | 2.63e-01 | -2.05e-01 | 4.95e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 40 | 2.53e-02 | -2.04e-01 | 1.11e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 17 | 1.45e-01 | -2.04e-01 | 3.48e-01 |
| GOBP NEURON RECOGNITION | 37 | 3.17e-02 | 2.04e-01 | 1.29e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 25 | 7.73e-02 | -2.04e-01 | 2.32e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 16 | 1.58e-01 | -2.04e-01 | 3.67e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 2.21e-01 | 2.04e-01 | 4.48e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 18 | 1.34e-01 | -2.04e-01 | 3.31e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 253 | 2.50e-08 | -2.04e-01 | 1.13e-06 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 36 | 3.43e-02 | 2.04e-01 | 1.36e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 52 | 1.10e-02 | -2.04e-01 | 6.12e-02 |
| GOBP RECEPTOR CATABOLIC PROCESS | 26 | 7.22e-02 | -2.04e-01 | 2.22e-01 |
| GOBP RESPONSE TO VIRUS | 278 | 5.43e-09 | -2.04e-01 | 2.79e-07 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 15 | 1.72e-01 | 2.04e-01 | 3.87e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 11 | 2.42e-01 | 2.04e-01 | 4.70e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 17 | 1.46e-01 | -2.04e-01 | 3.50e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 349 | 7.43e-11 | -2.03e-01 | 5.79e-09 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 42 | 2.27e-02 | -2.03e-01 | 1.03e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 161 | 8.97e-06 | -2.03e-01 | 1.84e-04 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 243 | 5.30e-08 | -2.03e-01 | 2.21e-06 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 12 | 2.24e-01 | -2.03e-01 | 4.51e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 17 | 1.48e-01 | 2.03e-01 | 3.52e-01 |
| GOBP VIRAL TRANSLATION | 17 | 1.48e-01 | -2.03e-01 | 3.52e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 94 | 6.90e-04 | -2.03e-01 | 7.32e-03 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 34 | 4.09e-02 | -2.03e-01 | 1.52e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 28 | 6.35e-02 | -2.03e-01 | 2.05e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 86 | 1.19e-03 | -2.02e-01 | 1.14e-02 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 20 | 1.17e-01 | 2.02e-01 | 3.04e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 32 | 4.77e-02 | 2.02e-01 | 1.69e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 106 | 3.26e-04 | -2.02e-01 | 3.88e-03 |
| GOBP CGMP METABOLIC PROCESS | 10 | 2.68e-01 | 2.02e-01 | 5.01e-01 |
| GOBP RETINA HOMEOSTASIS | 38 | 3.11e-02 | 2.02e-01 | 1.28e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 22 | 1.01e-01 | -2.02e-01 | 2.75e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 54 | 1.02e-02 | 2.02e-01 | 5.82e-02 |
| GOCC COPI COATED VESICLE MEMBRANE | 16 | 1.62e-01 | -2.02e-01 | 3.74e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 16 | 1.62e-01 | -2.02e-01 | 3.74e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 15 | 1.76e-01 | -2.02e-01 | 3.92e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 516 | 5.82e-15 | -2.02e-01 | 1.64e-12 |
| GOBP HEMOSTASIS | 130 | 7.28e-05 | -2.02e-01 | 1.12e-03 |
| GOBP WOUND HEALING | 288 | 4.25e-09 | -2.02e-01 | 2.25e-07 |
| GOBP NUCLEOTIDE SALVAGE | 19 | 1.28e-01 | 2.02e-01 | 3.21e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 18 | 1.39e-01 | -2.01e-01 | 3.38e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 29 | 6.05e-02 | -2.01e-01 | 1.99e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 63 | 5.73e-03 | -2.01e-01 | 3.80e-02 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 103 | 4.20e-04 | -2.01e-01 | 4.78e-03 |
| GOCC POSTSYNAPTIC ENDOSOME | 25 | 8.15e-02 | -2.01e-01 | 2.39e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 13 | 2.09e-01 | 2.01e-01 | 4.35e-01 |
| GOBP B CELL HOMEOSTASIS | 37 | 3.44e-02 | -2.01e-01 | 1.36e-01 |
| GOBP CELL SUBSTRATE ADHESION | 302 | 2.11e-09 | -2.01e-01 | 1.21e-07 |
| GOBP MESENCHYME MORPHOGENESIS | 49 | 1.50e-02 | -2.01e-01 | 7.63e-02 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1133 | 1.49e-29 | -2.01e-01 | 7.45e-26 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 25 | 8.22e-02 | -2.01e-01 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 84 | 1.48e-03 | -2.01e-01 | 1.35e-02 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 12 | 2.29e-01 | -2.01e-01 | 4.56e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 27 | 7.11e-02 | -2.01e-01 | 2.19e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 15 | 1.79e-01 | 2.01e-01 | 3.96e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 18 | 1.41e-01 | -2.01e-01 | 3.41e-01 |
| GOBP VIRAL LIFE CYCLE | 191 | 1.82e-06 | -2.01e-01 | 4.48e-05 |
| GOBP RESPONSE TO STEROL DEPLETION | 14 | 1.94e-01 | -2.01e-01 | 4.16e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 16 | 1.65e-01 | -2.00e-01 | 3.78e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 33 | 4.64e-02 | 2.00e-01 | 1.66e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 57 | 8.91e-03 | -2.00e-01 | 5.25e-02 |
| GOBP DENDRITIC CELL MIGRATION | 16 | 1.65e-01 | -2.00e-01 | 3.78e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 14 | 1.94e-01 | -2.00e-01 | 4.17e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 11 | 2.50e-01 | -2.00e-01 | 4.80e-01 |
| GOBP MITOTIC CYTOKINESIS | 81 | 1.85e-03 | -2.00e-01 | 1.62e-02 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 1.21e-01 | -2.00e-01 | 3.10e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 17 | 1.53e-01 | -2.00e-01 | 3.60e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 34 | 4.36e-02 | -2.00e-01 | 1.59e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 20 | 1.22e-01 | -2.00e-01 | 3.11e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 138 | 5.08e-05 | -2.00e-01 | 8.26e-04 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 11 | 2.51e-01 | -2.00e-01 | 4.81e-01 |
| GOBP ENDOTHELIAL CELL DIFFERENTIATION | 103 | 4.62e-04 | -2.00e-01 | 5.20e-03 |
| GOBP PRO B CELL DIFFERENTIATION | 11 | 2.51e-01 | 2.00e-01 | 4.82e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 184 | 3.07e-06 | -2.00e-01 | 7.11e-05 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 12 | 2.31e-01 | -2.00e-01 | 4.60e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 10 | 2.74e-01 | -2.00e-01 | 5.08e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 21 | 1.13e-01 | -2.00e-01 | 2.97e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 57 | 9.20e-03 | -2.00e-01 | 5.37e-02 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 27 | 7.31e-02 | -1.99e-01 | 2.24e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 16 | 1.68e-01 | -1.99e-01 | 3.80e-01 |
| GOCC SNARE COMPLEX | 42 | 2.56e-02 | -1.99e-01 | 1.11e-01 |
| GOBP VIRION ASSEMBLY | 26 | 7.90e-02 | -1.99e-01 | 2.35e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 42 | 2.57e-02 | -1.99e-01 | 1.11e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 18 | 1.44e-01 | 1.99e-01 | 3.46e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 10 | 2.76e-01 | -1.99e-01 | 5.10e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 70 | 4.05e-03 | -1.99e-01 | 2.93e-02 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 123 | 1.42e-04 | -1.99e-01 | 1.98e-03 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 20 | 1.24e-01 | -1.99e-01 | 3.14e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 45 | 2.11e-02 | -1.99e-01 | 9.69e-02 |
| GOMF GTPASE ACTIVITY | 246 | 8.47e-08 | -1.99e-01 | 3.19e-06 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 83 | 1.76e-03 | -1.99e-01 | 1.56e-02 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 62 | 6.89e-03 | -1.99e-01 | 4.36e-02 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 55 | 1.09e-02 | -1.98e-01 | 6.09e-02 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 13 | 2.15e-01 | -1.98e-01 | 4.42e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 36 | 3.95e-02 | -1.98e-01 | 1.49e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 35 | 4.25e-02 | 1.98e-01 | 1.56e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 55 | 1.11e-02 | 1.98e-01 | 6.16e-02 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 56 | 1.04e-02 | -1.98e-01 | 5.91e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 55 | 1.12e-02 | -1.98e-01 | 6.17e-02 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 48 | 1.78e-02 | -1.98e-01 | 8.59e-02 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 19 | 1.36e-01 | -1.98e-01 | 3.34e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 14 | 2.00e-01 | 1.98e-01 | 4.24e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 240 | 1.42e-07 | -1.98e-01 | 5.18e-06 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 12 | 2.36e-01 | -1.98e-01 | 4.64e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 72 | 3.77e-03 | -1.98e-01 | 2.77e-02 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 232 | 2.34e-07 | -1.97e-01 | 7.92e-06 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 377 | 5.37e-11 | -1.97e-01 | 4.45e-09 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 66 | 5.58e-03 | -1.97e-01 | 3.72e-02 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.57e-01 | -1.97e-01 | 4.87e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 11 | 2.57e-01 | -1.97e-01 | 4.87e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 11 | 2.57e-01 | -1.97e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 60 | 8.29e-03 | -1.97e-01 | 4.98e-02 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 23 | 1.02e-01 | -1.97e-01 | 2.76e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 10 | 2.81e-01 | 1.97e-01 | 5.14e-01 |
| GOBP VESICLE TETHERING | 31 | 5.78e-02 | -1.97e-01 | 1.92e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 16 | 1.73e-01 | -1.97e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY | 12 | 2.38e-01 | -1.97e-01 | 4.66e-01 |
| GOBP DEFENSE RESPONSE | 1176 | 2.30e-29 | -1.97e-01 | 7.45e-26 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 115 | 2.74e-04 | -1.97e-01 | 3.37e-03 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 13 | 2.20e-01 | -1.97e-01 | 4.46e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 35 | 4.44e-02 | 1.96e-01 | 1.61e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 125 | 1.52e-04 | -1.96e-01 | 2.09e-03 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 13 | 2.21e-01 | -1.96e-01 | 4.48e-01 |
| GOBP PROTEIN OXIDATION | 13 | 2.21e-01 | -1.96e-01 | 4.48e-01 |
| GOBP RESPONSE TO NICOTINE | 16 | 1.74e-01 | -1.96e-01 | 3.90e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 791 | 1.21e-20 | -1.96e-01 | 1.31e-17 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 31 | 5.89e-02 | 1.96e-01 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPEPTIDASE ACTIVITY | 89 | 1.40e-03 | -1.96e-01 | 1.30e-02 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 55 | 1.20e-02 | 1.96e-01 | 6.52e-02 |
| GOCC CELL CORTEX | 241 | 1.73e-07 | -1.96e-01 | 6.16e-06 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 12 | 2.40e-01 | -1.96e-01 | 4.68e-01 |
| GOBP ZYMOGEN ACTIVATION | 39 | 3.45e-02 | -1.96e-01 | 1.36e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 19 | 1.40e-01 | 1.96e-01 | 3.39e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 10 | 2.84e-01 | 1.96e-01 | 5.17e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 32 | 5.55e-02 | -1.96e-01 | 1.87e-01 |
| GOBP RESPONSE TO LEPTIN | 17 | 1.63e-01 | -1.96e-01 | 3.75e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 2.41e-01 | 1.95e-01 | 4.69e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 29 | 6.86e-02 | -1.95e-01 | 2.15e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 75 | 3.46e-03 | -1.95e-01 | 2.60e-02 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 65 | 6.54e-03 | -1.95e-01 | 4.21e-02 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 11 | 2.63e-01 | -1.95e-01 | 4.95e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 161 | 1.99e-05 | -1.95e-01 | 3.64e-04 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 22 | 1.14e-01 | -1.95e-01 | 2.97e-01 |
| GOBP ENDOSOME ORGANIZATION | 59 | 9.65e-03 | -1.95e-01 | 5.56e-02 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 46 | 2.22e-02 | -1.95e-01 | 1.01e-01 |
| GOBP DEFENSE RESPONSE TO VIRUS | 233 | 3.14e-07 | -1.95e-01 | 1.00e-05 |
| GOBP VIRAL BUDDING | 18 | 1.52e-01 | -1.95e-01 | 3.60e-01 |
| GOBP ANGIOGENESIS | 457 | 1.17e-12 | -1.95e-01 | 1.51e-10 |
| GOBP REGULATION OF IMMUNE RESPONSE | 641 | 6.45e-17 | -1.94e-01 | 2.98e-14 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 34 | 4.98e-02 | -1.94e-01 | 1.74e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 133 | 1.10e-04 | -1.94e-01 | 1.62e-03 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 520 | 4.27e-14 | -1.94e-01 | 8.91e-12 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 58 | 1.05e-02 | -1.94e-01 | 5.94e-02 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 43 | 2.75e-02 | -1.94e-01 | 1.17e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 11 | 2.65e-01 | -1.94e-01 | 4.97e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 31 | 6.14e-02 | -1.94e-01 | 2.00e-01 |
| GOBP AUDITORY BEHAVIOR | 10 | 2.88e-01 | -1.94e-01 | 5.21e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 29 | 7.05e-02 | 1.94e-01 | 2.18e-01 |
| GOMF SUMO LIGASE ACTIVITY | 11 | 2.65e-01 | 1.94e-01 | 4.97e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 529 | 2.94e-14 | -1.94e-01 | 6.78e-12 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 2.65e-01 | -1.94e-01 | 4.97e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 11 | 2.66e-01 | 1.94e-01 | 4.98e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 14 | 2.09e-01 | 1.94e-01 | 4.35e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 24 | 1.00e-01 | 1.94e-01 | 2.74e-01 |
| GOBP TISSUE MIGRATION | 281 | 2.46e-08 | -1.94e-01 | 1.13e-06 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 17 | 1.67e-01 | -1.94e-01 | 3.80e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 430 | 6.72e-12 | -1.94e-01 | 7.13e-10 |
| GOBP RENAL FILTRATION | 26 | 8.75e-02 | -1.94e-01 | 2.50e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 26 | 8.76e-02 | -1.94e-01 | 2.50e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 67 | 6.17e-03 | -1.94e-01 | 4.03e-02 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 146 | 5.60e-05 | -1.93e-01 | 8.89e-04 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 21 | 1.25e-01 | 1.93e-01 | 3.16e-01 |
| GOBP INFLAMMATORY RESPONSE | 559 | 7.66e-15 | -1.93e-01 | 2.04e-12 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 16 | 1.81e-01 | -1.93e-01 | 4.00e-01 |
| GOMF OLIGOPEPTIDE BINDING | 15 | 1.95e-01 | -1.93e-01 | 4.18e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 38 | 3.95e-02 | 1.93e-01 | 1.49e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 34 | 5.15e-02 | -1.93e-01 | 1.78e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 64 | 7.63e-03 | -1.93e-01 | 4.74e-02 |
| GOBP RESPONSE TO PROGESTERONE | 16 | 1.82e-01 | -1.93e-01 | 4.01e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 11 | 2.68e-01 | 1.93e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 23 | 1.10e-01 | -1.93e-01 | 2.91e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 45 | 2.55e-02 | -1.93e-01 | 1.11e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 91 | 1.52e-03 | -1.93e-01 | 1.38e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 13 | 2.30e-01 | -1.93e-01 | 4.57e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 80 | 2.93e-03 | -1.93e-01 | 2.31e-02 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 38 | 4.02e-02 | -1.92e-01 | 1.50e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 19 | 1.47e-01 | -1.92e-01 | 3.51e-01 |
| GOBP T CELL SELECTION | 39 | 3.77e-02 | -1.92e-01 | 1.44e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 200 | 2.86e-06 | -1.92e-01 | 6.68e-05 |
| GOBP CYTOPLASM ORGANIZATION | 11 | 2.70e-01 | -1.92e-01 | 5.01e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 79 | 3.19e-03 | -1.92e-01 | 2.45e-02 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 1.47e-01 | -1.92e-01 | 3.52e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 55 | 1.38e-02 | -1.92e-01 | 7.18e-02 |
| GOBP NUCLEAR BODY ORGANIZATION | 15 | 1.98e-01 | -1.92e-01 | 4.21e-01 |
| GOCC M BAND | 20 | 1.37e-01 | -1.92e-01 | 3.36e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 35 | 4.95e-02 | -1.92e-01 | 1.73e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 415 | 2.35e-11 | -1.92e-01 | 2.11e-09 |
| GOCC MICROVILLUS | 76 | 3.85e-03 | -1.92e-01 | 2.82e-02 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 31 | 6.46e-02 | -1.92e-01 | 2.07e-01 |
| GOCC CALYX OF HELD | 25 | 9.70e-02 | -1.92e-01 | 2.67e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 12 | 2.50e-01 | 1.92e-01 | 4.80e-01 |
| GOBP UTERUS DEVELOPMENT | 17 | 1.71e-01 | 1.92e-01 | 3.86e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 65 | 7.58e-03 | -1.92e-01 | 4.72e-02 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 36 | 4.67e-02 | -1.92e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 132 | 1.47e-04 | -1.92e-01 | 2.03e-03 |
| GOBP SENSORY PERCEPTION OF PAIN | 56 | 1.33e-02 | -1.91e-01 | 6.97e-02 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 66 | 7.24e-03 | -1.91e-01 | 4.53e-02 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 78 | 3.53e-03 | -1.91e-01 | 2.64e-02 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 1.86e-01 | -1.91e-01 | 4.05e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 79 | 3.33e-03 | -1.91e-01 | 2.54e-02 |
| GOCC COPI COATED VESICLE | 29 | 7.50e-02 | -1.91e-01 | 2.28e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 13 | 2.33e-01 | -1.91e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 16 | 1.86e-01 | -1.91e-01 | 4.05e-01 |
| GOBP FILOPODIUM ASSEMBLY | 61 | 1.00e-02 | -1.91e-01 | 5.71e-02 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 64 | 8.34e-03 | -1.91e-01 | 4.99e-02 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 31 | 6.61e-02 | -1.91e-01 | 2.10e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 197 | 4.07e-06 | -1.91e-01 | 9.17e-05 |
| GOCC MICROTUBULE END | 30 | 7.08e-02 | -1.91e-01 | 2.19e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 27 | 8.69e-02 | -1.90e-01 | 2.49e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 139 | 1.08e-04 | -1.90e-01 | 1.60e-03 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 14 | 2.18e-01 | -1.90e-01 | 4.45e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 2.98e-01 | 1.90e-01 | 5.31e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 51 | 1.89e-02 | -1.90e-01 | 8.97e-02 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 2.75e-01 | -1.90e-01 | 5.09e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 19 | 1.52e-01 | -1.90e-01 | 3.58e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 21 | 1.32e-01 | -1.90e-01 | 3.27e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 13 | 2.36e-01 | -1.90e-01 | 4.64e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 65 | 8.13e-03 | -1.90e-01 | 4.93e-02 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 39 | 4.02e-02 | -1.90e-01 | 1.50e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 335 | 2.62e-09 | -1.90e-01 | 1.48e-07 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 21 | 1.32e-01 | -1.90e-01 | 3.29e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 29 | 7.72e-02 | 1.90e-01 | 2.32e-01 |
| GOBP CHOLESTEROL IMPORT | 12 | 2.55e-01 | -1.90e-01 | 4.86e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 16 | 1.89e-01 | -1.90e-01 | 4.09e-01 |
| GOBP RESPONSE TO MONOAMINE | 38 | 4.32e-02 | -1.90e-01 | 1.58e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 23 | 1.16e-01 | -1.90e-01 | 3.01e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 61 | 1.05e-02 | -1.90e-01 | 5.94e-02 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 10 | 3.00e-01 | -1.89e-01 | 5.32e-01 |
| GOBP CELLULAR PIGMENTATION | 50 | 2.05e-02 | -1.89e-01 | 9.47e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 29 | 7.75e-02 | -1.89e-01 | 2.33e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 36 | 4.93e-02 | -1.89e-01 | 1.73e-01 |
| GOCC LAMELLIPODIUM | 162 | 3.27e-05 | -1.89e-01 | 5.57e-04 |
| GOCC SIDE OF MEMBRANE | 492 | 7.93e-13 | -1.89e-01 | 1.07e-10 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 12 | 2.56e-01 | -1.89e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 48 | 2.33e-02 | -1.89e-01 | 1.04e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 19 | 1.53e-01 | -1.89e-01 | 3.61e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 132 | 1.78e-04 | -1.89e-01 | 2.37e-03 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 17 | 1.77e-01 | -1.89e-01 | 3.94e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 11 | 2.78e-01 | -1.89e-01 | 5.12e-01 |
| GOMF TITIN BINDING | 12 | 2.57e-01 | -1.89e-01 | 4.87e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 12 | 2.57e-01 | 1.89e-01 | 4.87e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 18 | 1.65e-01 | -1.89e-01 | 3.78e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 76 | 4.47e-03 | -1.89e-01 | 3.17e-02 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 37 | 4.71e-02 | -1.89e-01 | 1.67e-01 |
| GOCC CELL DIVISION SITE | 41 | 3.66e-02 | -1.89e-01 | 1.42e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 789 | 3.71e-19 | -1.89e-01 | 2.99e-16 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 54 | 1.66e-02 | -1.89e-01 | 8.19e-02 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 54 | 1.66e-02 | -1.88e-01 | 8.19e-02 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 228 | 1.00e-06 | -1.88e-01 | 2.73e-05 |
| GOBP INTERLEUKIN 17 PRODUCTION | 28 | 8.46e-02 | -1.88e-01 | 2.44e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 11 | 2.80e-01 | 1.88e-01 | 5.13e-01 |
| GOBP TRANSLATIONAL INITIATION | 107 | 7.78e-04 | -1.88e-01 | 8.08e-03 |
| GOBP STEM CELL DIVISION | 34 | 5.76e-02 | -1.88e-01 | 1.92e-01 |
| GOBP ORGANELLE DISASSEMBLY | 141 | 1.17e-04 | -1.88e-01 | 1.69e-03 |
| GOMF INOSITOL PHOSPHATE KINASE ACTIVITY | 10 | 3.03e-01 | -1.88e-01 | 5.35e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 40 | 3.96e-02 | -1.88e-01 | 1.49e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 131 | 2.05e-04 | -1.88e-01 | 2.65e-03 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 59 | 1.25e-02 | -1.88e-01 | 6.72e-02 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 53 | 1.80e-02 | 1.88e-01 | 8.62e-02 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 90 | 2.07e-03 | -1.88e-01 | 1.76e-02 |
| GOBP MRNA SPLICE SITE RECOGNITION | 21 | 1.36e-01 | 1.88e-01 | 3.34e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 38 | 4.51e-02 | -1.88e-01 | 1.62e-01 |
| GOBP ENDOCRINE PROCESS | 64 | 9.39e-03 | -1.88e-01 | 5.46e-02 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 13 | 2.41e-01 | -1.88e-01 | 4.69e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 22 | 1.28e-01 | 1.88e-01 | 3.21e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 19 | 1.57e-01 | -1.88e-01 | 3.66e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 32 | 6.64e-02 | -1.88e-01 | 2.10e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 27 | 9.17e-02 | -1.88e-01 | 2.57e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 41 | 3.78e-02 | -1.88e-01 | 1.44e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 139 | 1.38e-04 | -1.88e-01 | 1.94e-03 |
| GOBP PLATELET ACTIVATION | 77 | 4.48e-03 | -1.87e-01 | 3.18e-02 |
| GOMF MAP KINASE KINASE ACTIVITY | 12 | 2.61e-01 | 1.87e-01 | 4.92e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 14 | 2.25e-01 | 1.87e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 100 | 1.22e-03 | -1.87e-01 | 1.17e-02 |
| GOBP REGULATION OF MACROAUTOPHAGY | 121 | 3.78e-04 | -1.87e-01 | 4.38e-03 |
| GOMF SNAP RECEPTOR ACTIVITY | 32 | 6.68e-02 | -1.87e-01 | 2.11e-01 |
| GOMF NUCLEOSIDE BINDING | 10 | 3.05e-01 | 1.87e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 85 | 2.87e-03 | -1.87e-01 | 2.27e-02 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING SIGNALING PATHWAY | 217 | 2.12e-06 | -1.87e-01 | 5.14e-05 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 13 | 2.43e-01 | -1.87e-01 | 4.71e-01 |
| GOBP GLIAL CELL ACTIVATION | 48 | 2.51e-02 | -1.87e-01 | 1.10e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 392 | 2.44e-10 | -1.87e-01 | 1.70e-08 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 284 | 6.46e-08 | -1.87e-01 | 2.55e-06 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 77 | 4.62e-03 | -1.87e-01 | 3.26e-02 |
| GOBP HYALURONAN METABOLIC PROCESS | 30 | 7.66e-02 | -1.87e-01 | 2.31e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 13 | 2.44e-01 | -1.87e-01 | 4.72e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 108 | 8.15e-04 | -1.87e-01 | 8.38e-03 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 31 | 7.23e-02 | -1.87e-01 | 2.22e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 34 | 5.99e-02 | -1.86e-01 | 1.97e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 227 | 1.39e-06 | -1.86e-01 | 3.62e-05 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 23 | 1.22e-01 | -1.86e-01 | 3.12e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 18 | 1.72e-01 | 1.86e-01 | 3.87e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 13 | 2.45e-01 | -1.86e-01 | 4.74e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 77 | 4.78e-03 | -1.86e-01 | 3.35e-02 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 17 | 1.84e-01 | -1.86e-01 | 4.03e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 20 | 1.50e-01 | -1.86e-01 | 3.56e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 14 | 2.28e-01 | -1.86e-01 | 4.56e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 2.65e-01 | -1.86e-01 | 4.97e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 30 | 7.85e-02 | -1.86e-01 | 2.34e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 40 | 4.25e-02 | -1.85e-01 | 1.56e-01 |
| GOMF PROTEIN LYSINE N METHYLTRANSFERASE ACTIVITY | 45 | 3.14e-02 | 1.85e-01 | 1.28e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 11 | 2.87e-01 | -1.85e-01 | 5.21e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 32 | 6.98e-02 | -1.85e-01 | 2.17e-01 |
| GOBP POSITIVE T CELL SELECTION | 29 | 8.45e-02 | -1.85e-01 | 2.44e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 10 | 3.11e-01 | -1.85e-01 | 5.42e-01 |
| GOBP OOCYTE MATURATION | 20 | 1.52e-01 | -1.85e-01 | 3.59e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 370 | 1.11e-09 | -1.85e-01 | 6.88e-08 |
| GOBP INTERLEUKIN 12 PRODUCTION | 42 | 3.81e-02 | -1.85e-01 | 1.45e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 78 | 4.76e-03 | -1.85e-01 | 3.34e-02 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 36 | 5.49e-02 | -1.85e-01 | 1.86e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 326 | 1.04e-08 | -1.85e-01 | 5.14e-07 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 62 | 1.19e-02 | -1.85e-01 | 6.45e-02 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 37 | 5.17e-02 | -1.85e-01 | 1.79e-01 |
| GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY | 13 | 2.49e-01 | -1.85e-01 | 4.79e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 16 | 2.01e-01 | -1.85e-01 | 4.24e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 11 | 2.89e-01 | 1.85e-01 | 5.22e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 74 | 6.10e-03 | -1.84e-01 | 4.00e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 27 | 9.72e-02 | -1.84e-01 | 2.68e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 14 | 2.32e-01 | -1.84e-01 | 4.61e-01 |
| GOMF ALDO KETO REDUCTASE NADPH ACTIVITY | 19 | 1.64e-01 | -1.84e-01 | 3.77e-01 |
| GOBP RESPONSE TO CYTOKINE | 697 | 1.75e-16 | -1.84e-01 | 7.06e-14 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 1.04e-01 | -1.84e-01 | 2.81e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 44 | 3.46e-02 | -1.84e-01 | 1.37e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 22 | 1.35e-01 | -1.84e-01 | 3.32e-01 |
| GOBP LOCOMOTOR RHYTHM | 17 | 1.89e-01 | -1.84e-01 | 4.09e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 29 | 8.66e-02 | -1.84e-01 | 2.48e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 50 | 2.46e-02 | -1.84e-01 | 1.08e-01 |
| GOBP CARDIAC CONDUCTION | 62 | 1.24e-02 | 1.84e-01 | 6.66e-02 |
| GOBP POST EMBRYONIC DEVELOPMENT | 99 | 1.62e-03 | 1.83e-01 | 1.46e-02 |
| GOBP PROTEIN METHYLATION | 49 | 2.64e-02 | -1.83e-01 | 1.14e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 2.72e-01 | -1.83e-01 | 5.04e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 250 | 6.43e-07 | -1.83e-01 | 1.90e-05 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 11 | 2.93e-01 | -1.83e-01 | 5.26e-01 |
| GOBP SPINDLE ELONGATION | 12 | 2.72e-01 | -1.83e-01 | 5.04e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 46 | 3.18e-02 | -1.83e-01 | 1.29e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 19 | 1.68e-01 | -1.83e-01 | 3.80e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 21 | 1.47e-01 | 1.83e-01 | 3.51e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 58 | 1.60e-02 | -1.83e-01 | 7.98e-02 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 17 | 1.92e-01 | -1.83e-01 | 4.14e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 268 | 2.74e-07 | -1.83e-01 | 8.98e-06 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 32 | 7.37e-02 | 1.83e-01 | 2.25e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 295 | 7.23e-08 | -1.83e-01 | 2.78e-06 |
| GOBP SISTER CHROMATID SEGREGATION | 189 | 1.53e-05 | -1.83e-01 | 2.95e-04 |
| GOCC SEX CHROMOSOME | 32 | 7.38e-02 | 1.83e-01 | 2.25e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 29 | 8.88e-02 | -1.83e-01 | 2.52e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 207 | 6.19e-06 | -1.83e-01 | 1.32e-04 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 15 | 2.21e-01 | -1.83e-01 | 4.48e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 101 | 1.54e-03 | -1.83e-01 | 1.40e-02 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 18 | 1.80e-01 | -1.82e-01 | 3.99e-01 |
| GOBP LONG TERM MEMORY | 37 | 5.51e-02 | -1.82e-01 | 1.86e-01 |
| GOBP GAS TRANSPORT | 11 | 2.95e-01 | 1.82e-01 | 5.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 71 | 7.98e-03 | -1.82e-01 | 4.87e-02 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 18 | 1.81e-01 | -1.82e-01 | 4.00e-01 |
| GOBP REGULATION OF VIRAL LIFE CYCLE | 109 | 1.03e-03 | -1.82e-01 | 1.01e-02 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 34 | 6.61e-02 | -1.82e-01 | 2.10e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 24 | 1.22e-01 | 1.82e-01 | 3.12e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 10 | 3.19e-01 | 1.82e-01 | 5.52e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 589 | 6.30e-14 | -1.82e-01 | 1.13e-11 |
| GOBP PHOSPHOLIPID EFFLUX | 10 | 3.19e-01 | 1.82e-01 | 5.52e-01 |
| GOBP MUSCLE CELL MIGRATION | 116 | 7.26e-04 | -1.82e-01 | 7.61e-03 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 15 | 2.23e-01 | -1.82e-01 | 4.50e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 41 | 4.41e-02 | 1.82e-01 | 1.60e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 12 | 2.76e-01 | 1.82e-01 | 5.09e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 10 | 3.20e-01 | 1.82e-01 | 5.52e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 76 | 6.25e-03 | -1.82e-01 | 4.06e-02 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 482 | 1.07e-11 | -1.82e-01 | 1.08e-09 |
| GOBP CELL MATRIX ADHESION | 190 | 1.66e-05 | -1.81e-01 | 3.14e-04 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 94 | 2.39e-03 | -1.81e-01 | 1.97e-02 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 10 | 3.21e-01 | 1.81e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 17 | 1.96e-01 | -1.81e-01 | 4.18e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 40 | 4.73e-02 | -1.81e-01 | 1.67e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 10 | 3.21e-01 | -1.81e-01 | 5.52e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 15 | 2.24e-01 | -1.81e-01 | 4.51e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 235 | 1.78e-06 | -1.81e-01 | 4.42e-05 |
| GOBP REGULATION OF AUTOPHAGY | 263 | 4.47e-07 | -1.81e-01 | 1.38e-05 |
| GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX | 11 | 2.98e-01 | -1.81e-01 | 5.31e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 271 | 3.07e-07 | -1.81e-01 | 9.84e-06 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 100 | 1.78e-03 | -1.81e-01 | 1.57e-02 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 11 | 2.99e-01 | -1.81e-01 | 5.31e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 2.25e-01 | -1.81e-01 | 4.52e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 18 | 1.84e-01 | -1.81e-01 | 4.03e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 23 | 1.33e-01 | 1.81e-01 | 3.29e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 17 | 1.97e-01 | 1.81e-01 | 4.19e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 25 | 1.18e-01 | -1.81e-01 | 3.05e-01 |
| GOBP WALKING BEHAVIOR | 43 | 4.04e-02 | 1.81e-01 | 1.51e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 20 | 1.62e-01 | -1.81e-01 | 3.74e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 16 | 2.11e-01 | -1.81e-01 | 4.37e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 3.23e-01 | -1.81e-01 | 5.55e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 38 | 5.41e-02 | 1.81e-01 | 1.85e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 26 | 1.11e-01 | -1.81e-01 | 2.93e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 67 | 1.06e-02 | -1.81e-01 | 5.99e-02 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1135 | 3.26e-24 | -1.81e-01 | 5.27e-21 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 16 | 2.11e-01 | 1.80e-01 | 4.37e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 14 | 2.42e-01 | -1.80e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 68 | 1.01e-02 | -1.80e-01 | 5.77e-02 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 77 | 6.22e-03 | -1.80e-01 | 4.05e-02 |
| GOBP GANGLION DEVELOPMENT | 12 | 2.79e-01 | 1.80e-01 | 5.13e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 393 | 9.85e-10 | -1.80e-01 | 6.22e-08 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 18 | 1.86e-01 | -1.80e-01 | 4.05e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 48 | 3.09e-02 | -1.80e-01 | 1.27e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 15 | 2.27e-01 | -1.80e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 165 | 6.72e-05 | -1.80e-01 | 1.04e-03 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 62 | 1.43e-02 | -1.80e-01 | 7.33e-02 |
| GOBP CONVERGENT EXTENSION | 15 | 2.27e-01 | 1.80e-01 | 4.55e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 11 | 3.01e-01 | -1.80e-01 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 12 | 2.80e-01 | 1.80e-01 | 5.14e-01 |
| GOBP L GLUTAMATE IMPORT | 34 | 6.95e-02 | -1.80e-01 | 2.17e-01 |
| GOBP GLIAL CELL MIGRATION | 64 | 1.29e-02 | -1.80e-01 | 6.89e-02 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 18 | 1.88e-01 | -1.79e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 310 | 6.07e-08 | -1.79e-01 | 2.47e-06 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 101 | 1.89e-03 | -1.79e-01 | 1.64e-02 |
| GOBP HEART VALVE DEVELOPMENT | 60 | 1.65e-02 | -1.79e-01 | 8.16e-02 |
| GOMF E BOX BINDING | 34 | 7.10e-02 | -1.79e-01 | 2.19e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 10 | 3.27e-01 | -1.79e-01 | 5.58e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 12 | 2.83e-01 | 1.79e-01 | 5.17e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 138 | 2.88e-04 | -1.79e-01 | 3.53e-03 |
| GOBP RESPONSE TO UV B | 16 | 2.15e-01 | -1.79e-01 | 4.42e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 45 | 3.79e-02 | -1.79e-01 | 1.44e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 21 | 1.56e-01 | -1.79e-01 | 3.65e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 12 | 2.83e-01 | 1.79e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 10 | 3.28e-01 | -1.79e-01 | 5.59e-01 |
| GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY | 17 | 2.02e-01 | -1.79e-01 | 4.25e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 13 | 2.65e-01 | -1.79e-01 | 4.97e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 18 | 1.89e-01 | -1.79e-01 | 4.09e-01 |
| GOMF PROLINE RICH REGION BINDING | 19 | 1.78e-01 | -1.79e-01 | 3.94e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 26 | 1.15e-01 | -1.79e-01 | 3.00e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 16 | 2.16e-01 | -1.79e-01 | 4.43e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 88 | 3.82e-03 | -1.79e-01 | 2.80e-02 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 11 | 3.06e-01 | -1.78e-01 | 5.38e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 12 | 2.85e-01 | -1.78e-01 | 5.18e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 39 | 5.42e-02 | -1.78e-01 | 1.85e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 26 | 1.16e-01 | -1.78e-01 | 3.01e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 45 | 3.87e-02 | -1.78e-01 | 1.47e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 186 | 2.87e-05 | -1.78e-01 | 4.97e-04 |
| GOBP STORE OPERATED CALCIUM ENTRY | 19 | 1.79e-01 | -1.78e-01 | 3.97e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 11 | 3.07e-01 | 1.78e-01 | 5.39e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 16 | 2.18e-01 | 1.78e-01 | 4.45e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 13 | 2.67e-01 | -1.78e-01 | 4.99e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 23 | 1.40e-01 | -1.78e-01 | 3.40e-01 |
| GOCC MYOSIN COMPLEX | 40 | 5.17e-02 | -1.78e-01 | 1.79e-01 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 1.64e-02 | -1.78e-01 | 8.10e-02 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 35 | 6.92e-02 | -1.78e-01 | 2.16e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 39 | 5.53e-02 | 1.77e-01 | 1.87e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 155 | 1.41e-04 | -1.77e-01 | 1.97e-03 |
| GOBP MAST CELL ACTIVATION | 54 | 2.42e-02 | -1.77e-01 | 1.07e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 15 | 2.35e-01 | 1.77e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 74 | 8.40e-03 | -1.77e-01 | 5.02e-02 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 16 | 2.20e-01 | 1.77e-01 | 4.46e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 15 | 2.35e-01 | 1.77e-01 | 4.63e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 11 | 3.09e-01 | -1.77e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 15 | 2.35e-01 | 1.77e-01 | 4.63e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 33 | 7.85e-02 | -1.77e-01 | 2.34e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 13 | 2.69e-01 | 1.77e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 33 | 7.85e-02 | -1.77e-01 | 2.34e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 30 | 9.35e-02 | 1.77e-01 | 2.61e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 75 | 8.13e-03 | -1.77e-01 | 4.93e-02 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 52 | 2.75e-02 | -1.77e-01 | 1.17e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 173 | 6.18e-05 | -1.77e-01 | 9.69e-04 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 361 | 8.91e-09 | -1.77e-01 | 4.43e-07 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 26 | 1.19e-01 | 1.77e-01 | 3.07e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 75 | 8.21e-03 | -1.77e-01 | 4.96e-02 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 18 | 1.95e-01 | -1.77e-01 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 2.90e-01 | 1.77e-01 | 5.23e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 13 | 2.70e-01 | -1.77e-01 | 5.02e-01 |
| GOBP RESPONSE TO WOUNDING | 402 | 1.43e-09 | -1.77e-01 | 8.55e-08 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 129 | 5.44e-04 | -1.77e-01 | 5.97e-03 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 1.52e-01 | 1.76e-01 | 3.59e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 37 | 6.34e-02 | -1.76e-01 | 2.04e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 44 | 4.31e-02 | -1.76e-01 | 1.57e-01 |
| GOCC AUTOPHAGOSOME | 82 | 5.86e-03 | -1.76e-01 | 3.86e-02 |
| GOBP OSTEOCLAST DIFFERENTIATION | 95 | 3.03e-03 | -1.76e-01 | 2.36e-02 |
| GOMF L ASCORBIC ACID BINDING | 18 | 1.96e-01 | -1.76e-01 | 4.18e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 15 | 2.38e-01 | -1.76e-01 | 4.66e-01 |
| GOMF BMP BINDING | 12 | 2.91e-01 | -1.76e-01 | 5.24e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 26 | 1.21e-01 | 1.76e-01 | 3.09e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 16 | 2.23e-01 | 1.76e-01 | 4.51e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 65 | 1.43e-02 | 1.76e-01 | 7.34e-02 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 20 | 1.74e-01 | -1.76e-01 | 3.89e-01 |
| GOBP REGULATION OF ARTERY MORPHOGENESIS | 10 | 3.36e-01 | -1.76e-01 | 5.66e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 12 | 2.92e-01 | 1.76e-01 | 5.25e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 161 | 1.22e-04 | -1.76e-01 | 1.75e-03 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 29 | 1.02e-01 | -1.76e-01 | 2.76e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 11 | 3.13e-01 | 1.76e-01 | 5.45e-01 |
| GOCC EXCITATORY SYNAPSE | 66 | 1.38e-02 | -1.75e-01 | 7.16e-02 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 16 | 2.25e-01 | -1.75e-01 | 4.52e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 392 | 2.93e-09 | -1.75e-01 | 1.62e-07 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 34 | 7.71e-02 | -1.75e-01 | 2.32e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 24 | 1.37e-01 | -1.75e-01 | 3.36e-01 |
| GOBP RHYTHMIC BEHAVIOR | 44 | 4.45e-02 | -1.75e-01 | 1.61e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 164 | 1.11e-04 | -1.75e-01 | 1.63e-03 |
| GOBP VITAMIN METABOLIC PROCESS | 70 | 1.14e-02 | -1.75e-01 | 6.25e-02 |
| GOBP SPINDLE ASSEMBLY | 113 | 1.33e-03 | -1.75e-01 | 1.25e-02 |
| GOBP MEMBRANE FUSION | 122 | 8.61e-04 | -1.75e-01 | 8.75e-03 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 151 | 2.18e-04 | -1.75e-01 | 2.77e-03 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 65 | 1.50e-02 | 1.74e-01 | 7.63e-02 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 51 | 3.12e-02 | -1.74e-01 | 1.28e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 200 | 2.19e-05 | -1.74e-01 | 3.94e-04 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 23 | 1.48e-01 | -1.74e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 10 | 3.40e-01 | -1.74e-01 | 5.71e-01 |
| GOCC EXTRACELLULAR EXOSOME | 70 | 1.18e-02 | -1.74e-01 | 6.44e-02 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 77 | 8.26e-03 | -1.74e-01 | 4.96e-02 |
| GOBP MICROAUTOPHAGY | 23 | 1.48e-01 | -1.74e-01 | 3.53e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 21 | 1.67e-01 | -1.74e-01 | 3.80e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 56 | 2.44e-02 | -1.74e-01 | 1.08e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 10 | 3.41e-01 | 1.74e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 90 | 4.41e-03 | -1.74e-01 | 3.15e-02 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 18 | 2.02e-01 | 1.74e-01 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 12 | 2.98e-01 | -1.74e-01 | 5.31e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 54 | 2.74e-02 | -1.74e-01 | 1.17e-01 |
| GOBP PREPULSE INHIBITION | 12 | 2.98e-01 | 1.74e-01 | 5.31e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 50 | 3.38e-02 | -1.74e-01 | 1.35e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 3.42e-01 | -1.74e-01 | 5.73e-01 |
| GOBP NAD METABOLIC PROCESS | 48 | 3.77e-02 | -1.73e-01 | 1.44e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 18 | 2.03e-01 | -1.73e-01 | 4.27e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 6.11e-02 | -1.73e-01 | 2.00e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 20 | 1.80e-01 | -1.73e-01 | 3.98e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 21 | 1.69e-01 | -1.73e-01 | 3.83e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 143 | 3.59e-04 | -1.73e-01 | 4.20e-03 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 25 | 1.34e-01 | -1.73e-01 | 3.31e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 2.63e-01 | 1.73e-01 | 4.95e-01 |
| GOMF GROWTH FACTOR BINDING | 120 | 1.08e-03 | -1.73e-01 | 1.05e-02 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 66 | 1.52e-02 | -1.73e-01 | 7.68e-02 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 14 | 2.63e-01 | -1.73e-01 | 4.95e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 77 | 8.76e-03 | -1.73e-01 | 5.18e-02 |
| GOCC MYOSIN FILAMENT | 15 | 2.46e-01 | -1.73e-01 | 4.75e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 454 | 3.28e-10 | -1.73e-01 | 2.25e-08 |
| GOBP COENZYME A METABOLIC PROCESS | 18 | 2.05e-01 | -1.73e-01 | 4.29e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 20 | 1.81e-01 | -1.73e-01 | 4.00e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 134 | 5.68e-04 | -1.73e-01 | 6.22e-03 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 98 | 3.21e-03 | -1.72e-01 | 2.46e-02 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 154 | 2.27e-04 | -1.72e-01 | 2.86e-03 |
| GOCC LATE ENDOSOME MEMBRANE | 73 | 1.10e-02 | -1.72e-01 | 6.11e-02 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 30 | 1.03e-01 | -1.72e-01 | 2.78e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 15 | 2.48e-01 | -1.72e-01 | 4.78e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 71 | 1.22e-02 | -1.72e-01 | 6.59e-02 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 13 | 2.83e-01 | 1.72e-01 | 5.17e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 78 | 8.68e-03 | -1.72e-01 | 5.16e-02 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 3.02e-01 | 1.72e-01 | 5.35e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 23 | 1.54e-01 | -1.72e-01 | 3.61e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 20 | 1.83e-01 | -1.72e-01 | 4.02e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 17 | 2.20e-01 | -1.72e-01 | 4.47e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 140 | 4.56e-04 | -1.72e-01 | 5.14e-03 |
| GOBP SPINDLE ORGANIZATION | 171 | 1.11e-04 | -1.72e-01 | 1.63e-03 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 5.47e-02 | -1.71e-01 | 1.85e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 32 | 9.35e-02 | -1.71e-01 | 2.61e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 124 | 9.94e-04 | -1.71e-01 | 9.92e-03 |
| GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY | 12 | 3.04e-01 | -1.71e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 21 | 1.75e-01 | -1.71e-01 | 3.90e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 28 | 1.17e-01 | -1.71e-01 | 3.04e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 41 | 5.80e-02 | -1.71e-01 | 1.93e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 29 | 1.11e-01 | -1.71e-01 | 2.92e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 62 | 1.99e-02 | -1.71e-01 | 9.28e-02 |
| GOBP PIGMENT GRANULE ORGANIZATION | 34 | 8.45e-02 | -1.71e-01 | 2.44e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 21 | 1.75e-01 | -1.71e-01 | 3.91e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 29 | 1.11e-01 | -1.71e-01 | 2.93e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 14 | 2.68e-01 | -1.71e-01 | 5.01e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 81 | 7.89e-03 | -1.71e-01 | 4.85e-02 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 343 | 6.00e-08 | -1.71e-01 | 2.47e-06 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 45 | 4.76e-02 | -1.71e-01 | 1.68e-01 |
| GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 14 | 2.69e-01 | -1.71e-01 | 5.01e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 13 | 2.87e-01 | 1.71e-01 | 5.20e-01 |
| GOBP SYNAPTIC VESICLE BUDDING FROM PRESYNAPTIC ENDOCYTIC ZONE MEMBRANE | 10 | 3.50e-01 | -1.71e-01 | 5.80e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 748 | 3.26e-15 | -1.70e-01 | 1.00e-12 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 23 | 1.58e-01 | -1.70e-01 | 3.67e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 27 | 1.26e-01 | -1.70e-01 | 3.17e-01 |
| GOBP CARDIAC CHAMBER FORMATION | 10 | 3.52e-01 | 1.70e-01 | 5.81e-01 |
| GOBP CYTOKINE PRODUCTION | 640 | 2.91e-13 | -1.70e-01 | 4.38e-11 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 550 | 1.16e-11 | -1.70e-01 | 1.16e-09 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 15 | 2.54e-01 | -1.70e-01 | 4.85e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 85 | 6.80e-03 | -1.70e-01 | 4.32e-02 |
| GOBP INTERLEUKIN 1 BETA PRODUCTION | 72 | 1.27e-02 | -1.70e-01 | 6.82e-02 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 113 | 1.83e-03 | 1.70e-01 | 1.61e-02 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 22 | 1.68e-01 | -1.70e-01 | 3.81e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 20 | 1.89e-01 | 1.70e-01 | 4.09e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 10 | 3.53e-01 | -1.70e-01 | 5.81e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 4.65e-02 | -1.70e-01 | 1.66e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 34 | 8.70e-02 | -1.70e-01 | 2.49e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 13 | 2.90e-01 | -1.70e-01 | 5.23e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 17 | 2.26e-01 | 1.70e-01 | 4.54e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 442 | 1.17e-09 | -1.69e-01 | 7.11e-08 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 13 | 2.90e-01 | -1.69e-01 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 41 | 6.08e-02 | -1.69e-01 | 1.99e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 13 | 2.92e-01 | -1.69e-01 | 5.25e-01 |
| GOBP FATTY ACID ELONGATION | 12 | 3.11e-01 | 1.69e-01 | 5.42e-01 |
| GOCC EXTRACELLULAR SPACE | 807 | 6.11e-16 | -1.69e-01 | 1.97e-13 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 214 | 2.18e-05 | -1.69e-01 | 3.93e-04 |
| GOBP MUSCLE ATROPHY | 10 | 3.56e-01 | -1.69e-01 | 5.85e-01 |
| GOBP REGULATION OF MAST CELL DEGRANULATION | 22 | 1.71e-01 | -1.69e-01 | 3.86e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 24 | 1.53e-01 | -1.69e-01 | 3.60e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 40 | 6.53e-02 | -1.69e-01 | 2.08e-01 |
| GOBP REGULATION OF ENDOPEPTIDASE ACTIVITY | 216 | 2.06e-05 | -1.68e-01 | 3.75e-04 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 15 | 2.59e-01 | -1.68e-01 | 4.90e-01 |
| GOBP PROTEIN TRIMERIZATION | 15 | 2.59e-01 | -1.68e-01 | 4.90e-01 |
| GOMF BMP RECEPTOR BINDING | 10 | 3.57e-01 | 1.68e-01 | 5.86e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 12 | 3.13e-01 | -1.68e-01 | 5.45e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED | 22 | 1.72e-01 | -1.68e-01 | 3.87e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 13 | 2.94e-01 | -1.68e-01 | 5.26e-01 |
| GOBP MACROAUTOPHAGY | 270 | 2.09e-06 | -1.68e-01 | 5.11e-05 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 154 | 3.25e-04 | -1.68e-01 | 3.88e-03 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 2.45e-01 | -1.68e-01 | 4.73e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 54 | 3.29e-02 | -1.68e-01 | 1.32e-01 |
| GOMF NADP BINDING | 41 | 6.29e-02 | -1.68e-01 | 2.03e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 25 | 1.46e-01 | -1.68e-01 | 3.51e-01 |
| GOMF GUANYL RIBONUCLEOTIDE BINDING | 313 | 3.58e-07 | -1.68e-01 | 1.12e-05 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 13 | 2.95e-01 | -1.68e-01 | 5.28e-01 |
| GOBP SULFATION | 11 | 3.36e-01 | -1.68e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 143 | 5.54e-04 | -1.67e-01 | 6.07e-03 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 169 | 1.76e-04 | -1.67e-01 | 2.36e-03 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 10 | 3.59e-01 | -1.67e-01 | 5.87e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 83 | 8.42e-03 | -1.67e-01 | 5.02e-02 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 178 | 1.20e-04 | -1.67e-01 | 1.72e-03 |
| GOCC CELL SURFACE | 626 | 1.20e-12 | -1.67e-01 | 1.52e-10 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 77 | 1.12e-02 | -1.67e-01 | 6.17e-02 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 20 | 1.95e-01 | -1.67e-01 | 4.18e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 130 | 1.01e-03 | -1.67e-01 | 9.98e-03 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 53 | 3.54e-02 | -1.67e-01 | 1.39e-01 |
| GOBP MEMBRANE BIOGENESIS | 55 | 3.22e-02 | -1.67e-01 | 1.30e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 31 | 1.08e-01 | -1.67e-01 | 2.87e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 682 | 1.49e-13 | -1.67e-01 | 2.35e-11 |
| GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 10 | 3.61e-01 | 1.67e-01 | 5.88e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 23 | 1.66e-01 | -1.67e-01 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 28 | 1.27e-01 | 1.67e-01 | 3.18e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 328 | 2.23e-07 | -1.67e-01 | 7.62e-06 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 215 | 2.59e-05 | -1.67e-01 | 4.53e-04 |
| GOCC KINETOCHORE MICROTUBULE | 15 | 2.64e-01 | -1.67e-01 | 4.96e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 31 | 1.08e-01 | -1.67e-01 | 2.89e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 26 | 1.42e-01 | -1.67e-01 | 3.42e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 59 | 2.70e-02 | -1.67e-01 | 1.16e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 19 | 2.09e-01 | -1.67e-01 | 4.34e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 66 | 1.94e-02 | -1.67e-01 | 9.13e-02 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 93 | 5.57e-03 | -1.66e-01 | 3.72e-02 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 18 | 2.22e-01 | -1.66e-01 | 4.49e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 22 | 1.77e-01 | -1.66e-01 | 3.94e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 13 | 2.99e-01 | 1.66e-01 | 5.32e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 22 | 1.77e-01 | 1.66e-01 | 3.94e-01 |
| GOBP PRE MIRNA PROCESSING | 12 | 3.19e-01 | 1.66e-01 | 5.51e-01 |
| GOBP RRNA TRANSCRIPTION | 29 | 1.22e-01 | -1.66e-01 | 3.11e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 159 | 3.08e-04 | -1.66e-01 | 3.70e-03 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 33 | 9.91e-02 | -1.66e-01 | 2.71e-01 |
| GOBP NADP METABOLIC PROCESS | 49 | 4.46e-02 | -1.66e-01 | 1.62e-01 |
| GOBP REGULATION OF CELL ADHESION | 619 | 2.47e-12 | -1.66e-01 | 2.90e-10 |
| GOBP NK T CELL DIFFERENTIATION | 12 | 3.20e-01 | -1.66e-01 | 5.52e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 13 | 3.01e-01 | 1.66e-01 | 5.33e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 32 | 1.05e-01 | -1.66e-01 | 2.83e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 2.83e-01 | 1.66e-01 | 5.17e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 2.67e-01 | -1.66e-01 | 4.99e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 39 | 7.37e-02 | -1.66e-01 | 2.25e-01 |
| GOBP DEVELOPMENTAL MATURATION | 266 | 3.53e-06 | -1.66e-01 | 8.08e-05 |
| GOBP VIRAL PROCESS | 258 | 4.92e-06 | -1.66e-01 | 1.08e-04 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 31 | 1.11e-01 | -1.66e-01 | 2.92e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 54 | 3.54e-02 | -1.66e-01 | 1.39e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 17 | 2.38e-01 | 1.65e-01 | 4.66e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 20 | 2.00e-01 | 1.65e-01 | 4.24e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 19 | 2.12e-01 | 1.65e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 103 | 3.77e-03 | -1.65e-01 | 2.77e-02 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 11 | 3.43e-01 | -1.65e-01 | 5.73e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 2.38e-01 | 1.65e-01 | 4.66e-01 |
| GOBP LOCOMOTION | 975 | 4.81e-18 | -1.65e-01 | 3.11e-15 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 45 | 5.52e-02 | 1.65e-01 | 1.87e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 16 | 2.53e-01 | -1.65e-01 | 4.83e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 14 | 2.85e-01 | -1.65e-01 | 5.18e-01 |
| GOBP PLACENTA DEVELOPMENT | 133 | 1.02e-03 | -1.65e-01 | 1.01e-02 |
| GOBP LIVER REGENERATION | 12 | 3.22e-01 | -1.65e-01 | 5.54e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 43 | 6.13e-02 | 1.65e-01 | 2.00e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 51 | 4.17e-02 | -1.65e-01 | 1.54e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 265 | 4.02e-06 | -1.65e-01 | 9.09e-05 |
| GOBP REGULATION OF LOCOMOTION | 865 | 3.20e-16 | -1.65e-01 | 1.11e-13 |
| GOBP RESPONSE TO BMP | 115 | 2.32e-03 | -1.65e-01 | 1.94e-02 |
| GOMF ACTIN BINDING | 369 | 6.26e-08 | -1.65e-01 | 2.51e-06 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 37 | 8.37e-02 | -1.64e-01 | 2.43e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 333 | 2.74e-07 | -1.64e-01 | 8.98e-06 |
| GOMF CARBOHYDRATE BINDING | 177 | 1.66e-04 | -1.64e-01 | 2.25e-03 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 75 | 1.39e-02 | -1.64e-01 | 7.21e-02 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 12 | 3.24e-01 | 1.64e-01 | 5.56e-01 |
| GOBP MICROVILLUS ORGANIZATION | 20 | 2.03e-01 | -1.64e-01 | 4.27e-01 |
| GOCC MCM COMPLEX | 11 | 3.46e-01 | -1.64e-01 | 5.75e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 36 | 8.82e-02 | -1.64e-01 | 2.51e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 89 | 7.48e-03 | -1.64e-01 | 4.66e-02 |
| GOBP INTERLEUKIN 4 PRODUCTION | 26 | 1.48e-01 | -1.64e-01 | 3.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 69 | 1.85e-02 | -1.64e-01 | 8.82e-02 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 13 | 3.06e-01 | 1.64e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 22 | 1.83e-01 | -1.64e-01 | 4.02e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 22 | 1.83e-01 | -1.64e-01 | 4.02e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 52 | 4.09e-02 | -1.64e-01 | 1.52e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 19 | 2.16e-01 | -1.64e-01 | 4.43e-01 |
| GOBP CGAS STING SIGNALING PATHWAY | 15 | 2.72e-01 | -1.64e-01 | 5.04e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 32 | 1.09e-01 | -1.64e-01 | 2.89e-01 |
| GOBP REGULATION OF INTERLEUKIN 4 PRODUCTION | 21 | 1.94e-01 | -1.64e-01 | 4.17e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 56 | 3.42e-02 | -1.64e-01 | 1.36e-01 |
| GOBP MANGANESE ION TRANSPORT | 11 | 3.47e-01 | -1.64e-01 | 5.77e-01 |
| GOBP REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 97 | 5.40e-03 | -1.64e-01 | 3.64e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 11 | 3.48e-01 | -1.64e-01 | 5.78e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 20 | 2.06e-01 | 1.63e-01 | 4.31e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 15 | 2.73e-01 | 1.63e-01 | 5.06e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 197 | 7.97e-05 | -1.63e-01 | 1.22e-03 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 11 | 3.49e-01 | -1.63e-01 | 5.78e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 371 | 7.38e-08 | -1.63e-01 | 2.82e-06 |
| GOMF CALCIUM ION BINDING | 401 | 2.37e-08 | -1.63e-01 | 1.09e-06 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 13 | 3.09e-01 | -1.63e-01 | 5.41e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 20 | 2.07e-01 | 1.63e-01 | 4.32e-01 |
| GOBP RESPONSE TO CADMIUM ION | 31 | 1.16e-01 | -1.63e-01 | 3.02e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 22 | 1.86e-01 | 1.63e-01 | 4.05e-01 |
| GOMF ACTIN FILAMENT BINDING | 184 | 1.42e-04 | -1.63e-01 | 1.98e-03 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.29e-01 | -1.63e-01 | 5.60e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 32 | 1.11e-01 | -1.63e-01 | 2.93e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 20 | 2.08e-01 | -1.63e-01 | 4.33e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 109 | 3.37e-03 | -1.63e-01 | 2.55e-02 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 18 | 2.32e-01 | -1.63e-01 | 4.61e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 27 | 1.44e-01 | 1.63e-01 | 3.46e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 1.78e-01 | -1.62e-01 | 3.94e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 61 | 2.84e-02 | -1.62e-01 | 1.20e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 38 | 8.35e-02 | -1.62e-01 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 13 | 3.11e-01 | -1.62e-01 | 5.42e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 123 | 1.91e-03 | -1.62e-01 | 1.65e-02 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 56 | 3.59e-02 | -1.62e-01 | 1.41e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 10 | 3.75e-01 | -1.62e-01 | 6.02e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 37 | 8.81e-02 | -1.62e-01 | 2.50e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 18 | 2.34e-01 | 1.62e-01 | 4.62e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 138 | 1.03e-03 | -1.62e-01 | 1.02e-02 |
| GOBP GLOMERULUS DEVELOPMENT | 63 | 2.63e-02 | -1.62e-01 | 1.14e-01 |
| GOBP REGULATION OF VESICLE SIZE | 19 | 2.22e-01 | -1.62e-01 | 4.49e-01 |
| GOMF POLY PURINE TRACT BINDING | 27 | 1.46e-01 | 1.62e-01 | 3.49e-01 |
| GOCC LIPID DROPLET | 87 | 9.12e-03 | -1.62e-01 | 5.33e-02 |
| GOMF ANNEALING ACTIVITY | 13 | 3.12e-01 | 1.62e-01 | 5.44e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 19 | 2.22e-01 | 1.62e-01 | 4.50e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 100 | 5.31e-03 | -1.61e-01 | 3.61e-02 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.33e-01 | 1.61e-01 | 3.29e-01 |
| GOBP KINETOCHORE ASSEMBLY | 12 | 3.33e-01 | -1.61e-01 | 5.64e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 3.77e-01 | 1.61e-01 | 6.04e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 17 | 2.50e-01 | 1.61e-01 | 4.80e-01 |
| GOBP PROTEIN POLYMERIZATION | 240 | 1.75e-05 | -1.61e-01 | 3.27e-04 |
| GOBP HINDBRAIN MORPHOGENESIS | 46 | 5.85e-02 | 1.61e-01 | 1.94e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 13 | 3.14e-01 | -1.61e-01 | 5.45e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 13 | 3.14e-01 | -1.61e-01 | 5.45e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 20 | 2.12e-01 | -1.61e-01 | 4.39e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 238 | 1.97e-05 | -1.61e-01 | 3.62e-04 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 69 | 2.09e-02 | -1.61e-01 | 9.60e-02 |
| GOBP LIPID DROPLET FORMATION | 12 | 3.35e-01 | -1.61e-01 | 5.65e-01 |
| GOMF CYCLOSPORIN A BINDING | 13 | 3.15e-01 | 1.61e-01 | 5.47e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 2.97e-01 | -1.61e-01 | 5.31e-01 |
| GOBP HAIR CYCLE PHASE | 12 | 3.35e-01 | -1.61e-01 | 5.65e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 11 | 3.56e-01 | 1.61e-01 | 5.85e-01 |
| GOBP BONE TRABECULA FORMATION | 10 | 3.80e-01 | 1.60e-01 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 55 | 3.97e-02 | 1.60e-01 | 1.49e-01 |
| GOCC NUCLEAR LAMINA | 14 | 2.99e-01 | -1.60e-01 | 5.31e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 23 | 1.83e-01 | -1.60e-01 | 4.02e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 18 | 2.39e-01 | -1.60e-01 | 4.67e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 17 | 2.53e-01 | -1.60e-01 | 4.83e-01 |
| GOBP VASCULATURE DEVELOPMENT | 668 | 2.27e-12 | -1.60e-01 | 2.71e-10 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 162 | 4.43e-04 | -1.60e-01 | 5.00e-03 |
| GOCC COATED VESICLE | 181 | 2.07e-04 | -1.60e-01 | 2.66e-03 |
| GOCC NURD COMPLEX | 17 | 2.53e-01 | -1.60e-01 | 4.83e-01 |
| GOBP MUCUS SECRETION | 16 | 2.68e-01 | -1.60e-01 | 5.00e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 26 | 1.58e-01 | -1.60e-01 | 3.67e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 12 | 3.37e-01 | -1.60e-01 | 5.68e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 20 | 2.16e-01 | -1.60e-01 | 4.43e-01 |
| GOBP RESPONSE TO VITAMIN | 29 | 1.36e-01 | -1.60e-01 | 3.34e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 14 | 3.01e-01 | 1.60e-01 | 5.33e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 18 | 2.41e-01 | -1.60e-01 | 4.69e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 21 | 2.06e-01 | -1.60e-01 | 4.31e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 11 | 3.60e-01 | 1.59e-01 | 5.88e-01 |
| GOBP RENAL ABSORPTION | 24 | 1.76e-01 | 1.59e-01 | 3.93e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 15 | 2.85e-01 | -1.59e-01 | 5.18e-01 |
| GOBP ORGANELLE FUSION | 131 | 1.65e-03 | -1.59e-01 | 1.48e-02 |
| GOBP T CELL ACTIVATION | 414 | 2.95e-08 | -1.59e-01 | 1.29e-06 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 18 | 2.42e-01 | -1.59e-01 | 4.70e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 13 | 3.20e-01 | 1.59e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 13 | 3.20e-01 | -1.59e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 12 | 3.39e-01 | 1.59e-01 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 68 | 2.31e-02 | -1.59e-01 | 1.04e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 31 | 1.25e-01 | -1.59e-01 | 3.16e-01 |
| GOCC SPECIFIC GRANULE | 10 | 3.83e-01 | -1.59e-01 | 6.10e-01 |
| GOBP MITOPHAGY | 53 | 4.51e-02 | -1.59e-01 | 1.62e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 22 | 1.96e-01 | -1.59e-01 | 4.19e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 99 | 6.29e-03 | -1.59e-01 | 4.08e-02 |
| GOCC RUFFLE MEMBRANE | 65 | 2.67e-02 | -1.59e-01 | 1.15e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 58 | 3.63e-02 | -1.59e-01 | 1.41e-01 |
| GOBP EXTRACELLULAR STRUCTURE ORGANIZATION | 251 | 1.50e-05 | -1.59e-01 | 2.90e-04 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 12 | 3.40e-01 | -1.59e-01 | 5.71e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 36 | 9.94e-02 | -1.59e-01 | 2.72e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 2.87e-01 | 1.59e-01 | 5.21e-01 |
| GOBP MICROVILLUS ASSEMBLY | 17 | 2.57e-01 | -1.59e-01 | 4.87e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 199 | 1.17e-04 | -1.59e-01 | 1.69e-03 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 44 | 6.87e-02 | -1.59e-01 | 2.15e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 16 | 2.72e-01 | -1.58e-01 | 5.05e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 14 | 3.05e-01 | -1.58e-01 | 5.37e-01 |
| GOCC INTERCELLULAR BRIDGE | 75 | 1.78e-02 | -1.58e-01 | 8.58e-02 |
| GOBP VESICLE ORGANIZATION | 301 | 2.44e-06 | -1.58e-01 | 5.80e-05 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 13 | 3.23e-01 | -1.58e-01 | 5.55e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 17 | 2.59e-01 | -1.58e-01 | 4.89e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 295 | 3.13e-06 | -1.58e-01 | 7.22e-05 |
| GOCC HOPS COMPLEX | 12 | 3.43e-01 | -1.58e-01 | 5.73e-01 |
| GOBP RESPONSE TO ETHANOL | 43 | 7.30e-02 | -1.58e-01 | 2.23e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 147 | 9.72e-04 | -1.58e-01 | 9.73e-03 |
| GOCC SARCOPLASMIC RETICULUM | 74 | 1.91e-02 | -1.58e-01 | 9.02e-02 |
| GOBP VACUOLAR LOCALIZATION | 65 | 2.80e-02 | -1.58e-01 | 1.18e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 15 | 2.90e-01 | 1.58e-01 | 5.23e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 76 | 1.76e-02 | -1.58e-01 | 8.53e-02 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 14 | 3.07e-01 | -1.58e-01 | 5.39e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 87 | 1.11e-02 | -1.58e-01 | 6.15e-02 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 45 | 6.75e-02 | -1.58e-01 | 2.12e-01 |
| GOMF PROTEASE BINDING | 131 | 1.86e-03 | -1.58e-01 | 1.63e-02 |
| GOCC ZYMOGEN GRANULE | 17 | 2.61e-01 | -1.58e-01 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 10 | 3.88e-01 | -1.58e-01 | 6.14e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 30 | 1.35e-01 | 1.58e-01 | 3.33e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 15 | 2.91e-01 | -1.57e-01 | 5.24e-01 |
| GOMF PHOSPHOLIPASE BINDING | 24 | 1.82e-01 | -1.57e-01 | 4.01e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 117 | 3.31e-03 | -1.57e-01 | 2.52e-02 |
| GOBP RESPONSE TO UV A | 10 | 3.89e-01 | -1.57e-01 | 6.14e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 18 | 2.48e-01 | 1.57e-01 | 4.78e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 17 | 2.62e-01 | -1.57e-01 | 4.93e-01 |
| GOBP ENDOCYTOSIS | 567 | 1.92e-10 | -1.57e-01 | 1.39e-08 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 22 | 2.02e-01 | -1.57e-01 | 4.25e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 37 | 9.84e-02 | 1.57e-01 | 2.70e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 19 | 2.36e-01 | -1.57e-01 | 4.64e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 84 | 1.30e-02 | -1.57e-01 | 6.90e-02 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 3.90e-01 | -1.57e-01 | 6.15e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 648 | 1.27e-11 | -1.57e-01 | 1.22e-09 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 27 | 1.59e-01 | -1.57e-01 | 3.68e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 56 | 4.25e-02 | -1.57e-01 | 1.56e-01 |
| GOBP HEART VALVE FORMATION | 15 | 2.93e-01 | -1.57e-01 | 5.26e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO PLASMA MEMBRANE | 10 | 3.91e-01 | -1.57e-01 | 6.15e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 36 | 1.04e-01 | -1.57e-01 | 2.80e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 77 | 1.76e-02 | -1.57e-01 | 8.56e-02 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 75 | 1.93e-02 | -1.56e-01 | 9.08e-02 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 117 | 3.51e-03 | -1.56e-01 | 2.63e-02 |
| GOBP RESPONSE TO INTERFERON ALPHA | 24 | 1.85e-01 | -1.56e-01 | 4.05e-01 |
| GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 37 | 1.00e-01 | -1.56e-01 | 2.74e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 15 | 2.95e-01 | -1.56e-01 | 5.28e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 1.39e-01 | 1.56e-01 | 3.38e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 28 | 1.53e-01 | -1.56e-01 | 3.60e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 39 | 9.17e-02 | -1.56e-01 | 2.57e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 13 | 3.30e-01 | -1.56e-01 | 5.61e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 10 | 3.93e-01 | -1.56e-01 | 6.17e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 3.30e-01 | -1.56e-01 | 5.61e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 613 | 5.70e-11 | -1.56e-01 | 4.61e-09 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 32 | 1.27e-01 | -1.56e-01 | 3.20e-01 |
| GOBP IMP METABOLIC PROCESS | 17 | 2.66e-01 | 1.56e-01 | 4.98e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 20 | 2.28e-01 | -1.56e-01 | 4.55e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 12 | 3.50e-01 | -1.56e-01 | 5.80e-01 |
| GOCC BRUSH BORDER MEMBRANE | 61 | 3.55e-02 | -1.56e-01 | 1.39e-01 |
| GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 144 | 1.27e-03 | -1.56e-01 | 1.21e-02 |
| GOBP AUTOPHAGY OF PEROXISOME | 14 | 3.13e-01 | -1.56e-01 | 5.45e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 14 | 3.13e-01 | -1.56e-01 | 5.45e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 24 | 1.87e-01 | 1.56e-01 | 4.07e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 14 | 3.14e-01 | 1.56e-01 | 5.45e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 11 | 3.72e-01 | -1.55e-01 | 5.98e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 258 | 1.80e-05 | -1.55e-01 | 3.36e-04 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 36 | 1.07e-01 | -1.55e-01 | 2.86e-01 |
| GOCC CCR4 NOT COMPLEX | 15 | 2.98e-01 | 1.55e-01 | 5.31e-01 |
| GOBP CELL ACTIVATION | 804 | 1.07e-13 | -1.55e-01 | 1.82e-11 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 63 | 3.31e-02 | -1.55e-01 | 1.33e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 84 | 1.39e-02 | -1.55e-01 | 7.21e-02 |
| GOBP NUCLEOPHAGY | 23 | 1.97e-01 | -1.55e-01 | 4.20e-01 |
| GOCC SITE OF POLARIZED GROWTH | 184 | 2.88e-04 | -1.55e-01 | 3.53e-03 |
| GOBP ETHER METABOLIC PROCESS | 19 | 2.42e-01 | -1.55e-01 | 4.70e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 85 | 1.35e-02 | -1.55e-01 | 7.05e-02 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 12 | 3.53e-01 | -1.55e-01 | 5.81e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 28 | 1.56e-01 | -1.55e-01 | 3.65e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 61 | 3.66e-02 | -1.55e-01 | 1.42e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 91 | 1.08e-02 | 1.55e-01 | 6.03e-02 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 13 | 3.34e-01 | -1.55e-01 | 5.64e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 837 | 4.52e-14 | -1.55e-01 | 9.13e-12 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 21 | 2.20e-01 | -1.55e-01 | 4.46e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 10 | 3.97e-01 | -1.55e-01 | 6.20e-01 |
| GOCC SARCOPLASM | 93 | 1.00e-02 | -1.55e-01 | 5.72e-02 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 13 | 3.35e-01 | -1.55e-01 | 5.65e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 15 | 3.00e-01 | -1.55e-01 | 5.33e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 226 | 6.50e-05 | -1.55e-01 | 1.02e-03 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 25 | 1.81e-01 | -1.54e-01 | 4.00e-01 |
| GOCC MICROTUBULE | 369 | 3.89e-07 | -1.54e-01 | 1.21e-05 |
| GOBP CYTOKINESIS | 143 | 1.46e-03 | -1.54e-01 | 1.34e-02 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 18 | 2.57e-01 | 1.54e-01 | 4.87e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 12 | 3.55e-01 | -1.54e-01 | 5.84e-01 |
| GOMF DELTA CATENIN BINDING | 10 | 3.99e-01 | -1.54e-01 | 6.21e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 117 | 4.05e-03 | -1.54e-01 | 2.93e-02 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 89 | 1.22e-02 | -1.54e-01 | 6.59e-02 |
| GOMF NEUROTROPHIN BINDING | 12 | 3.56e-01 | -1.54e-01 | 5.85e-01 |
| GOCC CLATHRIN COAT | 44 | 7.78e-02 | -1.54e-01 | 2.33e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 10 | 4.00e-01 | 1.54e-01 | 6.22e-01 |
| GOBP RESPONSE TO AXON INJURY | 64 | 3.37e-02 | -1.54e-01 | 1.35e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 18 | 2.60e-01 | 1.53e-01 | 4.91e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS | 12 | 3.58e-01 | -1.53e-01 | 5.87e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 24 | 1.94e-01 | -1.53e-01 | 4.16e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 33 | 1.28e-01 | -1.53e-01 | 3.21e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 311 | 3.64e-06 | -1.53e-01 | 8.28e-05 |
| GOBP REGULATION OF ACTIVATED T CELL PROLIFERATION | 25 | 1.85e-01 | -1.53e-01 | 4.05e-01 |
| GOMF DEAMINASE ACTIVITY | 21 | 2.25e-01 | -1.53e-01 | 4.52e-01 |
| GOBP ORGANELLE LOCALIZATION | 508 | 4.30e-09 | -1.53e-01 | 2.26e-07 |
| GOBP PLATELET AGGREGATION | 49 | 6.42e-02 | -1.53e-01 | 2.06e-01 |
| GOCC INO80 COMPLEX | 16 | 2.90e-01 | 1.53e-01 | 5.23e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 255 | 2.76e-05 | -1.53e-01 | 4.80e-04 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 20 | 2.37e-01 | -1.53e-01 | 4.65e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 134 | 2.31e-03 | -1.53e-01 | 1.94e-02 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 13 | 3.41e-01 | -1.53e-01 | 5.71e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 15 | 3.06e-01 | -1.53e-01 | 5.39e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 29 | 1.55e-01 | -1.53e-01 | 3.64e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 80 | 1.85e-02 | -1.53e-01 | 8.82e-02 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 21 | 2.27e-01 | -1.52e-01 | 4.54e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 112 | 5.38e-03 | -1.52e-01 | 3.64e-02 |
| GOBP CYTOSKELETON ORGANIZATION | 1150 | 6.97e-18 | -1.52e-01 | 3.75e-15 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 72 | 2.56e-02 | -1.52e-01 | 1.11e-01 |
| GOBP CGMP MEDIATED SIGNALING | 20 | 2.39e-01 | -1.52e-01 | 4.67e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 590 | 3.31e-10 | -1.52e-01 | 2.25e-08 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 23 | 2.06e-01 | -1.52e-01 | 4.31e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 12 | 3.62e-01 | -1.52e-01 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 35 | 1.20e-01 | -1.52e-01 | 3.08e-01 |
| GOBP STEROID CATABOLIC PROCESS | 12 | 3.62e-01 | -1.52e-01 | 5.89e-01 |
| GOMF PROTEIN KINASE C BINDING | 55 | 5.13e-02 | -1.52e-01 | 1.78e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 17 | 2.79e-01 | -1.52e-01 | 5.13e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 14 | 3.26e-01 | -1.52e-01 | 5.57e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 30 | 1.50e-01 | 1.52e-01 | 3.57e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 26 | 1.81e-01 | -1.52e-01 | 4.00e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 15 | 3.10e-01 | -1.51e-01 | 5.42e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 95 | 1.08e-02 | -1.51e-01 | 6.05e-02 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 13 | 3.45e-01 | 1.51e-01 | 5.74e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 50 | 6.41e-02 | -1.51e-01 | 2.06e-01 |
| GOCC CELL LEADING EDGE | 353 | 1.13e-06 | -1.51e-01 | 3.06e-05 |
| GOCC PRERIBOSOME | 100 | 9.02e-03 | -1.51e-01 | 5.29e-02 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 11 | 3.85e-01 | 1.51e-01 | 6.12e-01 |
| GOBP CHOLESTEROL STORAGE | 22 | 2.20e-01 | -1.51e-01 | 4.46e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 86 | 1.55e-02 | -1.51e-01 | 7.78e-02 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 35 | 1.22e-01 | -1.51e-01 | 3.11e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 461 | 3.09e-08 | -1.51e-01 | 1.34e-06 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 11 | 3.86e-01 | -1.51e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 365 | 7.94e-07 | -1.51e-01 | 2.25e-05 |
| GOMF NADPLUS ADP RIBOSYLTRANSFERASE ACTIVITY | 21 | 2.31e-01 | -1.51e-01 | 4.60e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 33 | 1.34e-01 | -1.51e-01 | 3.30e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 11 | 3.86e-01 | -1.51e-01 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 20 | 2.43e-01 | -1.51e-01 | 4.71e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 21 | 2.32e-01 | -1.51e-01 | 4.60e-01 |
| GOBP VESICLE LOCALIZATION | 194 | 3.00e-04 | -1.51e-01 | 3.66e-03 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 2.97e-01 | -1.51e-01 | 5.30e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 34 | 1.29e-01 | -1.51e-01 | 3.22e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 48 | 7.13e-02 | -1.51e-01 | 2.20e-01 |
| GOBP EMBRYO IMPLANTATION | 47 | 7.46e-02 | -1.50e-01 | 2.27e-01 |
| GOBP LIPID DIGESTION | 11 | 3.88e-01 | 1.50e-01 | 6.14e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 17 | 2.83e-01 | 1.50e-01 | 5.17e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 64 | 3.78e-02 | -1.50e-01 | 1.44e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 10 | 4.11e-01 | -1.50e-01 | 6.31e-01 |
| GOBP MAINTENANCE OF LOCATION | 280 | 1.62e-05 | -1.50e-01 | 3.11e-04 |
| GOBP P38MAPK CASCADE | 54 | 5.66e-02 | -1.50e-01 | 1.89e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 10 | 4.11e-01 | -1.50e-01 | 6.31e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 100 | 9.58e-03 | -1.50e-01 | 5.53e-02 |
| GOCC EARLY ENDOSOME | 290 | 1.16e-05 | -1.50e-01 | 2.32e-04 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 16 | 2.99e-01 | -1.50e-01 | 5.31e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 27 | 1.77e-01 | -1.50e-01 | 3.94e-01 |
| GOBP MITOCHONDRIAL FUSION | 26 | 1.86e-01 | -1.50e-01 | 4.05e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 193 | 3.35e-04 | -1.50e-01 | 3.97e-03 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 34 | 1.30e-01 | -1.50e-01 | 3.25e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 62 | 4.13e-02 | -1.50e-01 | 1.53e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 27 | 1.78e-01 | -1.50e-01 | 3.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 378 | 6.18e-07 | -1.50e-01 | 1.83e-05 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 65 | 3.69e-02 | -1.50e-01 | 1.43e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 3.90e-01 | -1.50e-01 | 6.15e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 167 | 8.58e-04 | -1.50e-01 | 8.75e-03 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 29 | 1.63e-01 | -1.50e-01 | 3.75e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 13 | 3.50e-01 | -1.50e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 15 | 3.16e-01 | -1.49e-01 | 5.48e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 3.51e-01 | -1.49e-01 | 5.81e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 148 | 1.73e-03 | -1.49e-01 | 1.54e-02 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 21 | 2.36e-01 | -1.49e-01 | 4.64e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 19 | 2.60e-01 | 1.49e-01 | 4.91e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 133 | 3.00e-03 | -1.49e-01 | 2.34e-02 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 14 | 3.34e-01 | 1.49e-01 | 5.64e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 47 | 7.70e-02 | -1.49e-01 | 2.32e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 25 | 1.97e-01 | -1.49e-01 | 4.19e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 10 | 4.14e-01 | 1.49e-01 | 6.35e-01 |
| GOBP CALCIUM ION IMPORT | 55 | 5.60e-02 | -1.49e-01 | 1.88e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 12 | 3.72e-01 | 1.49e-01 | 5.98e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 14 | 3.35e-01 | 1.49e-01 | 5.65e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 10 | 4.15e-01 | 1.49e-01 | 6.36e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 10 | 4.15e-01 | 1.49e-01 | 6.36e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 52 | 6.37e-02 | -1.49e-01 | 2.05e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 46 | 8.11e-02 | -1.49e-01 | 2.38e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 159 | 1.23e-03 | -1.49e-01 | 1.18e-02 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 17 | 2.89e-01 | -1.49e-01 | 5.21e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 73 | 2.83e-02 | -1.49e-01 | 1.19e-01 |
| GOBP T CELL HOMEOSTASIS | 43 | 9.20e-02 | -1.49e-01 | 2.58e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 18 | 2.75e-01 | -1.49e-01 | 5.09e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 55 | 5.70e-02 | -1.48e-01 | 1.91e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 16 | 3.04e-01 | -1.48e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 141 | 2.39e-03 | -1.48e-01 | 1.97e-02 |
| GOCC CILIARY TRANSITION FIBER | 10 | 4.17e-01 | 1.48e-01 | 6.36e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 1.74e-01 | -1.48e-01 | 3.90e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 39 | 1.09e-01 | -1.48e-01 | 2.90e-01 |
| GOBP KERATINIZATION | 11 | 3.95e-01 | -1.48e-01 | 6.18e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 10 | 4.17e-01 | -1.48e-01 | 6.37e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1187 | 2.10e-17 | -1.48e-01 | 1.04e-14 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 14 | 3.38e-01 | -1.48e-01 | 5.68e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 26 | 1.92e-01 | -1.48e-01 | 4.14e-01 |
| GOBP AXON EXTENSION | 108 | 8.01e-03 | -1.48e-01 | 4.87e-02 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 558 | 2.85e-09 | -1.48e-01 | 1.59e-07 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 191 | 4.36e-04 | -1.48e-01 | 4.93e-03 |
| GOCC OXIDOREDUCTASE COMPLEX | 104 | 9.26e-03 | 1.48e-01 | 5.39e-02 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 31 | 1.54e-01 | -1.48e-01 | 3.63e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 64 | 4.10e-02 | 1.48e-01 | 1.52e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 26 | 1.92e-01 | -1.48e-01 | 4.14e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 35 | 1.31e-01 | 1.48e-01 | 3.25e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 72 | 3.03e-02 | -1.48e-01 | 1.25e-01 |
| GOMF POLY A BINDING | 20 | 2.53e-01 | 1.48e-01 | 4.83e-01 |
| GOCC SIN3 TYPE COMPLEX | 13 | 3.57e-01 | 1.48e-01 | 5.86e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 17 | 2.92e-01 | -1.48e-01 | 5.25e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 10 | 4.19e-01 | -1.48e-01 | 6.38e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 10 | 4.19e-01 | -1.48e-01 | 6.38e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 461 | 6.40e-08 | -1.48e-01 | 2.55e-06 |
| GOMF GDP BINDING | 71 | 3.17e-02 | -1.48e-01 | 1.29e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 63 | 4.29e-02 | -1.48e-01 | 1.57e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 494 | 2.29e-08 | -1.48e-01 | 1.06e-06 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 32 | 1.49e-01 | -1.47e-01 | 3.54e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 366 | 1.38e-06 | -1.47e-01 | 3.61e-05 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 43 | 9.45e-02 | -1.47e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 28 | 1.77e-01 | -1.47e-01 | 3.94e-01 |
| GOBP INORGANIC ANION TRANSPORT | 94 | 1.36e-02 | -1.47e-01 | 7.12e-02 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 56 | 5.68e-02 | -1.47e-01 | 1.90e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 50 | 7.19e-02 | -1.47e-01 | 2.21e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 10 | 4.20e-01 | 1.47e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 108 | 8.31e-03 | -1.47e-01 | 4.98e-02 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 13 | 3.58e-01 | -1.47e-01 | 5.87e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 16 | 3.08e-01 | -1.47e-01 | 5.41e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 58 | 5.28e-02 | -1.47e-01 | 1.81e-01 |
| GOBP CELL MOTILITY | 1325 | 7.51e-19 | -1.47e-01 | 5.40e-16 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 351 | 2.40e-06 | -1.47e-01 | 5.75e-05 |
| GOMF LNCRNA BINDING | 23 | 2.23e-01 | 1.47e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 389 | 7.20e-07 | -1.47e-01 | 2.07e-05 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 114 | 6.79e-03 | -1.47e-01 | 4.32e-02 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 18 | 2.81e-01 | 1.47e-01 | 5.14e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 16 | 3.09e-01 | -1.47e-01 | 5.41e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 26 | 1.95e-01 | -1.47e-01 | 4.18e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 192 | 4.63e-04 | -1.47e-01 | 5.20e-03 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 32 | 1.51e-01 | -1.47e-01 | 3.57e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 3.10e-01 | -1.47e-01 | 5.41e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 72 | 3.14e-02 | -1.47e-01 | 1.28e-01 |
| GOCC CYTOSOLIC REGION | 64 | 4.26e-02 | -1.47e-01 | 1.56e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 142 | 2.61e-03 | -1.47e-01 | 2.10e-02 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 30 | 1.65e-01 | -1.47e-01 | 3.78e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 2.14e-01 | 1.46e-01 | 4.41e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 36 | 1.29e-01 | 1.46e-01 | 3.21e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 10 | 4.23e-01 | -1.46e-01 | 6.40e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 17 | 2.96e-01 | -1.46e-01 | 5.29e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 67 | 3.84e-02 | -1.46e-01 | 1.46e-01 |
| GOMF CERAMIDE BINDING | 14 | 3.43e-01 | -1.46e-01 | 5.73e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 18 | 2.83e-01 | 1.46e-01 | 5.17e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 14 | 3.44e-01 | 1.46e-01 | 5.73e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 36 | 1.29e-01 | -1.46e-01 | 3.22e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 10 | 4.24e-01 | 1.46e-01 | 6.41e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 50 | 7.40e-02 | -1.46e-01 | 2.26e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 133 | 3.68e-03 | -1.46e-01 | 2.72e-02 |
| GOMF MRNA 5 UTR BINDING | 22 | 2.36e-01 | -1.46e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 89 | 1.78e-02 | -1.45e-01 | 8.58e-02 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 20 | 2.60e-01 | 1.45e-01 | 4.91e-01 |
| GOMF SYNTAXIN BINDING | 56 | 5.99e-02 | -1.45e-01 | 1.97e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 24 | 2.18e-01 | -1.45e-01 | 4.45e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 11 | 4.04e-01 | -1.45e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 25 | 2.09e-01 | -1.45e-01 | 4.34e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 15 | 3.30e-01 | -1.45e-01 | 5.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 155 | 1.84e-03 | -1.45e-01 | 1.61e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 43 | 9.99e-02 | -1.45e-01 | 2.73e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 69 | 3.73e-02 | -1.45e-01 | 1.44e-01 |
| GOMF HEPARIN BINDING | 114 | 7.53e-03 | -1.45e-01 | 4.69e-02 |
| GOBP MYELOID CELL HOMEOSTASIS | 183 | 7.30e-04 | -1.45e-01 | 7.63e-03 |
| GOBP REGULATION OF KINASE ACTIVITY | 479 | 6.23e-08 | -1.45e-01 | 2.51e-06 |
| GOBP LAMELLIPODIUM ORGANIZATION | 85 | 2.10e-02 | -1.45e-01 | 9.63e-02 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 54 | 6.56e-02 | -1.45e-01 | 2.09e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 81 | 2.43e-02 | -1.45e-01 | 1.08e-01 |
| GOMF WW DOMAIN BINDING | 18 | 2.87e-01 | -1.45e-01 | 5.21e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 13 | 3.66e-01 | -1.45e-01 | 5.93e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 87 | 1.97e-02 | -1.45e-01 | 9.23e-02 |
| GOCC LYTIC VACUOLE MEMBRANE | 184 | 7.24e-04 | -1.45e-01 | 7.61e-03 |
| GOBP CELLULAR RESPIRATION | 197 | 4.72e-04 | 1.45e-01 | 5.26e-03 |
| GOMF ENZYME INHIBITOR ACTIVITY | 240 | 1.17e-04 | -1.45e-01 | 1.69e-03 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 29 | 1.78e-01 | -1.45e-01 | 3.94e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 1.85e-01 | -1.45e-01 | 4.05e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 11 | 4.06e-01 | -1.45e-01 | 6.27e-01 |
| GOBP NEURON PROJECTION EXTENSION | 156 | 1.86e-03 | -1.45e-01 | 1.62e-02 |
| GOCC AGGRESOME | 26 | 2.02e-01 | -1.45e-01 | 4.25e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 10 | 4.29e-01 | 1.45e-01 | 6.47e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 25 | 2.11e-01 | -1.45e-01 | 4.37e-01 |
| GOBP POLYOL METABOLIC PROCESS | 83 | 2.30e-02 | -1.44e-01 | 1.03e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 358 | 2.88e-06 | -1.44e-01 | 6.70e-05 |
| GOBP AXONAL TRANSPORT | 61 | 5.12e-02 | -1.44e-01 | 1.78e-01 |
| GOCC COPI VESICLE COAT | 11 | 4.07e-01 | -1.44e-01 | 6.28e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 50 | 7.75e-02 | -1.44e-01 | 2.33e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 39 | 1.19e-01 | -1.44e-01 | 3.07e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 42 | 1.06e-01 | 1.44e-01 | 2.84e-01 |
| GOBP VASCULAR WOUND HEALING | 17 | 3.03e-01 | -1.44e-01 | 5.35e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 399 | 8.27e-07 | -1.44e-01 | 2.33e-05 |
| GOBP CHLORIDE TRANSPORT | 62 | 4.97e-02 | -1.44e-01 | 1.74e-01 |
| GOMF PEPTIDE HORMONE BINDING | 26 | 2.03e-01 | 1.44e-01 | 4.27e-01 |
| GOBP MAPK CASCADE | 620 | 1.12e-09 | -1.44e-01 | 6.89e-08 |
| GOBP MITRAL VALVE DEVELOPMENT | 15 | 3.34e-01 | -1.44e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 22 | 2.42e-01 | -1.44e-01 | 4.70e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 20 | 2.65e-01 | -1.44e-01 | 4.97e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 51 | 7.54e-02 | -1.44e-01 | 2.28e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 28 | 1.87e-01 | -1.44e-01 | 4.07e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 29 | 1.80e-01 | -1.44e-01 | 3.98e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 149 | 2.47e-03 | -1.44e-01 | 2.03e-02 |
| GOBP MYOBLAST PROLIFERATION | 23 | 2.33e-01 | 1.44e-01 | 4.62e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 350 | 4.14e-06 | -1.44e-01 | 9.22e-05 |
| GOBP DETECTION OF LIGHT STIMULUS | 19 | 2.79e-01 | -1.44e-01 | 5.13e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 62 | 5.07e-02 | -1.44e-01 | 1.76e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 211 | 3.36e-04 | -1.44e-01 | 3.97e-03 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 10 | 4.32e-01 | 1.43e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 14 | 3.53e-01 | 1.43e-01 | 5.81e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 10 | 4.32e-01 | -1.43e-01 | 6.51e-01 |
| GOCC U2 SNRNP | 21 | 2.56e-01 | 1.43e-01 | 4.86e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 218 | 2.73e-04 | -1.43e-01 | 3.36e-03 |
| GOBP GOLGI LOCALIZATION | 12 | 3.90e-01 | -1.43e-01 | 6.15e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 40 | 1.17e-01 | -1.43e-01 | 3.04e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 40 | 1.17e-01 | -1.43e-01 | 3.04e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 13 | 3.72e-01 | -1.43e-01 | 5.98e-01 |
| GOBP DNA REPLICATION INITIATION | 30 | 1.75e-01 | 1.43e-01 | 3.91e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 42 | 1.09e-01 | -1.43e-01 | 2.89e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 145 | 2.98e-03 | -1.43e-01 | 2.34e-02 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 55 | 6.67e-02 | -1.43e-01 | 2.11e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 65 | 4.63e-02 | -1.43e-01 | 1.66e-01 |
| GOBP DENSE CORE GRANULE TRANSPORT | 12 | 3.91e-01 | -1.43e-01 | 6.15e-01 |
| GOBP VIRAL GENOME REPLICATION | 96 | 1.56e-02 | -1.43e-01 | 7.83e-02 |
| GOBP MATURATION OF LSU RRNA | 25 | 2.16e-01 | -1.43e-01 | 4.43e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 19 | 2.81e-01 | 1.43e-01 | 5.14e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 407 | 8.33e-07 | -1.43e-01 | 2.33e-05 |
| GOBP EXOCYTOSIS | 276 | 4.61e-05 | -1.43e-01 | 7.61e-04 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 24 | 2.26e-01 | -1.43e-01 | 4.53e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 23 | 2.36e-01 | -1.43e-01 | 4.64e-01 |
| GOBP FATTY ACID TRANSPORT | 72 | 3.62e-02 | -1.43e-01 | 1.41e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 20 | 2.69e-01 | 1.43e-01 | 5.01e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 20 | 2.69e-01 | -1.43e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 175 | 1.15e-03 | -1.43e-01 | 1.11e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 65 | 4.68e-02 | -1.43e-01 | 1.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 46 | 9.45e-02 | -1.43e-01 | 2.62e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 31 | 1.70e-01 | 1.43e-01 | 3.84e-01 |
| GOCC INTEGRIN COMPLEX | 30 | 1.77e-01 | -1.42e-01 | 3.94e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 10 | 4.35e-01 | 1.42e-01 | 6.53e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 10 | 4.35e-01 | -1.42e-01 | 6.53e-01 |
| GOMF SNARE BINDING | 93 | 1.77e-02 | -1.42e-01 | 8.58e-02 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 12 | 3.93e-01 | -1.42e-01 | 6.17e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 11 | 4.14e-01 | -1.42e-01 | 6.34e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 85 | 2.35e-02 | -1.42e-01 | 1.05e-01 |
| GOBP OVULATION CYCLE PROCESS | 34 | 1.51e-01 | -1.42e-01 | 3.58e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 341 | 6.81e-06 | -1.42e-01 | 1.43e-04 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 218 | 3.05e-04 | -1.42e-01 | 3.67e-03 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 97 | 1.56e-02 | -1.42e-01 | 7.83e-02 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 24 | 2.28e-01 | -1.42e-01 | 4.55e-01 |
| GOBP CALCIUM ION TRANSPORT | 307 | 1.95e-05 | -1.42e-01 | 3.61e-04 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 19 | 2.84e-01 | -1.42e-01 | 5.17e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 2.02e-01 | 1.42e-01 | 4.25e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 84 | 2.46e-02 | -1.42e-01 | 1.08e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 30 | 1.78e-01 | -1.42e-01 | 3.96e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 36 | 1.41e-01 | -1.42e-01 | 3.40e-01 |
| GOCC GOLGI MEMBRANE | 245 | 1.34e-04 | -1.42e-01 | 1.91e-03 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 62 | 5.35e-02 | -1.42e-01 | 1.83e-01 |
| GOCC NUCLEAR PORE | 73 | 3.63e-02 | -1.42e-01 | 1.41e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 16 | 3.26e-01 | -1.42e-01 | 5.57e-01 |
| GOBP TRACHEA DEVELOPMENT | 14 | 3.58e-01 | -1.42e-01 | 5.87e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 12 | 3.95e-01 | -1.42e-01 | 6.18e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 10 | 4.38e-01 | -1.42e-01 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 81 | 2.77e-02 | -1.42e-01 | 1.17e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 14 | 3.59e-01 | -1.42e-01 | 5.87e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 150 | 2.81e-03 | -1.42e-01 | 2.23e-02 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 306 | 2.21e-05 | -1.41e-01 | 3.94e-04 |
| GOBP IMPORT INTO CELL | 719 | 1.46e-10 | -1.41e-01 | 1.10e-08 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 13 | 3.78e-01 | -1.41e-01 | 6.04e-01 |
| GOBP REGULATION OF CELL GROWTH | 357 | 4.87e-06 | -1.41e-01 | 1.08e-04 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 21 | 2.63e-01 | -1.41e-01 | 4.95e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 18 | 3.00e-01 | 1.41e-01 | 5.33e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 62 | 5.49e-02 | 1.41e-01 | 1.86e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 4.18e-01 | -1.41e-01 | 6.38e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 14 | 3.61e-01 | 1.41e-01 | 5.89e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1086 | 8.27e-15 | -1.41e-01 | 2.06e-12 |
| GOBP RESPONSE TO DOPAMINE | 31 | 1.74e-01 | -1.41e-01 | 3.90e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 3.61e-01 | 1.41e-01 | 5.89e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 20 | 2.75e-01 | -1.41e-01 | 5.09e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 26 | 2.14e-01 | -1.41e-01 | 4.41e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 10 | 4.41e-01 | -1.41e-01 | 6.56e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 32 | 1.68e-01 | 1.41e-01 | 3.81e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 23 | 2.43e-01 | 1.41e-01 | 4.71e-01 |
| GOBP HIPPO SIGNALING | 39 | 1.29e-01 | -1.41e-01 | 3.22e-01 |
| GOBP SNRNA 3 END PROCESSING | 18 | 3.02e-01 | 1.41e-01 | 5.34e-01 |
| GOCC ASTER | 11 | 4.20e-01 | -1.40e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 39 | 1.29e-01 | -1.40e-01 | 3.23e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 95 | 1.82e-02 | -1.40e-01 | 8.70e-02 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 33 | 1.63e-01 | -1.40e-01 | 3.75e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 12 | 4.00e-01 | 1.40e-01 | 6.22e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 26 | 2.16e-01 | 1.40e-01 | 4.43e-01 |
| GOBP TUBULIN DEACETYLATION | 21 | 2.67e-01 | 1.40e-01 | 4.99e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 34 | 1.58e-01 | -1.40e-01 | 3.67e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 14 | 3.65e-01 | -1.40e-01 | 5.92e-01 |
| GOBP AMYLOID BETA CLEARANCE | 33 | 1.64e-01 | -1.40e-01 | 3.77e-01 |
| GOCC VACUOLE | 508 | 7.87e-08 | -1.40e-01 | 2.98e-06 |
| GOBP T CELL EXTRAVASATION | 12 | 4.02e-01 | -1.40e-01 | 6.23e-01 |
| GOBP OVULATION | 16 | 3.33e-01 | -1.40e-01 | 5.64e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 42 | 1.17e-01 | -1.40e-01 | 3.04e-01 |
| GOCC CMG COMPLEX | 11 | 4.23e-01 | -1.40e-01 | 6.40e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 18 | 3.05e-01 | 1.40e-01 | 5.38e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 16 | 3.34e-01 | -1.40e-01 | 5.64e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 76 | 3.55e-02 | -1.40e-01 | 1.39e-01 |
| GOMF TROPOMYOSIN BINDING | 13 | 3.84e-01 | -1.40e-01 | 6.10e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 328 | 1.49e-05 | -1.40e-01 | 2.89e-04 |
| GOCC DESMOSOME | 15 | 3.50e-01 | 1.39e-01 | 5.80e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 54 | 7.65e-02 | -1.39e-01 | 2.31e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 32 | 1.73e-01 | -1.39e-01 | 3.88e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 92 | 2.10e-02 | 1.39e-01 | 9.65e-02 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 45 | 1.06e-01 | -1.39e-01 | 2.85e-01 |
| GOMF PRE MRNA BINDING | 35 | 1.54e-01 | 1.39e-01 | 3.62e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 26 | 2.19e-01 | -1.39e-01 | 4.46e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 69 | 4.58e-02 | 1.39e-01 | 1.64e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 38 | 1.38e-01 | -1.39e-01 | 3.37e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 16 | 3.35e-01 | -1.39e-01 | 5.65e-01 |
| GOBP INTRACELLULAR SIGNALING CASSETTE | 1409 | 6.39e-18 | -1.39e-01 | 3.75e-15 |
| GOBP DETECTION OF OTHER ORGANISM | 13 | 3.85e-01 | -1.39e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 61 | 6.08e-02 | -1.39e-01 | 1.99e-01 |
| GOBP MEMBRANE ORGANIZATION | 630 | 3.38e-09 | -1.39e-01 | 1.83e-07 |
| GOBP HEME A METABOLIC PROCESS | 10 | 4.48e-01 | -1.39e-01 | 6.60e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 24 | 2.40e-01 | 1.39e-01 | 4.67e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1256 | 3.24e-16 | -1.39e-01 | 1.11e-13 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 15 | 3.53e-01 | 1.39e-01 | 5.81e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 79 | 3.33e-02 | -1.39e-01 | 1.33e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 189 | 1.04e-03 | -1.39e-01 | 1.02e-02 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 208 | 5.85e-04 | -1.39e-01 | 6.39e-03 |
| GOBP STEROL HOMEOSTASIS | 74 | 3.95e-02 | -1.39e-01 | 1.49e-01 |
| GOBP MATURATION OF SSU RRNA | 44 | 1.12e-01 | -1.38e-01 | 2.94e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 169 | 1.93e-03 | -1.38e-01 | 1.66e-02 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 23 | 2.51e-01 | -1.38e-01 | 4.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 86 | 2.70e-02 | -1.38e-01 | 1.16e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 569 | 2.19e-08 | -1.38e-01 | 1.02e-06 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 58 | 6.93e-02 | -1.38e-01 | 2.16e-01 |
| GOBP AXIS ELONGATION | 29 | 1.99e-01 | 1.38e-01 | 4.22e-01 |
| GOCC COPII VESICLE COAT | 15 | 3.55e-01 | -1.38e-01 | 5.84e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 267 | 1.09e-04 | -1.38e-01 | 1.61e-03 |
| GOMF PHOSPHOLIPID BINDING | 376 | 4.73e-06 | -1.38e-01 | 1.05e-04 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 23 | 2.52e-01 | 1.38e-01 | 4.83e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 4.50e-01 | -1.38e-01 | 6.63e-01 |
| GOBP LIPID STORAGE | 81 | 3.21e-02 | -1.38e-01 | 1.30e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 18 | 3.12e-01 | -1.38e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 657 | 2.16e-09 | -1.38e-01 | 1.23e-07 |
| GOCC ENDOSOME | 809 | 4.02e-11 | -1.38e-01 | 3.44e-09 |
| GOMF RRNA BINDING | 69 | 4.83e-02 | -1.38e-01 | 1.70e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 25 | 2.34e-01 | -1.38e-01 | 4.62e-01 |
| GOBP MEMBRANE FISSION | 31 | 1.85e-01 | -1.38e-01 | 4.05e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 49 | 9.59e-02 | -1.38e-01 | 2.65e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 41 | 1.28e-01 | -1.38e-01 | 3.21e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 364 | 7.12e-06 | -1.37e-01 | 1.48e-04 |
| GOCC SMALL SUBUNIT PROCESSOME | 68 | 5.01e-02 | -1.37e-01 | 1.75e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 41 | 1.28e-01 | -1.37e-01 | 3.21e-01 |
| GOMF ANKYRIN BINDING | 18 | 3.13e-01 | -1.37e-01 | 5.45e-01 |
| GOBP URETER DEVELOPMENT | 14 | 3.74e-01 | 1.37e-01 | 6.01e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 61 | 6.41e-02 | -1.37e-01 | 2.06e-01 |
| GOBP TRABECULA MORPHOGENESIS | 48 | 1.00e-01 | -1.37e-01 | 2.74e-01 |
| GOBP ICOSANOID SECRETION | 27 | 2.18e-01 | -1.37e-01 | 4.45e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 10 | 4.53e-01 | 1.37e-01 | 6.66e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 27 | 2.18e-01 | -1.37e-01 | 4.45e-01 |
| GOBP CELL MATURATION | 139 | 5.39e-03 | -1.37e-01 | 3.64e-02 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 147 | 4.23e-03 | -1.37e-01 | 3.04e-02 |
| GOMF GAMMA TUBULIN BINDING | 31 | 1.87e-01 | -1.37e-01 | 4.07e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 106 | 1.51e-02 | -1.37e-01 | 7.63e-02 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 61 | 6.48e-02 | -1.37e-01 | 2.07e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 18 | 3.15e-01 | -1.37e-01 | 5.47e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 26 | 2.28e-01 | -1.37e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 60 | 6.74e-02 | -1.37e-01 | 2.12e-01 |
| GOBP COCHLEA MORPHOGENESIS | 19 | 3.03e-01 | 1.37e-01 | 5.35e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 62 | 6.32e-02 | -1.36e-01 | 2.04e-01 |
| GOCC LYTIC VACUOLE | 426 | 1.49e-06 | -1.36e-01 | 3.80e-05 |
| GOBP LYMPHOCYTE ACTIVATION | 584 | 2.09e-08 | -1.36e-01 | 9.90e-07 |
| GOBP ORGANELLE FISSION | 370 | 7.16e-06 | -1.36e-01 | 1.49e-04 |
| GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 21 | 2.80e-01 | -1.36e-01 | 5.13e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 60 | 6.81e-02 | -1.36e-01 | 2.14e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 10 | 4.56e-01 | -1.36e-01 | 6.69e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 13 | 3.95e-01 | -1.36e-01 | 6.18e-01 |
| GOBP GERM CELL PROLIFERATION | 10 | 4.56e-01 | -1.36e-01 | 6.69e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 16 | 3.46e-01 | 1.36e-01 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 10 | 4.56e-01 | -1.36e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 23 | 2.59e-01 | 1.36e-01 | 4.90e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 13 | 3.96e-01 | -1.36e-01 | 6.19e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 22 | 2.70e-01 | -1.36e-01 | 5.01e-01 |
| GOBP MESODERM MORPHOGENESIS | 48 | 1.03e-01 | -1.36e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 20 | 2.93e-01 | -1.36e-01 | 5.25e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 276 | 1.06e-04 | -1.36e-01 | 1.57e-03 |
| GOCC VESICLE MEMBRANE | 542 | 7.58e-08 | -1.36e-01 | 2.88e-06 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 11 | 4.36e-01 | -1.36e-01 | 6.53e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 13 | 3.97e-01 | 1.36e-01 | 6.20e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 46 | 1.12e-01 | -1.36e-01 | 2.94e-01 |
| GOBP CELLULAR RESPONSE TO PH | 12 | 4.16e-01 | 1.36e-01 | 6.36e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 96 | 2.18e-02 | -1.36e-01 | 9.93e-02 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 51 | 9.42e-02 | -1.36e-01 | 2.62e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 19 | 3.07e-01 | -1.36e-01 | 5.39e-01 |
| GOBP PEPTIDE HORMONE PROCESSING | 17 | 3.34e-01 | -1.35e-01 | 5.64e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 24 | 2.51e-01 | 1.35e-01 | 4.81e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 55 | 8.24e-02 | -1.35e-01 | 2.41e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 45 | 1.16e-01 | -1.35e-01 | 3.02e-01 |
| GOBP BLASTOCYST GROWTH | 26 | 2.32e-01 | -1.35e-01 | 4.61e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 30 | 2.00e-01 | 1.35e-01 | 4.23e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 1006 | 6.41e-13 | -1.35e-01 | 9.01e-11 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 55 | 8.27e-02 | -1.35e-01 | 2.41e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 40 | 1.39e-01 | -1.35e-01 | 3.39e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 42 | 1.30e-01 | -1.35e-01 | 3.24e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 28 | 2.16e-01 | -1.35e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 56 | 8.05e-02 | -1.35e-01 | 2.38e-01 |
| GOBP NEUROBLAST DIVISION | 14 | 3.82e-01 | -1.35e-01 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 13 | 3.99e-01 | -1.35e-01 | 6.21e-01 |
| GOMF CYCLIN BINDING | 28 | 2.16e-01 | 1.35e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 11 | 4.38e-01 | -1.35e-01 | 6.54e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 254 | 2.19e-04 | -1.35e-01 | 2.78e-03 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 35 | 1.67e-01 | -1.35e-01 | 3.80e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 25 | 2.43e-01 | -1.35e-01 | 4.71e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 41 | 1.35e-01 | -1.35e-01 | 3.32e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 13 | 4.00e-01 | 1.35e-01 | 6.22e-01 |
| GOCC POLE PLASM | 13 | 4.00e-01 | -1.35e-01 | 6.22e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 49 | 1.03e-01 | -1.35e-01 | 2.79e-01 |
| GOMF HISTONE KINASE ACTIVITY | 23 | 2.64e-01 | 1.35e-01 | 4.96e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 743 | 5.64e-10 | -1.35e-01 | 3.72e-08 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1377 | 1.50e-16 | -1.35e-01 | 6.47e-14 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 15 | 3.67e-01 | -1.35e-01 | 5.93e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 16 | 3.52e-01 | -1.35e-01 | 5.81e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 205 | 9.24e-04 | -1.34e-01 | 9.35e-03 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 12 | 4.20e-01 | 1.34e-01 | 6.38e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 15 | 3.67e-01 | 1.34e-01 | 5.94e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 363 | 1.17e-05 | -1.34e-01 | 2.32e-04 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 291 | 8.46e-05 | -1.34e-01 | 1.29e-03 |
| GOCC CLATHRIN COATED VESICLE | 101 | 1.98e-02 | -1.34e-01 | 9.26e-02 |
| GOBP RESPONSE TO AMINE | 16 | 3.52e-01 | 1.34e-01 | 5.81e-01 |
| GOBP NEURON FATE SPECIFICATION | 16 | 3.53e-01 | 1.34e-01 | 5.81e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 115 | 1.30e-02 | -1.34e-01 | 6.90e-02 |
| GOBP AXO DENDRITIC TRANSPORT | 81 | 3.71e-02 | -1.34e-01 | 1.43e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 33 | 1.83e-01 | -1.34e-01 | 4.02e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 146 | 5.24e-03 | -1.34e-01 | 3.58e-02 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 43 | 1.28e-01 | -1.34e-01 | 3.21e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 20 | 3.00e-01 | 1.34e-01 | 5.32e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 1039 | 5.01e-13 | -1.34e-01 | 7.37e-11 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 13 | 4.03e-01 | -1.34e-01 | 6.25e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 66 | 6.01e-02 | -1.34e-01 | 1.98e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 277 | 1.35e-04 | -1.34e-01 | 1.91e-03 |
| GOBP SYNAPTIC VESICLE RECYCLING | 90 | 2.88e-02 | -1.33e-01 | 1.21e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 44 | 1.26e-01 | -1.33e-01 | 3.17e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 49 | 1.06e-01 | -1.33e-01 | 2.85e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 4.05e-01 | -1.33e-01 | 6.27e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 106 | 1.79e-02 | -1.33e-01 | 8.62e-02 |
| GOMF CYTOKINE ACTIVITY | 80 | 3.96e-02 | -1.33e-01 | 1.49e-01 |
| GOBP NODAL SIGNALING PATHWAY | 11 | 4.44e-01 | -1.33e-01 | 6.58e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 14 | 3.88e-01 | 1.33e-01 | 6.14e-01 |
| GOBP PROTEIN TARGETING | 248 | 3.14e-04 | -1.33e-01 | 3.76e-03 |
| GOCC TERMINAL BOUTON | 54 | 9.07e-02 | 1.33e-01 | 2.55e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 271 | 1.70e-04 | -1.33e-01 | 2.30e-03 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 23 | 2.70e-01 | -1.33e-01 | 5.01e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 265 | 2.02e-04 | -1.33e-01 | 2.63e-03 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 48 | 1.11e-01 | -1.33e-01 | 2.93e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 16 | 3.58e-01 | 1.33e-01 | 5.87e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 78 | 4.27e-02 | -1.33e-01 | 1.56e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 105 | 1.89e-02 | -1.33e-01 | 8.95e-02 |
| GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 14 | 3.90e-01 | -1.33e-01 | 6.15e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 146 | 5.71e-03 | -1.33e-01 | 3.78e-02 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 88 | 3.16e-02 | -1.33e-01 | 1.29e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 40 | 1.47e-01 | -1.33e-01 | 3.51e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 52 | 9.81e-02 | 1.33e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 19 | 3.17e-01 | -1.33e-01 | 5.49e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 232 | 5.14e-04 | -1.33e-01 | 5.70e-03 |
| GOBP REGULATION OF PHOSPHORYLATION | 865 | 5.25e-11 | -1.33e-01 | 4.41e-09 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 37 | 1.63e-01 | 1.33e-01 | 3.75e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 227 | 5.97e-04 | -1.33e-01 | 6.50e-03 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 40 | 1.47e-01 | -1.33e-01 | 3.52e-01 |
| GOCC MEMBRANE COAT | 89 | 3.11e-02 | -1.32e-01 | 1.28e-01 |
| GOCC GOLGI APPARATUS | 1190 | 3.09e-14 | -1.32e-01 | 6.88e-12 |
| GOCC COMPACT MYELIN | 15 | 3.75e-01 | -1.32e-01 | 6.02e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 138 | 7.38e-03 | -1.32e-01 | 4.61e-02 |
| GOMF MYOSIN BINDING | 62 | 7.19e-02 | -1.32e-01 | 2.21e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 71 | 5.42e-02 | -1.32e-01 | 1.85e-01 |
| GOMF KINASE BINDING | 749 | 9.70e-10 | -1.32e-01 | 6.21e-08 |
| GOMF SMAD BINDING | 74 | 4.94e-02 | -1.32e-01 | 1.73e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 4.48e-01 | 1.32e-01 | 6.61e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 35 | 1.76e-01 | 1.32e-01 | 3.93e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 385 | 9.24e-06 | -1.32e-01 | 1.88e-04 |
| GOCC COP9 SIGNALOSOME | 28 | 2.26e-01 | -1.32e-01 | 4.54e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 20 | 3.07e-01 | 1.32e-01 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 22 | 2.84e-01 | -1.32e-01 | 5.18e-01 |
| GOCC CILIARY MEMBRANE | 42 | 1.39e-01 | 1.32e-01 | 3.39e-01 |
| GOMF ORGANIC ACID BINDING | 137 | 7.77e-03 | -1.32e-01 | 4.80e-02 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 462 | 1.34e-06 | -1.32e-01 | 3.53e-05 |
| GOBP REGULATION OF GTPASE ACTIVITY | 249 | 3.53e-04 | -1.32e-01 | 4.14e-03 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 459 | 1.46e-06 | -1.32e-01 | 3.73e-05 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 16 | 3.62e-01 | 1.32e-01 | 5.89e-01 |
| GOBP SPROUTING ANGIOGENESIS | 111 | 1.66e-02 | -1.32e-01 | 8.19e-02 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 11 | 4.50e-01 | 1.32e-01 | 6.63e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 255 | 3.04e-04 | -1.32e-01 | 3.67e-03 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 12 | 4.30e-01 | -1.32e-01 | 6.48e-01 |
| GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 34 | 1.84e-01 | 1.32e-01 | 4.04e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 15 | 3.78e-01 | -1.32e-01 | 6.04e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 27 | 2.37e-01 | -1.32e-01 | 4.65e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 14 | 3.94e-01 | -1.32e-01 | 6.18e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 14 | 3.94e-01 | 1.31e-01 | 6.18e-01 |
| GOCC ENDOSOME MEMBRANE | 262 | 2.58e-04 | -1.31e-01 | 3.21e-03 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 46 | 1.23e-01 | -1.31e-01 | 3.13e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 77 | 4.66e-02 | -1.31e-01 | 1.66e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 463 | 1.46e-06 | -1.31e-01 | 3.73e-05 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 95 | 2.72e-02 | -1.31e-01 | 1.16e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 30 | 2.14e-01 | -1.31e-01 | 4.41e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 627 | 2.57e-08 | -1.31e-01 | 1.16e-06 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 27 | 2.39e-01 | -1.31e-01 | 4.67e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 204 | 1.30e-03 | -1.31e-01 | 1.23e-02 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 22 | 2.88e-01 | 1.31e-01 | 5.21e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 63 | 7.29e-02 | -1.31e-01 | 2.23e-01 |
| GOBP CHROMOSOME SEGREGATION | 327 | 5.16e-05 | -1.31e-01 | 8.34e-04 |
| GOBP REGULATION OF SPINDLE CHECKPOINT | 20 | 3.12e-01 | -1.31e-01 | 5.43e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 29 | 2.24e-01 | 1.31e-01 | 4.51e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 1064 | 1.08e-12 | -1.31e-01 | 1.42e-10 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 157 | 4.84e-03 | -1.30e-01 | 3.38e-02 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 15 | 3.82e-01 | -1.30e-01 | 6.08e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 58 | 8.59e-02 | -1.30e-01 | 2.47e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 76 | 4.95e-02 | -1.30e-01 | 1.73e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 16 | 3.67e-01 | -1.30e-01 | 5.93e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 23 | 2.80e-01 | -1.30e-01 | 5.13e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 851 | 1.59e-10 | -1.30e-01 | 1.17e-08 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 14 | 3.99e-01 | 1.30e-01 | 6.21e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 88 | 3.50e-02 | -1.30e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 47 | 1.23e-01 | -1.30e-01 | 3.13e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 17 | 3.53e-01 | 1.30e-01 | 5.82e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 43 | 1.40e-01 | 1.30e-01 | 3.40e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 281 | 1.85e-04 | -1.30e-01 | 2.44e-03 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1341 | 3.42e-15 | -1.30e-01 | 1.00e-12 |
| GOBP ATP TRANSPORT | 14 | 4.00e-01 | -1.30e-01 | 6.22e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 56 | 9.30e-02 | -1.30e-01 | 2.60e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 715 | 4.33e-09 | -1.30e-01 | 2.26e-07 |
| GOBP REPLACEMENT OSSIFICATION | 32 | 2.04e-01 | -1.30e-01 | 4.28e-01 |
| GOBP ACUTE PHASE RESPONSE | 22 | 2.92e-01 | -1.30e-01 | 5.25e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 17 | 3.55e-01 | -1.30e-01 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 27 | 2.44e-01 | -1.30e-01 | 4.72e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 84 | 4.01e-02 | -1.30e-01 | 1.50e-01 |
| GOCC TRANS GOLGI NETWORK | 206 | 1.37e-03 | -1.30e-01 | 1.28e-02 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 72 | 5.74e-02 | -1.30e-01 | 1.92e-01 |
| GOBP NEUTROPHIL ACTIVATION | 27 | 2.44e-01 | -1.30e-01 | 4.72e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 40 | 1.56e-01 | -1.30e-01 | 3.65e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 28 | 2.36e-01 | -1.29e-01 | 4.64e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 28 | 2.36e-01 | -1.29e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 397 | 1.06e-05 | -1.29e-01 | 2.13e-04 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 13 | 4.20e-01 | 1.29e-01 | 6.38e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 44 | 1.38e-01 | -1.29e-01 | 3.37e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 204 | 1.51e-03 | -1.29e-01 | 1.38e-02 |
| GOCC STEREOCILIUM | 33 | 2.00e-01 | -1.29e-01 | 4.23e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 12 | 4.39e-01 | -1.29e-01 | 6.55e-01 |
| GOCC VACUOLAR MEMBRANE | 232 | 7.26e-04 | -1.29e-01 | 7.61e-03 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 12 | 4.39e-01 | -1.29e-01 | 6.55e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 32 | 2.07e-01 | -1.29e-01 | 4.31e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 895 | 8.44e-11 | -1.29e-01 | 6.42e-09 |
| GOBP REGULATION OF BODY FLUID LEVELS | 229 | 7.90e-04 | -1.29e-01 | 8.15e-03 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 15 | 3.87e-01 | -1.29e-01 | 6.13e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 13 | 4.21e-01 | -1.29e-01 | 6.39e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 4.80e-01 | 1.29e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 38 | 1.69e-01 | -1.29e-01 | 3.83e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 110 | 1.96e-02 | -1.29e-01 | 9.21e-02 |
| GOBP AXONEME ASSEMBLY | 37 | 1.75e-01 | 1.29e-01 | 3.91e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 231 | 7.64e-04 | -1.29e-01 | 7.97e-03 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 19 | 3.31e-01 | -1.29e-01 | 5.62e-01 |
| GOMF 5S RRNA BINDING | 13 | 4.21e-01 | -1.29e-01 | 6.39e-01 |
| GOMF ALPHA TUBULIN BINDING | 38 | 1.70e-01 | -1.29e-01 | 3.84e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 20 | 3.19e-01 | -1.29e-01 | 5.52e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 23 | 2.85e-01 | -1.29e-01 | 5.19e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 12 | 4.40e-01 | -1.29e-01 | 6.56e-01 |
| GOMF HORMONE RECEPTOR BINDING | 15 | 3.88e-01 | -1.29e-01 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 30 | 2.23e-01 | -1.29e-01 | 4.50e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 16 | 3.74e-01 | 1.28e-01 | 6.01e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 4.05e-01 | -1.28e-01 | 6.27e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 83 | 4.33e-02 | 1.28e-01 | 1.58e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 11 | 4.61e-01 | -1.28e-01 | 6.73e-01 |
| GOBP CELL GROWTH | 435 | 4.90e-06 | -1.28e-01 | 1.08e-04 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 17 | 3.60e-01 | -1.28e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 52 | 1.10e-01 | -1.28e-01 | 2.92e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 24 | 2.78e-01 | -1.28e-01 | 5.12e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 59 | 8.92e-02 | -1.28e-01 | 2.52e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 116 | 1.74e-02 | -1.28e-01 | 8.47e-02 |
| GOBP CELL MIGRATION IN HINDBRAIN | 17 | 3.61e-01 | 1.28e-01 | 5.89e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 271 | 3.01e-04 | -1.28e-01 | 3.66e-03 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 40 | 1.62e-01 | -1.28e-01 | 3.74e-01 |
| GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 94 | 3.23e-02 | -1.28e-01 | 1.31e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 11 | 4.63e-01 | -1.28e-01 | 6.75e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 47 | 1.30e-01 | -1.28e-01 | 3.24e-01 |
| GOCC STEREOCILIUM BUNDLE | 39 | 1.68e-01 | -1.28e-01 | 3.80e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 38 | 1.73e-01 | -1.28e-01 | 3.88e-01 |
| GOBP REGULATION OF OSSIFICATION | 101 | 2.69e-02 | -1.28e-01 | 1.15e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 30 | 2.27e-01 | -1.28e-01 | 4.54e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 12 | 4.44e-01 | -1.28e-01 | 6.58e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 23 | 2.90e-01 | 1.27e-01 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 158 | 5.76e-03 | -1.27e-01 | 3.81e-02 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 308 | 1.26e-04 | -1.27e-01 | 1.80e-03 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 27 | 2.52e-01 | -1.27e-01 | 4.83e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 64 | 7.86e-02 | -1.27e-01 | 2.34e-01 |
| GOCC EXOCYST | 16 | 3.79e-01 | -1.27e-01 | 6.05e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 373 | 2.72e-05 | -1.27e-01 | 4.74e-04 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 25 | 2.72e-01 | -1.27e-01 | 5.04e-01 |
| GOBP HEMOPOIESIS | 792 | 1.69e-09 | -1.27e-01 | 1.00e-07 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 582 | 2.01e-07 | -1.27e-01 | 6.97e-06 |
| GOBP NUCLEUS ORGANIZATION | 123 | 1.53e-02 | -1.27e-01 | 7.71e-02 |
| GOBP REGULATION OF PROTEOLYSIS | 508 | 1.15e-06 | -1.27e-01 | 3.07e-05 |
| GOBP ENDOCARDIUM DEVELOPMENT | 12 | 4.47e-01 | -1.27e-01 | 6.60e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 887 | 2.21e-10 | -1.27e-01 | 1.55e-08 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 10 | 4.88e-01 | 1.27e-01 | 6.95e-01 |
| GOMF TETRAPYRROLE BINDING | 80 | 5.06e-02 | -1.27e-01 | 1.76e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 36 | 1.89e-01 | -1.27e-01 | 4.09e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 73 | 6.19e-02 | -1.26e-01 | 2.01e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 82 | 4.80e-02 | -1.26e-01 | 1.69e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 94 | 3.43e-02 | -1.26e-01 | 1.36e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 70 | 6.77e-02 | -1.26e-01 | 2.13e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 325 | 9.46e-05 | -1.26e-01 | 1.43e-03 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 29 | 2.39e-01 | -1.26e-01 | 4.67e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 11 | 4.68e-01 | 1.26e-01 | 6.80e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 11 | 4.68e-01 | -1.26e-01 | 6.80e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 11 | 4.68e-01 | -1.26e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 29 | 2.39e-01 | -1.26e-01 | 4.67e-01 |
| GOBP EXPORT FROM CELL | 706 | 1.38e-08 | -1.26e-01 | 6.64e-07 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 41 | 1.62e-01 | -1.26e-01 | 3.74e-01 |
| GOBP GOLGI ORGANIZATION | 129 | 1.34e-02 | -1.26e-01 | 7.02e-02 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 198 | 2.25e-03 | -1.26e-01 | 1.88e-02 |
| GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX | 20 | 3.29e-01 | 1.26e-01 | 5.60e-01 |
| GOBP RESPONSE TO INSULIN | 221 | 1.27e-03 | -1.26e-01 | 1.21e-02 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 20 | 3.29e-01 | -1.26e-01 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 132 | 1.25e-02 | -1.26e-01 | 6.72e-02 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 26 | 2.66e-01 | -1.26e-01 | 4.98e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 180 | 3.61e-03 | -1.26e-01 | 2.68e-02 |
| GOCC ENDOPLASMIC RETICULUM | 1396 | 7.90e-15 | -1.26e-01 | 2.04e-12 |
| GOMF GLUTAMATE RECEPTOR BINDING | 64 | 8.19e-02 | -1.26e-01 | 2.40e-01 |
| GOBP CELL ADHESION | 1056 | 8.19e-12 | -1.26e-01 | 8.54e-10 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 36 | 1.92e-01 | -1.26e-01 | 4.14e-01 |
| GOMF LIPID KINASE ACTIVITY | 35 | 1.98e-01 | -1.26e-01 | 4.21e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 18 | 3.56e-01 | -1.26e-01 | 5.85e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 42 | 1.59e-01 | -1.26e-01 | 3.69e-01 |
| GOBP NEGATIVE REGULATION OF CELL COMMUNICATION | 1188 | 5.80e-13 | -1.26e-01 | 8.34e-11 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 19 | 3.43e-01 | -1.26e-01 | 5.73e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 27 | 2.59e-01 | -1.25e-01 | 4.90e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 987 | 4.05e-11 | -1.25e-01 | 3.44e-09 |
| GOMF CARDIOLIPIN BINDING | 12 | 4.52e-01 | -1.25e-01 | 6.65e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 21 | 3.20e-01 | -1.25e-01 | 5.52e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 14 | 4.17e-01 | -1.25e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 31 | 2.27e-01 | -1.25e-01 | 4.55e-01 |
| GOBP PROTEIN SUMOYLATION | 41 | 1.65e-01 | -1.25e-01 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 233 | 1.02e-03 | -1.25e-01 | 1.01e-02 |
| GOBP NEGATIVE REGULATION OF GROWTH | 206 | 1.99e-03 | -1.25e-01 | 1.70e-02 |
| GOBP REGULATION OF LIPASE ACTIVITY | 38 | 1.82e-01 | -1.25e-01 | 4.01e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 126 | 1.54e-02 | -1.25e-01 | 7.74e-02 |
| GOBP ERYTHROCYTE DEVELOPMENT | 43 | 1.56e-01 | -1.25e-01 | 3.65e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 4.53e-01 | -1.25e-01 | 6.66e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 864 | 6.05e-10 | -1.25e-01 | 3.95e-08 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 11 | 4.73e-01 | -1.25e-01 | 6.83e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 18 | 3.58e-01 | -1.25e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 151 | 8.16e-03 | -1.25e-01 | 4.94e-02 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 35 | 2.01e-01 | -1.25e-01 | 4.25e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 16 | 3.87e-01 | -1.25e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 14 | 4.19e-01 | -1.25e-01 | 6.38e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 10 | 4.94e-01 | 1.25e-01 | 7.00e-01 |
| GOBP T CELL DIFFERENTIATION | 250 | 6.98e-04 | -1.25e-01 | 7.39e-03 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 16 | 3.88e-01 | 1.25e-01 | 6.14e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 43 | 1.57e-01 | -1.25e-01 | 3.66e-01 |
| GOBP OVULATION CYCLE | 43 | 1.57e-01 | -1.25e-01 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 21 | 3.23e-01 | -1.25e-01 | 5.55e-01 |
| GOBP TORC2 SIGNALING | 14 | 4.20e-01 | -1.24e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 614 | 1.69e-07 | -1.24e-01 | 6.02e-06 |
| GOBP GLOMERULUS MORPHOGENESIS | 11 | 4.75e-01 | 1.24e-01 | 6.85e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 35 | 2.03e-01 | -1.24e-01 | 4.27e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 114 | 2.20e-02 | -1.24e-01 | 9.98e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1048 | 1.69e-11 | -1.24e-01 | 1.58e-09 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 461 | 5.33e-06 | -1.24e-01 | 1.15e-04 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 24 | 2.92e-01 | -1.24e-01 | 5.25e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 11 | 4.76e-01 | 1.24e-01 | 6.86e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 30 | 2.39e-01 | -1.24e-01 | 4.67e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 14 | 4.21e-01 | 1.24e-01 | 6.39e-01 |
| GOBP AMP METABOLIC PROCESS | 21 | 3.25e-01 | 1.24e-01 | 5.56e-01 |
| GOCC PARANODE REGION OF AXON | 12 | 4.57e-01 | 1.24e-01 | 6.70e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 217 | 1.67e-03 | -1.24e-01 | 1.50e-02 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 31 | 2.32e-01 | -1.24e-01 | 4.61e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 75 | 6.36e-02 | -1.24e-01 | 2.05e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 759 | 7.96e-09 | -1.24e-01 | 3.99e-07 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 60 | 9.70e-02 | -1.24e-01 | 2.67e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 778 | 5.48e-09 | -1.24e-01 | 2.79e-07 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 25 | 2.84e-01 | -1.24e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 23 | 3.04e-01 | 1.24e-01 | 5.37e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 10 | 4.98e-01 | -1.24e-01 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 28 | 2.57e-01 | -1.24e-01 | 4.87e-01 |
| GOBP ICOSANOID TRANSPORT | 37 | 1.93e-01 | -1.24e-01 | 4.15e-01 |
| GOCC RIBBON SYNAPSE | 27 | 2.66e-01 | 1.24e-01 | 4.98e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 144 | 1.05e-02 | -1.24e-01 | 5.95e-02 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 12 | 4.58e-01 | 1.24e-01 | 6.71e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 12 | 4.58e-01 | 1.24e-01 | 6.71e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 109 | 2.59e-02 | -1.24e-01 | 1.12e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 31 | 2.34e-01 | 1.24e-01 | 4.62e-01 |
| GOCC SECONDARY LYSOSOME | 18 | 3.64e-01 | -1.24e-01 | 5.91e-01 |
| GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION | 13 | 4.41e-01 | 1.23e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 216 | 1.83e-03 | -1.23e-01 | 1.61e-02 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1349 | 6.97e-14 | -1.23e-01 | 1.22e-11 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 31 | 2.35e-01 | -1.23e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 447 | 8.84e-06 | -1.23e-01 | 1.82e-04 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 14 | 4.25e-01 | -1.23e-01 | 6.43e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 20 | 3.41e-01 | -1.23e-01 | 5.71e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 25 | 2.87e-01 | -1.23e-01 | 5.21e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 3.80e-01 | -1.23e-01 | 6.06e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 32 | 2.29e-01 | 1.23e-01 | 4.56e-01 |
| GOBP BONE GROWTH | 29 | 2.52e-01 | -1.23e-01 | 4.82e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 11 | 4.80e-01 | -1.23e-01 | 6.88e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 57 | 1.08e-01 | -1.23e-01 | 2.89e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 64 | 8.90e-02 | -1.23e-01 | 2.52e-01 |
| GOBP SNRNA PROCESSING | 21 | 3.29e-01 | 1.23e-01 | 5.60e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 16 | 3.95e-01 | 1.23e-01 | 6.18e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 4.80e-01 | -1.23e-01 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 173 | 5.37e-03 | -1.23e-01 | 3.64e-02 |
| GOBP ACTION POTENTIAL | 121 | 1.97e-02 | 1.23e-01 | 9.23e-02 |
| GOMF SYNTAXIN 1 BINDING | 16 | 3.95e-01 | -1.23e-01 | 6.18e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 86 | 4.91e-02 | -1.23e-01 | 1.73e-01 |
| GOBP INNER EAR MORPHOGENESIS | 73 | 7.01e-02 | 1.23e-01 | 2.17e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 19 | 3.55e-01 | -1.23e-01 | 5.84e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 1002 | 8.24e-11 | -1.23e-01 | 6.34e-09 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 175 | 5.26e-03 | -1.23e-01 | 3.59e-02 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 27 | 2.71e-01 | -1.22e-01 | 5.03e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 60 | 1.01e-01 | -1.22e-01 | 2.75e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 48 | 1.42e-01 | -1.22e-01 | 3.44e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 31 | 2.38e-01 | 1.22e-01 | 4.66e-01 |
| GOMF UBIQUITIN BINDING | 90 | 4.50e-02 | -1.22e-01 | 1.62e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 372 | 5.44e-05 | -1.22e-01 | 8.70e-04 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 17 | 3.83e-01 | -1.22e-01 | 6.09e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 33 | 2.24e-01 | -1.22e-01 | 4.51e-01 |
| GOMF AMYLOID BETA BINDING | 53 | 1.24e-01 | -1.22e-01 | 3.15e-01 |
| GOBP REGULATION OF CENTROSOME DUPLICATION | 45 | 1.57e-01 | -1.22e-01 | 3.66e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 48 | 1.44e-01 | -1.22e-01 | 3.46e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 39 | 1.87e-01 | -1.22e-01 | 4.07e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 179 | 4.93e-03 | -1.22e-01 | 3.41e-02 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 20 | 3.45e-01 | 1.22e-01 | 5.75e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 723 | 2.88e-08 | -1.22e-01 | 1.27e-06 |
| GOCC KINESIN COMPLEX | 40 | 1.82e-01 | -1.22e-01 | 4.01e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 38 | 1.93e-01 | -1.22e-01 | 4.15e-01 |
| GOBP ERAD PATHWAY | 97 | 3.80e-02 | -1.22e-01 | 1.45e-01 |
| GOCC MITOTIC SPINDLE | 160 | 7.84e-03 | -1.22e-01 | 4.83e-02 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 26 | 2.82e-01 | -1.22e-01 | 5.15e-01 |
| GOCC MITOCHONDRIAL CRISTA | 12 | 4.65e-01 | -1.22e-01 | 6.77e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 102 | 3.35e-02 | -1.22e-01 | 1.34e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 860 | 1.77e-09 | -1.22e-01 | 1.04e-07 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 30 | 2.48e-01 | 1.22e-01 | 4.78e-01 |
| GOCC SARCOMERE | 184 | 4.42e-03 | -1.22e-01 | 3.15e-02 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 19 | 3.58e-01 | -1.22e-01 | 5.87e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1153 | 5.42e-12 | -1.22e-01 | 6.04e-10 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 141 | 1.26e-02 | -1.22e-01 | 6.77e-02 |
| GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 290 | 3.75e-04 | -1.22e-01 | 4.36e-03 |
| GOBP PROTEOLYSIS | 1231 | 1.25e-12 | -1.22e-01 | 1.56e-10 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 144 | 1.18e-02 | -1.22e-01 | 6.44e-02 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 4.30e-01 | 1.22e-01 | 6.48e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 43 | 1.67e-01 | -1.22e-01 | 3.80e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 71 | 7.64e-02 | -1.22e-01 | 2.31e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 165 | 7.08e-03 | -1.22e-01 | 4.45e-02 |
| GOBP GRANULOCYTE ACTIVATION | 32 | 2.34e-01 | -1.22e-01 | 4.62e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 3.23e-01 | -1.22e-01 | 5.55e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 32 | 2.34e-01 | -1.22e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 1035 | 6.00e-11 | -1.22e-01 | 4.79e-09 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 16 | 4.00e-01 | 1.21e-01 | 6.22e-01 |
| GOMF PROTEASOME BINDING | 18 | 3.72e-01 | -1.21e-01 | 5.99e-01 |
| GOCC FILAMENTOUS ACTIN | 31 | 2.42e-01 | -1.21e-01 | 4.70e-01 |
| GOBP GLIAL CELL FATE COMMITMENT | 12 | 4.66e-01 | -1.21e-01 | 6.79e-01 |
| GOBP PRESYNAPTIC ENDOCYTOSIS | 84 | 5.46e-02 | -1.21e-01 | 1.85e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 78 | 6.39e-02 | -1.21e-01 | 2.06e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 15 | 4.16e-01 | -1.21e-01 | 6.36e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 11 | 4.86e-01 | 1.21e-01 | 6.93e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 208 | 2.60e-03 | -1.21e-01 | 2.10e-02 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 10 | 5.07e-01 | 1.21e-01 | 7.09e-01 |
| GOCC STEREOCILIUM TIP | 12 | 4.67e-01 | -1.21e-01 | 6.79e-01 |
| GOMF DEMETHYLASE ACTIVITY | 34 | 2.21e-01 | 1.21e-01 | 4.49e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 5.07e-01 | -1.21e-01 | 7.09e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 319 | 2.08e-04 | -1.21e-01 | 2.67e-03 |
| GOCC DENDRITIC SHAFT | 54 | 1.24e-01 | 1.21e-01 | 3.14e-01 |
| GOCC NUCLEAR INCLUSION BODY | 13 | 4.50e-01 | 1.21e-01 | 6.63e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 198 | 3.40e-03 | -1.21e-01 | 2.56e-02 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 74 | 7.22e-02 | -1.21e-01 | 2.22e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 20 | 3.49e-01 | -1.21e-01 | 5.79e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 19 | 3.62e-01 | -1.21e-01 | 5.89e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 142 | 1.31e-02 | -1.21e-01 | 6.91e-02 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 50 | 1.40e-01 | -1.21e-01 | 3.39e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 453 | 1.16e-05 | -1.21e-01 | 2.31e-04 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 541 | 1.78e-06 | -1.21e-01 | 4.42e-05 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 1004 | 1.49e-10 | -1.21e-01 | 1.11e-08 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 63 | 9.78e-02 | -1.21e-01 | 2.69e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 13 | 4.51e-01 | -1.21e-01 | 6.64e-01 |
| GOBP ADULT HEART DEVELOPMENT | 15 | 4.19e-01 | 1.21e-01 | 6.38e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 10 | 5.09e-01 | -1.21e-01 | 7.11e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 96 | 4.13e-02 | -1.21e-01 | 1.53e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 22 | 3.28e-01 | -1.21e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 98 | 3.93e-02 | -1.21e-01 | 1.48e-01 |
| GOCC SCAR COMPLEX | 12 | 4.70e-01 | -1.21e-01 | 6.82e-01 |
| GOMF FAD BINDING | 36 | 2.11e-01 | -1.20e-01 | 4.37e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 15 | 4.19e-01 | 1.20e-01 | 6.38e-01 |
| GOBP PIGMENTATION | 92 | 4.60e-02 | -1.20e-01 | 1.65e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 469 | 8.63e-06 | -1.20e-01 | 1.78e-04 |
| GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY | 19 | 3.64e-01 | -1.20e-01 | 5.91e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 26 | 2.88e-01 | -1.20e-01 | 5.21e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 78 | 6.64e-02 | 1.20e-01 | 2.10e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 17 | 3.91e-01 | -1.20e-01 | 6.15e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 24 | 3.08e-01 | -1.20e-01 | 5.41e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 11 | 4.90e-01 | 1.20e-01 | 6.97e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 108 | 3.13e-02 | -1.20e-01 | 1.28e-01 |
| GOBP RESPONSE TO FOOD | 21 | 3.41e-01 | -1.20e-01 | 5.71e-01 |
| GOCC ANCHORING JUNCTION | 581 | 8.91e-07 | -1.20e-01 | 2.47e-05 |
| GOCC FIBRILLAR COLLAGEN TRIMER | 11 | 4.91e-01 | -1.20e-01 | 6.98e-01 |
| GOBP VIRAL GENE EXPRESSION | 68 | 8.76e-02 | -1.20e-01 | 2.50e-01 |
| GOBP LIPID EXPORT FROM CELL | 38 | 2.01e-01 | -1.20e-01 | 4.25e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 11 | 4.92e-01 | -1.20e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 10 | 5.12e-01 | 1.20e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 334 | 1.77e-04 | -1.20e-01 | 2.37e-03 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 101 | 3.79e-02 | -1.20e-01 | 1.45e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 11 | 4.92e-01 | -1.20e-01 | 6.98e-01 |
| GOMF TRNA BINDING | 64 | 9.82e-02 | -1.20e-01 | 2.69e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 16 | 4.08e-01 | 1.20e-01 | 6.29e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 10 | 5.13e-01 | 1.20e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 117 | 2.56e-02 | -1.20e-01 | 1.11e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 41 | 1.85e-01 | -1.20e-01 | 4.05e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 26 | 2.91e-01 | -1.20e-01 | 5.25e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 5.13e-01 | 1.20e-01 | 7.13e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 11 | 4.93e-01 | -1.19e-01 | 6.98e-01 |
| GOBP ENDOSOMAL TRANSPORT | 251 | 1.15e-03 | -1.19e-01 | 1.11e-02 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 12 | 4.74e-01 | 1.19e-01 | 6.84e-01 |
| GOBP RENAL TUBULAR SECRETION | 15 | 4.24e-01 | -1.19e-01 | 6.41e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 12 | 4.74e-01 | -1.19e-01 | 6.85e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 118 | 2.55e-02 | -1.19e-01 | 1.11e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 37 | 2.10e-01 | 1.19e-01 | 4.36e-01 |
| GOMF SH2 DOMAIN BINDING | 35 | 2.23e-01 | -1.19e-01 | 4.50e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 15 | 4.24e-01 | 1.19e-01 | 6.42e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 1181 | 9.39e-12 | -1.19e-01 | 9.63e-10 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 716 | 7.03e-08 | -1.19e-01 | 2.74e-06 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 16 | 4.10e-01 | 1.19e-01 | 6.30e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 67 | 9.23e-02 | -1.19e-01 | 2.58e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 16 | 4.10e-01 | -1.19e-01 | 6.31e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 37 | 2.11e-01 | -1.19e-01 | 4.37e-01 |
| GOCC SITE OF DNA DAMAGE | 101 | 3.91e-02 | -1.19e-01 | 1.48e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 973 | 5.00e-10 | -1.19e-01 | 3.36e-08 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 12 | 4.76e-01 | -1.19e-01 | 6.86e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 29 | 2.68e-01 | 1.19e-01 | 5.01e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 79 | 6.81e-02 | -1.19e-01 | 2.14e-01 |
| GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY | 16 | 4.11e-01 | -1.19e-01 | 6.31e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 14 | 4.43e-01 | -1.18e-01 | 6.57e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 194 | 4.56e-03 | -1.18e-01 | 3.23e-02 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 27 | 2.87e-01 | -1.18e-01 | 5.21e-01 |
| GOBP NOREPINEPHRINE SECRETION | 12 | 4.78e-01 | -1.18e-01 | 6.87e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 94 | 4.77e-02 | -1.18e-01 | 1.69e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 1126 | 3.66e-11 | -1.18e-01 | 3.20e-09 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 27 | 2.88e-01 | -1.18e-01 | 5.21e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 4.79e-01 | -1.18e-01 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 123 | 2.41e-02 | -1.18e-01 | 1.07e-01 |
| GOCC I BAND | 131 | 2.00e-02 | -1.18e-01 | 9.29e-02 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 94 | 4.84e-02 | -1.18e-01 | 1.71e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 11 | 4.98e-01 | -1.18e-01 | 7.03e-01 |
| GOCC OUTER KINETOCHORE | 16 | 4.15e-01 | -1.18e-01 | 6.35e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 69 | 9.09e-02 | -1.18e-01 | 2.56e-01 |
| GOBP PROTEIN PROCESSING | 190 | 5.21e-03 | -1.18e-01 | 3.57e-02 |
| GOBP REGULATION OF ACTION POTENTIAL | 54 | 1.35e-01 | 1.18e-01 | 3.32e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 11 | 4.99e-01 | -1.18e-01 | 7.03e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 23 | 3.29e-01 | 1.18e-01 | 5.60e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 23 | 3.29e-01 | -1.18e-01 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 67 | 9.64e-02 | -1.18e-01 | 2.66e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 68 | 9.41e-02 | -1.17e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 42 | 1.88e-01 | -1.17e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 431 | 3.12e-05 | -1.17e-01 | 5.37e-04 |
| GOCC EXORIBONUCLEASE COMPLEX | 21 | 3.52e-01 | 1.17e-01 | 5.81e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL CONTRACTION | 38 | 2.11e-01 | 1.17e-01 | 4.37e-01 |
| GOBP VACUOLE ORGANIZATION | 211 | 3.36e-03 | -1.17e-01 | 2.55e-02 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 16 | 4.16e-01 | -1.17e-01 | 6.36e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 52 | 1.43e-01 | -1.17e-01 | 3.46e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 19 | 3.76e-01 | 1.17e-01 | 6.03e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 48 | 1.60e-01 | -1.17e-01 | 3.71e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 15 | 4.32e-01 | 1.17e-01 | 6.50e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 10 | 5.21e-01 | -1.17e-01 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 56 | 1.30e-01 | -1.17e-01 | 3.23e-01 |
| GOBP DOPAMINE SECRETION | 23 | 3.31e-01 | -1.17e-01 | 5.62e-01 |
| GOBP RRNA METHYLATION | 17 | 4.03e-01 | 1.17e-01 | 6.25e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 29 | 2.76e-01 | -1.17e-01 | 5.09e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 204 | 4.05e-03 | -1.17e-01 | 2.93e-02 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 305 | 4.64e-04 | -1.17e-01 | 5.20e-03 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 76 | 7.83e-02 | -1.17e-01 | 2.34e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 215 | 3.22e-03 | -1.17e-01 | 2.46e-02 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 126 | 2.38e-02 | -1.17e-01 | 1.06e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 23 | 3.33e-01 | -1.17e-01 | 5.63e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 141 | 1.68e-02 | -1.17e-01 | 8.26e-02 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 107 | 3.72e-02 | -1.17e-01 | 1.43e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 11 | 5.03e-01 | -1.17e-01 | 7.06e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 30 | 2.69e-01 | -1.17e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 15 | 4.34e-01 | 1.17e-01 | 6.52e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 24 | 3.23e-01 | -1.17e-01 | 5.55e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 24 | 3.23e-01 | -1.16e-01 | 5.55e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 33 | 2.47e-01 | 1.16e-01 | 4.76e-01 |
| GOBP G0 TO G1 TRANSITION | 32 | 2.54e-01 | -1.16e-01 | 4.85e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 82 | 6.86e-02 | -1.16e-01 | 2.15e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 541 | 4.09e-06 | -1.16e-01 | 9.17e-05 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 591 | 1.55e-06 | -1.16e-01 | 3.93e-05 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 29 | 2.78e-01 | -1.16e-01 | 5.13e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 69 | 9.50e-02 | -1.16e-01 | 2.63e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 225 | 2.71e-03 | -1.16e-01 | 2.18e-02 |
| GOCC MICROBODY LUMEN | 26 | 3.05e-01 | -1.16e-01 | 5.37e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 202 | 4.47e-03 | -1.16e-01 | 3.17e-02 |
| GOBP SMOOTH MUSCLE CONTRACTION | 86 | 6.26e-02 | -1.16e-01 | 2.02e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 87 | 6.11e-02 | -1.16e-01 | 2.00e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 654 | 4.68e-07 | -1.16e-01 | 1.44e-05 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 14 | 4.52e-01 | -1.16e-01 | 6.65e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 199 | 4.82e-03 | -1.16e-01 | 3.37e-02 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 378 | 1.13e-04 | -1.16e-01 | 1.64e-03 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 181 | 7.18e-03 | -1.16e-01 | 4.51e-02 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 294 | 6.43e-04 | -1.16e-01 | 6.90e-03 |
| GOBP ESTROGEN METABOLIC PROCESS | 17 | 4.08e-01 | 1.16e-01 | 6.29e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 21 | 3.58e-01 | -1.16e-01 | 5.87e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 64 | 1.09e-01 | -1.16e-01 | 2.89e-01 |
| GOBP KINETOCHORE ORGANIZATION | 15 | 4.37e-01 | -1.16e-01 | 6.54e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 198 | 4.98e-03 | -1.16e-01 | 3.44e-02 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 20 | 3.69e-01 | -1.16e-01 | 5.96e-01 |
| GOBP REGULATION OF TRANSPORT | 1310 | 3.63e-12 | -1.16e-01 | 4.19e-10 |
| GOBP CELL VOLUME HOMEOSTASIS | 33 | 2.49e-01 | -1.16e-01 | 4.80e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 22 | 3.47e-01 | 1.16e-01 | 5.77e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 52 | 1.49e-01 | -1.16e-01 | 3.54e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 16 | 4.23e-01 | -1.16e-01 | 6.40e-01 |
| GOCC SPINDLE POLE CENTROSOME | 16 | 4.23e-01 | -1.16e-01 | 6.40e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 45 | 1.80e-01 | 1.16e-01 | 3.98e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 21 | 3.59e-01 | -1.16e-01 | 5.87e-01 |
| GOBP IMPORT INTO NUCLEUS | 163 | 1.10e-02 | -1.16e-01 | 6.11e-02 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 88 | 6.10e-02 | 1.16e-01 | 2.00e-01 |
| GOBP BLOOD VESSEL REMODELING | 52 | 1.49e-01 | -1.16e-01 | 3.55e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 45 | 1.80e-01 | -1.15e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 45 | 1.80e-01 | -1.15e-01 | 3.99e-01 |
| GOBP FEMALE PREGNANCY | 104 | 4.22e-02 | -1.15e-01 | 1.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 177 | 8.24e-03 | -1.15e-01 | 4.96e-02 |
| GOBP REGULATED EXOCYTOSIS | 175 | 8.63e-03 | -1.15e-01 | 5.14e-02 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 35 | 2.38e-01 | -1.15e-01 | 4.66e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 21 | 3.61e-01 | 1.15e-01 | 5.88e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 18 | 3.97e-01 | -1.15e-01 | 6.20e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 20 | 3.72e-01 | -1.15e-01 | 5.99e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 23 | 3.39e-01 | 1.15e-01 | 5.70e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 5.28e-01 | -1.15e-01 | 7.25e-01 |
| GOBP SPINDLE CHECKPOINT SIGNALING | 42 | 1.97e-01 | -1.15e-01 | 4.19e-01 |
| GOMF SULFUR COMPOUND BINDING | 196 | 5.57e-03 | -1.15e-01 | 3.72e-02 |
| GOMF ACTIVIN BINDING | 10 | 5.29e-01 | -1.15e-01 | 7.25e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 16 | 4.26e-01 | -1.15e-01 | 6.43e-01 |
| GOBP PHAGOSOME MATURATION | 26 | 3.10e-01 | 1.15e-01 | 5.42e-01 |
| GOBP DOPAMINE TRANSPORT | 32 | 2.60e-01 | -1.15e-01 | 4.91e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 25 | 3.20e-01 | -1.15e-01 | 5.52e-01 |
| GOBP CELL DIVISION | 509 | 1.02e-05 | -1.15e-01 | 2.05e-04 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 461 | 2.59e-05 | -1.15e-01 | 4.53e-04 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 22 | 3.51e-01 | -1.15e-01 | 5.81e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 14 | 4.57e-01 | -1.15e-01 | 6.70e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 25 | 3.21e-01 | -1.15e-01 | 5.52e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 17 | 4.13e-01 | 1.15e-01 | 6.34e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 249 | 1.90e-03 | -1.15e-01 | 1.64e-02 |
| GOBP RESPONSE TO COCAINE | 28 | 2.94e-01 | 1.15e-01 | 5.27e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 84 | 6.98e-02 | -1.15e-01 | 2.17e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 72 | 9.34e-02 | -1.14e-01 | 2.61e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1274 | 1.25e-11 | -1.14e-01 | 1.22e-09 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 128 | 2.56e-02 | -1.14e-01 | 1.11e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 226 | 3.11e-03 | -1.14e-01 | 2.41e-02 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 20 | 3.76e-01 | -1.14e-01 | 6.03e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 710 | 2.56e-07 | -1.14e-01 | 8.55e-06 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 10 | 5.31e-01 | 1.14e-01 | 7.27e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 33 | 2.56e-01 | -1.14e-01 | 4.87e-01 |
| GOBP SECRETION | 735 | 1.64e-07 | -1.14e-01 | 5.91e-06 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 182 | 8.00e-03 | -1.14e-01 | 4.87e-02 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 72 | 9.41e-02 | -1.14e-01 | 2.62e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 4.30e-01 | -1.14e-01 | 6.48e-01 |
| GOBP STEROL METABOLIC PROCESS | 110 | 3.89e-02 | -1.14e-01 | 1.47e-01 |
| GOBP LIPID LOCALIZATION | 342 | 3.02e-04 | -1.14e-01 | 3.66e-03 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 393 | 1.11e-04 | -1.14e-01 | 1.63e-03 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 11 | 5.13e-01 | -1.14e-01 | 7.13e-01 |
| GOBP SKIN MORPHOGENESIS | 13 | 4.77e-01 | -1.14e-01 | 6.86e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 30 | 2.80e-01 | -1.14e-01 | 5.14e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 40 | 2.13e-01 | -1.14e-01 | 4.39e-01 |
| GOMF METHYL CPG BINDING | 21 | 3.67e-01 | -1.14e-01 | 5.93e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 18 | 4.03e-01 | -1.14e-01 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 41 | 2.07e-01 | -1.14e-01 | 4.33e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 217 | 3.94e-03 | -1.14e-01 | 2.87e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 669 | 6.15e-07 | -1.14e-01 | 1.83e-05 |
| GOMF PURINE NUCLEOTIDE BINDING | 1574 | 1.27e-13 | -1.14e-01 | 2.08e-11 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 14 | 4.61e-01 | -1.14e-01 | 6.73e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 10 | 5.33e-01 | -1.14e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION | 1253 | 2.31e-11 | -1.14e-01 | 2.11e-09 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 12 | 4.95e-01 | -1.14e-01 | 7.01e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 128 | 2.66e-02 | -1.14e-01 | 1.15e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 254 | 1.87e-03 | -1.14e-01 | 1.63e-02 |
| GOCC LUMENAL SIDE OF MEMBRANE | 17 | 4.18e-01 | 1.13e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 342 | 3.27e-04 | -1.13e-01 | 3.89e-03 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 201 | 5.65e-03 | -1.13e-01 | 3.75e-02 |
| GOBP TUBE MORPHOGENESIS | 780 | 9.01e-08 | -1.13e-01 | 3.33e-06 |
| GOBP STRESS FIBER ASSEMBLY | 105 | 4.49e-02 | -1.13e-01 | 1.62e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 265 | 1.53e-03 | -1.13e-01 | 1.39e-02 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 28 | 2.99e-01 | 1.13e-01 | 5.32e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 40 | 2.15e-01 | -1.13e-01 | 4.42e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 898 | 1.15e-08 | -1.13e-01 | 5.62e-07 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 385 | 1.44e-04 | -1.13e-01 | 2.00e-03 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 232 | 3.02e-03 | -1.13e-01 | 2.35e-02 |
| GOMF KINASE ACTIVATOR ACTIVITY | 115 | 3.61e-02 | -1.13e-01 | 1.41e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 12 | 4.97e-01 | 1.13e-01 | 7.02e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 32 | 2.68e-01 | -1.13e-01 | 5.00e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 150 | 1.69e-02 | -1.13e-01 | 8.28e-02 |
| GOBP RESPONSE TO STEROL | 24 | 3.37e-01 | 1.13e-01 | 5.68e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 153 | 1.59e-02 | -1.13e-01 | 7.93e-02 |
| GOMF CHROMATIN DNA BINDING | 82 | 7.70e-02 | 1.13e-01 | 2.32e-01 |
| GOBP REGULATION OF T CELL PROLIFERATION | 130 | 2.63e-02 | -1.13e-01 | 1.14e-01 |
| GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS | 23 | 3.49e-01 | -1.13e-01 | 5.78e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 168 | 1.17e-02 | -1.13e-01 | 6.40e-02 |
| GOBP STEROL TRANSPORT | 86 | 7.06e-02 | -1.13e-01 | 2.18e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 36 | 2.42e-01 | -1.13e-01 | 4.70e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 10 | 5.37e-01 | 1.13e-01 | 7.30e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 52 | 1.60e-01 | -1.13e-01 | 3.71e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE | 19 | 3.95e-01 | 1.13e-01 | 6.18e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1443 | 1.73e-12 | -1.13e-01 | 2.11e-10 |
| GOCC MEMBRANE MICRODOMAIN | 244 | 2.51e-03 | -1.13e-01 | 2.05e-02 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 26 | 3.21e-01 | 1.13e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 99 | 5.32e-02 | -1.13e-01 | 1.82e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 1.42e-01 | 1.12e-01 | 3.44e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 117 | 3.59e-02 | 1.12e-01 | 1.41e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 13 | 4.83e-01 | 1.12e-01 | 6.91e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 104 | 4.79e-02 | -1.12e-01 | 1.69e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 41 | 2.13e-01 | -1.12e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 15 | 4.51e-01 | -1.12e-01 | 6.64e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 187 | 8.18e-03 | -1.12e-01 | 4.95e-02 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 16 | 4.37e-01 | -1.12e-01 | 6.54e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 84 | 7.54e-02 | -1.12e-01 | 2.28e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 18 | 4.10e-01 | -1.12e-01 | 6.30e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 12 | 5.01e-01 | 1.12e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 460 | 4.03e-05 | -1.12e-01 | 6.73e-04 |
| GOBP RESPONSE TO DECREASED OXYGEN LEVELS | 202 | 6.07e-03 | -1.12e-01 | 3.99e-02 |
| GOBP NEURAL TUBE PATTERNING | 31 | 2.80e-01 | 1.12e-01 | 5.13e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 23 | 3.52e-01 | -1.12e-01 | 5.81e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 272 | 1.50e-03 | -1.12e-01 | 1.37e-02 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 22 | 3.63e-01 | -1.12e-01 | 5.90e-01 |
| GOBP REGULATION OF HEAT GENERATION | 13 | 4.84e-01 | -1.12e-01 | 6.91e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 10 | 5.40e-01 | -1.12e-01 | 7.32e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 20 | 3.86e-01 | -1.12e-01 | 6.12e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1161 | 2.06e-10 | -1.12e-01 | 1.46e-08 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 3.86e-01 | -1.12e-01 | 6.12e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 13 | 4.85e-01 | -1.12e-01 | 6.92e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 99 | 5.47e-02 | -1.12e-01 | 1.85e-01 |
| GOBP MITOTIC CELL CYCLE | 743 | 2.57e-07 | -1.12e-01 | 8.55e-06 |
| GOCC DNA POLYMERASE COMPLEX | 18 | 4.12e-01 | 1.12e-01 | 6.32e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 179 | 1.01e-02 | -1.12e-01 | 5.75e-02 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 983 | 4.39e-09 | -1.12e-01 | 2.27e-07 |
| GOMF TUBULIN BINDING | 315 | 6.80e-04 | -1.12e-01 | 7.24e-03 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 65 | 1.20e-01 | -1.12e-01 | 3.08e-01 |
| GOBP EXCITATORY POSTSYNAPTIC POTENTIAL | 67 | 1.14e-01 | -1.12e-01 | 2.98e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 22 | 3.65e-01 | -1.12e-01 | 5.92e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 29 | 2.99e-01 | 1.11e-01 | 5.31e-01 |
| GOBP RESPONSE TO COLD | 31 | 2.83e-01 | 1.11e-01 | 5.17e-01 |
| GOMF BETA TUBULIN BINDING | 38 | 2.35e-01 | -1.11e-01 | 4.63e-01 |
| GOCC RECYCLING ENDOSOME | 135 | 2.57e-02 | -1.11e-01 | 1.11e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 107 | 4.69e-02 | -1.11e-01 | 1.67e-01 |
| GOMF TRANSPORTER REGULATOR ACTIVITY | 104 | 5.00e-02 | -1.11e-01 | 1.75e-01 |
| GOCC ACROSOMAL MEMBRANE | 14 | 4.71e-01 | 1.11e-01 | 6.82e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 64 | 1.24e-01 | -1.11e-01 | 3.15e-01 |
| GOMF RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 868 | 3.51e-08 | 1.11e-01 | 1.51e-06 |
| GOBP CELL CELL ADHESION | 630 | 2.19e-06 | -1.11e-01 | 5.29e-05 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 4.14e-01 | 1.11e-01 | 6.35e-01 |
| GOBP CELL MORPHOGENESIS | 838 | 5.96e-08 | -1.11e-01 | 2.47e-06 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 31 | 2.85e-01 | -1.11e-01 | 5.18e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 20 | 3.90e-01 | 1.11e-01 | 6.15e-01 |
| GOBP REGULATION OF JNK CASCADE | 129 | 2.96e-02 | -1.11e-01 | 1.23e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 34 | 2.63e-01 | -1.11e-01 | 4.95e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 266 | 1.89e-03 | -1.11e-01 | 1.64e-02 |
| GOBP AMINE METABOLIC PROCESS | 83 | 8.09e-02 | -1.11e-01 | 2.38e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 356 | 3.40e-04 | -1.11e-01 | 4.00e-03 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 3.91e-01 | -1.11e-01 | 6.15e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 73 | 1.02e-01 | -1.11e-01 | 2.76e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 16 | 4.43e-01 | -1.11e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 820 | 8.89e-08 | -1.11e-01 | 3.31e-06 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 66 | 1.20e-01 | -1.11e-01 | 3.08e-01 |
| GOMF LIPID BINDING | 628 | 2.52e-06 | -1.11e-01 | 5.97e-05 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 51 | 1.72e-01 | -1.11e-01 | 3.87e-01 |
| GOBP EAR MORPHOGENESIS | 89 | 7.14e-02 | 1.11e-01 | 2.20e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 34 | 2.65e-01 | -1.11e-01 | 4.97e-01 |
| GOBP CELLULAR RESPONSE TO METAL ION | 121 | 3.60e-02 | -1.11e-01 | 1.41e-01 |
| GOCC NEURON SPINE | 165 | 1.45e-02 | -1.10e-01 | 7.42e-02 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 40 | 2.27e-01 | -1.10e-01 | 4.54e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 3.93e-01 | 1.10e-01 | 6.17e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 124 | 3.41e-02 | -1.10e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 27 | 3.21e-01 | -1.10e-01 | 5.53e-01 |
| GOBP CHOLESTEROL EFFLUX | 43 | 2.11e-01 | -1.10e-01 | 4.37e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 108 | 4.81e-02 | -1.10e-01 | 1.70e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 25 | 3.40e-01 | -1.10e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 183 | 1.03e-02 | -1.10e-01 | 5.85e-02 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 482 | 3.78e-05 | -1.10e-01 | 6.41e-04 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 130 | 3.05e-02 | -1.10e-01 | 1.26e-01 |
| GOBP CATECHOLAMINE UPTAKE | 11 | 5.28e-01 | -1.10e-01 | 7.25e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 79 | 9.13e-02 | -1.10e-01 | 2.57e-01 |
| GOBP RNA 5 END PROCESSING | 25 | 3.41e-01 | 1.10e-01 | 5.72e-01 |
| GOBP RESPONSE TO SALT STRESS | 19 | 4.07e-01 | -1.10e-01 | 6.28e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 464 | 5.40e-05 | -1.10e-01 | 8.67e-04 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 14 | 4.77e-01 | -1.10e-01 | 6.86e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 529 | 1.72e-05 | -1.10e-01 | 3.23e-04 |
| GOBP INORGANIC ION HOMEOSTASIS | 395 | 1.91e-04 | -1.10e-01 | 2.51e-03 |
| GOBP VESICLE CARGO LOADING | 25 | 3.42e-01 | -1.10e-01 | 5.73e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 44 | 2.08e-01 | -1.10e-01 | 4.33e-01 |
| GOBP MATING BEHAVIOR | 24 | 3.52e-01 | 1.10e-01 | 5.81e-01 |
| GOMF OXYSTEROL BINDING | 13 | 4.93e-01 | 1.10e-01 | 6.99e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 54 | 1.63e-01 | 1.10e-01 | 3.75e-01 |
| GOCC DENDRITE TERMINUS | 17 | 4.34e-01 | 1.10e-01 | 6.52e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 10 | 5.48e-01 | -1.10e-01 | 7.36e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 833 | 9.72e-08 | -1.10e-01 | 3.57e-06 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 11 | 5.29e-01 | 1.10e-01 | 7.25e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 12 | 5.11e-01 | -1.10e-01 | 7.12e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 410 | 1.49e-04 | -1.10e-01 | 2.05e-03 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 42 | 2.19e-01 | -1.10e-01 | 4.46e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 166 | 1.50e-02 | -1.10e-01 | 7.63e-02 |
| GOBP ADRENAL GLAND DEVELOPMENT | 17 | 4.34e-01 | -1.10e-01 | 6.52e-01 |
| GOMF P53 BINDING | 68 | 1.19e-01 | -1.10e-01 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 108 | 4.95e-02 | -1.09e-01 | 1.74e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 12 | 5.12e-01 | -1.09e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 10 | 5.49e-01 | -1.09e-01 | 7.36e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 10 | 5.49e-01 | -1.09e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 20 | 3.98e-01 | -1.09e-01 | 6.20e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 5.12e-01 | -1.09e-01 | 7.13e-01 |
| GOBP PROTEIN TRANSPORT | 1226 | 2.05e-10 | -1.09e-01 | 1.46e-08 |
| GOBP T CELL PROLIFERATION | 166 | 1.53e-02 | -1.09e-01 | 7.72e-02 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 40 | 2.32e-01 | -1.09e-01 | 4.61e-01 |
| GOCC BRAHMA COMPLEX | 13 | 4.95e-01 | -1.09e-01 | 7.01e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 70 | 1.14e-01 | -1.09e-01 | 2.98e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 93 | 6.90e-02 | -1.09e-01 | 2.16e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 153 | 1.99e-02 | -1.09e-01 | 9.29e-02 |
| GOBP RESPONSE TO UV C | 12 | 5.13e-01 | -1.09e-01 | 7.13e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 43 | 2.16e-01 | -1.09e-01 | 4.43e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 612 | 4.62e-06 | -1.09e-01 | 1.03e-04 |
| GOBP RESPONSE TO LIPID | 571 | 9.44e-06 | -1.09e-01 | 1.92e-04 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 10 | 5.51e-01 | 1.09e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 89 | 7.59e-02 | -1.09e-01 | 2.29e-01 |
| GOMF GTPASE BINDING | 302 | 1.19e-03 | -1.09e-01 | 1.14e-02 |
| GOMF MICROTUBULE BINDING | 225 | 5.04e-03 | -1.09e-01 | 3.48e-02 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 26 | 3.37e-01 | 1.09e-01 | 5.68e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 132 | 3.13e-02 | -1.09e-01 | 1.28e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 39 | 2.41e-01 | 1.09e-01 | 4.69e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 16 | 4.52e-01 | -1.09e-01 | 6.65e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 748 | 5.22e-07 | -1.09e-01 | 1.60e-05 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 35 | 2.66e-01 | -1.09e-01 | 4.99e-01 |
| GOBP FAT CELL DIFFERENTIATION | 219 | 5.75e-03 | -1.09e-01 | 3.80e-02 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 31 | 2.96e-01 | -1.09e-01 | 5.29e-01 |
| GOBP PHOSPHATIDIC ACID BIOSYNTHETIC PROCESS | 20 | 4.01e-01 | 1.09e-01 | 6.22e-01 |
| GOCC SECRETORY VESICLE | 414 | 1.62e-04 | -1.08e-01 | 2.22e-03 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 24 | 3.58e-01 | -1.08e-01 | 5.87e-01 |
| GOCC MIDBODY | 147 | 2.36e-02 | -1.08e-01 | 1.05e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 19 | 4.14e-01 | -1.08e-01 | 6.34e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 80 | 9.43e-02 | -1.08e-01 | 2.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 24 | 3.59e-01 | 1.08e-01 | 5.87e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 23 | 3.69e-01 | -1.08e-01 | 5.96e-01 |
| GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY | 10 | 5.54e-01 | 1.08e-01 | 7.38e-01 |
| GOBP RESPONSE TO DSRNA | 35 | 2.68e-01 | -1.08e-01 | 5.01e-01 |
| GOCC NODE OF RANVIER | 11 | 5.34e-01 | 1.08e-01 | 7.28e-01 |
| GOBP TRANSLATION AT SYNAPSE | 47 | 2.00e-01 | -1.08e-01 | 4.23e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 3.40e-01 | 1.08e-01 | 5.71e-01 |
| GOCC SAGA TYPE COMPLEX | 35 | 2.69e-01 | 1.08e-01 | 5.01e-01 |
| GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS | 526 | 2.52e-05 | -1.08e-01 | 4.42e-04 |
| GOBP RESPONSE TO CAMP | 47 | 2.01e-01 | 1.08e-01 | 4.24e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 17 | 4.42e-01 | -1.08e-01 | 6.57e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 292 | 1.60e-03 | -1.08e-01 | 1.44e-02 |
| GOBP SULFUR COMPOUND TRANSPORT | 40 | 2.39e-01 | -1.08e-01 | 4.67e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 44 | 2.17e-01 | -1.08e-01 | 4.44e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 49 | 1.93e-01 | 1.07e-01 | 4.15e-01 |
| GOBP RESPONSE TO ACTIVITY | 31 | 3.01e-01 | -1.07e-01 | 5.34e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 45 | 2.13e-01 | -1.07e-01 | 4.40e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 34 | 2.80e-01 | -1.07e-01 | 5.14e-01 |
| GOMF ALCOHOL BINDING | 64 | 1.39e-01 | -1.07e-01 | 3.38e-01 |
| GOBP INORGANIC ION TRANSMEMBRANE TRANSPORT | 510 | 3.82e-05 | -1.07e-01 | 6.47e-04 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 51 | 1.86e-01 | 1.07e-01 | 4.05e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 44 | 2.20e-01 | -1.07e-01 | 4.46e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 16 | 4.59e-01 | -1.07e-01 | 6.72e-01 |
| GOBP RESPONSE TO UV | 134 | 3.33e-02 | -1.07e-01 | 1.33e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 752 | 7.95e-07 | -1.07e-01 | 2.25e-05 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 97 | 7.00e-02 | -1.07e-01 | 2.17e-01 |
| GOBP REGULATION OF TUBE SIZE | 146 | 2.65e-02 | -1.07e-01 | 1.14e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 26 | 3.48e-01 | 1.06e-01 | 5.77e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 5.41e-01 | -1.06e-01 | 7.33e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 165 | 1.85e-02 | -1.06e-01 | 8.84e-02 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 13 | 5.07e-01 | -1.06e-01 | 7.09e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 230 | 5.58e-03 | -1.06e-01 | 3.72e-02 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 42 | 2.34e-01 | -1.06e-01 | 4.62e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 11 | 5.42e-01 | 1.06e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 136 | 3.26e-02 | -1.06e-01 | 1.32e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 47 | 2.08e-01 | -1.06e-01 | 4.33e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 4.00e-01 | -1.06e-01 | 6.22e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 50 | 1.94e-01 | -1.06e-01 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 10 | 5.61e-01 | 1.06e-01 | 7.45e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 15 | 4.77e-01 | -1.06e-01 | 6.86e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 194 | 1.10e-02 | -1.06e-01 | 6.12e-02 |
| GOBP SALIVARY GLAND DEVELOPMENT | 31 | 3.07e-01 | -1.06e-01 | 5.39e-01 |
| GOCC SPERM MIDPIECE | 26 | 3.50e-01 | 1.06e-01 | 5.79e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1161 | 1.78e-09 | -1.06e-01 | 1.04e-07 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 236 | 5.13e-03 | -1.06e-01 | 3.53e-02 |
| GOBP TRANSLATIONAL TERMINATION | 11 | 5.43e-01 | 1.06e-01 | 7.33e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 772 | 6.74e-07 | -1.06e-01 | 1.96e-05 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 13 | 5.09e-01 | 1.06e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 30 | 3.16e-01 | 1.06e-01 | 5.47e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 60 | 1.56e-01 | -1.06e-01 | 3.65e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 11 | 5.43e-01 | -1.06e-01 | 7.33e-01 |
| GOBP ACROSOME ASSEMBLY | 18 | 4.37e-01 | 1.06e-01 | 6.54e-01 |
| GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 341 | 8.17e-04 | -1.06e-01 | 8.38e-03 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 18 | 4.38e-01 | -1.06e-01 | 6.54e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 32 | 3.01e-01 | 1.06e-01 | 5.33e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 11 | 5.44e-01 | -1.06e-01 | 7.34e-01 |
| GOBP ERBB SIGNALING PATHWAY | 108 | 5.81e-02 | -1.06e-01 | 1.93e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 25 | 3.61e-01 | 1.06e-01 | 5.88e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 10 | 5.63e-01 | 1.06e-01 | 7.46e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 113 | 5.29e-02 | -1.06e-01 | 1.81e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 42 | 2.37e-01 | -1.05e-01 | 4.65e-01 |
| GOBP DNA STRAND ELONGATION | 35 | 2.80e-01 | 1.05e-01 | 5.14e-01 |
| GOBP MRNA TRANSCRIPTION | 49 | 2.02e-01 | -1.05e-01 | 4.25e-01 |
| GOBP ANOIKIS | 29 | 3.26e-01 | -1.05e-01 | 5.57e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 559 | 2.32e-05 | -1.05e-01 | 4.13e-04 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 10 | 5.65e-01 | -1.05e-01 | 7.47e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 18 | 4.40e-01 | -1.05e-01 | 6.56e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 133 | 3.67e-02 | -1.05e-01 | 1.42e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 12 | 5.29e-01 | 1.05e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 25 | 3.63e-01 | -1.05e-01 | 5.91e-01 |
| GOBP RESPONSE TO CHOLESTEROL | 20 | 4.16e-01 | 1.05e-01 | 6.36e-01 |
| GOBP VACUOLAR TRANSPORT | 147 | 2.82e-02 | -1.05e-01 | 1.19e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MITOCHONDRION | 15 | 4.82e-01 | -1.05e-01 | 6.89e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 40 | 2.51e-01 | -1.05e-01 | 4.81e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 11 | 5.47e-01 | -1.05e-01 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 115 | 5.23e-02 | -1.05e-01 | 1.80e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 51 | 1.95e-01 | -1.05e-01 | 4.18e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 247 | 4.64e-03 | -1.05e-01 | 3.28e-02 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 846 | 2.86e-07 | 1.05e-01 | 9.28e-06 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 10 | 5.66e-01 | -1.05e-01 | 7.48e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 10 | 5.66e-01 | -1.05e-01 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 140 | 3.27e-02 | -1.05e-01 | 1.32e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 569 | 2.20e-05 | -1.05e-01 | 3.94e-04 |
| GOMF COPPER ION BINDING | 45 | 2.25e-01 | -1.05e-01 | 4.52e-01 |
| GOBP MITOCHONDRIAL FISSION | 42 | 2.41e-01 | -1.05e-01 | 4.69e-01 |
| GOCC MYELIN SHEATH | 172 | 1.82e-02 | -1.05e-01 | 8.69e-02 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 31 | 3.14e-01 | -1.05e-01 | 5.45e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 19 | 4.30e-01 | 1.05e-01 | 6.48e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 33 | 2.99e-01 | -1.04e-01 | 5.32e-01 |
| GOCC CONTRACTILE MUSCLE FIBER | 218 | 8.03e-03 | -1.04e-01 | 4.89e-02 |
| GOBP PROTEIN FOLDING | 147 | 2.91e-02 | -1.04e-01 | 1.21e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 147 | 2.92e-02 | -1.04e-01 | 1.21e-01 |
| GOBP SEGMENTATION | 79 | 1.09e-01 | 1.04e-01 | 2.90e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 4.84e-01 | -1.04e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 31 | 3.15e-01 | -1.04e-01 | 5.46e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 12 | 5.32e-01 | -1.04e-01 | 7.27e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 20 | 4.20e-01 | 1.04e-01 | 6.38e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 18 | 4.44e-01 | -1.04e-01 | 6.58e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 221 | 7.74e-03 | -1.04e-01 | 4.79e-02 |
| GOCC CATENIN COMPLEX | 18 | 4.44e-01 | -1.04e-01 | 6.58e-01 |
| GOBP LACTATION | 28 | 3.40e-01 | 1.04e-01 | 5.71e-01 |
| GOBP GASTRULATION | 139 | 3.43e-02 | -1.04e-01 | 1.36e-01 |
| GOCC VACUOLAR LUMEN | 21 | 4.09e-01 | -1.04e-01 | 6.30e-01 |
| GOMF NF KAPPAB BINDING | 31 | 3.16e-01 | -1.04e-01 | 5.48e-01 |
| GOBP NITROGEN COMPOUND TRANSPORT | 1553 | 1.64e-11 | -1.04e-01 | 1.56e-09 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 51 | 1.99e-01 | -1.04e-01 | 4.22e-01 |
| GOBP REGULATION OF HEART RATE | 90 | 8.83e-02 | 1.04e-01 | 2.51e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 71 | 1.30e-01 | -1.04e-01 | 3.24e-01 |
| GOBP TISSUE REMODELING | 167 | 2.07e-02 | -1.04e-01 | 9.53e-02 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 45 | 2.28e-01 | -1.04e-01 | 4.55e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 230 | 6.76e-03 | -1.04e-01 | 4.30e-02 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 10 | 5.70e-01 | -1.04e-01 | 7.50e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 14 | 5.01e-01 | -1.04e-01 | 7.05e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 87 | 9.47e-02 | 1.04e-01 | 2.63e-01 |
| GOBP ENDOCYTIC RECYCLING | 78 | 1.14e-01 | -1.04e-01 | 2.97e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 3.51e-01 | 1.04e-01 | 5.81e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 17 | 4.59e-01 | 1.04e-01 | 6.72e-01 |
| GOCC AXONEMAL MICROTUBULE | 13 | 5.18e-01 | -1.04e-01 | 7.17e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 12 | 5.34e-01 | 1.04e-01 | 7.28e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 51 | 2.01e-01 | 1.04e-01 | 4.24e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 33 | 3.04e-01 | 1.04e-01 | 5.36e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 52 | 1.97e-01 | -1.04e-01 | 4.19e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 84 | 1.01e-01 | -1.04e-01 | 2.75e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 38 | 2.70e-01 | -1.03e-01 | 5.01e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 45 | 2.31e-01 | -1.03e-01 | 4.59e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 34 | 2.98e-01 | -1.03e-01 | 5.31e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 81 | 1.09e-01 | -1.03e-01 | 2.90e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 11 | 5.54e-01 | -1.03e-01 | 7.39e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 320 | 1.59e-03 | -1.03e-01 | 1.44e-02 |
| GOCC DENDRITIC GROWTH CONE | 12 | 5.37e-01 | 1.03e-01 | 7.30e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 18 | 4.50e-01 | -1.03e-01 | 6.63e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 685 | 5.17e-06 | -1.03e-01 | 1.12e-04 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 16 | 4.77e-01 | 1.03e-01 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 526 | 6.06e-05 | -1.03e-01 | 9.54e-04 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 42 | 2.50e-01 | -1.03e-01 | 4.80e-01 |
| GOCC AXON INITIAL SEGMENT | 20 | 4.27e-01 | 1.03e-01 | 6.44e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 33 | 3.07e-01 | -1.03e-01 | 5.40e-01 |
| GOBP REGULATION OF NEUROGENESIS | 378 | 6.39e-04 | -1.03e-01 | 6.86e-03 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 27 | 3.56e-01 | -1.03e-01 | 5.85e-01 |
| GOBP CARDIAC CELL FATE COMMITMENT | 11 | 5.56e-01 | 1.03e-01 | 7.40e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 43 | 2.45e-01 | -1.03e-01 | 4.73e-01 |
| GOBP RRNA MODIFICATION | 26 | 3.65e-01 | 1.03e-01 | 5.93e-01 |
| GOCC BOUNDING MEMBRANE OF ORGANELLE | 1070 | 2.10e-08 | -1.03e-01 | 9.90e-07 |
| GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT | 243 | 6.03e-03 | -1.03e-01 | 3.97e-02 |
| GOBP MICROTUBULE POLYMERIZATION | 82 | 1.09e-01 | -1.03e-01 | 2.89e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 462 | 1.71e-04 | -1.03e-01 | 2.31e-03 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 15 | 4.92e-01 | 1.02e-01 | 6.98e-01 |
| GOBP GENITALIA DEVELOPMENT | 34 | 3.02e-01 | 1.02e-01 | 5.34e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 4.40e-01 | 1.02e-01 | 6.56e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 248 | 5.62e-03 | -1.02e-01 | 3.74e-02 |
| GOBP BONE MORPHOGENESIS | 80 | 1.14e-01 | -1.02e-01 | 2.98e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 33 | 3.09e-01 | -1.02e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 98 | 8.06e-02 | -1.02e-01 | 2.38e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN PROGRAMMED CELL DEATH | 33 | 3.10e-01 | -1.02e-01 | 5.41e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 22 | 4.07e-01 | -1.02e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 96 | 8.39e-02 | -1.02e-01 | 2.43e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 140 | 3.73e-02 | -1.02e-01 | 1.44e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 27 | 3.59e-01 | -1.02e-01 | 5.87e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 115 | 5.91e-02 | -1.02e-01 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 29 | 3.42e-01 | -1.02e-01 | 5.73e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 13 | 5.25e-01 | 1.02e-01 | 7.23e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 23 | 3.98e-01 | -1.02e-01 | 6.20e-01 |
| GOBP PROTEIN ACYLATION | 82 | 1.11e-01 | 1.02e-01 | 2.93e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 27 | 3.60e-01 | -1.02e-01 | 5.88e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 5.77e-01 | 1.02e-01 | 7.57e-01 |
| GOCC CYTOSOLIC RIBOSOME | 112 | 6.31e-02 | -1.02e-01 | 2.04e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 98 | 8.21e-02 | -1.02e-01 | 2.40e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 47 | 2.28e-01 | 1.02e-01 | 4.55e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 111 | 6.45e-02 | -1.02e-01 | 2.06e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 140 | 3.82e-02 | -1.02e-01 | 1.45e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 21 | 4.20e-01 | 1.02e-01 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 17 | 4.68e-01 | -1.02e-01 | 6.80e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 94 | 8.90e-02 | -1.02e-01 | 2.52e-01 |
| GOCC INCLUSION BODY | 62 | 1.67e-01 | -1.02e-01 | 3.80e-01 |
| GOBP GROOMING BEHAVIOR | 13 | 5.27e-01 | 1.01e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 67 | 1.51e-01 | -1.01e-01 | 3.58e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 13 | 5.27e-01 | -1.01e-01 | 7.24e-01 |
| GOBP CYTOSOLIC TRANSPORT | 115 | 6.08e-02 | -1.01e-01 | 1.99e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 73 | 1.35e-01 | -1.01e-01 | 3.32e-01 |
| GOMF PEPTIDASE ACTIVITY | 372 | 8.42e-04 | -1.01e-01 | 8.59e-03 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 13 | 5.28e-01 | -1.01e-01 | 7.25e-01 |
| GOCC LEADING EDGE MEMBRANE | 121 | 5.50e-02 | -1.01e-01 | 1.86e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT | 29 | 3.46e-01 | -1.01e-01 | 5.75e-01 |
| GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS | 17 | 4.70e-01 | -1.01e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 45 | 2.41e-01 | 1.01e-01 | 4.69e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 19 | 4.46e-01 | 1.01e-01 | 6.59e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 10 | 5.80e-01 | -1.01e-01 | 7.59e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 195 | 1.51e-02 | -1.01e-01 | 7.68e-02 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 219 | 1.02e-02 | -1.01e-01 | 5.80e-02 |
| GOBP RECEPTOR METABOLIC PROCESS | 72 | 1.39e-01 | -1.01e-01 | 3.38e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 232 | 8.23e-03 | -1.01e-01 | 4.96e-02 |
| GOBP LUNG CELL DIFFERENTIATION | 30 | 3.39e-01 | 1.01e-01 | 5.70e-01 |
| GOBP JNK CASCADE | 156 | 2.99e-02 | -1.01e-01 | 1.24e-01 |
| GOBP REGULATION OF GROWTH | 529 | 7.86e-05 | -1.01e-01 | 1.20e-03 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 57 | 1.88e-01 | -1.01e-01 | 4.07e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 778 | 2.07e-06 | -1.01e-01 | 5.06e-05 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 359 | 1.08e-03 | -1.01e-01 | 1.05e-02 |
| GOBP PHAGOSOME LYSOSOME FUSION | 11 | 5.63e-01 | 1.01e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 920 | 2.95e-07 | -1.01e-01 | 9.53e-06 |
| GOBP RESPONSE TO IRON ION | 14 | 5.15e-01 | -1.01e-01 | 7.15e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 18 | 4.60e-01 | -1.01e-01 | 6.72e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 250 | 6.36e-03 | -1.00e-01 | 4.11e-02 |
| GOMF PHOSPHOPROTEIN BINDING | 97 | 8.80e-02 | -1.00e-01 | 2.50e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 145 | 3.73e-02 | -1.00e-01 | 1.44e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 24 | 3.95e-01 | -1.00e-01 | 6.18e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 36 | 2.98e-01 | 1.00e-01 | 5.31e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 40 | 2.73e-01 | -1.00e-01 | 5.06e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 16 | 4.88e-01 | 1.00e-01 | 6.94e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 58 | 1.87e-01 | -1.00e-01 | 4.06e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 17 | 4.75e-01 | -1.00e-01 | 6.85e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 5.48e-01 | 1.00e-01 | 7.36e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 11 | 5.65e-01 | 1.00e-01 | 7.47e-01 |
| GOBP RESPONSE TO NUTRIENT | 66 | 1.60e-01 | -1.00e-01 | 3.70e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 82 | 1.17e-01 | -1.00e-01 | 3.04e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 65 | 1.63e-01 | -1.00e-01 | 3.75e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 108 | 7.28e-02 | -1.00e-01 | 2.23e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 29 | 3.51e-01 | -1.00e-01 | 5.81e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 70 | 1.48e-01 | -1.00e-01 | 3.53e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 32 | 3.28e-01 | -1.00e-01 | 5.59e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 14 | 5.18e-01 | -9.99e-02 | 7.17e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 17 | 4.76e-01 | -9.98e-02 | 6.86e-01 |
| GOCC ADHERENS JUNCTION | 120 | 5.94e-02 | -9.98e-02 | 1.96e-01 |
| GOCC DISTAL AXON | 285 | 3.90e-03 | -9.96e-02 | 2.85e-02 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 66 | 1.62e-01 | -9.96e-02 | 3.74e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 16 | 4.90e-01 | -9.96e-02 | 6.97e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1175 | 1.32e-08 | -9.96e-02 | 6.43e-07 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 25 | 3.89e-01 | -9.95e-02 | 6.15e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 2.65e-01 | 9.95e-02 | 4.97e-01 |
| GOCC CLATHRIN COATED PIT | 67 | 1.59e-01 | -9.95e-02 | 3.70e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 39 | 2.83e-01 | -9.94e-02 | 5.17e-01 |
| GOBP INSULIN METABOLIC PROCESS | 13 | 5.35e-01 | 9.94e-02 | 7.28e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 72 | 1.45e-01 | -9.94e-02 | 3.48e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 5.87e-01 | 9.93e-02 | 7.64e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 10 | 5.87e-01 | -9.93e-02 | 7.64e-01 |
| GOCC MICROBODY MEMBRANE | 44 | 2.55e-01 | -9.93e-02 | 4.85e-01 |
| GOCC SPERM PRINCIPAL PIECE | 15 | 5.06e-01 | 9.93e-02 | 7.09e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 54 | 2.07e-01 | -9.92e-02 | 4.33e-01 |
| GOBP RESPONSE TO CALCIUM ION | 105 | 7.93e-02 | -9.92e-02 | 2.35e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 16 | 4.92e-01 | -9.92e-02 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 28 | 3.64e-01 | -9.92e-02 | 5.91e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 11 | 5.69e-01 | 9.92e-02 | 7.50e-01 |
| GOBP GLIOGENESIS | 306 | 2.94e-03 | -9.91e-02 | 2.31e-02 |
| GOBP NEURON PROJECTION ORGANIZATION | 99 | 8.88e-02 | -9.91e-02 | 2.52e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 10 | 5.88e-01 | -9.89e-02 | 7.65e-01 |
| GOBP DNA DUPLEX UNWINDING | 40 | 2.80e-01 | -9.89e-02 | 5.13e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 94 | 9.80e-02 | -9.88e-02 | 2.69e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 117 | 6.51e-02 | -9.88e-02 | 2.08e-01 |
| GOBP TRANSPOSITION | 14 | 5.22e-01 | -9.88e-02 | 7.20e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 139 | 4.48e-02 | -9.87e-02 | 1.62e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 96 | 9.51e-02 | -9.87e-02 | 2.63e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 15 | 5.08e-01 | -9.87e-02 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 211 | 1.37e-02 | -9.86e-02 | 7.15e-02 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 25 | 3.94e-01 | -9.86e-02 | 6.17e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 151 | 3.68e-02 | -9.86e-02 | 1.42e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 72 | 1.48e-01 | -9.86e-02 | 3.53e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 101 | 8.73e-02 | -9.86e-02 | 2.49e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 31 | 3.42e-01 | -9.85e-02 | 5.73e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 14 | 5.23e-01 | -9.85e-02 | 7.21e-01 |
| GOBP REGULATION OF CELL SIZE | 176 | 2.44e-02 | -9.85e-02 | 1.08e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 191 | 1.92e-02 | -9.85e-02 | 9.06e-02 |
| GOBP ENDOCHONDRAL BONE GROWTH | 25 | 3.95e-01 | -9.84e-02 | 6.18e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 84 | 1.19e-01 | -9.84e-02 | 3.08e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 22 | 4.25e-01 | -9.83e-02 | 6.42e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 46 | 2.49e-01 | -9.83e-02 | 4.79e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 25 | 3.95e-01 | -9.83e-02 | 6.18e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 263 | 6.22e-03 | -9.83e-02 | 4.05e-02 |
| GOBP POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION | 13 | 5.40e-01 | 9.82e-02 | 7.32e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 10 | 5.91e-01 | 9.82e-02 | 7.66e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 41 | 2.77e-01 | -9.82e-02 | 5.11e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 117 | 6.70e-02 | -9.81e-02 | 2.12e-01 |
| GOCC SPINDLE POLE | 131 | 5.28e-02 | -9.81e-02 | 1.81e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 56 | 2.04e-01 | -9.81e-02 | 4.29e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 10 | 5.91e-01 | -9.81e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 130 | 5.38e-02 | -9.81e-02 | 1.84e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 17 | 4.84e-01 | -9.80e-02 | 6.91e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 19 | 4.60e-01 | -9.80e-02 | 6.72e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 24 | 4.07e-01 | 9.79e-02 | 6.28e-01 |
| GOBP MOTOR BEHAVIOR | 26 | 3.88e-01 | -9.77e-02 | 6.14e-01 |
| GOBP KIDNEY MORPHOGENESIS | 75 | 1.44e-01 | 9.77e-02 | 3.46e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 23 | 4.18e-01 | -9.76e-02 | 6.38e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 84 | 1.23e-01 | -9.75e-02 | 3.12e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 159 | 3.44e-02 | -9.74e-02 | 1.36e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 1007 | 2.31e-07 | -9.73e-02 | 7.86e-06 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 371 | 1.35e-03 | -9.73e-02 | 1.26e-02 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 26 | 3.91e-01 | -9.73e-02 | 6.15e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 145 | 4.36e-02 | -9.72e-02 | 1.59e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 3.20e-01 | 9.72e-02 | 5.52e-01 |
| GOBP DOLICHOL LINKED OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 11 | 5.77e-01 | 9.71e-02 | 7.57e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 55 | 2.13e-01 | -9.71e-02 | 4.40e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 756 | 6.53e-06 | 9.71e-02 | 1.38e-04 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 25 | 4.01e-01 | 9.70e-02 | 6.22e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 16 | 5.02e-01 | 9.70e-02 | 7.05e-01 |
| GOMF LIPASE ACTIVITY | 79 | 1.36e-01 | -9.70e-02 | 3.34e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 4.53e-01 | -9.70e-02 | 6.66e-01 |
| GOBP PROTEIN MATURATION | 396 | 9.70e-04 | -9.70e-02 | 9.73e-03 |
| GOBP MYOBLAST DIFFERENTIATION | 96 | 1.01e-01 | -9.69e-02 | 2.75e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 15 | 5.16e-01 | 9.69e-02 | 7.16e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 19 | 4.65e-01 | 9.69e-02 | 6.78e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 10 | 5.96e-01 | 9.68e-02 | 7.70e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 55 | 2.14e-01 | -9.68e-02 | 4.41e-01 |
| GOBP GENOMIC IMPRINTING | 26 | 3.93e-01 | 9.68e-02 | 6.17e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 18 | 4.77e-01 | -9.68e-02 | 6.86e-01 |
| GOBP CELLULAR SENESCENCE | 80 | 1.35e-01 | -9.68e-02 | 3.32e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 13 | 5.46e-01 | -9.67e-02 | 7.35e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 374 | 1.37e-03 | -9.67e-02 | 1.28e-02 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 10 | 5.96e-01 | -9.67e-02 | 7.70e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 51 | 2.32e-01 | -9.67e-02 | 4.61e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 772 | 5.76e-06 | -9.67e-02 | 1.24e-04 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 13 | 5.46e-01 | 9.67e-02 | 7.35e-01 |
| GOMF MANGANESE ION BINDING | 53 | 2.24e-01 | -9.66e-02 | 4.51e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 12 | 5.62e-01 | -9.66e-02 | 7.45e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 805 | 3.86e-06 | -9.66e-02 | 8.75e-05 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 10 | 5.97e-01 | 9.65e-02 | 7.71e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 57 | 2.08e-01 | -9.64e-02 | 4.34e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 21 | 4.45e-01 | -9.64e-02 | 6.58e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 4.80e-01 | -9.63e-02 | 6.88e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 260 | 7.69e-03 | -9.63e-02 | 4.77e-02 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 56 | 2.13e-01 | -9.62e-02 | 4.40e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 505 | 2.30e-04 | -9.62e-02 | 2.90e-03 |
| GOBP RESPONSE TO METAL ION | 227 | 1.28e-02 | -9.61e-02 | 6.84e-02 |
| GOBP PHOSPHORYLATION | 1333 | 6.45e-09 | -9.60e-02 | 3.26e-07 |
| GOCC SPINDLE | 313 | 3.58e-03 | -9.60e-02 | 2.67e-02 |
| GOBP CALCIUM ION HOMEOSTASIS | 247 | 9.56e-03 | -9.60e-02 | 5.52e-02 |
| GOBP RESPONSE TO OXYGEN LEVELS | 221 | 1.42e-02 | -9.60e-02 | 7.30e-02 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 54 | 2.23e-01 | -9.60e-02 | 4.50e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 20 | 4.58e-01 | -9.59e-02 | 6.70e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 95 | 1.07e-01 | -9.59e-02 | 2.86e-01 |
| GOCC NBAF COMPLEX | 14 | 5.35e-01 | -9.59e-02 | 7.28e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 19 | 4.69e-01 | -9.59e-02 | 6.82e-01 |
| GOBP ADULT BEHAVIOR | 127 | 6.24e-02 | 9.59e-02 | 2.02e-01 |
| GOBP VESICLE DOCKING | 49 | 2.46e-01 | -9.59e-02 | 4.75e-01 |
| GOBP CELL PROJECTION MORPHOGENESIS | 578 | 9.01e-05 | -9.59e-02 | 1.37e-03 |
| GOBP CELLULAR RESPONSE TO HEAT | 43 | 2.77e-01 | -9.58e-02 | 5.11e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 16 | 5.07e-01 | -9.58e-02 | 7.09e-01 |
| GOBP CELL CELL RECOGNITION | 39 | 3.01e-01 | -9.58e-02 | 5.33e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 23 | 4.27e-01 | -9.58e-02 | 6.44e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1172 | 4.85e-08 | -9.57e-02 | 2.05e-06 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 54 | 2.24e-01 | 9.57e-02 | 4.51e-01 |
| GOBP RESPONSE TO CAFFEINE | 13 | 5.50e-01 | -9.57e-02 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS | 84 | 1.30e-01 | 9.57e-02 | 3.24e-01 |
| GOCC LATE ENDOSOME | 204 | 1.87e-02 | -9.57e-02 | 8.92e-02 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 161 | 3.65e-02 | -9.57e-02 | 1.42e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 5.51e-01 | -9.56e-02 | 7.36e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 155 | 4.03e-02 | -9.56e-02 | 1.50e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 16 | 5.08e-01 | -9.56e-02 | 7.10e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 65 | 1.83e-01 | 9.55e-02 | 4.02e-01 |
| GOBP L AMINO ACID CATABOLIC PROCESS | 45 | 2.68e-01 | -9.55e-02 | 5.00e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 14 | 5.36e-01 | 9.55e-02 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 31 | 3.58e-01 | -9.54e-02 | 5.87e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 121 | 7.03e-02 | -9.54e-02 | 2.18e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 44 | 2.74e-01 | -9.53e-02 | 5.08e-01 |
| GOBP TUBE DEVELOPMENT | 953 | 7.98e-07 | -9.53e-02 | 2.25e-05 |
| GOBP DEFINITIVE HEMOPOIESIS | 22 | 4.39e-01 | -9.53e-02 | 6.55e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 82 | 1.36e-01 | -9.52e-02 | 3.34e-01 |
| GOBP PROTEIN NEDDYLATION | 17 | 4.97e-01 | -9.52e-02 | 7.02e-01 |
| GOBP AMIDE TRANSPORT | 265 | 7.80e-03 | -9.52e-02 | 4.81e-02 |
| GOBP ALCOHOL METABOLIC PROCESS | 249 | 9.88e-03 | -9.52e-02 | 5.67e-02 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 24 | 4.20e-01 | -9.52e-02 | 6.38e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 48 | 2.54e-01 | -9.51e-02 | 4.85e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 112 | 8.23e-02 | -9.51e-02 | 2.41e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 36 | 3.24e-01 | -9.51e-02 | 5.55e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 48 | 2.55e-01 | 9.50e-02 | 4.86e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 19 | 4.74e-01 | 9.49e-02 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 12 | 5.69e-01 | -9.49e-02 | 7.50e-01 |
| GOBP LUNG MORPHOGENESIS | 54 | 2.28e-01 | -9.48e-02 | 4.55e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 292 | 5.46e-03 | -9.48e-02 | 3.67e-02 |
| GOMF HEAT SHOCK PROTEIN BINDING | 131 | 6.15e-02 | -9.47e-02 | 2.00e-01 |
| GOMF LYASE ACTIVITY | 148 | 4.70e-02 | -9.47e-02 | 1.67e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 26 | 4.03e-01 | -9.47e-02 | 6.25e-01 |
| GOMF CALMODULIN BINDING | 155 | 4.22e-02 | -9.47e-02 | 1.55e-01 |
| GOBP MEMBRANE DOCKING | 70 | 1.71e-01 | -9.47e-02 | 3.86e-01 |
| GOBP PROTEIN ACETYLATION | 51 | 2.42e-01 | 9.47e-02 | 4.70e-01 |
| GOMF IRON ION BINDING | 96 | 1.09e-01 | -9.47e-02 | 2.90e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 657 | 3.93e-05 | -9.47e-02 | 6.60e-04 |
| GOBP VIRAL RNA GENOME REPLICATION | 22 | 4.42e-01 | -9.46e-02 | 6.57e-01 |
| GOCC EXOCYTIC VESICLE | 217 | 1.66e-02 | -9.46e-02 | 8.17e-02 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 37 | 3.20e-01 | -9.46e-02 | 5.52e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 24 | 4.23e-01 | -9.45e-02 | 6.40e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 10 | 6.05e-01 | -9.45e-02 | 7.76e-01 |
| GOBP SOMITE DEVELOPMENT | 62 | 1.99e-01 | 9.44e-02 | 4.22e-01 |
| GOCC SECRETORY GRANULE | 244 | 1.13e-02 | -9.44e-02 | 6.21e-02 |
| GOBP CATECHOLAMINE TRANSPORT | 49 | 2.54e-01 | -9.43e-02 | 4.84e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 257 | 9.46e-03 | -9.42e-02 | 5.48e-02 |
| GOBP RESPONSE TO X RAY | 20 | 4.66e-01 | 9.42e-02 | 6.78e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 27 | 3.97e-01 | -9.42e-02 | 6.20e-01 |
| GOCC GOLGI CISTERNA | 59 | 2.11e-01 | -9.42e-02 | 4.37e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 43 | 2.86e-01 | 9.42e-02 | 5.19e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 218 | 1.69e-02 | -9.41e-02 | 8.27e-02 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 491 | 3.81e-04 | -9.41e-02 | 4.41e-03 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 22 | 4.45e-01 | 9.41e-02 | 6.58e-01 |
| GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION | 36 | 3.29e-01 | 9.40e-02 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 28 | 3.89e-01 | -9.40e-02 | 6.15e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 37 | 3.23e-01 | -9.40e-02 | 5.55e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 60 | 2.08e-01 | -9.40e-02 | 4.34e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 12 | 5.73e-01 | -9.39e-02 | 7.54e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 27 | 3.99e-01 | -9.39e-02 | 6.21e-01 |
| GOBP REGULATION OF SARCOMERE ORGANIZATION | 11 | 5.90e-01 | 9.39e-02 | 7.65e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 10 | 6.08e-01 | -9.37e-02 | 7.78e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 58 | 2.17e-01 | 9.37e-02 | 4.44e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 144 | 5.26e-02 | -9.37e-02 | 1.81e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 196 | 2.40e-02 | -9.37e-02 | 1.07e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 3.91e-01 | 9.36e-02 | 6.15e-01 |
| GOBP REGULATION OF SECRETION | 488 | 4.23e-04 | -9.36e-02 | 4.81e-03 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 17 | 5.04e-01 | -9.36e-02 | 7.07e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 87 | 1.32e-01 | -9.36e-02 | 3.27e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 384 | 1.71e-03 | -9.36e-02 | 1.52e-02 |
| GOBP REGULATION OF RNA SPLICING | 162 | 4.02e-02 | 9.36e-02 | 1.50e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 22 | 4.48e-01 | -9.36e-02 | 6.60e-01 |
| GOCC TRANSPORT VESICLE | 289 | 6.36e-03 | -9.36e-02 | 4.11e-02 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 539 | 2.20e-04 | -9.35e-02 | 2.78e-03 |
| GOBP PROSTAGLANDIN SECRETION | 14 | 5.45e-01 | -9.35e-02 | 7.35e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 5.60e-01 | -9.35e-02 | 7.43e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 25 | 4.19e-01 | -9.35e-02 | 6.38e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 104 | 1.00e-01 | -9.35e-02 | 2.73e-01 |
| GOCC INHIBITORY SYNAPSE | 17 | 5.05e-01 | 9.33e-02 | 7.08e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 61 | 2.08e-01 | -9.33e-02 | 4.33e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 15 | 5.32e-01 | 9.33e-02 | 7.27e-01 |
| GOCC PHOSPHATASE COMPLEX | 43 | 2.90e-01 | -9.33e-02 | 5.23e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 19 | 4.82e-01 | -9.33e-02 | 6.89e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 28 | 3.93e-01 | -9.33e-02 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 3.77e-01 | -9.32e-02 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 85 | 1.38e-01 | -9.32e-02 | 3.37e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1297 | 2.68e-08 | -9.32e-02 | 1.19e-06 |
| GOBP RENAL TUBULE MORPHOGENESIS | 63 | 2.01e-01 | 9.32e-02 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 41 | 3.02e-01 | 9.31e-02 | 5.35e-01 |
| GOCC CELL CELL JUNCTION | 388 | 1.71e-03 | -9.31e-02 | 1.52e-02 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 210 | 2.03e-02 | 9.31e-02 | 9.38e-02 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 453 | 7.26e-04 | -9.31e-02 | 7.61e-03 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 37 | 3.28e-01 | -9.30e-02 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS | 19 | 4.83e-01 | -9.30e-02 | 6.91e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 5.20e-01 | -9.29e-02 | 7.18e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1223 | 6.85e-08 | -9.28e-02 | 2.68e-06 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 68 | 1.86e-01 | -9.28e-02 | 4.05e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 28 | 3.95e-01 | 9.28e-02 | 6.18e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 116 | 8.46e-02 | -9.28e-02 | 2.44e-01 |
| GOBP PEPTIDE TRANSPORT | 228 | 1.60e-02 | -9.28e-02 | 7.98e-02 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 30 | 3.79e-01 | 9.28e-02 | 6.05e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 10 | 6.12e-01 | 9.27e-02 | 7.80e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 40 | 3.11e-01 | -9.26e-02 | 5.42e-01 |
| GOBP BONE RESORPTION | 59 | 2.19e-01 | -9.26e-02 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 24 | 4.32e-01 | -9.26e-02 | 6.51e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 38 | 3.23e-01 | 9.26e-02 | 5.55e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 279 | 7.98e-03 | -9.25e-02 | 4.87e-02 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 228 | 1.63e-02 | -9.25e-02 | 8.08e-02 |
| GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 14 | 5.49e-01 | 9.25e-02 | 7.36e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 13 | 5.64e-01 | 9.25e-02 | 7.46e-01 |
| GOCC APICAL PART OF CELL | 362 | 2.59e-03 | -9.25e-02 | 2.10e-02 |
| GOBP NEURON DEVELOPMENT | 996 | 1.01e-06 | -9.25e-02 | 2.75e-05 |
| GOBP STRESS GRANULE ASSEMBLY | 32 | 3.66e-01 | -9.24e-02 | 5.93e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 60 | 2.16e-01 | -9.24e-02 | 4.43e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 74 | 1.70e-01 | -9.24e-02 | 3.84e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 25 | 4.24e-01 | -9.24e-02 | 6.42e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 18 | 4.98e-01 | -9.23e-02 | 7.02e-01 |
| GOMF FERROUS IRON BINDING | 23 | 4.44e-01 | 9.23e-02 | 6.58e-01 |
| GOBP RELAXATION OF MUSCLE | 28 | 3.98e-01 | 9.22e-02 | 6.21e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 33 | 3.59e-01 | -9.22e-02 | 5.87e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 74 | 1.71e-01 | -9.22e-02 | 3.85e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 95 | 1.21e-01 | -9.21e-02 | 3.10e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 28 | 3.99e-01 | 9.21e-02 | 6.21e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 12 | 5.81e-01 | -9.20e-02 | 7.60e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 276 | 8.71e-03 | -9.20e-02 | 5.16e-02 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 126 | 7.49e-02 | 9.20e-02 | 2.28e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 139 | 6.15e-02 | -9.20e-02 | 2.00e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 21 | 4.66e-01 | -9.20e-02 | 6.78e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 11 | 5.97e-01 | -9.20e-02 | 7.71e-01 |
| GOCC AXONAL GROWTH CONE | 41 | 3.09e-01 | -9.19e-02 | 5.41e-01 |
| GOCC NEURON PROJECTION | 1062 | 5.66e-07 | -9.19e-02 | 1.71e-05 |
| GOCC POSTSYNAPTIC CYTOSOL | 42 | 3.03e-01 | -9.18e-02 | 5.36e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 14 | 5.52e-01 | -9.18e-02 | 7.38e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 17 | 5.13e-01 | -9.17e-02 | 7.13e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 123 | 7.93e-02 | -9.17e-02 | 2.35e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 329 | 4.37e-03 | -9.17e-02 | 3.13e-02 |
| GOMF PROTEIN FOLDING CHAPERONE | 50 | 2.62e-01 | -9.17e-02 | 4.95e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 11 | 5.99e-01 | 9.17e-02 | 7.72e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 15 | 5.39e-01 | -9.16e-02 | 7.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 127 | 7.50e-02 | -9.16e-02 | 2.28e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 5.26e-01 | -9.16e-02 | 7.24e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 167 | 4.16e-02 | -9.15e-02 | 1.54e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 122 | 8.13e-02 | -9.15e-02 | 2.39e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 121 | 8.26e-02 | -9.15e-02 | 2.41e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 106 | 1.04e-01 | -9.14e-02 | 2.81e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 28 | 4.03e-01 | -9.14e-02 | 6.24e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 373 | 2.53e-03 | -9.14e-02 | 2.06e-02 |
| GOBP REGULATION OF AXONOGENESIS | 149 | 5.45e-02 | -9.14e-02 | 1.85e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 19 | 4.91e-01 | -9.13e-02 | 6.98e-01 |
| GOCC NUCLEOID | 44 | 2.95e-01 | -9.13e-02 | 5.28e-01 |
| GOBP FOREGUT MORPHOGENESIS | 10 | 6.18e-01 | -9.12e-02 | 7.83e-01 |
| GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 519 | 4.07e-04 | -9.12e-02 | 4.66e-03 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 22 | 4.60e-01 | 9.11e-02 | 6.72e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 18 | 5.04e-01 | -9.11e-02 | 7.07e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 46 | 2.86e-01 | 9.10e-02 | 5.19e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 14 | 5.55e-01 | -9.10e-02 | 7.40e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 60 | 2.23e-01 | -9.10e-02 | 4.50e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 19 | 4.92e-01 | 9.10e-02 | 6.98e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 18 | 5.04e-01 | -9.10e-02 | 7.07e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 11 | 6.02e-01 | 9.09e-02 | 7.74e-01 |
| GOMF HORMONE ACTIVITY | 33 | 3.66e-01 | -9.09e-02 | 5.93e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 33 | 3.66e-01 | -9.09e-02 | 5.93e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 24 | 4.41e-01 | 9.08e-02 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 15 | 5.43e-01 | -9.08e-02 | 7.33e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 107 | 1.05e-01 | 9.08e-02 | 2.83e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 78 | 1.66e-01 | -9.07e-02 | 3.79e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 6.02e-01 | -9.07e-02 | 7.75e-01 |
| GOBP ORGAN INDUCTION | 15 | 5.43e-01 | 9.07e-02 | 7.33e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 140 | 6.45e-02 | -9.06e-02 | 2.06e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 17 | 5.18e-01 | -9.06e-02 | 7.17e-01 |
| GOMF ATPASE BINDING | 82 | 1.57e-01 | -9.06e-02 | 3.65e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 223 | 2.01e-02 | -9.06e-02 | 9.32e-02 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 87 | 1.45e-01 | -9.05e-02 | 3.48e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 17 | 5.18e-01 | -9.05e-02 | 7.17e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 45 | 2.94e-01 | -9.05e-02 | 5.26e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 107 | 1.06e-01 | -9.05e-02 | 2.85e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 99 | 1.20e-01 | -9.05e-02 | 3.09e-01 |
| GOBP MALE MEIOSIS I | 16 | 5.31e-01 | 9.05e-02 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 6.20e-01 | 9.05e-02 | 7.86e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 32 | 3.76e-01 | -9.04e-02 | 6.03e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 66 | 2.04e-01 | -9.04e-02 | 4.28e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 12 | 5.88e-01 | -9.04e-02 | 7.65e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 10 | 6.21e-01 | -9.04e-02 | 7.86e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 276 | 9.97e-03 | -9.04e-02 | 5.70e-02 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 282 | 9.23e-03 | -9.03e-02 | 5.38e-02 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 368 | 3.03e-03 | -9.03e-02 | 2.36e-02 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 13 | 5.73e-01 | -9.03e-02 | 7.54e-01 |
| GOBP REGULATION OF NECROPTOTIC PROCESS | 22 | 4.64e-01 | -9.03e-02 | 6.76e-01 |
| GOBP STRIATUM DEVELOPMENT | 15 | 5.45e-01 | 9.03e-02 | 7.35e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 16 | 5.32e-01 | -9.02e-02 | 7.27e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 90 | 1.40e-01 | -9.02e-02 | 3.39e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 15 | 5.45e-01 | -9.02e-02 | 7.35e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 465 | 9.16e-04 | -9.01e-02 | 9.28e-03 |
| GOMF ACID THIOL LIGASE ACTIVITY | 24 | 4.45e-01 | -9.01e-02 | 6.58e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 21 | 4.75e-01 | -9.01e-02 | 6.85e-01 |
| GOCC NUCLEAR REPLICATION FORK | 37 | 3.43e-01 | 9.01e-02 | 5.73e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 30 | 3.93e-01 | -9.01e-02 | 6.17e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 31 | 3.86e-01 | 9.00e-02 | 6.12e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 48 | 2.81e-01 | -8.99e-02 | 5.15e-01 |
| GOBP GLIAL CELL PROLIFERATION | 65 | 2.11e-01 | -8.99e-02 | 4.37e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 23 | 4.56e-01 | -8.99e-02 | 6.69e-01 |
| GOBP RETICULOPHAGY | 16 | 5.34e-01 | -8.99e-02 | 7.28e-01 |
| GOBP TELOMERE ORGANIZATION | 139 | 6.78e-02 | 8.98e-02 | 2.13e-01 |
| GOMF CAMP BINDING | 20 | 4.87e-01 | -8.98e-02 | 6.94e-01 |
| GOBP SIGNAL RELEASE | 397 | 2.24e-03 | -8.97e-02 | 1.88e-02 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 64 | 2.15e-01 | -8.96e-02 | 4.42e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 285 | 9.47e-03 | 8.96e-02 | 5.48e-02 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 24 | 4.48e-01 | -8.95e-02 | 6.61e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 34 | 3.67e-01 | -8.95e-02 | 5.93e-01 |
| GOBP GROWTH | 834 | 1.34e-05 | -8.95e-02 | 2.61e-04 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 40 | 3.28e-01 | -8.95e-02 | 5.59e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 18 | 5.11e-01 | 8.94e-02 | 7.13e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 121 | 8.98e-02 | -8.94e-02 | 2.53e-01 |
| GOBP VIRAL TRANSCRIPTION | 49 | 2.79e-01 | -8.94e-02 | 5.13e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 46 | 2.95e-01 | -8.94e-02 | 5.27e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 14 | 5.63e-01 | 8.94e-02 | 7.45e-01 |
| GOCC AXON | 547 | 3.83e-04 | -8.93e-02 | 4.42e-03 |
| GOCC APICAL PLASMA MEMBRANE | 284 | 9.90e-03 | -8.92e-02 | 5.68e-02 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 110 | 1.07e-01 | -8.92e-02 | 2.86e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 35 | 3.62e-01 | -8.91e-02 | 5.89e-01 |
| GOMF ACYL COA BINDING | 21 | 4.80e-01 | -8.91e-02 | 6.88e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 63 | 2.22e-01 | -8.90e-02 | 4.49e-01 |
| GOBP ENAMEL MINERALIZATION | 14 | 5.64e-01 | 8.90e-02 | 7.46e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 151 | 5.94e-02 | -8.90e-02 | 1.96e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME ACTIVITY | 31 | 3.91e-01 | -8.90e-02 | 6.15e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 70 | 1.98e-01 | -8.90e-02 | 4.21e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 207 | 2.77e-02 | -8.90e-02 | 1.17e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 68 | 2.05e-01 | -8.90e-02 | 4.30e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 149 | 6.13e-02 | -8.89e-02 | 2.00e-01 |
| GOBP ARTERY MORPHOGENESIS | 75 | 1.83e-01 | -8.89e-02 | 4.02e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 606 | 2.02e-04 | -8.89e-02 | 2.63e-03 |
| GOBP CELLULAR RESPONSE TO HYPOXIA | 101 | 1.23e-01 | -8.88e-02 | 3.13e-01 |
| GOBP NEUROGENESIS | 1448 | 2.61e-08 | -8.87e-02 | 1.16e-06 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 11 | 6.11e-01 | -8.87e-02 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 15 | 5.52e-01 | -8.86e-02 | 7.38e-01 |
| GOBP AORTA DEVELOPMENT | 68 | 2.07e-01 | -8.86e-02 | 4.32e-01 |
| GOBP AXON REGENERATION | 48 | 2.88e-01 | -8.86e-02 | 5.21e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 46 | 2.99e-01 | -8.86e-02 | 5.31e-01 |
| GOBP ENERGY HOMEOSTASIS | 66 | 2.14e-01 | -8.85e-02 | 4.41e-01 |
| GOBP STEM CELL DEVELOPMENT | 75 | 1.86e-01 | -8.84e-02 | 4.05e-01 |
| GOBP BLASTOCYST FORMATION | 45 | 3.06e-01 | 8.83e-02 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 14 | 5.67e-01 | -8.83e-02 | 7.49e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 233 | 2.06e-02 | -8.82e-02 | 9.50e-02 |
| GOBP MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 50 | 2.81e-01 | -8.81e-02 | 5.15e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 15 | 5.55e-01 | -8.81e-02 | 7.39e-01 |
| GOMF FRIZZLED BINDING | 26 | 4.38e-01 | 8.80e-02 | 6.54e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 30 | 4.05e-01 | 8.79e-02 | 6.26e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 6.14e-01 | -8.79e-02 | 7.81e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 39 | 3.42e-01 | -8.79e-02 | 5.73e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 14 | 5.69e-01 | 8.79e-02 | 7.50e-01 |
| GOCC INO80 TYPE COMPLEX | 27 | 4.29e-01 | 8.79e-02 | 6.48e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 214 | 2.72e-02 | -8.78e-02 | 1.16e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 17 | 5.31e-01 | 8.78e-02 | 7.27e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 14 | 5.70e-01 | 8.78e-02 | 7.50e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 187 | 3.90e-02 | -8.77e-02 | 1.47e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 46 | 3.04e-01 | 8.77e-02 | 5.36e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 292 | 1.02e-02 | -8.76e-02 | 5.80e-02 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 114 | 1.07e-01 | -8.76e-02 | 2.86e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 100 | 1.31e-01 | -8.76e-02 | 3.25e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 26 | 4.40e-01 | -8.76e-02 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 201 | 3.27e-02 | -8.75e-02 | 1.32e-01 |
| GOBP TRNA 5 END PROCESSING | 14 | 5.71e-01 | 8.75e-02 | 7.51e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 17 | 5.32e-01 | -8.75e-02 | 7.27e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 38 | 3.51e-01 | 8.74e-02 | 5.81e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 22 | 4.78e-01 | -8.74e-02 | 6.87e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 22 | 4.78e-01 | -8.74e-02 | 6.87e-01 |
| GOBP WATER TRANSPORT | 10 | 6.32e-01 | 8.74e-02 | 7.95e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1082 | 1.59e-06 | 8.74e-02 | 4.02e-05 |
| GOBP RESPONSE TO HYDROPEROXIDE | 16 | 5.45e-01 | -8.73e-02 | 7.35e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 17 | 5.33e-01 | 8.73e-02 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 15 | 5.58e-01 | -8.73e-02 | 7.42e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 19 | 5.10e-01 | -8.73e-02 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 6.16e-01 | -8.73e-02 | 7.83e-01 |
| GOBP GENERATION OF NEURONS | 1238 | 3.49e-07 | -8.72e-02 | 1.10e-05 |
| GOBP REGULATION OF VESICLE FUSION | 20 | 5.00e-01 | 8.72e-02 | 7.04e-01 |
| GOBP ENDODERM DEVELOPMENT | 55 | 2.64e-01 | -8.72e-02 | 4.96e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 18 | 5.22e-01 | -8.71e-02 | 7.20e-01 |
| GOBP VASCULOGENESIS | 85 | 1.65e-01 | -8.71e-02 | 3.78e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 12 | 6.01e-01 | -8.71e-02 | 7.74e-01 |
| GOBP MICROTUBULE BASED PROCESS | 691 | 1.06e-04 | -8.71e-02 | 1.58e-03 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 96 | 1.41e-01 | -8.71e-02 | 3.41e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 39 | 3.47e-01 | -8.71e-02 | 5.77e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 61 | 2.40e-01 | -8.71e-02 | 4.68e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 22 | 4.80e-01 | 8.70e-02 | 6.88e-01 |
| GOCC CELL PROJECTION MEMBRANE | 247 | 1.88e-02 | -8.70e-02 | 8.95e-02 |
| GOMF SULFOTRANSFERASE ACTIVITY | 27 | 4.34e-01 | -8.70e-02 | 6.52e-01 |
| GOBP MISMATCH REPAIR | 23 | 4.70e-01 | -8.70e-02 | 6.82e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 106 | 1.22e-01 | -8.69e-02 | 3.12e-01 |
| GOBP CELLULAR HOMEOSTASIS | 627 | 2.24e-04 | -8.69e-02 | 2.82e-03 |
| GOBP PRENYLATION | 13 | 5.88e-01 | -8.68e-02 | 7.65e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 43 | 3.25e-01 | 8.68e-02 | 5.56e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 129 | 8.92e-02 | -8.68e-02 | 2.52e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 149 | 6.80e-02 | -8.68e-02 | 2.13e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 25 | 4.53e-01 | -8.67e-02 | 6.66e-01 |
| GOBP SYNAPTIC VESICLE CYCLE | 195 | 3.71e-02 | -8.67e-02 | 1.43e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 52 | 2.80e-01 | -8.67e-02 | 5.13e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 847 | 2.18e-05 | -8.66e-02 | 3.93e-04 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 58 | 2.54e-01 | -8.66e-02 | 4.85e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 13 | 5.89e-01 | 8.66e-02 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 25 | 4.54e-01 | -8.66e-02 | 6.66e-01 |
| GOCC DENDRITIC TREE | 574 | 4.25e-04 | -8.66e-02 | 4.82e-03 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 53 | 2.76e-01 | -8.65e-02 | 5.10e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 64 | 2.32e-01 | -8.65e-02 | 4.61e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 64 | 2.32e-01 | 8.65e-02 | 4.61e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 41 | 3.38e-01 | -8.64e-02 | 5.69e-01 |
| GOBP NUCLEAR TRANSPORT | 310 | 9.08e-03 | -8.64e-02 | 5.31e-02 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 442 | 1.93e-03 | -8.64e-02 | 1.66e-02 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 295 | 1.10e-02 | -8.63e-02 | 6.12e-02 |
| GOBP XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE | 10 | 6.37e-01 | -8.62e-02 | 7.97e-01 |
| GOBP INTERFERON BETA PRODUCTION | 65 | 2.30e-01 | -8.62e-02 | 4.57e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 13 | 5.91e-01 | 8.62e-02 | 7.66e-01 |
| GOCC APICAL DENDRITE | 23 | 4.75e-01 | -8.62e-02 | 6.85e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 12 | 6.06e-01 | -8.61e-02 | 7.77e-01 |
| GOCC FIBRILLAR CENTER | 134 | 8.58e-02 | -8.61e-02 | 2.47e-01 |
| GOBP REGULATION OF CELL POPULATION PROLIFERATION | 1295 | 2.85e-07 | -8.61e-02 | 9.28e-06 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 238 | 2.25e-02 | -8.61e-02 | 1.02e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 25 | 4.57e-01 | -8.60e-02 | 6.70e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 17 | 5.39e-01 | -8.60e-02 | 7.31e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 50 | 2.93e-01 | -8.60e-02 | 5.26e-01 |
| GOCC COSTAMERE | 19 | 5.17e-01 | -8.60e-02 | 7.16e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 35 | 3.79e-01 | -8.59e-02 | 6.05e-01 |
| GOMF DNA HELICASE ACTIVITY | 50 | 2.94e-01 | -8.59e-02 | 5.26e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 18 | 5.28e-01 | -8.59e-02 | 7.25e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 107 | 1.25e-01 | -8.58e-02 | 3.17e-01 |
| GOCC FASCIA ADHERENS | 13 | 5.92e-01 | -8.58e-02 | 7.67e-01 |
| GOBP OOCYTE DIFFERENTIATION | 37 | 3.67e-01 | -8.57e-02 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 18 | 5.29e-01 | -8.56e-02 | 7.26e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 14 | 5.79e-01 | -8.56e-02 | 7.59e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 47 | 3.10e-01 | -8.56e-02 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 15 | 5.66e-01 | -8.56e-02 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 21 | 4.97e-01 | 8.56e-02 | 7.02e-01 |
| GOMF HELICASE ACTIVITY | 135 | 8.64e-02 | -8.56e-02 | 2.48e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 108 | 1.25e-01 | -8.56e-02 | 3.16e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 16 | 5.54e-01 | 8.56e-02 | 7.38e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 59 | 2.56e-01 | -8.55e-02 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 77 | 1.95e-01 | -8.54e-02 | 4.18e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 23 | 4.79e-01 | -8.54e-02 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 90 | 1.62e-01 | -8.54e-02 | 3.74e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 13 | 5.94e-01 | 8.53e-02 | 7.69e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 77 | 1.96e-01 | -8.53e-02 | 4.18e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 30 | 4.19e-01 | -8.53e-02 | 6.38e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 5.09e-01 | 8.53e-02 | 7.11e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 67 | 2.28e-01 | -8.52e-02 | 4.55e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 37 | 3.70e-01 | 8.52e-02 | 5.96e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 600 | 4.00e-04 | -8.51e-02 | 4.60e-03 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 27 | 4.44e-01 | -8.51e-02 | 6.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 6.10e-01 | -8.51e-02 | 7.79e-01 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 10 | 6.42e-01 | -8.50e-02 | 7.99e-01 |
| GOCC A BAND | 36 | 3.78e-01 | -8.50e-02 | 6.04e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 78 | 1.95e-01 | -8.50e-02 | 4.17e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1299 | 3.85e-07 | -8.50e-02 | 1.20e-05 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 37 | 3.71e-01 | -8.50e-02 | 5.98e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 69 | 2.23e-01 | -8.49e-02 | 4.50e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 13 | 5.96e-01 | -8.49e-02 | 7.70e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 94 | 1.55e-01 | -8.49e-02 | 3.64e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 10 | 6.42e-01 | -8.49e-02 | 8.00e-01 |
| GOCC SYNAPSE | 1352 | 2.46e-07 | -8.49e-02 | 8.29e-06 |
| GOBP METANEPHROS DEVELOPMENT | 63 | 2.45e-01 | -8.48e-02 | 4.73e-01 |
| GOBP INTRACILIARY TRANSPORT | 38 | 3.66e-01 | 8.47e-02 | 5.93e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 71 | 2.17e-01 | -8.47e-02 | 4.44e-01 |
| GOBP MELANOSOME ASSEMBLY | 17 | 5.45e-01 | -8.47e-02 | 7.35e-01 |
| GOBP OSSIFICATION | 327 | 8.67e-03 | -8.47e-02 | 5.15e-02 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 12 | 6.11e-01 | -8.47e-02 | 7.80e-01 |
| GOCC INTERSTITIAL MATRIX | 15 | 5.70e-01 | 8.47e-02 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 61 | 2.53e-01 | -8.47e-02 | 4.83e-01 |
| GOBP VASODILATION | 49 | 3.05e-01 | -8.47e-02 | 5.38e-01 |
| GOBP PROTEIN DEUBIQUITINATION | 83 | 1.83e-01 | -8.47e-02 | 4.02e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 545 | 7.74e-04 | -8.47e-02 | 8.06e-03 |
| GOBP NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 20 | 5.12e-01 | -8.46e-02 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 63 | 2.46e-01 | -8.46e-02 | 4.74e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 251 | 2.14e-02 | -8.46e-02 | 9.77e-02 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 30 | 4.23e-01 | -8.46e-02 | 6.40e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 12 | 6.12e-01 | -8.46e-02 | 7.80e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 39 | 3.61e-01 | -8.45e-02 | 5.89e-01 |
| GOMF ACTIN MONOMER BINDING | 20 | 5.13e-01 | -8.45e-02 | 7.13e-01 |
| GOBP MUSCLE CELL FATE COMMITMENT | 11 | 6.28e-01 | 8.44e-02 | 7.91e-01 |
| GOMF PROTEIN KINASE A BINDING | 49 | 3.07e-01 | -8.44e-02 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 23 | 4.84e-01 | 8.44e-02 | 6.91e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 22 | 4.93e-01 | 8.44e-02 | 6.99e-01 |
| GOBP TRNA WOBBLE URIDINE MODIFICATION | 14 | 5.85e-01 | -8.44e-02 | 7.63e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 40 | 3.56e-01 | -8.43e-02 | 5.85e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 13 | 5.99e-01 | 8.43e-02 | 7.72e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 32 | 4.10e-01 | 8.43e-02 | 6.30e-01 |
| GOBP IRON ION TRANSPORT | 46 | 3.24e-01 | -8.41e-02 | 5.55e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 20 | 5.15e-01 | -8.41e-02 | 7.15e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 18 | 5.37e-01 | 8.41e-02 | 7.30e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 6.45e-01 | -8.41e-02 | 8.02e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 461 | 2.08e-03 | -8.41e-02 | 1.76e-02 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 38 | 3.70e-01 | -8.41e-02 | 5.96e-01 |
| GOBP LIPID HOMEOSTASIS | 135 | 9.23e-02 | -8.40e-02 | 2.58e-01 |
| GOCC PLASMA MEMBRANE REGION | 921 | 1.85e-05 | -8.40e-02 | 3.43e-04 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 49 | 3.09e-01 | 8.40e-02 | 5.41e-01 |
| GOBP SKIN DEVELOPMENT | 203 | 3.95e-02 | -8.40e-02 | 1.49e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 18 | 5.38e-01 | 8.39e-02 | 7.30e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 781 | 7.61e-05 | -8.39e-02 | 1.17e-03 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 28 | 4.43e-01 | -8.38e-02 | 6.57e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 116 | 1.20e-01 | -8.38e-02 | 3.08e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 31 | 4.20e-01 | -8.38e-02 | 6.38e-01 |
| GOBP LYSOSOMAL TRANSPORT | 112 | 1.26e-01 | -8.37e-02 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION | 14 | 5.88e-01 | 8.37e-02 | 7.65e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 51 | 3.02e-01 | -8.37e-02 | 5.34e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 29 | 4.36e-01 | 8.37e-02 | 6.53e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 17 | 5.51e-01 | 8.36e-02 | 7.36e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 50 | 3.07e-01 | 8.36e-02 | 5.39e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 19 | 5.28e-01 | 8.36e-02 | 7.25e-01 |
| GOMF MRNA 3 UTR BINDING | 94 | 1.62e-01 | 8.35e-02 | 3.74e-01 |
| GOCC ATPASE COMPLEX | 113 | 1.26e-01 | -8.34e-02 | 3.17e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 21 | 5.08e-01 | 8.34e-02 | 7.10e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 13 | 6.03e-01 | -8.34e-02 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 10 | 6.48e-01 | 8.34e-02 | 8.04e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 194 | 4.57e-02 | -8.34e-02 | 1.64e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 17 | 5.52e-01 | 8.34e-02 | 7.37e-01 |
| GOBP REGULATION OF CELL DIVISION | 142 | 8.68e-02 | -8.34e-02 | 2.49e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 140 | 8.91e-02 | -8.33e-02 | 2.52e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 114 | 1.25e-01 | -8.33e-02 | 3.16e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 381 | 5.47e-03 | -8.32e-02 | 3.67e-02 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 14 | 5.90e-01 | 8.32e-02 | 7.65e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 10 | 6.49e-01 | -8.32e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 17 | 5.53e-01 | -8.31e-02 | 7.38e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 72 | 2.23e-01 | 8.31e-02 | 4.51e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 123 | 1.12e-01 | -8.31e-02 | 2.94e-01 |
| GOBP NEURAL CREST FORMATION | 13 | 6.04e-01 | 8.30e-02 | 7.76e-01 |
| GOBP AXON DEVELOPMENT | 422 | 3.63e-03 | -8.29e-02 | 2.69e-02 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 76 | 2.12e-01 | -8.28e-02 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 30 | 4.33e-01 | 8.28e-02 | 6.51e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 24 | 4.83e-01 | -8.28e-02 | 6.91e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 17 | 5.55e-01 | -8.27e-02 | 7.39e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 39 | 3.72e-01 | 8.27e-02 | 5.98e-01 |
| GOBP RRNA METABOLIC PROCESS | 220 | 3.49e-02 | -8.27e-02 | 1.37e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 462 | 2.43e-03 | -8.27e-02 | 2.00e-02 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 25 | 4.74e-01 | -8.27e-02 | 6.85e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 37 | 3.84e-01 | 8.27e-02 | 6.11e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 326 | 1.06e-02 | -8.26e-02 | 5.97e-02 |
| GOBP NEUROBLAST PROLIFERATION | 69 | 2.36e-01 | -8.26e-02 | 4.64e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 22 | 5.03e-01 | -8.26e-02 | 7.06e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 14 | 5.93e-01 | -8.25e-02 | 7.68e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 174 | 6.10e-02 | -8.25e-02 | 2.00e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 21 | 5.13e-01 | -8.25e-02 | 7.13e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 134 | 9.98e-02 | -8.24e-02 | 2.73e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1310 | 7.70e-07 | -8.24e-02 | 2.20e-05 |
| GOMF CARBOXY LYASE ACTIVITY | 26 | 4.67e-01 | -8.24e-02 | 6.79e-01 |
| GOCC MLL1 2 COMPLEX | 30 | 4.35e-01 | 8.24e-02 | 6.52e-01 |
| GOBP CD40 SIGNALING PATHWAY | 13 | 6.07e-01 | -8.23e-02 | 7.78e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 36 | 3.93e-01 | -8.23e-02 | 6.17e-01 |
| GOMF TRANSPORTER ACTIVITY | 740 | 1.54e-04 | -8.23e-02 | 2.11e-03 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.22e-01 | -8.23e-02 | 7.86e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 75 | 2.18e-01 | -8.23e-02 | 4.45e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 78 | 2.09e-01 | -8.23e-02 | 4.35e-01 |
| GOBP HORMONE TRANSPORT | 265 | 2.15e-02 | -8.23e-02 | 9.82e-02 |
| GOBP RECEPTOR RECYCLING | 48 | 3.25e-01 | -8.22e-02 | 5.56e-01 |
| GOBP VASOCONSTRICTION | 86 | 1.88e-01 | -8.22e-02 | 4.07e-01 |
| GOBP MESODERM DEVELOPMENT | 77 | 2.13e-01 | -8.22e-02 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 20 | 5.25e-01 | 8.22e-02 | 7.23e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 5.58e-01 | 8.21e-02 | 7.42e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 39 | 3.75e-01 | 8.21e-02 | 6.02e-01 |
| GOBP REGULATION OF HAIR CYCLE | 17 | 5.58e-01 | 8.20e-02 | 7.42e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 6.38e-01 | -8.20e-02 | 7.97e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 105 | 1.47e-01 | -8.20e-02 | 3.51e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 21 | 5.15e-01 | 8.20e-02 | 7.15e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 4.87e-01 | -8.20e-02 | 6.94e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 24 | 4.87e-01 | -8.19e-02 | 6.94e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 375 | 6.67e-03 | -8.19e-02 | 4.27e-02 |
| GOBP FORELIMB MORPHOGENESIS | 26 | 4.70e-01 | -8.19e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 743 | 1.63e-04 | -8.19e-02 | 2.22e-03 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 5.84e-01 | -8.18e-02 | 7.62e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 98 | 1.62e-01 | -8.18e-02 | 3.74e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 698 | 2.59e-04 | -8.17e-02 | 3.22e-03 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 3.43e-01 | -8.17e-02 | 5.73e-01 |
| GOBP EATING BEHAVIOR | 25 | 4.80e-01 | -8.17e-02 | 6.88e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 29 | 4.47e-01 | 8.16e-02 | 6.60e-01 |
| GOCC NUCLEAR ENVELOPE | 385 | 6.19e-03 | -8.16e-02 | 4.04e-02 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 11 | 6.40e-01 | 8.15e-02 | 7.98e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 26 | 4.72e-01 | 8.15e-02 | 6.83e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 16 | 5.73e-01 | -8.14e-02 | 7.53e-01 |
| GOBP IMPORT INTO THE MITOCHONDRION | 45 | 3.45e-01 | -8.14e-02 | 5.75e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 455 | 3.06e-03 | -8.14e-02 | 2.37e-02 |
| GOMF METALLOPEPTIDASE ACTIVITY | 130 | 1.10e-01 | -8.14e-02 | 2.90e-01 |
| GOBP RESPONSE TO FATTY ACID | 34 | 4.12e-01 | -8.14e-02 | 6.32e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 39 | 3.79e-01 | -8.14e-02 | 6.05e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 46 | 3.40e-01 | -8.13e-02 | 5.71e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 89 | 1.85e-01 | 8.13e-02 | 4.05e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 22 | 5.09e-01 | -8.13e-02 | 7.11e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 745 | 1.79e-04 | -8.12e-02 | 2.39e-03 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 101 | 1.59e-01 | -8.11e-02 | 3.69e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 20 | 5.30e-01 | -8.11e-02 | 7.26e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 50 | 3.21e-01 | 8.11e-02 | 5.53e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 27 | 4.66e-01 | 8.11e-02 | 6.79e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 49 | 3.27e-01 | -8.10e-02 | 5.58e-01 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 10 | 6.57e-01 | 8.10e-02 | 8.11e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 970 | 2.41e-05 | -8.09e-02 | 4.28e-04 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 52 | 3.13e-01 | -8.09e-02 | 5.45e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 25 | 4.84e-01 | 8.09e-02 | 6.91e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 13 | 6.14e-01 | 8.09e-02 | 7.81e-01 |
| GOCC NUCLEAR MEMBRANE | 223 | 3.79e-02 | -8.08e-02 | 1.45e-01 |
| GOMF PROTEIN KINASE B BINDING | 17 | 5.64e-01 | -8.08e-02 | 7.46e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 11 | 6.43e-01 | -8.07e-02 | 8.00e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 23 | 5.03e-01 | 8.07e-02 | 7.06e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 47 | 3.39e-01 | -8.06e-02 | 5.70e-01 |
| GOBP REGULATION OF GASTRULATION | 12 | 6.29e-01 | 8.05e-02 | 7.92e-01 |
| GOBP CARTILAGE DEVELOPMENT | 159 | 8.02e-02 | -8.05e-02 | 2.37e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 190 | 5.63e-02 | -8.05e-02 | 1.89e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 14 | 6.03e-01 | -8.04e-02 | 7.75e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 82 | 2.09e-01 | -8.04e-02 | 4.34e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 15 | 5.90e-01 | -8.03e-02 | 7.66e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 35 | 4.11e-01 | 8.03e-02 | 6.31e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 40 | 3.80e-01 | -8.03e-02 | 6.06e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 11 | 6.45e-01 | -8.02e-02 | 8.02e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 183 | 6.20e-02 | -8.01e-02 | 2.01e-01 |
| GOBP RNA METHYLATION | 58 | 2.91e-01 | 8.01e-02 | 5.25e-01 |
| GOBP NUCLEAR MIGRATION | 30 | 4.48e-01 | -8.01e-02 | 6.60e-01 |
| GOBP CELLULAR RESPONSE TO NITRIC OXIDE | 11 | 6.46e-01 | -8.01e-02 | 8.02e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 20 | 5.35e-01 | 8.01e-02 | 7.28e-01 |
| GOBP RESPONSE TO ATP | 25 | 4.88e-01 | -8.01e-02 | 6.95e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 23 | 5.06e-01 | -8.01e-02 | 7.09e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 11 | 6.46e-01 | -8.00e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 27 | 4.72e-01 | -8.00e-02 | 6.83e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 19 | 5.46e-01 | -8.00e-02 | 7.35e-01 |
| GOBP SPERMATID DIFFERENTIATION | 115 | 1.39e-01 | 8.00e-02 | 3.38e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 43 | 3.65e-01 | -8.00e-02 | 5.92e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 13 | 6.18e-01 | -7.99e-02 | 7.83e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 26 | 4.81e-01 | -7.99e-02 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 20 | 5.37e-01 | -7.98e-02 | 7.29e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 23 | 5.08e-01 | -7.98e-02 | 7.10e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 89 | 1.94e-01 | -7.98e-02 | 4.16e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 74 | 2.36e-01 | 7.97e-02 | 4.64e-01 |
| GOCC MITOTIC SPINDLE POLE | 38 | 3.96e-01 | -7.97e-02 | 6.18e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 18 | 5.59e-01 | -7.97e-02 | 7.42e-01 |
| GOBP MYELIN ASSEMBLY | 21 | 5.28e-01 | 7.95e-02 | 7.25e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 17 | 5.70e-01 | -7.95e-02 | 7.51e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 16 | 5.82e-01 | 7.95e-02 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 257 | 2.87e-02 | -7.94e-02 | 1.21e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 303 | 1.77e-02 | -7.94e-02 | 8.58e-02 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 244 | 3.31e-02 | 7.94e-02 | 1.33e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 15 | 5.95e-01 | 7.94e-02 | 7.69e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 16 | 5.83e-01 | -7.93e-02 | 7.61e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 319 | 1.52e-02 | -7.93e-02 | 7.69e-02 |
| GOBP PROTEIN REFOLDING | 23 | 5.11e-01 | -7.93e-02 | 7.12e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 94 | 1.85e-01 | -7.92e-02 | 4.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 28 | 4.69e-01 | -7.91e-02 | 6.81e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 10 | 6.65e-01 | 7.91e-02 | 8.16e-01 |
| GOBP RIG I SIGNALING PATHWAY | 21 | 5.30e-01 | -7.91e-02 | 7.26e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 12 | 6.35e-01 | -7.91e-02 | 7.97e-01 |
| GOBP DETECTION OF STIMULUS | 119 | 1.37e-01 | -7.91e-02 | 3.35e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 43 | 3.70e-01 | -7.90e-02 | 5.96e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 12 | 6.36e-01 | 7.90e-02 | 7.97e-01 |
| GOBP TRANSLATION | 564 | 1.43e-03 | -7.90e-02 | 1.32e-02 |
| GOBP SECRETION BY TISSUE | 37 | 4.06e-01 | -7.90e-02 | 6.27e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 129 | 1.22e-01 | -7.89e-02 | 3.12e-01 |
| GOBP RECEPTOR CLUSTERING | 66 | 2.68e-01 | -7.88e-02 | 5.01e-01 |
| GOCC CILIARY TIP | 11 | 6.51e-01 | 7.88e-02 | 8.06e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 38 | 4.01e-01 | 7.88e-02 | 6.22e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 204 | 5.29e-02 | -7.88e-02 | 1.81e-01 |
| GOBP CILIUM MOVEMENT | 82 | 2.18e-01 | 7.88e-02 | 4.45e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 10 | 6.66e-01 | 7.88e-02 | 8.17e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 11 | 6.52e-01 | -7.86e-02 | 8.06e-01 |
| GOCC FILOPODIUM TIP | 14 | 6.11e-01 | -7.86e-02 | 7.79e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 12 | 6.38e-01 | 7.86e-02 | 7.97e-01 |
| GOBP FIBROBLAST PROLIFERATION | 128 | 1.25e-01 | -7.85e-02 | 3.17e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 21 | 5.34e-01 | 7.85e-02 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.38e-01 | 7.85e-02 | 7.97e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 123 | 1.33e-01 | -7.85e-02 | 3.29e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 40 | 3.91e-01 | 7.84e-02 | 6.15e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 47 | 3.53e-01 | 7.84e-02 | 5.81e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 70 | 2.57e-01 | -7.84e-02 | 4.87e-01 |
| GOCC ISWI TYPE COMPLEX | 13 | 6.25e-01 | -7.83e-02 | 7.89e-01 |
| GOCC CELL CORTEX REGION | 32 | 4.43e-01 | -7.83e-02 | 6.57e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 40 | 3.92e-01 | -7.83e-02 | 6.16e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 16 | 5.88e-01 | 7.82e-02 | 7.65e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 20 | 5.45e-01 | -7.81e-02 | 7.35e-01 |
| GOBP MESENCHYME DEVELOPMENT | 246 | 3.53e-02 | -7.81e-02 | 1.39e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 62 | 2.88e-01 | -7.80e-02 | 5.21e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 206 | 5.43e-02 | -7.79e-02 | 1.85e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 29 | 4.68e-01 | 7.79e-02 | 6.80e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 49 | 3.46e-01 | 7.79e-02 | 5.75e-01 |
| GOBP RIBOSOME BIOGENESIS | 286 | 2.38e-02 | -7.79e-02 | 1.06e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 294 | 2.21e-02 | -7.78e-02 | 1.00e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 45 | 3.67e-01 | -7.78e-02 | 5.93e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 134 | 1.21e-01 | -7.78e-02 | 3.09e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 622 | 1.00e-03 | -7.77e-02 | 9.98e-03 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 22 | 5.28e-01 | -7.77e-02 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 57 | 3.11e-01 | -7.77e-02 | 5.42e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 6.56e-01 | -7.77e-02 | 8.09e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 168 | 8.32e-02 | -7.76e-02 | 2.42e-01 |
| GOCC REPLICATION FORK | 66 | 2.76e-01 | 7.76e-02 | 5.10e-01 |
| GOBP ALPHA AMINO ACID BIOSYNTHETIC PROCESS | 50 | 3.43e-01 | -7.75e-02 | 5.73e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 12 | 6.42e-01 | -7.75e-02 | 8.00e-01 |
| GOBP ORGANIC CATION TRANSPORT | 84 | 2.20e-01 | -7.74e-02 | 4.47e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 20 | 5.49e-01 | -7.74e-02 | 7.36e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 22 | 5.30e-01 | 7.74e-02 | 7.26e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 14 | 6.17e-01 | -7.73e-02 | 7.83e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 242 | 3.88e-02 | -7.73e-02 | 1.47e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 423 | 6.63e-03 | -7.73e-02 | 4.25e-02 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 62 | 2.93e-01 | -7.72e-02 | 5.26e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION | 20 | 5.50e-01 | 7.72e-02 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 21 | 5.41e-01 | -7.72e-02 | 7.32e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 158 | 9.49e-02 | -7.71e-02 | 2.63e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 38 | 4.11e-01 | -7.71e-02 | 6.31e-01 |
| GOBP CHROMOSOME SEPARATION | 65 | 2.83e-01 | -7.71e-02 | 5.17e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 38 | 4.11e-01 | -7.70e-02 | 6.31e-01 |
| GOBP SCHWANN CELL MIGRATION | 11 | 6.58e-01 | -7.70e-02 | 8.11e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 11 | 6.59e-01 | -7.69e-02 | 8.12e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 21 | 5.42e-01 | -7.69e-02 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 20 | 5.52e-01 | -7.69e-02 | 7.37e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 886 | 1.20e-04 | -7.69e-02 | 1.72e-03 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 22 | 5.33e-01 | -7.68e-02 | 7.27e-01 |
| GOCC DENDRITE CYTOPLASM | 29 | 4.74e-01 | 7.68e-02 | 6.84e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 25 | 5.06e-01 | 7.68e-02 | 7.09e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 102 | 1.81e-01 | -7.68e-02 | 4.00e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE MEMBRANE | 13 | 6.32e-01 | -7.67e-02 | 7.95e-01 |
| GOBP PROTEIN STABILIZATION | 173 | 8.24e-02 | -7.67e-02 | 2.41e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 26 | 4.99e-01 | -7.67e-02 | 7.03e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 11 | 6.60e-01 | -7.66e-02 | 8.12e-01 |
| GOCC BASAL PART OF CELL | 232 | 4.48e-02 | -7.66e-02 | 1.62e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 58 | 3.14e-01 | -7.65e-02 | 5.45e-01 |
| GOBP REGULATION OF GLIOGENESIS | 106 | 1.74e-01 | -7.65e-02 | 3.90e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 17 | 5.85e-01 | -7.65e-02 | 7.63e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 16 | 5.97e-01 | -7.64e-02 | 7.70e-01 |
| GOCC GAP JUNCTION | 15 | 6.08e-01 | -7.64e-02 | 7.78e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 94 | 2.01e-01 | 7.64e-02 | 4.24e-01 |
| GOBP RESPONSE TO ZINC ION | 26 | 5.00e-01 | -7.64e-02 | 7.04e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 172 | 8.43e-02 | -7.64e-02 | 2.44e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 14 | 6.21e-01 | -7.64e-02 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 24 | 5.17e-01 | -7.64e-02 | 7.17e-01 |
| GOBP NEURON MIGRATION | 153 | 1.04e-01 | -7.63e-02 | 2.80e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 24 | 5.18e-01 | 7.63e-02 | 7.17e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 10 | 6.76e-01 | -7.62e-02 | 8.23e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 27 | 4.93e-01 | -7.62e-02 | 6.99e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 709 | 6.05e-04 | -7.61e-02 | 6.56e-03 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 60 | 3.08e-01 | -7.61e-02 | 5.40e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 14 | 6.22e-01 | -7.61e-02 | 7.86e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 34 | 4.43e-01 | -7.61e-02 | 6.57e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 57 | 3.21e-01 | -7.61e-02 | 5.52e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 24 | 5.19e-01 | 7.61e-02 | 7.18e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 62 | 3.00e-01 | -7.61e-02 | 5.33e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 28 | 4.86e-01 | -7.61e-02 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 6.48e-01 | -7.60e-02 | 8.04e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 40 | 4.06e-01 | -7.60e-02 | 6.27e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 40 | 4.06e-01 | -7.60e-02 | 6.27e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 236 | 4.50e-02 | -7.59e-02 | 1.62e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 32 | 4.57e-01 | -7.59e-02 | 6.70e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 24 | 5.20e-01 | -7.59e-02 | 7.18e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 33 | 4.51e-01 | -7.58e-02 | 6.64e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 193 | 6.99e-02 | -7.58e-02 | 2.17e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 81 | 2.39e-01 | 7.58e-02 | 4.67e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 24 | 5.21e-01 | 7.58e-02 | 7.19e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 10 | 6.78e-01 | 7.58e-02 | 8.24e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 13 | 6.37e-01 | 7.57e-02 | 7.97e-01 |
| GOMF PHOSPHATASE BINDING | 200 | 6.56e-02 | -7.57e-02 | 2.09e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 95 | 2.03e-01 | 7.56e-02 | 4.27e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 12 | 6.51e-01 | -7.55e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 55 | 3.33e-01 | -7.55e-02 | 5.64e-01 |
| GOMF VITAMIN B6 BINDING | 36 | 4.33e-01 | -7.55e-02 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 96 | 2.02e-01 | -7.54e-02 | 4.25e-01 |
| GOMF TELOMERASE RNA BINDING | 16 | 6.01e-01 | 7.54e-02 | 7.74e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 10 | 6.80e-01 | -7.54e-02 | 8.25e-01 |
| GOBP FEMALE GAMETE GENERATION | 101 | 1.91e-01 | -7.54e-02 | 4.12e-01 |
| GOBP INSULIN SECRETION | 183 | 7.91e-02 | -7.54e-02 | 2.35e-01 |
| GOBP BONE DEVELOPMENT | 177 | 8.42e-02 | -7.54e-02 | 2.44e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 6.25e-01 | 7.54e-02 | 7.90e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1052 | 4.41e-05 | -7.53e-02 | 7.29e-04 |
| GOBP RETINOL METABOLIC PROCESS | 13 | 6.39e-01 | 7.52e-02 | 7.97e-01 |
| GOBP BONE MINERALIZATION | 104 | 1.86e-01 | -7.52e-02 | 4.05e-01 |
| GOBP BIOLOGICAL PHASE | 28 | 4.91e-01 | -7.52e-02 | 6.98e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 69 | 2.81e-01 | -7.52e-02 | 5.14e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 13 | 6.39e-01 | -7.52e-02 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION | 12 | 6.52e-01 | -7.52e-02 | 8.07e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 80 | 2.46e-01 | -7.51e-02 | 4.75e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 22 | 5.42e-01 | 7.51e-02 | 7.33e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 44 | 3.89e-01 | 7.50e-02 | 6.15e-01 |
| GOBP TRANSCYTOSIS | 18 | 5.82e-01 | -7.50e-02 | 7.60e-01 |
| GOBP SYNAPSE ORGANIZATION | 485 | 4.88e-03 | -7.50e-02 | 3.39e-02 |
| GOBP REGULATION OF BINDING | 282 | 3.07e-02 | -7.50e-02 | 1.26e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 14 | 6.27e-01 | 7.49e-02 | 7.91e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 604 | 1.78e-03 | -7.49e-02 | 1.57e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 21 | 5.53e-01 | -7.49e-02 | 7.38e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 10 | 6.82e-01 | -7.48e-02 | 8.27e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 38 | 4.25e-01 | -7.48e-02 | 6.42e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 23 | 5.35e-01 | -7.48e-02 | 7.28e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 13 | 6.41e-01 | -7.48e-02 | 7.99e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 55 | 3.38e-01 | -7.48e-02 | 5.68e-01 |
| GOCC RECEPTOR COMPLEX | 262 | 3.78e-02 | -7.47e-02 | 1.44e-01 |
| GOMF MYOSIN V BINDING | 15 | 6.17e-01 | 7.47e-02 | 7.83e-01 |
| GOBP LIPID CATABOLIC PROCESS | 230 | 5.18e-02 | -7.46e-02 | 1.79e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 16 | 6.06e-01 | 7.45e-02 | 7.77e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 240 | 4.76e-02 | 7.44e-02 | 1.69e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 49 | 3.69e-01 | -7.43e-02 | 5.95e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 18 | 5.85e-01 | -7.43e-02 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 33 | 4.61e-01 | 7.43e-02 | 6.73e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 21 | 5.57e-01 | -7.41e-02 | 7.41e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 288 | 3.14e-02 | -7.39e-02 | 1.28e-01 |
| GOBP LATERAL SPROUTING FROM AN EPITHELIUM | 10 | 6.86e-01 | 7.39e-02 | 8.28e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 70 | 2.85e-01 | -7.39e-02 | 5.19e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 87 | 2.34e-01 | 7.39e-02 | 4.62e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 36 | 4.43e-01 | -7.39e-02 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 48 | 3.76e-01 | 7.39e-02 | 6.03e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 33 | 4.63e-01 | 7.39e-02 | 6.75e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 57 | 3.36e-01 | -7.38e-02 | 5.65e-01 |
| GOBP ORGANIC ANION TRANSPORT | 286 | 3.23e-02 | -7.38e-02 | 1.31e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 118 | 1.67e-01 | -7.37e-02 | 3.80e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 93 | 2.20e-01 | 7.37e-02 | 4.46e-01 |
| GOBP NOSE DEVELOPMENT | 11 | 6.72e-01 | 7.36e-02 | 8.21e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 338 | 2.05e-02 | -7.36e-02 | 9.47e-02 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 14 | 6.34e-01 | -7.35e-02 | 7.96e-01 |
| GOBP CELL CYCLE PROCESS | 1010 | 9.20e-05 | -7.35e-02 | 1.39e-03 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 17 | 6.00e-01 | -7.34e-02 | 7.73e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 87 | 2.37e-01 | 7.34e-02 | 4.65e-01 |
| GOBP TRNA MODIFICATION | 80 | 2.57e-01 | 7.34e-02 | 4.87e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 20 | 5.70e-01 | 7.34e-02 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 10 | 6.88e-01 | -7.34e-02 | 8.29e-01 |
| GOBP TRANSLESION SYNTHESIS | 21 | 5.61e-01 | -7.33e-02 | 7.44e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 181 | 8.94e-02 | 7.33e-02 | 2.53e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 41 | 4.17e-01 | -7.33e-02 | 6.36e-01 |
| GOBP SISTER CHROMATID COHESION | 41 | 4.17e-01 | 7.33e-02 | 6.36e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 57 | 3.39e-01 | -7.33e-02 | 5.70e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 16 | 6.12e-01 | -7.33e-02 | 7.80e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 6.35e-01 | -7.32e-02 | 7.97e-01 |
| GOCC LYSOSOMAL LUMEN | 19 | 5.81e-01 | -7.32e-02 | 7.60e-01 |
| GOMF NADPLUS BINDING | 16 | 6.13e-01 | -7.31e-02 | 7.80e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 28 | 5.03e-01 | -7.31e-02 | 7.06e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 60 | 3.28e-01 | -7.31e-02 | 5.59e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 142 | 1.33e-01 | -7.31e-02 | 3.29e-01 |
| GOBP NK T CELL ACTIVATION | 10 | 6.89e-01 | 7.31e-02 | 8.30e-01 |
| GOCC DENDRITIC SPINE HEAD | 11 | 6.75e-01 | 7.30e-02 | 8.23e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 48 | 3.82e-01 | 7.30e-02 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 10 | 6.89e-01 | -7.30e-02 | 8.30e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 15 | 6.25e-01 | -7.30e-02 | 7.89e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 126 | 1.58e-01 | 7.30e-02 | 3.67e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 12 | 6.62e-01 | -7.30e-02 | 8.14e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 112 | 1.83e-01 | -7.29e-02 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 22 | 5.54e-01 | -7.29e-02 | 7.39e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 292 | 3.27e-02 | -7.28e-02 | 1.32e-01 |
| GOBP NUCLEUS LOCALIZATION | 37 | 4.43e-01 | -7.28e-02 | 6.57e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 49 | 3.78e-01 | -7.28e-02 | 6.04e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 11 | 6.76e-01 | -7.28e-02 | 8.23e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 17 | 6.04e-01 | -7.28e-02 | 7.76e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1319 | 1.22e-05 | -7.27e-02 | 2.40e-04 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 166 | 1.07e-01 | -7.27e-02 | 2.86e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 217 | 6.54e-02 | -7.27e-02 | 2.08e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 33 | 4.70e-01 | -7.27e-02 | 6.82e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 12 | 6.63e-01 | -7.27e-02 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 140 | 1.38e-01 | -7.26e-02 | 3.38e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 16 | 6.15e-01 | -7.26e-02 | 7.82e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 38 | 4.39e-01 | -7.26e-02 | 6.55e-01 |
| GOCC PRESYNAPSE | 589 | 2.78e-03 | -7.26e-02 | 2.21e-02 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 130 | 1.54e-01 | -7.25e-02 | 3.62e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 78 | 2.69e-01 | -7.25e-02 | 5.01e-01 |
| GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY | 10 | 6.91e-01 | -7.25e-02 | 8.30e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 15 | 6.27e-01 | -7.25e-02 | 7.91e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 158 | 1.16e-01 | -7.25e-02 | 3.02e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 30 | 4.92e-01 | 7.24e-02 | 6.98e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 19 | 5.85e-01 | 7.24e-02 | 7.63e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 65 | 3.13e-01 | 7.24e-02 | 5.45e-01 |
| GOBP MONOAMINE TRANSPORT | 61 | 3.28e-01 | -7.24e-02 | 5.60e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 129 | 1.57e-01 | -7.23e-02 | 3.66e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 297 | 3.28e-02 | -7.22e-02 | 1.32e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 66 | 3.11e-01 | -7.22e-02 | 5.42e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 12 | 6.65e-01 | -7.21e-02 | 8.16e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 23 | 5.49e-01 | -7.21e-02 | 7.36e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 142 | 1.39e-01 | -7.21e-02 | 3.38e-01 |
| GOBP BASE EXCISION REPAIR | 38 | 4.42e-01 | -7.21e-02 | 6.57e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 6.41e-01 | 7.21e-02 | 7.99e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 25 | 5.34e-01 | 7.19e-02 | 7.27e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 61 | 3.32e-01 | -7.19e-02 | 5.62e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 15 | 6.30e-01 | 7.19e-02 | 7.93e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 117 | 1.80e-01 | -7.19e-02 | 3.98e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 459 | 8.62e-03 | -7.19e-02 | 5.14e-02 |
| GOBP CELL REDOX HOMEOSTASIS | 25 | 5.34e-01 | -7.18e-02 | 7.28e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 229 | 6.20e-02 | -7.17e-02 | 2.01e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 6.67e-01 | -7.17e-02 | 8.18e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 57 | 3.49e-01 | -7.17e-02 | 5.79e-01 |
| GOBP RRNA PROCESSING | 195 | 8.48e-02 | -7.17e-02 | 2.45e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 546 | 4.44e-03 | -7.16e-02 | 3.16e-02 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 74 | 2.87e-01 | -7.16e-02 | 5.21e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 6.10e-01 | 7.16e-02 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 12 | 6.68e-01 | -7.15e-02 | 8.18e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 6.55e-01 | -7.15e-02 | 8.09e-01 |
| GOMF CHOLESTEROL BINDING | 40 | 4.34e-01 | -7.15e-02 | 6.52e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 48 | 3.92e-01 | 7.15e-02 | 6.16e-01 |
| GOBP BONE CELL DEVELOPMENT | 13 | 6.55e-01 | -7.15e-02 | 8.09e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 86 | 2.52e-01 | -7.15e-02 | 4.83e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 6.44e-01 | -7.14e-02 | 8.01e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 16 | 6.22e-01 | -7.13e-02 | 7.86e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 24 | 5.46e-01 | -7.13e-02 | 7.35e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 64 | 3.25e-01 | -7.12e-02 | 5.56e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 41 | 4.30e-01 | -7.12e-02 | 6.48e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 13 | 6.57e-01 | 7.12e-02 | 8.10e-01 |
| GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 4.86e-01 | -7.12e-02 | 6.93e-01 |
| GOBP ORGANELLE ASSEMBLY | 808 | 6.49e-04 | -7.12e-02 | 6.94e-03 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 45 | 4.09e-01 | -7.12e-02 | 6.30e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 26 | 5.30e-01 | -7.12e-02 | 7.26e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 149 | 1.35e-01 | 7.11e-02 | 3.32e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 23 | 5.55e-01 | 7.11e-02 | 7.40e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 50 | 3.85e-01 | -7.10e-02 | 6.12e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 95 | 2.32e-01 | -7.10e-02 | 4.61e-01 |
| GOCC CAJAL BODY | 34 | 4.74e-01 | 7.10e-02 | 6.84e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 44 | 4.16e-01 | -7.09e-02 | 6.36e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 46 | 4.06e-01 | 7.08e-02 | 6.27e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 44 | 4.16e-01 | -7.08e-02 | 6.36e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 15 | 6.35e-01 | -7.08e-02 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 33 | 4.82e-01 | -7.08e-02 | 6.89e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 318 | 3.06e-02 | -7.08e-02 | 1.26e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 19 | 5.94e-01 | -7.07e-02 | 7.68e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 31 | 4.96e-01 | -7.06e-02 | 7.01e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 11 | 6.85e-01 | -7.06e-02 | 8.28e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 26 | 5.33e-01 | -7.06e-02 | 7.27e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 13 | 6.59e-01 | -7.06e-02 | 8.12e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 22 | 5.67e-01 | 7.05e-02 | 7.48e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 33 | 4.84e-01 | -7.05e-02 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 17 | 6.15e-01 | -7.05e-02 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 198 | 8.88e-02 | -7.03e-02 | 2.52e-01 |
| GOBP STEROID HORMONE SECRETION | 19 | 5.96e-01 | -7.03e-02 | 7.70e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 23 | 5.60e-01 | 7.02e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 19 | 5.96e-01 | 7.02e-02 | 7.70e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 16 | 6.27e-01 | 7.02e-02 | 7.91e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 118 | 1.88e-01 | -7.02e-02 | 4.08e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 135 | 1.60e-01 | -7.02e-02 | 3.70e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 18 | 6.06e-01 | -7.01e-02 | 7.78e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 32 | 4.92e-01 | -7.01e-02 | 6.98e-01 |
| GOCC SPERM HEAD | 12 | 6.74e-01 | -7.01e-02 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 81 | 2.76e-01 | -7.01e-02 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 738 | 1.30e-03 | -7.01e-02 | 1.23e-02 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 18 | 6.07e-01 | -7.00e-02 | 7.78e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 53 | 3.78e-01 | -7.00e-02 | 6.04e-01 |
| GOCC GOLGI STACK | 81 | 2.77e-01 | -7.00e-02 | 5.10e-01 |
| GOMF SH3 DOMAIN BINDING | 118 | 1.90e-01 | -7.00e-02 | 4.10e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 31 | 5.01e-01 | 6.99e-02 | 7.04e-01 |
| GOBP PALLIUM DEVELOPMENT | 130 | 1.69e-01 | -6.99e-02 | 3.83e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 394 | 1.77e-02 | -6.99e-02 | 8.58e-02 |
| GOBP CATECHOLAMINE SECRETION | 39 | 4.51e-01 | -6.98e-02 | 6.64e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 49 | 3.98e-01 | 6.98e-02 | 6.20e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 22 | 5.71e-01 | 6.98e-02 | 7.51e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 214 | 7.92e-02 | -6.98e-02 | 2.35e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 13 | 6.63e-01 | 6.98e-02 | 8.15e-01 |
| GOMF DNA POLYMERASE BINDING | 20 | 5.89e-01 | 6.98e-02 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 13 | 6.63e-01 | 6.98e-02 | 8.15e-01 |
| GOCC GLIAL CELL PROJECTION | 31 | 5.02e-01 | -6.97e-02 | 7.05e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 106 | 2.16e-01 | 6.97e-02 | 4.43e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 5.39e-01 | -6.96e-02 | 7.31e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 40 | 4.46e-01 | 6.96e-02 | 6.60e-01 |
| GOCC SWI SNF COMPLEX | 25 | 5.47e-01 | -6.96e-02 | 7.36e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 18 | 6.10e-01 | -6.95e-02 | 7.79e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 11 | 6.90e-01 | -6.95e-02 | 8.30e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 16 | 6.31e-01 | -6.94e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 41 | 4.42e-01 | -6.94e-02 | 6.57e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 100 | 2.31e-01 | -6.94e-02 | 4.60e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 447 | 1.24e-02 | -6.93e-02 | 6.68e-02 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 49 | 4.02e-01 | -6.92e-02 | 6.24e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 11 | 6.91e-01 | 6.92e-02 | 8.30e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 12 | 6.79e-01 | 6.91e-02 | 8.24e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 22 | 5.75e-01 | 6.91e-02 | 7.55e-01 |
| GOBP BRAIN MORPHOGENESIS | 29 | 5.20e-01 | 6.90e-02 | 7.18e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 17 | 6.22e-01 | -6.90e-02 | 7.87e-01 |
| GOBP REGULATION OF DNA BINDING | 83 | 2.78e-01 | -6.90e-02 | 5.12e-01 |
| GOBP SARCOMERE ORGANIZATION | 52 | 3.90e-01 | -6.90e-02 | 6.15e-01 |
| GOMF STEROL BINDING | 54 | 3.81e-01 | -6.89e-02 | 6.07e-01 |
| GOBP TELOMERE CAPPING | 35 | 4.81e-01 | 6.89e-02 | 6.88e-01 |
| GOBP HOMEOSTATIC PROCESS | 1344 | 2.95e-05 | -6.89e-02 | 5.08e-04 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 226 | 7.52e-02 | -6.88e-02 | 2.28e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 29 | 5.21e-01 | 6.88e-02 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 14 | 6.56e-01 | 6.87e-02 | 8.10e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 20 | 5.95e-01 | 6.87e-02 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 18 | 6.14e-01 | -6.87e-02 | 7.81e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 224 | 7.76e-02 | -6.86e-02 | 2.33e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 511 | 8.33e-03 | -6.85e-02 | 4.99e-02 |
| GOBP GTP METABOLIC PROCESS | 23 | 5.70e-01 | -6.85e-02 | 7.50e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 69 | 3.26e-01 | 6.85e-02 | 5.57e-01 |
| GOBP PROTEIN HYDROXYLATION | 24 | 5.62e-01 | -6.84e-02 | 7.45e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 236 | 7.09e-02 | -6.84e-02 | 2.19e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 10 | 7.08e-01 | -6.84e-02 | 8.40e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 19 | 6.06e-01 | -6.84e-02 | 7.77e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 81 | 2.88e-01 | -6.84e-02 | 5.21e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 12 | 6.82e-01 | 6.83e-02 | 8.27e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 13 | 6.70e-01 | 6.83e-02 | 8.20e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 187 | 1.08e-01 | 6.82e-02 | 2.89e-01 |
| GOBP REGULATION OF PH | 78 | 2.98e-01 | 6.82e-02 | 5.31e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 33 | 4.98e-01 | 6.82e-02 | 7.03e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 122 | 1.94e-01 | -6.81e-02 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 38 | 4.68e-01 | 6.81e-02 | 6.80e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 94 | 2.54e-01 | 6.81e-02 | 4.85e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1330 | 4.13e-05 | -6.79e-02 | 6.89e-04 |
| GOMF CHEMOATTRACTANT ACTIVITY | 20 | 5.99e-01 | -6.79e-02 | 7.72e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 12 | 6.84e-01 | -6.79e-02 | 8.28e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 21 | 5.90e-01 | -6.79e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 29 | 5.28e-01 | 6.78e-02 | 7.25e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 23 | 5.74e-01 | 6.77e-02 | 7.55e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 754 | 1.70e-03 | -6.77e-02 | 1.52e-02 |
| GOBP PROTEIN NITROSYLATION | 12 | 6.85e-01 | 6.77e-02 | 8.28e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 29 | 5.28e-01 | 6.77e-02 | 7.25e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 11 | 6.98e-01 | -6.76e-02 | 8.34e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 69 | 3.32e-01 | 6.75e-02 | 5.63e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 36 | 4.84e-01 | -6.75e-02 | 6.91e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 23 | 5.76e-01 | 6.75e-02 | 7.56e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 50 | 4.10e-01 | -6.75e-02 | 6.30e-01 |
| GOBP GLYCOSYLATION | 175 | 1.25e-01 | -6.74e-02 | 3.16e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 23 | 5.76e-01 | -6.73e-02 | 7.56e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 12 | 6.87e-01 | -6.73e-02 | 8.29e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 228 | 8.09e-02 | -6.72e-02 | 2.38e-01 |
| GOBP LIVER MORPHOGENESIS | 28 | 5.38e-01 | -6.72e-02 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 100 | 2.46e-01 | -6.72e-02 | 4.75e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 13 | 6.75e-01 | 6.71e-02 | 8.23e-01 |
| GOCC CELL BODY | 623 | 4.50e-03 | -6.71e-02 | 3.19e-02 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 5.62e-01 | -6.71e-02 | 7.45e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 22 | 5.87e-01 | 6.70e-02 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 25 | 5.62e-01 | -6.70e-02 | 7.45e-01 |
| GOCC OUTER MEMBRANE | 177 | 1.25e-01 | -6.69e-02 | 3.17e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 260 | 6.41e-02 | -6.69e-02 | 2.06e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 45 | 4.38e-01 | -6.69e-02 | 6.54e-01 |
| GOCC SARCOLEMMA | 153 | 1.54e-01 | -6.69e-02 | 3.62e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 31 | 5.20e-01 | -6.68e-02 | 7.18e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 13 | 6.77e-01 | -6.68e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 55 | 3.93e-01 | -6.67e-02 | 6.17e-01 |
| GOBP MEMORY | 127 | 1.95e-01 | -6.67e-02 | 4.17e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 211 | 9.60e-02 | -6.66e-02 | 2.65e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 10 | 7.15e-01 | -6.66e-02 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 51 | 4.11e-01 | -6.66e-02 | 6.31e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 17 | 6.35e-01 | 6.65e-02 | 7.97e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 17 | 6.35e-01 | -6.65e-02 | 7.97e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 25 | 5.65e-01 | -6.65e-02 | 7.47e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 12 | 6.90e-01 | 6.65e-02 | 8.30e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 6.46e-01 | 6.64e-02 | 8.02e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 56 | 3.90e-01 | -6.64e-02 | 6.15e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 143 | 1.71e-01 | -6.64e-02 | 3.86e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 14 | 6.67e-01 | 6.64e-02 | 8.18e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 162 | 1.46e-01 | -6.64e-02 | 3.49e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 35 | 4.97e-01 | -6.64e-02 | 7.02e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 20 | 6.08e-01 | -6.63e-02 | 7.78e-01 |
| GOBP REGULATION OF DOPAMINE SECRETION | 19 | 6.17e-01 | -6.62e-02 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 45 | 4.43e-01 | -6.62e-02 | 6.57e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 10 | 7.17e-01 | 6.61e-02 | 8.46e-01 |
| GOBP EYE MORPHOGENESIS | 128 | 1.97e-01 | 6.61e-02 | 4.20e-01 |
| GOBP REGULATION OF CELL CYCLE | 872 | 1.04e-03 | -6.60e-02 | 1.02e-02 |
| GOBP SENSORY PERCEPTION OF TASTE | 11 | 7.05e-01 | 6.60e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 23 | 5.84e-01 | -6.60e-02 | 7.62e-01 |
| GOCC PROXIMAL DENDRITE | 12 | 6.92e-01 | -6.60e-02 | 8.30e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 379 | 2.82e-02 | -6.59e-02 | 1.19e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 27 | 5.54e-01 | 6.59e-02 | 7.38e-01 |
| GOBP CELL CELL SIGNALING | 868 | 1.10e-03 | -6.59e-02 | 1.07e-02 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 217 | 9.54e-02 | -6.58e-02 | 2.64e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 114 | 2.25e-01 | -6.58e-02 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 6.93e-01 | -6.58e-02 | 8.31e-01 |
| GOBP REGULATION OF CYTOKINESIS | 73 | 3.32e-01 | -6.57e-02 | 5.63e-01 |
| GOCC AUTOLYSOSOME | 14 | 6.71e-01 | -6.57e-02 | 8.20e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 55 | 4.00e-01 | 6.56e-02 | 6.22e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 81 | 3.08e-01 | -6.56e-02 | 5.40e-01 |
| GOBP UV PROTECTION | 10 | 7.20e-01 | -6.55e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 6.50e-01 | 6.55e-02 | 8.06e-01 |
| GOBP ALANINE TRANSPORT | 13 | 6.83e-01 | -6.55e-02 | 8.27e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 690 | 3.59e-03 | -6.55e-02 | 2.67e-02 |
| GOMF TOLL LIKE RECEPTOR BINDING | 12 | 6.94e-01 | -6.55e-02 | 8.32e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 24 | 5.79e-01 | 6.55e-02 | 7.58e-01 |
| GOBP REGULATION OF CELLULAR PH | 67 | 3.55e-01 | 6.55e-02 | 5.84e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 21 | 6.04e-01 | 6.54e-02 | 7.76e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 28 | 5.49e-01 | -6.54e-02 | 7.36e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 61 | 3.77e-01 | -6.54e-02 | 6.04e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 7.21e-01 | -6.53e-02 | 8.48e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 46 | 4.44e-01 | -6.52e-02 | 6.58e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 35 | 5.05e-01 | -6.52e-02 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 126 | 2.07e-01 | -6.52e-02 | 4.32e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 242 | 8.17e-02 | -6.51e-02 | 2.39e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 17 | 6.42e-01 | -6.51e-02 | 8.00e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 7.09e-01 | -6.51e-02 | 8.41e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 102 | 2.57e-01 | -6.50e-02 | 4.87e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 12 | 6.97e-01 | -6.50e-02 | 8.34e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 41 | 4.72e-01 | 6.49e-02 | 6.83e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 116 | 2.28e-01 | -6.49e-02 | 4.55e-01 |
| GOBP ARGININE METABOLIC PROCESS | 13 | 6.86e-01 | -6.48e-02 | 8.28e-01 |
| GOBP GLUTAMATE SECRETION | 26 | 5.67e-01 | 6.48e-02 | 7.49e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 94 | 2.78e-01 | 6.48e-02 | 5.12e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 190 | 1.25e-01 | -6.47e-02 | 3.16e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 247 | 8.06e-02 | -6.47e-02 | 2.38e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 6.98e-01 | -6.47e-02 | 8.34e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 60 | 3.86e-01 | -6.47e-02 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 44 | 4.58e-01 | -6.47e-02 | 6.71e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 6.35e-01 | -6.47e-02 | 7.97e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 114 | 2.34e-01 | 6.46e-02 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 78 | 3.25e-01 | 6.46e-02 | 5.56e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 42 | 4.70e-01 | 6.45e-02 | 6.82e-01 |
| GOBP SEROTONIN TRANSPORT | 18 | 6.36e-01 | 6.45e-02 | 7.97e-01 |
| GOCC ZYMOGEN GRANULE MEMBRANE | 10 | 7.24e-01 | -6.44e-02 | 8.50e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 12 | 6.99e-01 | -6.44e-02 | 8.35e-01 |
| GOCC INNER KINETOCHORE | 11 | 7.12e-01 | 6.43e-02 | 8.43e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 12 | 7.00e-01 | 6.43e-02 | 8.35e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 114 | 2.36e-01 | 6.43e-02 | 4.64e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 14 | 6.77e-01 | 6.43e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 62 | 3.82e-01 | -6.43e-02 | 6.08e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 91 | 2.90e-01 | 6.43e-02 | 5.23e-01 |
| GOBP DEVELOPMENTAL GROWTH | 634 | 6.12e-03 | -6.42e-02 | 4.01e-02 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 77 | 3.31e-01 | -6.42e-02 | 5.62e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 42 | 4.72e-01 | -6.41e-02 | 6.83e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 115 | 2.36e-01 | -6.41e-02 | 4.64e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 13 | 6.89e-01 | -6.41e-02 | 8.30e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 124 | 2.19e-01 | -6.41e-02 | 4.45e-01 |
| GOBP LIPID OXIDATION | 100 | 2.69e-01 | -6.40e-02 | 5.01e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 77 | 3.32e-01 | -6.40e-02 | 5.62e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 11 | 7.13e-01 | 6.40e-02 | 8.44e-01 |
| GOBP MYOBLAST MIGRATION | 13 | 6.90e-01 | 6.40e-02 | 8.30e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 73 | 3.45e-01 | -6.40e-02 | 5.75e-01 |
| GOCC NUCLEAR CHROMOSOME | 185 | 1.34e-01 | 6.40e-02 | 3.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 38 | 4.96e-01 | -6.39e-02 | 7.01e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 7.02e-01 | 6.38e-02 | 8.37e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 972 | 8.61e-04 | -6.38e-02 | 8.75e-03 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 27 | 5.67e-01 | -6.38e-02 | 7.48e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 42 | 4.76e-01 | -6.36e-02 | 6.86e-01 |
| GOMF CORECEPTOR ACTIVITY | 32 | 5.33e-01 | -6.36e-02 | 7.27e-01 |
| GOBP DEPHOSPHORYLATION | 260 | 7.84e-02 | -6.36e-02 | 2.34e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 54 | 4.19e-01 | -6.35e-02 | 6.38e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 52 | 4.28e-01 | -6.35e-02 | 6.47e-01 |
| GOMF APOLIPOPROTEIN BINDING | 16 | 6.60e-01 | -6.35e-02 | 8.13e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 23 | 5.98e-01 | 6.35e-02 | 7.72e-01 |
| GOMF ACTININ BINDING | 38 | 4.99e-01 | -6.35e-02 | 7.03e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 6.92e-01 | 6.34e-02 | 8.30e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 43 | 4.72e-01 | 6.34e-02 | 6.83e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 167 | 1.59e-01 | -6.33e-02 | 3.68e-01 |
| GOBP MRNA CATABOLIC PROCESS | 203 | 1.21e-01 | 6.33e-02 | 3.10e-01 |
| GOBP REGULATION OF AXON REGENERATION | 32 | 5.36e-01 | -6.33e-02 | 7.29e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 6.93e-01 | 6.33e-02 | 8.31e-01 |
| GOBP NEURON REMODELING | 15 | 6.72e-01 | -6.32e-02 | 8.21e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 10 | 7.30e-01 | -6.31e-02 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 175 | 1.50e-01 | -6.31e-02 | 3.57e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 12 | 7.05e-01 | -6.31e-02 | 8.39e-01 |
| GOMF RNA STEM LOOP BINDING | 15 | 6.72e-01 | -6.31e-02 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 12 | 7.05e-01 | -6.31e-02 | 8.39e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 49 | 4.45e-01 | 6.31e-02 | 6.58e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 115 | 2.43e-01 | -6.31e-02 | 4.71e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 15 | 6.73e-01 | -6.30e-02 | 8.21e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 127 | 2.21e-01 | 6.30e-02 | 4.48e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 14 | 6.83e-01 | 6.30e-02 | 8.27e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 35 | 5.20e-01 | 6.29e-02 | 7.18e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 19 | 6.35e-01 | -6.29e-02 | 7.97e-01 |
| GOBP NEURON PROJECTION REGENERATION | 59 | 4.04e-01 | -6.29e-02 | 6.25e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 10 | 7.31e-01 | -6.28e-02 | 8.55e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 6.36e-01 | -6.27e-02 | 7.97e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 14 | 6.85e-01 | -6.27e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 125 | 2.27e-01 | -6.27e-02 | 4.54e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 34 | 5.27e-01 | 6.27e-02 | 7.25e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 10 | 7.31e-01 | -6.27e-02 | 8.55e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 11 | 7.19e-01 | 6.27e-02 | 8.47e-01 |
| GOBP DENDRITE DEVELOPMENT | 264 | 8.06e-02 | -6.26e-02 | 2.38e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 80 | 3.34e-01 | -6.26e-02 | 5.64e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 14 | 6.85e-01 | -6.25e-02 | 8.28e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 138 | 2.05e-01 | -6.25e-02 | 4.31e-01 |
| GOBP REGULATION OF ANOIKIS | 20 | 6.29e-01 | -6.25e-02 | 7.92e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 77 | 3.44e-01 | 6.24e-02 | 5.73e-01 |
| GOCC PERIKARYON | 101 | 2.79e-01 | -6.24e-02 | 5.13e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 53 | 4.33e-01 | -6.23e-02 | 6.51e-01 |
| GOBP MUSCLE ADAPTATION | 119 | 2.41e-01 | -6.23e-02 | 4.69e-01 |
| GOBP REGULATION OF POSTSYNAPSE ASSEMBLY | 34 | 5.30e-01 | 6.23e-02 | 7.26e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 11 | 7.21e-01 | 6.22e-02 | 8.48e-01 |
| GOCC CILIARY BASAL BODY | 141 | 2.03e-01 | 6.22e-02 | 4.27e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 29 | 5.62e-01 | 6.22e-02 | 7.45e-01 |
| GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY | 14 | 6.87e-01 | -6.21e-02 | 8.29e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 58 | 4.14e-01 | -6.21e-02 | 6.34e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 22 | 6.14e-01 | 6.21e-02 | 7.82e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 73 | 3.60e-01 | -6.21e-02 | 5.88e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 384 | 3.76e-02 | -6.20e-02 | 1.44e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 222 | 1.12e-01 | -6.20e-02 | 2.94e-01 |
| GOBP ODONTOGENESIS | 85 | 3.24e-01 | -6.20e-02 | 5.55e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 66 | 3.84e-01 | -6.20e-02 | 6.10e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 11 | 7.22e-01 | 6.20e-02 | 8.48e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 6.99e-01 | -6.19e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 93 | 3.03e-01 | -6.19e-02 | 5.35e-01 |
| GOCC HISTONE ACETYLTRANSFERASE COMPLEX | 82 | 3.33e-01 | 6.19e-02 | 5.64e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 79 | 3.43e-01 | -6.18e-02 | 5.73e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 18 | 6.50e-01 | -6.18e-02 | 8.06e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 100 | 2.87e-01 | 6.17e-02 | 5.20e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH CORE COMPLEX | 10 | 7.36e-01 | 6.16e-02 | 8.59e-01 |
| GOMF ANTIPORTER ACTIVITY | 96 | 2.98e-01 | -6.15e-02 | 5.31e-01 |
| GOMF QUINONE BINDING | 12 | 7.13e-01 | -6.14e-02 | 8.44e-01 |
| GOCC SWR1 COMPLEX | 13 | 7.01e-01 | -6.14e-02 | 8.36e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 22 | 6.18e-01 | 6.14e-02 | 7.83e-01 |
| GOBP REGULATION OF TRANSLATION | 296 | 7.00e-02 | -6.14e-02 | 2.17e-01 |
| GOBP CHROMOSOME ORGANIZATION | 455 | 2.56e-02 | -6.13e-02 | 1.11e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 138 | 2.14e-01 | -6.13e-02 | 4.41e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 70 | 3.75e-01 | 6.13e-02 | 6.02e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 10 | 7.37e-01 | -6.13e-02 | 8.60e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 25 | 5.96e-01 | 6.13e-02 | 7.70e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 18 | 6.53e-01 | 6.13e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 321 | 6.01e-02 | -6.12e-02 | 1.98e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 72 | 3.69e-01 | -6.12e-02 | 5.96e-01 |
| GOCC POSTSYNAPSE | 727 | 5.28e-03 | -6.12e-02 | 3.60e-02 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 166 | 1.75e-01 | 6.12e-02 | 3.90e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 33 | 5.43e-01 | -6.12e-02 | 7.33e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 21 | 6.28e-01 | 6.11e-02 | 7.91e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 18 | 6.54e-01 | -6.10e-02 | 8.08e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 48 | 4.65e-01 | 6.10e-02 | 6.78e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 78 | 3.52e-01 | 6.10e-02 | 5.81e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 208 | 1.30e-01 | -6.10e-02 | 3.25e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 13 | 7.04e-01 | -6.09e-02 | 8.38e-01 |
| GOMF AMP BINDING | 16 | 6.73e-01 | -6.09e-02 | 8.22e-01 |
| GOBP TOOTH MINERALIZATION | 21 | 6.29e-01 | -6.09e-02 | 7.92e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 20 | 6.38e-01 | 6.09e-02 | 7.97e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 11 | 7.27e-01 | -6.07e-02 | 8.52e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 38 | 5.18e-01 | -6.07e-02 | 7.17e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 42 | 4.97e-01 | 6.06e-02 | 7.02e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 7.16e-01 | -6.06e-02 | 8.46e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 163 | 1.83e-01 | -6.06e-02 | 4.02e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 17 | 6.65e-01 | -6.06e-02 | 8.16e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 252 | 9.85e-02 | 6.06e-02 | 2.70e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 425 | 3.30e-02 | -6.05e-02 | 1.33e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 11 | 7.28e-01 | 6.05e-02 | 8.52e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 71 | 3.78e-01 | -6.05e-02 | 6.04e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 480 | 2.39e-02 | -6.05e-02 | 1.06e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1526 | 1.04e-04 | -6.04e-02 | 1.56e-03 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 60 | 4.19e-01 | -6.04e-02 | 6.38e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS INVOLVED IN IMMUNE RESPONSE | 37 | 5.25e-01 | -6.04e-02 | 7.23e-01 |
| GOBP POTASSIUM ION TRANSPORT | 162 | 1.85e-01 | -6.04e-02 | 4.05e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 22 | 6.24e-01 | 6.04e-02 | 7.89e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 108 | 2.79e-01 | -6.04e-02 | 5.13e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 23 | 6.17e-01 | -6.03e-02 | 7.83e-01 |
| GOBP FLUID TRANSPORT | 17 | 6.67e-01 | 6.02e-02 | 8.18e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 27 | 5.88e-01 | 6.02e-02 | 7.65e-01 |
| GOBP ORGANIC ACID TRANSPORT | 233 | 1.14e-01 | -6.02e-02 | 2.98e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 53 | 4.49e-01 | -6.01e-02 | 6.62e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 23 | 6.18e-01 | -6.01e-02 | 7.83e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 120 | 2.56e-01 | -6.01e-02 | 4.86e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 6.10e-01 | 6.01e-02 | 7.79e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 159 | 1.92e-01 | -6.00e-02 | 4.14e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 13 | 7.08e-01 | 6.00e-02 | 8.40e-01 |
| GOBP DNA LIGATION | 12 | 7.19e-01 | 6.00e-02 | 8.47e-01 |
| GOBP VACUOLAR ACIDIFICATION | 25 | 6.04e-01 | 6.00e-02 | 7.76e-01 |
| GOBP CELL CYCLE | 1411 | 2.04e-04 | -5.99e-02 | 2.64e-03 |
| GOBP TRABECULA FORMATION | 24 | 6.12e-01 | 5.99e-02 | 7.80e-01 |
| GOBP STEM CELL DIFFERENTIATION | 211 | 1.35e-01 | -5.99e-02 | 3.32e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 12 | 7.20e-01 | -5.99e-02 | 8.47e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 441 | 3.22e-02 | -5.98e-02 | 1.30e-01 |
| GOCC MYOFILAMENT | 24 | 6.13e-01 | 5.97e-02 | 7.80e-01 |
| GOBP PRESYNAPSE ASSEMBLY | 37 | 5.30e-01 | -5.97e-02 | 7.26e-01 |
| GOBP NECROPTOTIC PROCESS | 35 | 5.41e-01 | -5.97e-02 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 39 | 5.19e-01 | 5.97e-02 | 7.18e-01 |
| GOBP MATURATION OF 5 8S RRNA | 34 | 5.47e-01 | -5.97e-02 | 7.36e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 6.89e-01 | -5.96e-02 | 8.30e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 12 | 7.21e-01 | 5.96e-02 | 8.48e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 24 | 6.14e-01 | -5.96e-02 | 7.81e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 146 | 2.15e-01 | -5.95e-02 | 4.42e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 21 | 6.37e-01 | -5.95e-02 | 7.97e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 23 | 6.22e-01 | 5.95e-02 | 7.86e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 78 | 3.64e-01 | -5.95e-02 | 5.91e-01 |
| GOBP RESPONSE TO ALKALOID | 58 | 4.34e-01 | 5.95e-02 | 6.52e-01 |
| GOBP REGENERATION | 129 | 2.44e-01 | -5.94e-02 | 4.73e-01 |
| GOCC ESCRT COMPLEX | 24 | 6.15e-01 | -5.94e-02 | 7.82e-01 |
| GOBP RESPONSE TO KETONE | 106 | 2.92e-01 | -5.93e-02 | 5.25e-01 |
| GOCC HETEROCHROMATIN | 87 | 3.40e-01 | 5.93e-02 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 40 | 5.17e-01 | 5.93e-02 | 7.17e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 60 | 4.28e-01 | -5.92e-02 | 6.46e-01 |
| GOMF MAP KINASE ACTIVITY | 14 | 7.01e-01 | -5.92e-02 | 8.36e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 201 | 1.49e-01 | -5.92e-02 | 3.53e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 7.34e-01 | -5.92e-02 | 8.58e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 96 | 3.18e-01 | -5.91e-02 | 5.50e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 22 | 6.32e-01 | 5.91e-02 | 7.94e-01 |
| GOMF TRANSITION METAL ION BINDING | 744 | 6.57e-03 | -5.90e-02 | 4.22e-02 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 99 | 3.11e-01 | -5.90e-02 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 14 | 7.02e-01 | -5.90e-02 | 8.37e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 6.65e-01 | 5.90e-02 | 8.16e-01 |
| GOMF RNA POLYMERASE BINDING | 59 | 4.34e-01 | 5.89e-02 | 6.52e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 100 | 3.09e-01 | -5.89e-02 | 5.41e-01 |
| GOBP MRNA PROCESSING | 422 | 3.88e-02 | 5.89e-02 | 1.47e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 78 | 3.69e-01 | -5.89e-02 | 5.96e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 312 | 7.46e-02 | -5.89e-02 | 2.27e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 371 | 5.25e-02 | -5.88e-02 | 1.80e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 109 | 2.89e-01 | -5.88e-02 | 5.23e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 30 | 5.77e-01 | -5.88e-02 | 7.57e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 29 | 5.84e-01 | -5.88e-02 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 99 | 3.13e-01 | 5.88e-02 | 5.45e-01 |
| GOCC U5 SNRNP | 16 | 6.84e-01 | -5.87e-02 | 8.28e-01 |
| GOCC NUCLEOLUS | 794 | 5.28e-03 | -5.87e-02 | 3.60e-02 |
| GOBP RESPONSE TO TUMOR CELL | 28 | 5.91e-01 | -5.87e-02 | 7.66e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 16 | 6.85e-01 | -5.86e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF ICOSANOID SECRETION | 13 | 7.15e-01 | -5.86e-02 | 8.45e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 153 | 2.12e-01 | -5.85e-02 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 38 | 5.33e-01 | -5.85e-02 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 12 | 7.26e-01 | -5.85e-02 | 8.51e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT | 113 | 2.84e-01 | -5.84e-02 | 5.18e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 35 | 5.50e-01 | 5.84e-02 | 7.36e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 10 | 7.49e-01 | 5.84e-02 | 8.68e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 13 | 7.16e-01 | 5.83e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 47 | 4.90e-01 | -5.83e-02 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 42 | 5.14e-01 | -5.82e-02 | 7.14e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 70 | 4.00e-01 | 5.82e-02 | 6.22e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 12 | 7.27e-01 | 5.82e-02 | 8.52e-01 |
| GOMF MAGNESIUM ION BINDING | 186 | 1.72e-01 | -5.82e-02 | 3.87e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 74 | 3.87e-01 | -5.82e-02 | 6.13e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 16 | 6.87e-01 | -5.82e-02 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 12 | 7.28e-01 | 5.81e-02 | 8.52e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 12 | 7.28e-01 | 5.81e-02 | 8.52e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 206 | 1.52e-01 | -5.80e-02 | 3.59e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 76 | 3.83e-01 | 5.80e-02 | 6.09e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 170 | 1.93e-01 | -5.79e-02 | 4.15e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 37 | 5.42e-01 | -5.79e-02 | 7.33e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 29 | 5.90e-01 | 5.79e-02 | 7.65e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 19 | 6.62e-01 | -5.79e-02 | 8.14e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 814 | 5.43e-03 | -5.78e-02 | 3.65e-02 |
| GOBP CELL CYCLE DNA REPLICATION | 39 | 5.32e-01 | 5.78e-02 | 7.27e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 59 | 4.43e-01 | 5.78e-02 | 6.57e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 40 | 5.28e-01 | 5.78e-02 | 7.25e-01 |
| GOBP RESPONSE TO NUTRIENT LEVELS | 298 | 8.73e-02 | -5.78e-02 | 2.49e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 36 | 5.49e-01 | 5.77e-02 | 7.36e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 65 | 4.21e-01 | 5.77e-02 | 6.39e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 33 | 5.67e-01 | -5.76e-02 | 7.48e-01 |
| GOBP MAST CELL CHEMOTAXIS | 10 | 7.52e-01 | 5.76e-02 | 8.70e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 88 | 3.51e-01 | -5.76e-02 | 5.81e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 778 | 6.73e-03 | -5.76e-02 | 4.30e-02 |
| GOCC DYNEIN COMPLEX | 26 | 6.11e-01 | -5.76e-02 | 7.80e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 78 | 3.80e-01 | 5.76e-02 | 6.06e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 231 | 1.33e-01 | -5.76e-02 | 3.29e-01 |
| GOBP EXPLORATION BEHAVIOR | 30 | 5.85e-01 | -5.75e-02 | 7.63e-01 |
| GOBP MRNA TRANSPORT | 101 | 3.18e-01 | -5.75e-02 | 5.51e-01 |
| GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION | 14 | 7.10e-01 | 5.75e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 17 | 6.82e-01 | 5.74e-02 | 8.27e-01 |
| GOBP P BODY ASSEMBLY | 18 | 6.73e-01 | -5.74e-02 | 8.22e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 262 | 1.11e-01 | -5.74e-02 | 2.92e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 171 | 1.97e-01 | -5.73e-02 | 4.19e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 117 | 2.85e-01 | -5.73e-02 | 5.18e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 99 | 3.26e-01 | -5.72e-02 | 5.57e-01 |
| GOBP RESPONSE TO HORMONE | 576 | 1.98e-02 | -5.72e-02 | 9.23e-02 |
| GOBP LIPID METABOLIC PROCESS | 999 | 2.52e-03 | -5.71e-02 | 2.06e-02 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 201 | 1.64e-01 | 5.70e-02 | 3.77e-01 |
| GOBP CAMP MEDIATED SIGNALING | 47 | 4.99e-01 | -5.70e-02 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION | 44 | 5.13e-01 | -5.70e-02 | 7.13e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 10 | 7.55e-01 | -5.70e-02 | 8.71e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 84 | 3.67e-01 | 5.70e-02 | 5.93e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 15 | 7.02e-01 | 5.70e-02 | 8.37e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 13 | 7.22e-01 | -5.69e-02 | 8.48e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 843 | 5.41e-03 | -5.69e-02 | 3.64e-02 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 77 | 3.89e-01 | -5.68e-02 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 904 | 4.10e-03 | -5.68e-02 | 2.96e-02 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 29 | 5.96e-01 | -5.68e-02 | 7.70e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 26 | 6.16e-01 | -5.68e-02 | 7.83e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 265 | 1.13e-01 | -5.68e-02 | 2.95e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 4.97e-01 | 5.68e-02 | 7.02e-01 |
| GOBP CILIUM ORGANIZATION | 281 | 1.03e-01 | 5.67e-02 | 2.78e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 782 | 7.48e-03 | -5.67e-02 | 4.66e-02 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 15 | 7.04e-01 | 5.67e-02 | 8.38e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 426 | 4.57e-02 | -5.67e-02 | 1.64e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 44 | 5.16e-01 | 5.67e-02 | 7.15e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 15 | 7.05e-01 | 5.65e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 10 | 7.57e-01 | -5.65e-02 | 8.72e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 7.15e-01 | 5.64e-02 | 8.45e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 303 | 9.23e-02 | -5.64e-02 | 2.58e-01 |
| GOBP MEIOTIC CELL CYCLE | 177 | 1.96e-01 | -5.64e-02 | 4.19e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 291 | 9.91e-02 | -5.64e-02 | 2.71e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 129 | 2.70e-01 | 5.63e-02 | 5.01e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 100 | 3.31e-01 | -5.63e-02 | 5.62e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 110 | 3.08e-01 | -5.63e-02 | 5.41e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 56 | 4.67e-01 | 5.63e-02 | 6.79e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 10 | 7.58e-01 | 5.63e-02 | 8.72e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 28 | 6.07e-01 | 5.62e-02 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 32 | 5.83e-01 | -5.62e-02 | 7.61e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 131 | 2.68e-01 | -5.61e-02 | 5.00e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 16 | 6.98e-01 | 5.61e-02 | 8.34e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 39 | 5.45e-01 | 5.60e-02 | 7.35e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 89 | 3.61e-01 | -5.60e-02 | 5.89e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 37 | 5.56e-01 | 5.60e-02 | 7.40e-01 |
| GOBP RIBOSOME ASSEMBLY | 59 | 4.57e-01 | -5.60e-02 | 6.70e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 14 | 7.17e-01 | -5.60e-02 | 8.46e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 178 | 1.99e-01 | -5.60e-02 | 4.22e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 436 | 4.61e-02 | -5.59e-02 | 1.65e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 59 | 4.58e-01 | -5.59e-02 | 6.70e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 39 | 5.46e-01 | -5.58e-02 | 7.35e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 23 | 6.43e-01 | 5.58e-02 | 8.00e-01 |
| GOCC APICAL JUNCTION COMPLEX | 106 | 3.21e-01 | -5.58e-02 | 5.53e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 7.18e-01 | 5.58e-02 | 8.47e-01 |
| GOBP OOGENESIS | 63 | 4.45e-01 | -5.57e-02 | 6.58e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 317 | 8.94e-02 | -5.57e-02 | 2.53e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 84 | 3.78e-01 | -5.57e-02 | 6.04e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 69 | 4.25e-01 | 5.56e-02 | 6.42e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 22 | 6.52e-01 | 5.56e-02 | 8.06e-01 |
| GOBP PROTEIN HOMOTRIMERIZATION | 12 | 7.39e-01 | -5.55e-02 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 13 | 7.29e-01 | -5.55e-02 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 11 | 7.50e-01 | 5.54e-02 | 8.68e-01 |
| GOBP RNA MODIFICATION | 127 | 2.82e-01 | 5.53e-02 | 5.16e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 47 | 5.12e-01 | -5.53e-02 | 7.13e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 731 | 1.15e-02 | -5.53e-02 | 6.32e-02 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 49 | 5.04e-01 | -5.53e-02 | 7.07e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 32 | 5.89e-01 | -5.53e-02 | 7.65e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 217 | 1.63e-01 | -5.51e-02 | 3.75e-01 |
| GOCC PIGMENT GRANULE | 29 | 6.08e-01 | -5.51e-02 | 7.78e-01 |
| GOBP RESPONSE TO FORSKOLIN | 14 | 7.22e-01 | 5.49e-02 | 8.48e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 119 | 3.02e-01 | -5.48e-02 | 5.35e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 11 | 7.53e-01 | 5.47e-02 | 8.70e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 217 | 1.66e-01 | 5.47e-02 | 3.78e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 11 | 7.54e-01 | 5.47e-02 | 8.70e-01 |
| GOBP GLAND MORPHOGENESIS | 119 | 3.05e-01 | -5.45e-02 | 5.38e-01 |
| GOBP TISSUE MORPHOGENESIS | 521 | 3.44e-02 | -5.44e-02 | 1.36e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 27 | 6.25e-01 | 5.44e-02 | 7.89e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 41 | 5.47e-01 | -5.44e-02 | 7.36e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 25 | 6.38e-01 | -5.44e-02 | 7.97e-01 |
| GOBP SPONGIOTROPHOBLAST LAYER DEVELOPMENT | 11 | 7.55e-01 | 5.44e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 41 | 5.47e-01 | -5.44e-02 | 7.36e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 59 | 4.71e-01 | 5.43e-02 | 6.82e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 29 | 6.14e-01 | -5.42e-02 | 7.81e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 19 | 6.83e-01 | -5.42e-02 | 8.27e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 92 | 3.70e-01 | -5.42e-02 | 5.96e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 196 | 1.92e-01 | -5.41e-02 | 4.14e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 18 | 6.92e-01 | 5.40e-02 | 8.30e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 560 | 3.00e-02 | -5.39e-02 | 1.24e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 78 | 4.11e-01 | -5.39e-02 | 6.31e-01 |
| GOBP POSTREPLICATION REPAIR | 28 | 6.23e-01 | -5.37e-02 | 7.88e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 43 | 5.43e-01 | 5.36e-02 | 7.33e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS | 12 | 7.48e-01 | 5.36e-02 | 8.67e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 18 | 6.94e-01 | -5.36e-02 | 8.32e-01 |
| GOBP POSITIVE CHEMOTAXIS | 33 | 5.95e-01 | -5.36e-02 | 7.69e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 120 | 3.12e-01 | -5.36e-02 | 5.43e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 167 | 2.34e-01 | -5.35e-02 | 4.62e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 42 | 5.49e-01 | -5.35e-02 | 7.36e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 795 | 1.10e-02 | -5.34e-02 | 6.12e-02 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 46 | 5.32e-01 | 5.33e-02 | 7.27e-01 |
| GOBP RNA SPLICING | 391 | 7.16e-02 | 5.33e-02 | 2.20e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 59 | 4.80e-01 | 5.32e-02 | 6.88e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 25 | 6.45e-01 | -5.32e-02 | 8.02e-01 |
| GOBP REFLEX | 19 | 6.89e-01 | 5.31e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 6.74e-01 | 5.30e-02 | 8.22e-01 |
| GOMF GATED CHANNEL ACTIVITY | 164 | 2.42e-01 | -5.30e-02 | 4.70e-01 |
| GOBP MICROTUBULE ANCHORING | 22 | 6.67e-01 | -5.30e-02 | 8.18e-01 |
| GOCC SPINDLE MICROTUBULE | 72 | 4.38e-01 | -5.29e-02 | 6.54e-01 |
| GOBP MOLTING CYCLE PROCESS | 86 | 3.97e-01 | -5.29e-02 | 6.20e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 73 | 4.35e-01 | 5.29e-02 | 6.52e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 46 | 5.35e-01 | -5.28e-02 | 7.28e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 10 | 7.72e-01 | -5.28e-02 | 8.81e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 158 | 2.53e-01 | -5.28e-02 | 4.83e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.72e-01 | -5.28e-02 | 8.81e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 13 | 7.42e-01 | -5.27e-02 | 8.63e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 55 | 4.99e-01 | -5.27e-02 | 7.03e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 42 | 5.55e-01 | -5.27e-02 | 7.39e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 21 | 6.76e-01 | -5.27e-02 | 8.23e-01 |
| GOBP RESPONSE TO ESTROGEN | 43 | 5.50e-01 | 5.27e-02 | 7.36e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 27 | 6.36e-01 | -5.27e-02 | 7.97e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 7.73e-01 | 5.26e-02 | 8.81e-01 |
| GOBP INNERVATION | 25 | 6.50e-01 | -5.25e-02 | 8.05e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 18 | 7.00e-01 | -5.25e-02 | 8.35e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 787 | 1.30e-02 | -5.25e-02 | 6.90e-02 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 12 | 7.53e-01 | -5.24e-02 | 8.70e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 161 | 2.52e-01 | -5.24e-02 | 4.83e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 109 | 3.45e-01 | 5.24e-02 | 5.75e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 37 | 5.82e-01 | 5.23e-02 | 7.60e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 16 | 7.17e-01 | 5.23e-02 | 8.46e-01 |
| GOBP CENTRIOLE ASSEMBLY | 41 | 5.63e-01 | 5.22e-02 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 22 | 6.72e-01 | 5.22e-02 | 8.21e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 17 | 7.09e-01 | 5.22e-02 | 8.41e-01 |
| GOCC CENTRIOLE | 119 | 3.26e-01 | 5.22e-02 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 55 | 5.04e-01 | -5.21e-02 | 7.07e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 44 | 5.50e-01 | 5.21e-02 | 7.36e-01 |
| GOMF U6 SNRNA BINDING | 11 | 7.65e-01 | 5.21e-02 | 8.76e-01 |
| GOBP ARTERY DEVELOPMENT | 109 | 3.48e-01 | -5.20e-02 | 5.78e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 57 | 4.97e-01 | -5.20e-02 | 7.02e-01 |
| GOCC PLATELET ALPHA GRANULE | 17 | 7.11e-01 | -5.20e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 17 | 7.11e-01 | -5.20e-02 | 8.42e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 76 | 4.34e-01 | -5.19e-02 | 6.52e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 170 | 2.44e-01 | -5.19e-02 | 4.72e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 901 | 8.86e-03 | -5.19e-02 | 5.22e-02 |
| GOBP CHROMOSOME CONDENSATION | 26 | 6.47e-01 | -5.18e-02 | 8.04e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 17 | 7.11e-01 | 5.18e-02 | 8.43e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 80 | 4.23e-01 | 5.18e-02 | 6.41e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 6.29e-01 | 5.18e-02 | 7.92e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 88 | 4.02e-01 | 5.17e-02 | 6.24e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 249 | 1.61e-01 | -5.17e-02 | 3.73e-01 |
| GOBP RESPONSE TO LEAD ION | 11 | 7.67e-01 | 5.17e-02 | 8.77e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 19 | 6.97e-01 | -5.17e-02 | 8.34e-01 |
| GOCC ASTROCYTE PROJECTION | 12 | 7.57e-01 | 5.17e-02 | 8.72e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 39 | 5.77e-01 | -5.16e-02 | 7.57e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 23 | 6.68e-01 | -5.16e-02 | 8.19e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 21 | 6.83e-01 | 5.15e-02 | 8.27e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 28 | 6.37e-01 | -5.15e-02 | 7.97e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 149 | 2.79e-01 | -5.15e-02 | 5.13e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 11 | 7.68e-01 | -5.14e-02 | 8.78e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 18 | 7.06e-01 | -5.13e-02 | 8.39e-01 |
| GOBP COCHLEA DEVELOPMENT | 40 | 5.75e-01 | 5.13e-02 | 7.55e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 105 | 3.64e-01 | -5.13e-02 | 5.91e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 146 | 2.86e-01 | 5.12e-02 | 5.19e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 10 | 7.79e-01 | 5.12e-02 | 8.84e-01 |
| GOMF HMG BOX DOMAIN BINDING | 11 | 7.69e-01 | -5.12e-02 | 8.78e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 44 | 5.57e-01 | -5.12e-02 | 7.41e-01 |
| GOBP ACROSOME REACTION | 16 | 7.23e-01 | -5.12e-02 | 8.49e-01 |
| GOMF KINASE ACTIVITY | 594 | 3.41e-02 | -5.12e-02 | 1.36e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 77 | 4.38e-01 | -5.12e-02 | 6.54e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 11 | 7.69e-01 | 5.11e-02 | 8.78e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 109 | 3.57e-01 | -5.11e-02 | 5.86e-01 |
| GOBP CARTILAGE CONDENSATION | 11 | 7.69e-01 | -5.11e-02 | 8.78e-01 |
| GOBP CELL AGGREGATION | 11 | 7.69e-01 | -5.11e-02 | 8.78e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 59 | 4.98e-01 | -5.10e-02 | 7.03e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 13 | 7.50e-01 | 5.10e-02 | 8.68e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 43 | 5.63e-01 | 5.10e-02 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 14 | 7.42e-01 | -5.09e-02 | 8.63e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 25 | 6.60e-01 | -5.09e-02 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 26 | 6.54e-01 | 5.08e-02 | 8.08e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 28 | 6.42e-01 | -5.08e-02 | 8.00e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 56 | 5.12e-01 | -5.07e-02 | 7.13e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 10 | 7.81e-01 | -5.07e-02 | 8.86e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 687 | 2.45e-02 | -5.07e-02 | 1.08e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 12 | 7.61e-01 | -5.07e-02 | 8.74e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 11 | 7.71e-01 | 5.07e-02 | 8.80e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 79 | 4.37e-01 | -5.07e-02 | 6.54e-01 |
| GOBP MITOTIC DNA REPLICATION | 15 | 7.34e-01 | -5.07e-02 | 8.58e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 124 | 3.31e-01 | -5.06e-02 | 5.62e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 16 | 7.26e-01 | 5.06e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 24 | 6.69e-01 | -5.05e-02 | 8.19e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 21 | 6.89e-01 | -5.05e-02 | 8.30e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 7.82e-01 | -5.05e-02 | 8.86e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 143 | 2.98e-01 | -5.05e-02 | 5.31e-01 |
| GOMF HYDRO LYASE ACTIVITY | 44 | 5.63e-01 | -5.04e-02 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 68 | 4.73e-01 | -5.04e-02 | 6.83e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1260 | 3.03e-03 | 5.03e-02 | 2.36e-02 |
| GOBP REGULATION OF CATECHOLAMINE SECRETION | 31 | 6.28e-01 | -5.03e-02 | 7.92e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 12 | 7.63e-01 | -5.03e-02 | 8.76e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 342 | 1.12e-01 | -5.02e-02 | 2.94e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 41 | 5.78e-01 | -5.02e-02 | 7.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 40 | 5.84e-01 | -5.01e-02 | 7.62e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 433 | 7.56e-02 | -5.00e-02 | 2.29e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 80 | 4.40e-01 | -5.00e-02 | 6.56e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 15 | 7.38e-01 | 4.99e-02 | 8.60e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 524 | 5.18e-02 | -4.99e-02 | 1.79e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 7.65e-01 | -4.99e-02 | 8.76e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 17 | 7.22e-01 | 4.99e-02 | 8.48e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 67 | 4.81e-01 | 4.98e-02 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 7.85e-01 | 4.98e-02 | 8.89e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 94 | 4.05e-01 | -4.97e-02 | 6.27e-01 |
| GOCC EARLY PHAGOSOME | 14 | 7.48e-01 | -4.97e-02 | 8.67e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 29 | 6.44e-01 | -4.97e-02 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 13 | 7.57e-01 | 4.96e-02 | 8.72e-01 |
| GOMF ACYL COA HYDROLASE ACTIVITY | 23 | 6.81e-01 | -4.96e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 103 | 3.85e-01 | -4.96e-02 | 6.12e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 68 | 4.81e-01 | -4.95e-02 | 6.88e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 206 | 2.22e-01 | 4.95e-02 | 4.49e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 38 | 5.98e-01 | -4.94e-02 | 7.71e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 37 | 6.03e-01 | -4.94e-02 | 7.75e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 23 | 6.82e-01 | -4.93e-02 | 8.27e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 47 | 5.59e-01 | 4.93e-02 | 7.43e-01 |
| GOBP MALE GAMETE GENERATION | 330 | 1.25e-01 | 4.93e-02 | 3.17e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 94 | 4.10e-01 | -4.92e-02 | 6.31e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 15 | 7.42e-01 | 4.91e-02 | 8.63e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 174 | 2.65e-01 | -4.91e-02 | 4.97e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 44 | 5.73e-01 | -4.91e-02 | 7.54e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 54 | 5.33e-01 | -4.90e-02 | 7.27e-01 |
| GOBP TRNA METHYLATION | 37 | 6.07e-01 | 4.89e-02 | 7.78e-01 |
| GOBP SYNAPTIC SIGNALING | 583 | 4.51e-02 | -4.89e-02 | 1.62e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 61 | 5.10e-01 | -4.88e-02 | 7.11e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 10 | 7.89e-01 | -4.88e-02 | 8.90e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 7.89e-01 | 4.88e-02 | 8.90e-01 |
| GOMF LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE ACTIVITY | 13 | 7.61e-01 | 4.88e-02 | 8.74e-01 |
| GOBP SEX DETERMINATION | 14 | 7.53e-01 | 4.87e-02 | 8.70e-01 |
| GOBP RESPONSE TO STARVATION | 159 | 2.90e-01 | -4.87e-02 | 5.23e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 21 | 7.00e-01 | -4.86e-02 | 8.35e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 164 | 2.84e-01 | -4.85e-02 | 5.18e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 46 | 5.69e-01 | -4.85e-02 | 7.50e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 35 | 6.20e-01 | -4.84e-02 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 27 | 6.63e-01 | -4.84e-02 | 8.15e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 36 | 6.16e-01 | -4.83e-02 | 7.83e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 49 | 5.59e-01 | 4.83e-02 | 7.43e-01 |
| GOBP RESPONSE TO HEAT | 73 | 4.76e-01 | -4.83e-02 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 130 | 3.43e-01 | -4.82e-02 | 5.73e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 576 | 4.94e-02 | -4.82e-02 | 1.73e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 88 | 4.35e-01 | -4.82e-02 | 6.52e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 28 | 6.60e-01 | 4.81e-02 | 8.12e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 70 | 4.87e-01 | 4.81e-02 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 61 | 5.17e-01 | 4.80e-02 | 7.17e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 15 | 7.47e-01 | 4.80e-02 | 8.67e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 11 | 7.83e-01 | 4.79e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 23 | 6.91e-01 | -4.79e-02 | 8.30e-01 |
| GOBP NEURON MATURATION | 55 | 5.40e-01 | -4.78e-02 | 7.32e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 139 | 3.31e-01 | 4.78e-02 | 5.62e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 12 | 7.74e-01 | -4.78e-02 | 8.82e-01 |
| GOBP ACYL COA METABOLIC PROCESS | 74 | 4.78e-01 | 4.77e-02 | 6.87e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 7.94e-01 | -4.77e-02 | 8.93e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 10 | 7.94e-01 | -4.77e-02 | 8.93e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 6.46e-01 | 4.77e-02 | 8.02e-01 |
| GOBP MRNA METABOLIC PROCESS | 622 | 4.36e-02 | 4.77e-02 | 1.59e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 14 | 7.58e-01 | 4.77e-02 | 8.72e-01 |
| GOBP REGULATION OF LIPID STORAGE | 45 | 5.81e-01 | -4.76e-02 | 7.60e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 140 | 3.31e-01 | 4.76e-02 | 5.62e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 22 | 6.99e-01 | -4.76e-02 | 8.35e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 134 | 3.43e-01 | -4.75e-02 | 5.73e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 23 | 6.94e-01 | -4.75e-02 | 8.31e-01 |
| GOBP ANIMAL ORGAN FORMATION | 53 | 5.50e-01 | 4.74e-02 | 7.36e-01 |
| GOBP SYNAPSE ASSEMBLY | 200 | 2.49e-01 | -4.74e-02 | 4.79e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 18 | 7.28e-01 | -4.74e-02 | 8.52e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 23 | 6.96e-01 | 4.71e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 13 | 7.69e-01 | -4.71e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 85 | 4.53e-01 | -4.71e-02 | 6.66e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 26 | 6.78e-01 | -4.71e-02 | 8.24e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 82 | 4.62e-01 | -4.71e-02 | 6.74e-01 |
| GOBP VISUAL BEHAVIOR | 59 | 5.33e-01 | 4.70e-02 | 7.27e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 124 | 3.67e-01 | -4.70e-02 | 5.93e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 12 | 7.78e-01 | -4.70e-02 | 8.84e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 388 | 1.14e-01 | -4.69e-02 | 2.98e-01 |
| GOBP L AMINO ACID TRANSPORT | 67 | 5.07e-01 | -4.69e-02 | 7.09e-01 |
| GOCC CILIARY BASE | 31 | 6.52e-01 | 4.69e-02 | 8.06e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 85 | 4.56e-01 | -4.68e-02 | 6.69e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 16 | 7.46e-01 | 4.68e-02 | 8.66e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 60 | 5.32e-01 | -4.67e-02 | 7.27e-01 |
| GOBP ANATOMICAL STRUCTURE HOMEOSTASIS | 204 | 2.52e-01 | -4.67e-02 | 4.82e-01 |
| GOMF POLYSACCHARIDE BINDING | 18 | 7.32e-01 | 4.66e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 17 | 7.40e-01 | 4.66e-02 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 17 | 7.40e-01 | -4.66e-02 | 8.61e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 303 | 1.65e-01 | -4.65e-02 | 3.78e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 11 | 7.90e-01 | 4.65e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 177 | 2.87e-01 | -4.65e-02 | 5.21e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 26 | 6.82e-01 | -4.65e-02 | 8.27e-01 |
| GOBP PROTEIN DEACETYLATION | 42 | 6.03e-01 | 4.64e-02 | 7.75e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 56 | 5.48e-01 | 4.64e-02 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 37 | 6.26e-01 | -4.63e-02 | 7.91e-01 |
| GOBP REGULATION OF RNA STABILITY | 149 | 3.31e-01 | 4.62e-02 | 5.62e-01 |
| GOBP RESPONSE TO ALCOHOL | 127 | 3.69e-01 | -4.62e-02 | 5.96e-01 |
| GOBP DNA CONFORMATION CHANGE | 54 | 5.58e-01 | -4.61e-02 | 7.42e-01 |
| GOCC CILIARY TRANSITION ZONE | 59 | 5.41e-01 | 4.60e-02 | 7.33e-01 |
| GOCC CELL CELL CONTACT ZONE | 80 | 4.77e-01 | -4.60e-02 | 6.86e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 57 | 5.48e-01 | -4.60e-02 | 7.36e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 71 | 5.03e-01 | 4.60e-02 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 79 | 4.80e-01 | 4.60e-02 | 6.88e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 24 | 6.97e-01 | 4.59e-02 | 8.34e-01 |
| GOBP COPULATION | 10 | 8.01e-01 | 4.59e-02 | 8.98e-01 |
| GOBP MUSCLE HYPERTROPHY | 108 | 4.10e-01 | -4.59e-02 | 6.31e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 124 | 3.78e-01 | -4.59e-02 | 6.04e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 75 | 4.92e-01 | -4.59e-02 | 6.98e-01 |
| GOCC PLASMA MEMBRANE RAFT | 109 | 4.09e-01 | -4.59e-02 | 6.30e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 27 | 6.80e-01 | -4.59e-02 | 8.26e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 658 | 4.67e-02 | -4.58e-02 | 1.66e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 25 | 6.92e-01 | -4.58e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 10 | 8.03e-01 | -4.57e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 49 | 5.81e-01 | -4.56e-02 | 7.60e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 11 | 7.93e-01 | 4.56e-02 | 8.93e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 17 | 7.45e-01 | -4.56e-02 | 8.65e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 7.85e-01 | -4.56e-02 | 8.88e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 84 | 4.71e-01 | -4.55e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 13 | 7.76e-01 | -4.55e-02 | 8.83e-01 |
| GOCC DENSE CORE GRANULE | 33 | 6.52e-01 | 4.54e-02 | 8.06e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 23 | 7.06e-01 | 4.54e-02 | 8.39e-01 |
| GOBP CENTROSOME SEPARATION | 13 | 7.77e-01 | 4.54e-02 | 8.83e-01 |
| GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 12 | 7.86e-01 | -4.53e-02 | 8.89e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 23 | 7.07e-01 | 4.53e-02 | 8.40e-01 |
| GOCC PROTEIN KINASE COMPLEX | 117 | 3.98e-01 | 4.53e-02 | 6.21e-01 |
| GOCC INTERCALATED DISC | 60 | 5.45e-01 | -4.52e-02 | 7.35e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 22 | 7.14e-01 | -4.52e-02 | 8.45e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 48 | 5.89e-01 | -4.51e-02 | 7.65e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 158 | 3.29e-01 | -4.51e-02 | 5.60e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 7.15e-01 | -4.50e-02 | 8.45e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 33 | 6.55e-01 | 4.50e-02 | 8.09e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 17 | 7.48e-01 | -4.50e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 36 | 6.41e-01 | -4.50e-02 | 7.99e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 621 | 5.75e-02 | -4.49e-02 | 1.92e-01 |
| GOCC PML BODY | 77 | 4.96e-01 | -4.49e-02 | 7.01e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 16 | 7.56e-01 | -4.49e-02 | 8.72e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 7.79e-01 | 4.49e-02 | 8.84e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 165 | 3.21e-01 | 4.49e-02 | 5.52e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 157 | 3.33e-01 | -4.48e-02 | 5.64e-01 |
| GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 13 | 7.80e-01 | 4.48e-02 | 8.84e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 73 | 5.09e-01 | 4.48e-02 | 7.11e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 10 | 8.07e-01 | -4.47e-02 | 9.01e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 105 | 4.29e-01 | -4.47e-02 | 6.48e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 44 | 6.08e-01 | 4.47e-02 | 7.78e-01 |
| GOBP RESPONSE TO L LEUCINE | 11 | 7.98e-01 | 4.47e-02 | 8.95e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 22 | 7.17e-01 | 4.46e-02 | 8.46e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 58 | 5.57e-01 | -4.46e-02 | 7.41e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 24 | 7.06e-01 | 4.46e-02 | 8.39e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 87 | 4.73e-01 | -4.45e-02 | 6.84e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 696 | 4.71e-02 | -4.45e-02 | 1.67e-01 |
| GOBP HETEROCHROMATIN FORMATION | 100 | 4.43e-01 | 4.45e-02 | 6.57e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 18 | 7.44e-01 | 4.45e-02 | 8.65e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 7.01e-01 | -4.44e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 38 | 6.36e-01 | -4.44e-02 | 7.97e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 27 | 6.90e-01 | 4.44e-02 | 8.30e-01 |
| GOBP POTASSIUM ION TRANSMEMBRANE TRANSPORT | 133 | 3.78e-01 | -4.44e-02 | 6.04e-01 |
| GOBP MOLTING CYCLE | 94 | 4.58e-01 | -4.44e-02 | 6.70e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 12 | 7.90e-01 | -4.44e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 28 | 6.85e-01 | -4.43e-02 | 8.28e-01 |
| GOCC CYTOPLASMIC REGION | 160 | 3.34e-01 | -4.43e-02 | 5.64e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 17 | 7.52e-01 | -4.42e-02 | 8.70e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 355 | 1.56e-01 | -4.40e-02 | 3.65e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 47 | 6.03e-01 | -4.39e-02 | 7.75e-01 |
| GOMF CHROMATIN BINDING | 533 | 8.52e-02 | 4.38e-02 | 2.45e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 14 | 7.77e-01 | 4.38e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 25 | 7.05e-01 | 4.38e-02 | 8.39e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 14 | 7.77e-01 | 4.37e-02 | 8.83e-01 |
| GOBP L AMINO ACID METABOLIC PROCESS | 132 | 3.87e-01 | -4.37e-02 | 6.13e-01 |
| GOCC NON MOTILE CILIUM | 106 | 4.38e-01 | 4.37e-02 | 6.54e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 51 | 5.90e-01 | 4.37e-02 | 7.65e-01 |
| GOCC ORGANELLE ENVELOPE | 1020 | 1.97e-02 | -4.36e-02 | 9.23e-02 |
| GOBP MITOCHONDRION ORGANIZATION | 458 | 1.12e-01 | -4.36e-02 | 2.94e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 15 | 7.70e-01 | 4.36e-02 | 8.79e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 39 | 6.38e-01 | -4.35e-02 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 11 | 8.03e-01 | -4.35e-02 | 8.98e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 56 | 5.74e-01 | 4.35e-02 | 7.54e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 4.79e-01 | 4.34e-02 | 6.88e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 73 | 5.22e-01 | 4.34e-02 | 7.20e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 17 | 7.57e-01 | 4.34e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 47 | 6.07e-01 | -4.34e-02 | 7.78e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 7.14e-01 | -4.33e-02 | 8.44e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 7.87e-01 | -4.32e-02 | 8.89e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 14 | 7.80e-01 | 4.32e-02 | 8.84e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 68 | 5.38e-01 | -4.32e-02 | 7.30e-01 |
| GOCC CENTROSOME | 571 | 7.94e-02 | -4.32e-02 | 2.35e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 109 | 4.36e-01 | -4.32e-02 | 6.53e-01 |
| GOBP HEART PROCESS | 211 | 2.81e-01 | 4.32e-02 | 5.14e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 10 | 8.13e-01 | -4.32e-02 | 9.05e-01 |
| GOBP PANCREAS DEVELOPMENT | 47 | 6.09e-01 | 4.31e-02 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 15 | 7.73e-01 | -4.31e-02 | 8.81e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 16 | 7.66e-01 | -4.31e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 19 | 7.46e-01 | -4.30e-02 | 8.66e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 7.52e-01 | -4.30e-02 | 8.70e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 28 | 6.94e-01 | -4.30e-02 | 8.32e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 303 | 2.00e-01 | -4.30e-02 | 4.23e-01 |
| GOMF SYMPORTER ACTIVITY | 93 | 4.75e-01 | 4.29e-02 | 6.85e-01 |
| GOBP DOLICHOL METABOLIC PROCESS | 13 | 7.89e-01 | 4.29e-02 | 8.90e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 7.05e-01 | 4.29e-02 | 8.39e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 12 | 7.97e-01 | 4.28e-02 | 8.95e-01 |
| GOBP REGULATION OF AMYLOID BETA FORMATION | 33 | 6.70e-01 | -4.28e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 18 | 7.53e-01 | -4.28e-02 | 8.70e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 29 | 6.90e-01 | -4.28e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 29 | 6.91e-01 | 4.27e-02 | 8.30e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 96 | 4.70e-01 | -4.27e-02 | 6.82e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 23 | 7.23e-01 | 4.26e-02 | 8.49e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 36 | 6.58e-01 | 4.26e-02 | 8.11e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 11 | 8.07e-01 | -4.25e-02 | 9.01e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 46 | 6.19e-01 | -4.24e-02 | 7.84e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 7.63e-01 | -4.23e-02 | 8.75e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 35 | 6.65e-01 | -4.22e-02 | 8.16e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 8.17e-01 | -4.22e-02 | 9.06e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 8.17e-01 | 4.22e-02 | 9.06e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 53 | 5.96e-01 | -4.21e-02 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 29 | 6.95e-01 | 4.21e-02 | 8.32e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 442 | 1.31e-01 | -4.21e-02 | 3.26e-01 |
| GOBP RESPONSE TO PH | 26 | 7.11e-01 | -4.20e-02 | 8.42e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 33 | 6.77e-01 | 4.19e-02 | 8.24e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 42 | 6.39e-01 | -4.19e-02 | 7.97e-01 |
| GOCC DNA REPAIR COMPLEX | 20 | 7.46e-01 | 4.19e-02 | 8.66e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 15 | 7.79e-01 | 4.18e-02 | 8.84e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 11 | 8.10e-01 | -4.18e-02 | 9.03e-01 |
| GOBP TONGUE DEVELOPMENT | 16 | 7.73e-01 | 4.17e-02 | 8.81e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 25 | 7.18e-01 | -4.17e-02 | 8.47e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 155 | 3.72e-01 | -4.16e-02 | 5.98e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 164 | 3.59e-01 | 4.16e-02 | 5.87e-01 |
| GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION | 10 | 8.20e-01 | 4.16e-02 | 9.08e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 10 | 8.20e-01 | 4.15e-02 | 9.08e-01 |
| GOBP STEROID METABOLIC PROCESS | 213 | 2.98e-01 | -4.15e-02 | 5.31e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 70 | 5.49e-01 | 4.15e-02 | 7.36e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 87 | 5.04e-01 | -4.15e-02 | 7.07e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 89 | 4.99e-01 | 4.15e-02 | 7.03e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 16 | 7.74e-01 | -4.14e-02 | 8.82e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 34 | 6.76e-01 | -4.14e-02 | 8.23e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 253 | 2.59e-01 | -4.14e-02 | 4.89e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 35 | 6.72e-01 | 4.13e-02 | 8.21e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 143 | 3.95e-01 | 4.12e-02 | 6.18e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 38 | 6.60e-01 | 4.12e-02 | 8.13e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 14 | 7.90e-01 | 4.12e-02 | 8.90e-01 |
| GOCC MYOSIN II COMPLEX | 19 | 7.56e-01 | -4.12e-02 | 8.72e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 15 | 7.83e-01 | -4.12e-02 | 8.87e-01 |
| GOBP MICROTUBULE NUCLEATION | 34 | 6.79e-01 | -4.11e-02 | 8.24e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 354 | 1.86e-01 | -4.10e-02 | 4.05e-01 |
| GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION | 10 | 8.22e-01 | 4.10e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 76 | 5.37e-01 | -4.10e-02 | 7.30e-01 |
| GOBP SOMITOGENESIS | 50 | 6.16e-01 | 4.10e-02 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 12 | 8.06e-01 | -4.10e-02 | 9.01e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 16 | 7.77e-01 | 4.09e-02 | 8.83e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 38 | 6.63e-01 | 4.09e-02 | 8.15e-01 |
| GOBP DNA RECOMBINATION | 246 | 2.71e-01 | 4.09e-02 | 5.03e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 94 | 4.95e-01 | -4.08e-02 | 7.00e-01 |
| GOBP MIRNA PROCESSING | 36 | 6.72e-01 | 4.08e-02 | 8.21e-01 |
| GOCC CHROMOSOMAL REGION | 290 | 2.34e-01 | -4.08e-02 | 4.62e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 35 | 6.77e-01 | 4.08e-02 | 8.23e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 11 | 8.15e-01 | 4.07e-02 | 9.06e-01 |
| GOBP RENAL SYSTEM PROCESS | 89 | 5.07e-01 | -4.07e-02 | 7.09e-01 |
| GOBP REGULATION OF HETEROCHROMATIN FORMATION | 19 | 7.59e-01 | 4.07e-02 | 8.73e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 46 | 6.34e-01 | -4.06e-02 | 7.96e-01 |
| GOBP RNA LOCALIZATION | 153 | 3.87e-01 | -4.06e-02 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 33 | 6.87e-01 | -4.06e-02 | 8.29e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 431 | 1.51e-01 | -4.06e-02 | 3.57e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 11 | 8.16e-01 | 4.06e-02 | 9.06e-01 |
| GOMF NUCLEASE ACTIVITY | 168 | 3.66e-01 | -4.05e-02 | 5.93e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 36 | 6.74e-01 | 4.05e-02 | 8.22e-01 |
| GOBP BICARBONATE TRANSPORT | 11 | 8.16e-01 | -4.05e-02 | 9.06e-01 |
| GOMF GABA RECEPTOR BINDING | 12 | 8.09e-01 | 4.03e-02 | 9.02e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 164 | 3.74e-01 | -4.03e-02 | 6.01e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 161 | 3.78e-01 | -4.03e-02 | 6.04e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 15 | 7.87e-01 | -4.02e-02 | 8.89e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 123 | 4.42e-01 | -4.02e-02 | 6.57e-01 |
| GOBP GLUCOSE IMPORT | 71 | 5.59e-01 | 4.01e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 11 | 8.18e-01 | 4.01e-02 | 9.07e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 68 | 5.68e-01 | 4.01e-02 | 7.49e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 20 | 7.57e-01 | -4.00e-02 | 8.72e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 7.19e-01 | 4.00e-02 | 8.47e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 36 | 6.78e-01 | -4.00e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 20 | 7.57e-01 | -4.00e-02 | 8.72e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 16 | 7.82e-01 | -3.99e-02 | 8.86e-01 |
| GOBP CARDIAC MUSCLE ADAPTATION | 30 | 7.06e-01 | 3.99e-02 | 8.39e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 27 | 7.20e-01 | 3.98e-02 | 8.47e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 87 | 5.21e-01 | 3.98e-02 | 7.19e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 21 | 7.52e-01 | 3.98e-02 | 8.70e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 56 | 6.07e-01 | 3.98e-02 | 7.78e-01 |
| GOBP POST TRANSCRIPTIONAL GENE SILENCING | 60 | 5.95e-01 | 3.97e-02 | 7.69e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC SPECIALIZATION | 13 | 8.05e-01 | -3.96e-02 | 9.00e-01 |
| GOMF REGULATORY RNA BINDING | 36 | 6.81e-01 | -3.96e-02 | 8.26e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 465 | 1.46e-01 | -3.95e-02 | 3.50e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 175 | 3.68e-01 | -3.95e-02 | 5.95e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 13 | 8.05e-01 | -3.95e-02 | 9.00e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 41 | 6.62e-01 | 3.95e-02 | 8.14e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 8.05e-01 | 3.95e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 19 | 7.66e-01 | -3.95e-02 | 8.77e-01 |
| GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX | 67 | 5.77e-01 | 3.94e-02 | 7.57e-01 |
| GOBP RESPONSE TO LITHIUM ION | 12 | 8.13e-01 | 3.94e-02 | 9.05e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 12 | 8.13e-01 | -3.94e-02 | 9.05e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 64 | 5.87e-01 | -3.93e-02 | 7.64e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 13 | 8.07e-01 | -3.92e-02 | 9.01e-01 |
| GOCC NEURON PROJECTION TERMINUS | 142 | 4.20e-01 | -3.92e-02 | 6.38e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 20 | 7.62e-01 | 3.92e-02 | 8.75e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 14 | 8.00e-01 | -3.92e-02 | 8.96e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 129 | 4.43e-01 | -3.92e-02 | 6.57e-01 |
| GOBP MYELIN MAINTENANCE | 15 | 7.93e-01 | -3.91e-02 | 8.93e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 20 | 7.62e-01 | 3.91e-02 | 8.75e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS | 58 | 6.08e-01 | -3.89e-02 | 7.78e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 33 | 6.99e-01 | 3.89e-02 | 8.35e-01 |
| GOBP AMIDE METABOLIC PROCESS | 333 | 2.24e-01 | -3.89e-02 | 4.51e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 34 | 6.95e-01 | 3.89e-02 | 8.32e-01 |
| GOBP AXIS SPECIFICATION | 64 | 5.92e-01 | -3.88e-02 | 7.66e-01 |
| GOBP HEART TRABECULA FORMATION | 13 | 8.09e-01 | -3.88e-02 | 9.02e-01 |
| GOBP RESPONSE TO VITAMIN D | 14 | 8.02e-01 | 3.88e-02 | 8.98e-01 |
| GOBP FATTY ACID BETA OXIDATION | 64 | 5.92e-01 | -3.87e-02 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 7.18e-01 | 3.87e-02 | 8.47e-01 |
| GOMF MIRNA BINDING | 27 | 7.28e-01 | -3.87e-02 | 8.52e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 40 | 6.73e-01 | -3.86e-02 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 55 | 6.21e-01 | -3.86e-02 | 7.86e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 56 | 6.18e-01 | 3.86e-02 | 7.83e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 16 | 7.90e-01 | 3.85e-02 | 8.90e-01 |
| GOBP CELL CYCLE PHASE | 15 | 7.97e-01 | -3.84e-02 | 8.95e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 86 | 5.38e-01 | 3.84e-02 | 7.30e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 19 | 7.72e-01 | -3.84e-02 | 8.80e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 27 | 7.30e-01 | -3.84e-02 | 8.53e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 8.19e-01 | 3.83e-02 | 9.07e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 389 | 1.99e-01 | 3.81e-02 | 4.22e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 18 | 7.80e-01 | 3.81e-02 | 8.84e-01 |
| GOBP DNA MODIFICATION | 18 | 7.80e-01 | -3.80e-02 | 8.84e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 136 | 4.45e-01 | 3.80e-02 | 6.58e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 159 | 4.09e-01 | -3.80e-02 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 114 | 4.87e-01 | 3.77e-02 | 6.94e-01 |
| GOBP LUTEINIZATION | 12 | 8.21e-01 | 3.77e-02 | 9.08e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 7.17e-01 | 3.77e-02 | 8.46e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 62 | 6.08e-01 | 3.77e-02 | 7.78e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 55 | 6.30e-01 | -3.76e-02 | 7.93e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 12 | 8.22e-01 | 3.75e-02 | 9.09e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 14 | 8.08e-01 | -3.75e-02 | 9.02e-01 |
| GOBP REGULATION OF BONE REMODELING | 46 | 6.60e-01 | 3.75e-02 | 8.12e-01 |
| GOBP PANCREATIC JUICE SECRETION | 11 | 8.30e-01 | 3.75e-02 | 9.13e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 124 | 4.72e-01 | -3.75e-02 | 6.83e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 26 | 7.41e-01 | -3.75e-02 | 8.63e-01 |
| GOBP RNA 3 END PROCESSING | 75 | 5.75e-01 | 3.74e-02 | 7.55e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 8.30e-01 | -3.74e-02 | 9.13e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 16 | 7.96e-01 | -3.73e-02 | 8.95e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 78 | 5.69e-01 | 3.73e-02 | 7.50e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 10 | 8.38e-01 | -3.73e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 39 | 6.87e-01 | 3.72e-02 | 8.29e-01 |
| GOBP ANIMAL ORGAN MATURATION | 25 | 7.47e-01 | 3.72e-02 | 8.67e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 449 | 1.78e-01 | -3.72e-02 | 3.96e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 25 | 7.48e-01 | 3.72e-02 | 8.67e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE | 21 | 7.68e-01 | -3.72e-02 | 8.78e-01 |
| GOCC MICROBODY | 124 | 4.75e-01 | -3.72e-02 | 6.85e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 99 | 5.23e-01 | 3.72e-02 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 12 | 8.24e-01 | -3.71e-02 | 9.09e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 186 | 3.84e-01 | -3.71e-02 | 6.10e-01 |
| GOCC DNA REPLICATION FACTOR A COMPLEX | 13 | 8.17e-01 | 3.71e-02 | 9.06e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 22 | 7.63e-01 | 3.71e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 118 | 4.88e-01 | -3.70e-02 | 6.94e-01 |
| GOBP TRNA PROCESSING | 116 | 4.92e-01 | 3.70e-02 | 6.98e-01 |
| GOBP NUCLEAR EXPORT | 148 | 4.38e-01 | -3.70e-02 | 6.54e-01 |
| GOBP EXCRETION | 23 | 7.59e-01 | -3.70e-02 | 8.73e-01 |
| GOCC CHROMOCENTER | 15 | 8.04e-01 | 3.70e-02 | 9.00e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 40 | 6.86e-01 | -3.70e-02 | 8.28e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 103 | 5.18e-01 | 3.69e-02 | 7.17e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 45 | 6.69e-01 | -3.69e-02 | 8.19e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 132 | 4.65e-01 | -3.69e-02 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 17 | 7.93e-01 | -3.68e-02 | 8.92e-01 |
| GOMF DAMAGED DNA BINDING | 63 | 6.15e-01 | 3.67e-02 | 7.82e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 10 | 8.41e-01 | -3.67e-02 | 9.19e-01 |
| GOBP REGULATION OF CELL MATURATION | 23 | 7.61e-01 | -3.67e-02 | 8.74e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 207 | 3.64e-01 | -3.67e-02 | 5.91e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 166 | 4.16e-01 | 3.67e-02 | 6.36e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 64 | 6.12e-01 | 3.66e-02 | 7.80e-01 |
| GOBP GLAND DEVELOPMENT | 337 | 2.50e-01 | -3.66e-02 | 4.80e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 8.34e-01 | -3.65e-02 | 9.15e-01 |
| GOBP SPERM MOTILITY | 56 | 6.37e-01 | 3.65e-02 | 7.97e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 13 | 8.20e-01 | -3.64e-02 | 9.08e-01 |
| GOCC MICROFIBRIL | 13 | 8.21e-01 | -3.64e-02 | 9.08e-01 |
| GOBP MACROMOLECULE METHYLATION | 106 | 5.19e-01 | -3.63e-02 | 7.18e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 254 | 3.21e-01 | -3.62e-02 | 5.53e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 59 | 6.31e-01 | 3.62e-02 | 7.93e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 8.35e-01 | -3.62e-02 | 9.16e-01 |
| GOBP BONE REMODELING | 80 | 5.76e-01 | -3.62e-02 | 7.56e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 35 | 7.12e-01 | 3.61e-02 | 8.43e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 51 | 6.56e-01 | -3.61e-02 | 8.09e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 105 | 5.23e-01 | -3.61e-02 | 7.21e-01 |
| GOCC ENDONUCLEASE COMPLEX | 36 | 7.08e-01 | -3.61e-02 | 8.40e-01 |
| GOCC CELL BODY MEMBRANE | 26 | 7.50e-01 | -3.61e-02 | 8.68e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 96 | 5.42e-01 | -3.60e-02 | 7.33e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 287 | 2.95e-01 | -3.60e-02 | 5.28e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 53 | 6.51e-01 | 3.59e-02 | 8.06e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 232 | 3.48e-01 | -3.59e-02 | 5.78e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 51 | 6.58e-01 | 3.58e-02 | 8.11e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 214 | 3.69e-01 | -3.57e-02 | 5.95e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 25 | 7.57e-01 | 3.57e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 27 | 7.48e-01 | -3.57e-02 | 8.67e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 13 | 8.24e-01 | 3.56e-02 | 9.10e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 21 | 7.78e-01 | 3.56e-02 | 8.84e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 164 | 4.33e-01 | 3.56e-02 | 6.51e-01 |
| GOBP GMP METABOLIC PROCESS | 19 | 7.88e-01 | -3.56e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 29 | 7.41e-01 | 3.55e-02 | 8.63e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 51 | 6.61e-01 | -3.55e-02 | 8.14e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 674 | 1.20e-01 | -3.54e-02 | 3.08e-01 |
| GOMF RIBOSOME BINDING | 98 | 5.45e-01 | -3.54e-02 | 7.35e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 30 | 7.37e-01 | 3.54e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 53 | 6.57e-01 | -3.52e-02 | 8.11e-01 |
| GOBP METHYLATION | 169 | 4.30e-01 | 3.52e-02 | 6.48e-01 |
| GOCC GOLGI TRANS CISTERNA | 10 | 8.47e-01 | -3.52e-02 | 9.23e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 10 | 8.48e-01 | 3.51e-02 | 9.23e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 96 | 5.53e-01 | -3.51e-02 | 7.38e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 26 | 7.57e-01 | 3.50e-02 | 8.72e-01 |
| GOMF FLIPPASE ACTIVITY | 13 | 8.27e-01 | -3.50e-02 | 9.12e-01 |
| GOBP COGNITION | 269 | 3.25e-01 | -3.50e-02 | 5.56e-01 |
| GOBP REGULATION OF NEURON MATURATION | 15 | 8.15e-01 | 3.49e-02 | 9.06e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 34 | 7.25e-01 | -3.49e-02 | 8.50e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME | 20 | 7.87e-01 | 3.49e-02 | 8.89e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 77 | 5.98e-01 | -3.48e-02 | 7.71e-01 |
| GOBP RESPONSE TO ESTRADIOL | 30 | 7.42e-01 | -3.48e-02 | 8.63e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 14 | 8.22e-01 | -3.47e-02 | 9.09e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 119 | 5.15e-01 | -3.46e-02 | 7.15e-01 |
| GOMF METAL CLUSTER BINDING | 68 | 6.22e-01 | 3.46e-02 | 7.86e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 20 | 7.89e-01 | 3.46e-02 | 8.90e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 106 | 5.39e-01 | -3.46e-02 | 7.31e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 87 | 5.78e-01 | -3.45e-02 | 7.58e-01 |
| GOBP NEPHRON DEVELOPMENT | 128 | 5.01e-01 | -3.45e-02 | 7.04e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 14 | 8.23e-01 | -3.45e-02 | 9.09e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 120 | 5.15e-01 | 3.44e-02 | 7.15e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 113 | 5.29e-01 | -3.43e-02 | 7.25e-01 |
| GOMF WNT PROTEIN BINDING | 27 | 7.58e-01 | -3.42e-02 | 8.72e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 167 | 4.47e-01 | 3.42e-02 | 6.60e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 25 | 7.68e-01 | -3.41e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 117 | 5.26e-01 | 3.40e-02 | 7.24e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 78 | 6.05e-01 | -3.39e-02 | 7.76e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 37 | 7.21e-01 | 3.39e-02 | 8.48e-01 |
| GOCC NUCLEOSOME | 39 | 7.15e-01 | 3.38e-02 | 8.45e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 60 | 6.51e-01 | 3.38e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 49 | 6.83e-01 | 3.38e-02 | 8.27e-01 |
| GOBP METALLO SULFUR CLUSTER ASSEMBLY | 20 | 7.94e-01 | -3.37e-02 | 8.93e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 37 | 7.23e-01 | 3.36e-02 | 8.49e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 64 | 6.43e-01 | 3.36e-02 | 8.00e-01 |
| GOBP MAST CELL MIGRATION | 13 | 8.34e-01 | -3.36e-02 | 9.15e-01 |
| GOBP TISSUE REGENERATION | 49 | 6.85e-01 | -3.36e-02 | 8.28e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 638 | 1.51e-01 | 3.35e-02 | 3.58e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 25 | 7.72e-01 | 3.35e-02 | 8.80e-01 |
| GOCC PROTEIN DNA COMPLEX | 691 | 1.36e-01 | 3.35e-02 | 3.34e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 237 | 3.75e-01 | 3.35e-02 | 6.02e-01 |
| GOBP B CELL ACTIVATION | 209 | 4.06e-01 | -3.35e-02 | 6.27e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 50 | 6.83e-01 | 3.34e-02 | 8.27e-01 |
| GOBP SNO S RNA PROCESSING | 11 | 8.48e-01 | -3.34e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 13 | 8.35e-01 | 3.34e-02 | 9.16e-01 |
| GOCC TRANSFERASE COMPLEX | 731 | 1.28e-01 | 3.33e-02 | 3.21e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 53 | 6.76e-01 | -3.32e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 8.36e-01 | -3.32e-02 | 9.16e-01 |
| GOBP SPLEEN DEVELOPMENT | 37 | 7.27e-01 | 3.32e-02 | 8.52e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 19 | 8.03e-01 | 3.31e-02 | 8.98e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 128 | 5.20e-01 | -3.30e-02 | 7.18e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 10 | 8.57e-01 | 3.29e-02 | 9.28e-01 |
| GOMF EXONUCLEASE ACTIVITY | 73 | 6.27e-01 | -3.29e-02 | 7.91e-01 |
| GOMF FMN BINDING | 14 | 8.31e-01 | -3.29e-02 | 9.14e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 7.99e-01 | 3.29e-02 | 8.96e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 49 | 6.91e-01 | -3.29e-02 | 8.30e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 143 | 4.98e-01 | -3.28e-02 | 7.03e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 38 | 7.26e-01 | 3.28e-02 | 8.51e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 35 | 7.37e-01 | 3.28e-02 | 8.60e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 38 | 7.26e-01 | 3.28e-02 | 8.51e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 491 | 2.15e-01 | -3.28e-02 | 4.42e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 23 | 7.85e-01 | -3.28e-02 | 8.89e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 71 | 6.33e-01 | 3.28e-02 | 7.96e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 14 | 8.32e-01 | 3.28e-02 | 9.14e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 31 | 7.52e-01 | -3.28e-02 | 8.70e-01 |
| GOMF LIGASE ACTIVITY | 113 | 5.48e-01 | -3.27e-02 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 12 | 8.45e-01 | 3.27e-02 | 9.22e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 16 | 8.21e-01 | -3.27e-02 | 9.08e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 53 | 6.81e-01 | 3.27e-02 | 8.26e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 17 | 8.16e-01 | 3.27e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 113 | 5.49e-01 | -3.26e-02 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 32 | 7.50e-01 | 3.26e-02 | 8.68e-01 |
| GOBP RNA DECAPPING | 18 | 8.11e-01 | -3.26e-02 | 9.03e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 17 | 8.16e-01 | -3.26e-02 | 9.06e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 14 | 8.33e-01 | -3.25e-02 | 9.15e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 59 | 6.66e-01 | -3.25e-02 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 69 | 6.41e-01 | -3.25e-02 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 15 | 8.28e-01 | 3.23e-02 | 9.13e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 26 | 7.76e-01 | 3.23e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 36 | 7.37e-01 | -3.23e-02 | 8.60e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 11 | 8.53e-01 | -3.23e-02 | 9.26e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 30 | 7.60e-01 | 3.23e-02 | 8.73e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 248 | 3.83e-01 | 3.22e-02 | 6.10e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 34 | 7.45e-01 | -3.22e-02 | 8.65e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 58 | 6.72e-01 | 3.22e-02 | 8.21e-01 |
| GOCC RIBOSOME | 229 | 4.02e-01 | -3.22e-02 | 6.24e-01 |
| GOCC MITOCHONDRION | 1542 | 3.80e-02 | -3.22e-02 | 1.45e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 12 | 8.47e-01 | 3.21e-02 | 9.23e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 15 | 8.30e-01 | -3.20e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 11 | 8.54e-01 | 3.20e-02 | 9.27e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 368 | 2.94e-01 | -3.20e-02 | 5.26e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 34 | 7.47e-01 | -3.19e-02 | 8.67e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 10 | 8.61e-01 | -3.19e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 10 | 8.61e-01 | 3.19e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 63 | 6.62e-01 | 3.19e-02 | 8.14e-01 |
| GOCC MEDIATOR COMPLEX | 36 | 7.41e-01 | 3.18e-02 | 8.63e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 241 | 3.96e-01 | -3.18e-02 | 6.19e-01 |
| GOBP THYROID HORMONE GENERATION | 12 | 8.49e-01 | 3.18e-02 | 9.24e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 79 | 6.26e-01 | -3.17e-02 | 7.91e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 43 | 7.19e-01 | 3.17e-02 | 8.47e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 100 | 5.85e-01 | -3.16e-02 | 7.63e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 37 | 7.39e-01 | -3.16e-02 | 8.61e-01 |
| GOBP DNA REPAIR | 504 | 2.27e-01 | 3.16e-02 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 24 | 7.89e-01 | 3.16e-02 | 8.90e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 11 | 8.56e-01 | 3.16e-02 | 9.27e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 51 | 6.97e-01 | 3.15e-02 | 8.34e-01 |
| GOBP RECEPTOR INTERNALIZATION | 122 | 5.48e-01 | -3.15e-02 | 7.36e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 18 | 8.17e-01 | -3.15e-02 | 9.06e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 17 | 8.22e-01 | 3.15e-02 | 9.09e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 115 | 5.61e-01 | 3.15e-02 | 7.44e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 89 | 6.09e-01 | 3.14e-02 | 7.78e-01 |
| GOCC GABA ERGIC SYNAPSE | 99 | 5.90e-01 | 3.14e-02 | 7.65e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 101 | 5.86e-01 | -3.14e-02 | 7.64e-01 |
| GOBP PRIMARY NEURAL TUBE FORMATION | 105 | 5.80e-01 | 3.13e-02 | 7.59e-01 |
| GOBP PROTEIN TETRAMERIZATION | 70 | 6.51e-01 | 3.13e-02 | 8.06e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 105 | 5.80e-01 | -3.13e-02 | 7.59e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 100 | 5.89e-01 | -3.13e-02 | 7.65e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 14 | 8.39e-01 | 3.13e-02 | 9.19e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 10 | 8.64e-01 | 3.13e-02 | 9.32e-01 |
| GOBP SINGLE FERTILIZATION | 80 | 6.30e-01 | -3.12e-02 | 7.92e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS | 192 | 4.57e-01 | -3.12e-02 | 6.70e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 20 | 8.09e-01 | -3.12e-02 | 9.02e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 464 | 2.52e-01 | -3.12e-02 | 4.83e-01 |
| GOCC PLASMA MEMBRANE BOUNDED CELL PROJECTION CYTOPLASM | 129 | 5.42e-01 | -3.11e-02 | 7.33e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 51 | 7.01e-01 | -3.11e-02 | 8.36e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 8.59e-01 | 3.10e-02 | 9.29e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 44 | 7.22e-01 | -3.10e-02 | 8.48e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 78 | 6.37e-01 | -3.10e-02 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF AXON REGENERATION | 15 | 8.36e-01 | 3.09e-02 | 9.16e-01 |
| GOMF CADHERIN BINDING | 50 | 7.06e-01 | -3.09e-02 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 16 | 8.31e-01 | -3.08e-02 | 9.14e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 393 | 2.99e-01 | -3.07e-02 | 5.31e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 109 | 5.81e-01 | -3.06e-02 | 7.60e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 11 | 8.61e-01 | 3.05e-02 | 9.31e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 120 | 5.64e-01 | -3.05e-02 | 7.46e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 17 | 8.28e-01 | -3.05e-02 | 9.12e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 47 | 7.18e-01 | -3.04e-02 | 8.47e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 11 | 8.61e-01 | -3.04e-02 | 9.31e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 20 | 8.14e-01 | -3.04e-02 | 9.05e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 11 | 8.62e-01 | 3.03e-02 | 9.31e-01 |
| GOBP HEART MORPHOGENESIS | 239 | 4.20e-01 | 3.03e-02 | 6.38e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 17 | 8.29e-01 | 3.03e-02 | 9.13e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 19 | 8.20e-01 | -3.02e-02 | 9.08e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 131 | 5.52e-01 | -3.01e-02 | 7.37e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 99 | 6.05e-01 | 3.01e-02 | 7.76e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 27 | 7.86e-01 | -3.01e-02 | 8.89e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 16 | 8.35e-01 | 3.01e-02 | 9.16e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 63 | 6.81e-01 | -3.00e-02 | 8.26e-01 |
| GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 14 | 8.46e-01 | 2.99e-02 | 9.23e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 8.52e-01 | 2.99e-02 | 9.26e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 19 | 8.22e-01 | 2.99e-02 | 9.09e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 65 | 6.78e-01 | -2.98e-02 | 8.24e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 10 | 8.70e-01 | 2.98e-02 | 9.34e-01 |
| GOCC NUCLEAR PORE OUTER RING | 10 | 8.70e-01 | 2.98e-02 | 9.34e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 13 | 8.53e-01 | 2.98e-02 | 9.26e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 11 | 8.65e-01 | 2.96e-02 | 9.32e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 24 | 8.02e-01 | 2.96e-02 | 8.98e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 30 | 7.79e-01 | -2.96e-02 | 8.84e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 30 | 7.80e-01 | 2.95e-02 | 8.84e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 211 | 4.61e-01 | 2.95e-02 | 6.73e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 61 | 6.91e-01 | -2.94e-02 | 8.30e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 19 | 8.24e-01 | -2.94e-02 | 9.10e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 32 | 7.74e-01 | -2.94e-02 | 8.81e-01 |
| GOBP PROLINE TRANSPORT | 11 | 8.67e-01 | 2.93e-02 | 9.33e-01 |
| GOBP REGULATION OF MYELINATION | 52 | 7.15e-01 | -2.92e-02 | 8.45e-01 |
| GOCC ACROSOMAL VESICLE | 69 | 6.75e-01 | -2.92e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 68 | 6.78e-01 | 2.92e-02 | 8.24e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 104 | 6.08e-01 | 2.92e-02 | 7.78e-01 |
| GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX | 15 | 8.45e-01 | -2.92e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 13 | 8.56e-01 | 2.91e-02 | 9.27e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 30 | 7.83e-01 | -2.91e-02 | 8.87e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 58 | 7.02e-01 | -2.90e-02 | 8.37e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 33 | 7.74e-01 | -2.89e-02 | 8.81e-01 |
| GOBP RESPONSE TO PEPTIDE | 11 | 8.68e-01 | -2.89e-02 | 9.33e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.51e-01 | -2.89e-02 | 9.25e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 157 | 5.34e-01 | -2.88e-02 | 7.27e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 10 | 8.75e-01 | -2.87e-02 | 9.37e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 361 | 3.50e-01 | -2.87e-02 | 5.80e-01 |
| GOBP ASSOCIATIVE LEARNING | 84 | 6.50e-01 | -2.87e-02 | 8.05e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 72 | 6.74e-01 | -2.87e-02 | 8.22e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 198 | 4.88e-01 | -2.87e-02 | 6.94e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 22 | 8.16e-01 | 2.86e-02 | 9.06e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 22 | 8.16e-01 | -2.86e-02 | 9.06e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 10 | 8.76e-01 | 2.86e-02 | 9.37e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 14 | 8.53e-01 | -2.86e-02 | 9.26e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 54 | 7.17e-01 | 2.86e-02 | 8.46e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 40 | 7.55e-01 | -2.86e-02 | 8.71e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 92 | 6.37e-01 | 2.85e-02 | 7.97e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 43 | 7.47e-01 | -2.85e-02 | 8.66e-01 |
| GOBP MUSCLE CONTRACTION | 249 | 4.40e-01 | -2.85e-02 | 6.56e-01 |
| GOBP MRNA METHYLGUANOSINE CAP DECAPPING | 15 | 8.49e-01 | -2.85e-02 | 9.24e-01 |
| GOBP MEMBRANE REPOLARIZATION | 41 | 7.53e-01 | 2.84e-02 | 8.70e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 12 | 8.65e-01 | 2.84e-02 | 9.32e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 39 | 7.59e-01 | -2.84e-02 | 8.73e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 30 | 7.88e-01 | -2.84e-02 | 8.90e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 440 | 3.10e-01 | -2.83e-02 | 5.42e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 19 | 8.31e-01 | -2.83e-02 | 9.14e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 25 | 8.07e-01 | 2.82e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 68 | 6.88e-01 | 2.82e-02 | 8.29e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 233 | 4.61e-01 | -2.81e-02 | 6.73e-01 |
| GOBP MIRNA TRANSCRIPTION | 70 | 6.84e-01 | -2.81e-02 | 8.28e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 430 | 3.20e-01 | -2.81e-02 | 5.52e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 22 | 8.20e-01 | -2.80e-02 | 9.08e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 32 | 7.84e-01 | 2.80e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 69 | 6.87e-01 | -2.80e-02 | 8.29e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 17 | 8.42e-01 | 2.79e-02 | 9.20e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 91 | 6.46e-01 | 2.78e-02 | 8.03e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 109 | 6.17e-01 | -2.77e-02 | 7.83e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 34 | 7.80e-01 | 2.77e-02 | 8.84e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 163 | 5.43e-01 | -2.77e-02 | 7.33e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 32 | 7.86e-01 | -2.77e-02 | 8.89e-01 |
| GOCC RIBOSOMAL SUBUNIT | 183 | 5.20e-01 | -2.76e-02 | 7.18e-01 |
| GOMF FILAMIN BINDING | 13 | 8.63e-01 | 2.76e-02 | 9.32e-01 |
| GOBP XENOBIOTIC TRANSPORT | 32 | 7.87e-01 | -2.76e-02 | 8.89e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 16 | 8.48e-01 | 2.76e-02 | 9.23e-01 |
| GOBP NERVE DEVELOPMENT | 70 | 6.91e-01 | -2.75e-02 | 8.30e-01 |
| GOBP AMELOGENESIS | 17 | 8.45e-01 | 2.74e-02 | 9.22e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 20 | 8.32e-01 | -2.74e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 39 | 7.68e-01 | -2.73e-02 | 8.78e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 12 | 8.70e-01 | -2.73e-02 | 9.34e-01 |
| GOBP BONE MATURATION | 23 | 8.21e-01 | 2.73e-02 | 9.08e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 11 | 8.76e-01 | 2.72e-02 | 9.38e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 19 | 8.38e-01 | -2.72e-02 | 9.18e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 337 | 3.95e-01 | -2.71e-02 | 6.18e-01 |
| GOBP WNT SIGNALING PATHWAY | 364 | 3.77e-01 | -2.71e-02 | 6.04e-01 |
| GOBP NEURON FATE COMMITMENT | 38 | 7.73e-01 | 2.70e-02 | 8.81e-01 |
| GOMF HSP90 PROTEIN BINDING | 45 | 7.54e-01 | -2.70e-02 | 8.71e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 10 | 8.82e-01 | -2.70e-02 | 9.41e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 440 | 3.33e-01 | -2.70e-02 | 5.64e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 16 | 8.52e-01 | 2.69e-02 | 9.26e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 7.86e-01 | -2.69e-02 | 8.89e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 18 | 8.43e-01 | -2.69e-02 | 9.21e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 53 | 7.36e-01 | -2.68e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 175 | 5.43e-01 | -2.67e-02 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 27 | 8.10e-01 | -2.67e-02 | 9.03e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 46 | 7.54e-01 | -2.67e-02 | 8.71e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 31 | 7.97e-01 | -2.67e-02 | 8.95e-01 |
| GOCC CILIARY PLASM | 86 | 6.69e-01 | -2.67e-02 | 8.19e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 57 | 7.28e-01 | 2.66e-02 | 8.52e-01 |
| GOMF DYNEIN COMPLEX BINDING | 20 | 8.37e-01 | -2.66e-02 | 9.17e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 75 | 6.91e-01 | -2.65e-02 | 8.30e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 20 | 8.38e-01 | 2.64e-02 | 9.18e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 19 | 8.42e-01 | -2.64e-02 | 9.20e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 22 | 8.31e-01 | -2.63e-02 | 9.14e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 22 | 8.31e-01 | -2.63e-02 | 9.14e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 14 | 8.65e-01 | 2.63e-02 | 9.32e-01 |
| GOMF CALCIUM CHANNEL ACTIVITY | 66 | 7.13e-01 | -2.62e-02 | 8.44e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 11 | 8.80e-01 | 2.62e-02 | 9.41e-01 |
| GOBP SPINAL CORD PATTERNING | 13 | 8.70e-01 | -2.62e-02 | 9.34e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 301 | 4.36e-01 | 2.62e-02 | 6.53e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 47 | 7.57e-01 | -2.61e-02 | 8.72e-01 |
| GOBP RESPONSE TO RADIATION | 332 | 4.15e-01 | -2.61e-02 | 6.36e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 69 | 7.09e-01 | 2.60e-02 | 8.41e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 23 | 8.29e-01 | 2.60e-02 | 9.13e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 8.82e-01 | -2.60e-02 | 9.41e-01 |
| GOBP REGULATION OF BEHAVIOR | 55 | 7.40e-01 | -2.59e-02 | 8.62e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 21 | 8.37e-01 | -2.59e-02 | 9.17e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 28 | 8.13e-01 | -2.59e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 45 | 7.64e-01 | -2.58e-02 | 8.76e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 94 | 6.65e-01 | -2.58e-02 | 8.16e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 11 | 8.82e-01 | -2.58e-02 | 9.41e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 512 | 3.21e-01 | -2.58e-02 | 5.52e-01 |
| GOBP RNA CATABOLIC PROCESS | 240 | 4.93e-01 | 2.58e-02 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 30 | 8.07e-01 | -2.57e-02 | 9.01e-01 |
| GOBP ERBB3 SIGNALING PATHWAY | 14 | 8.68e-01 | -2.57e-02 | 9.33e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 17 | 8.55e-01 | -2.57e-02 | 9.27e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 157 | 5.79e-01 | -2.57e-02 | 7.59e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 38 | 7.85e-01 | -2.56e-02 | 8.89e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 11 | 8.83e-01 | 2.56e-02 | 9.41e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 135 | 6.09e-01 | 2.55e-02 | 7.78e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 23 | 8.33e-01 | -2.55e-02 | 9.14e-01 |
| GOBP ANAGEN | 10 | 8.89e-01 | -2.55e-02 | 9.45e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 10 | 8.89e-01 | 2.54e-02 | 9.45e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 47 | 7.64e-01 | -2.54e-02 | 8.76e-01 |
| GOBP PEROXISOMAL TRANSPORT | 21 | 8.41e-01 | 2.54e-02 | 9.19e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 8.65e-01 | -2.54e-02 | 9.32e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 110 | 6.46e-01 | -2.54e-02 | 8.02e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 18 | 8.53e-01 | -2.53e-02 | 9.26e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 655 | 2.73e-01 | -2.53e-02 | 5.05e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 11 | 8.85e-01 | 2.52e-02 | 9.42e-01 |
| GOMF NAD BINDING | 56 | 7.45e-01 | -2.52e-02 | 8.65e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 48 | 7.63e-01 | 2.51e-02 | 8.76e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 35 | 7.97e-01 | 2.51e-02 | 8.95e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 14 | 8.71e-01 | 2.51e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 37 | 7.92e-01 | -2.51e-02 | 8.92e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 15 | 8.67e-01 | 2.50e-02 | 9.33e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 16 | 8.62e-01 | 2.50e-02 | 9.31e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 196 | 5.47e-01 | -2.50e-02 | 7.36e-01 |
| GOMF ISOPRENOID BINDING | 17 | 8.58e-01 | -2.50e-02 | 9.29e-01 |
| GOBP B CELL DIFFERENTIATION | 118 | 6.40e-01 | -2.50e-02 | 7.99e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 12 | 8.81e-01 | 2.49e-02 | 9.41e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 30 | 8.14e-01 | -2.49e-02 | 9.05e-01 |
| GOMF ZINC ION BINDING | 563 | 3.17e-01 | -2.48e-02 | 5.49e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 18 | 8.56e-01 | -2.48e-02 | 9.27e-01 |
| GOBP AMINO ACID TRANSPORT | 122 | 6.37e-01 | -2.48e-02 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 16 | 8.64e-01 | 2.48e-02 | 9.32e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 48 | 7.67e-01 | -2.47e-02 | 8.77e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 19 | 8.52e-01 | -2.47e-02 | 9.26e-01 |
| GOBP MALE SEX DETERMINATION | 10 | 8.92e-01 | 2.47e-02 | 9.46e-01 |
| GOCC VARICOSITY | 10 | 8.92e-01 | 2.47e-02 | 9.46e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 30 | 8.15e-01 | 2.47e-02 | 9.06e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 15 | 8.69e-01 | -2.45e-02 | 9.34e-01 |
| GOBP RHYTHMIC PROCESS | 236 | 5.17e-01 | -2.45e-02 | 7.17e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 73 | 7.18e-01 | 2.45e-02 | 8.47e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 114 | 6.52e-01 | -2.45e-02 | 8.06e-01 |
| GOBP STARTLE RESPONSE | 23 | 8.39e-01 | -2.45e-02 | 9.18e-01 |
| GOBP HISTAMINE TRANSPORT | 12 | 8.83e-01 | 2.45e-02 | 9.41e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 77 | 7.12e-01 | 2.44e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 14 | 8.75e-01 | 2.43e-02 | 9.37e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 80 | 7.08e-01 | -2.42e-02 | 8.40e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 119 | 6.50e-01 | -2.41e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 16 | 8.67e-01 | 2.41e-02 | 9.33e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 129 | 6.37e-01 | -2.41e-02 | 7.97e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 101 | 6.76e-01 | -2.41e-02 | 8.23e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 159 | 6.01e-01 | -2.41e-02 | 7.74e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 17 | 8.64e-01 | -2.40e-02 | 9.32e-01 |
| GOBP N GLYCAN PROCESSING | 12 | 8.86e-01 | 2.40e-02 | 9.43e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 176 | 5.84e-01 | -2.40e-02 | 7.62e-01 |
| GOBP DENDRITE MORPHOGENESIS | 157 | 6.05e-01 | -2.40e-02 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 61 | 7.47e-01 | -2.39e-02 | 8.66e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 52 | 7.65e-01 | 2.39e-02 | 8.76e-01 |
| GOBP CHLORIDE TRANSMEMBRANE TRANSPORT | 31 | 8.18e-01 | -2.39e-02 | 9.07e-01 |
| GOBP RNA PROCESSING | 797 | 2.55e-01 | 2.39e-02 | 4.86e-01 |
| GOMF STEROID BINDING | 81 | 7.11e-01 | -2.38e-02 | 8.42e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 17 | 8.65e-01 | 2.38e-02 | 9.32e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 11 | 8.92e-01 | -2.37e-02 | 9.46e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 25 | 8.37e-01 | -2.37e-02 | 9.17e-01 |
| GOBP PEROXISOME ORGANIZATION | 35 | 8.08e-01 | 2.37e-02 | 9.02e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 8.48e-01 | 2.37e-02 | 9.23e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 77 | 7.20e-01 | 2.36e-02 | 8.47e-01 |
| GOCC MANCHETTE | 11 | 8.92e-01 | -2.36e-02 | 9.46e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 11 | 8.92e-01 | -2.36e-02 | 9.46e-01 |
| GOMF AMIDE BINDING | 169 | 5.98e-01 | -2.36e-02 | 7.71e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 25 | 8.39e-01 | 2.35e-02 | 9.18e-01 |
| GOBP DEVELOPMENT OF PRIMARY MALE SEXUAL CHARACTERISTICS | 92 | 6.97e-01 | -2.35e-02 | 8.34e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 92 | 6.98e-01 | -2.34e-02 | 8.34e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 15 | 8.76e-01 | 2.33e-02 | 9.37e-01 |
| GOBP HEAD DEVELOPMENT | 550 | 3.52e-01 | -2.33e-02 | 5.81e-01 |
| GOCC RNA POLYMERASE COMPLEX | 89 | 7.04e-01 | 2.33e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 8.85e-01 | 2.33e-02 | 9.42e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 11 | 8.94e-01 | -2.32e-02 | 9.47e-01 |
| GOMF HORMONE BINDING | 55 | 7.67e-01 | 2.32e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 17 | 8.69e-01 | -2.31e-02 | 9.34e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 125 | 6.59e-01 | 2.29e-02 | 8.12e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 22 | 8.54e-01 | -2.27e-02 | 9.26e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 36 | 8.14e-01 | -2.27e-02 | 9.05e-01 |
| GOCC ESCRT I COMPLEX | 10 | 9.01e-01 | 2.27e-02 | 9.52e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 10 | 9.01e-01 | 2.27e-02 | 9.52e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 14 | 8.84e-01 | -2.26e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 43 | 7.98e-01 | -2.25e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 15 | 8.80e-01 | 2.25e-02 | 9.41e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 57 | 7.70e-01 | -2.24e-02 | 8.78e-01 |
| GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY | 21 | 8.59e-01 | 2.24e-02 | 9.29e-01 |
| GOBP NEURON PROJECTION GUIDANCE | 173 | 6.12e-01 | -2.24e-02 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 26 | 8.44e-01 | 2.23e-02 | 9.22e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 18 | 8.70e-01 | -2.23e-02 | 9.34e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 160 | 6.28e-01 | -2.22e-02 | 7.92e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 53 | 7.80e-01 | 2.22e-02 | 8.84e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 14 | 8.86e-01 | -2.20e-02 | 9.43e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 55 | 7.78e-01 | 2.20e-02 | 8.84e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 31 | 8.32e-01 | -2.20e-02 | 9.14e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 170 | 6.22e-01 | 2.20e-02 | 7.86e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 60 | 7.70e-01 | 2.19e-02 | 8.78e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 28 | 8.42e-01 | 2.18e-02 | 9.20e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 42 | 8.07e-01 | 2.18e-02 | 9.01e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 13 | 8.92e-01 | -2.18e-02 | 9.46e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 57 | 7.76e-01 | -2.18e-02 | 8.83e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 15 | 8.84e-01 | 2.18e-02 | 9.41e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 171 | 6.25e-01 | -2.17e-02 | 7.89e-01 |
| GOCC CATION CHANNEL COMPLEX | 111 | 6.93e-01 | 2.17e-02 | 8.31e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 30 | 8.37e-01 | 2.17e-02 | 9.17e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE ASSEMBLY | 17 | 8.77e-01 | 2.17e-02 | 9.38e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 16 | 8.81e-01 | 2.16e-02 | 9.41e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 78 | 7.42e-01 | -2.16e-02 | 8.63e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 11 | 9.01e-01 | -2.16e-02 | 9.52e-01 |
| GOBP MRNA 3 END PROCESSING | 36 | 8.23e-01 | 2.15e-02 | 9.09e-01 |
| GOBP LIPID MODIFICATION | 158 | 6.41e-01 | -2.15e-02 | 7.99e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 42 | 8.10e-01 | 2.15e-02 | 9.02e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 14 | 8.90e-01 | -2.14e-02 | 9.45e-01 |
| GOBP SPERM EGG RECOGNITION | 26 | 8.50e-01 | -2.14e-02 | 9.24e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 10 | 9.07e-01 | 2.13e-02 | 9.55e-01 |
| GOBP DIGESTION | 68 | 7.61e-01 | -2.13e-02 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 37 | 8.22e-01 | -2.13e-02 | 9.09e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 439 | 4.47e-01 | -2.12e-02 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 19 | 8.73e-01 | -2.12e-02 | 9.35e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 51 | 7.94e-01 | -2.12e-02 | 8.93e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 119 | 6.91e-01 | 2.12e-02 | 8.30e-01 |
| GOMF JUN KINASE BINDING | 16 | 8.84e-01 | -2.11e-02 | 9.41e-01 |
| GOBP EAR DEVELOPMENT | 172 | 6.35e-01 | -2.10e-02 | 7.97e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 68 | 7.65e-01 | -2.10e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 25 | 8.56e-01 | 2.10e-02 | 9.27e-01 |
| GOCC MITOCHONDRIAL MATRIX | 275 | 5.51e-01 | 2.10e-02 | 7.37e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 469 | 4.40e-01 | -2.09e-02 | 6.56e-01 |
| GOBP TOR SIGNALING | 142 | 6.69e-01 | -2.08e-02 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 39 | 8.22e-01 | -2.08e-02 | 9.09e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 70 | 7.64e-01 | 2.08e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 35 | 8.32e-01 | -2.08e-02 | 9.14e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 57 | 7.87e-01 | 2.07e-02 | 8.89e-01 |
| GOBP FEAR RESPONSE | 37 | 8.28e-01 | 2.07e-02 | 9.12e-01 |
| GOBP G1 TO G0 TRANSITION | 15 | 8.90e-01 | -2.06e-02 | 9.46e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 32 | 8.41e-01 | -2.05e-02 | 9.20e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 427 | 4.70e-01 | -2.05e-02 | 6.82e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 73 | 7.63e-01 | -2.04e-02 | 8.76e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 30 | 8.47e-01 | 2.04e-02 | 9.23e-01 |
| GOCC XY BODY | 17 | 8.84e-01 | 2.04e-02 | 9.42e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 11 | 9.07e-01 | -2.03e-02 | 9.55e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 49 | 8.06e-01 | -2.02e-02 | 9.01e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 44 | 8.16e-01 | -2.02e-02 | 9.06e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 39 | 8.27e-01 | -2.02e-02 | 9.12e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 77 | 7.59e-01 | 2.02e-02 | 8.73e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 30 | 8.48e-01 | 2.02e-02 | 9.23e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 11 | 9.08e-01 | -2.02e-02 | 9.56e-01 |
| GOBP DNA REPLICATION | 241 | 5.90e-01 | -2.02e-02 | 7.65e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 19 | 8.79e-01 | -2.02e-02 | 9.40e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 138 | 6.83e-01 | -2.02e-02 | 8.27e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 77 | 7.60e-01 | -2.02e-02 | 8.73e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 12 | 9.04e-01 | 2.02e-02 | 9.54e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 22 | 8.71e-01 | -2.00e-02 | 9.34e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 54 | 8.00e-01 | 2.00e-02 | 8.96e-01 |
| GOBP RNA SURVEILLANCE | 17 | 8.87e-01 | -2.00e-02 | 9.43e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 119 | 7.08e-01 | 1.99e-02 | 8.40e-01 |
| GOBP FEEDING BEHAVIOR | 59 | 7.91e-01 | 1.99e-02 | 8.91e-01 |
| GOCC P BODY | 74 | 7.67e-01 | -1.99e-02 | 8.77e-01 |
| GOBP CHROMATIN REMODELING | 424 | 4.84e-01 | 1.99e-02 | 6.91e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 24 | 8.66e-01 | 1.99e-02 | 9.33e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 30 | 8.51e-01 | -1.98e-02 | 9.25e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 12 | 9.06e-01 | 1.98e-02 | 9.55e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 283 | 5.68e-01 | 1.98e-02 | 7.49e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 11 | 9.10e-01 | 1.97e-02 | 9.57e-01 |
| GOMF RNA CAP BINDING | 14 | 8.99e-01 | -1.96e-02 | 9.50e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 332 | 5.41e-01 | 1.96e-02 | 7.33e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 9.03e-01 | 1.95e-02 | 9.53e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 98 | 7.38e-01 | -1.95e-02 | 8.61e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 68 | 7.82e-01 | 1.95e-02 | 8.86e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 72 | 7.76e-01 | 1.94e-02 | 8.83e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 10 | 9.15e-01 | 1.94e-02 | 9.60e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 179 | 6.55e-01 | 1.94e-02 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 10 | 9.15e-01 | -1.94e-02 | 9.60e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 13 | 9.04e-01 | -1.94e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 15 | 8.97e-01 | -1.94e-02 | 9.48e-01 |
| GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 52 | 8.09e-01 | -1.93e-02 | 9.02e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 45 | 8.23e-01 | 1.93e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 183 | 6.53e-01 | -1.93e-02 | 8.08e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 81 | 7.64e-01 | -1.93e-02 | 8.76e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 12 | 9.08e-01 | -1.92e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 72 | 7.79e-01 | 1.92e-02 | 8.84e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 22 | 8.76e-01 | 1.92e-02 | 9.38e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 168 | 6.69e-01 | 1.91e-02 | 8.19e-01 |
| GOBP DENDRITIC TRANSPORT | 18 | 8.89e-01 | 1.91e-02 | 9.45e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 21 | 8.80e-01 | -1.90e-02 | 9.41e-01 |
| GOBP REGULATION OF HEART GROWTH | 82 | 7.66e-01 | 1.90e-02 | 8.77e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 84 | 7.64e-01 | 1.90e-02 | 8.76e-01 |
| GOMF NUCLEOSOME BINDING | 35 | 8.46e-01 | 1.89e-02 | 9.23e-01 |
| GOMF DEACETYLASE ACTIVITY | 30 | 8.58e-01 | -1.88e-02 | 9.29e-01 |
| GOBP CELL FATE SPECIFICATION | 61 | 7.99e-01 | 1.88e-02 | 8.96e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 259 | 6.03e-01 | 1.88e-02 | 7.75e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 124 | 7.18e-01 | 1.88e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 44 | 8.29e-01 | -1.88e-02 | 9.13e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 23 | 8.76e-01 | -1.88e-02 | 9.38e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 91 | 7.57e-01 | -1.88e-02 | 8.72e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 35 | 8.48e-01 | -1.87e-02 | 9.23e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 12 | 9.11e-01 | -1.87e-02 | 9.58e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 27 | 8.66e-01 | -1.87e-02 | 9.33e-01 |
| GOBP GAMETE GENERATION | 458 | 4.95e-01 | 1.87e-02 | 7.00e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 7.97e-01 | 1.86e-02 | 8.95e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 105 | 7.43e-01 | -1.86e-02 | 8.63e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 45 | 8.30e-01 | -1.85e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 11 | 9.15e-01 | -1.85e-02 | 9.60e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 72 | 7.87e-01 | -1.85e-02 | 8.89e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 103 | 7.46e-01 | 1.85e-02 | 8.66e-01 |
| GOBP EPITHELIAL CELL MATURATION | 18 | 8.93e-01 | -1.83e-02 | 9.46e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 10 | 9.20e-01 | -1.83e-02 | 9.62e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 57 | 8.12e-01 | 1.83e-02 | 9.04e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 51 | 8.22e-01 | -1.82e-02 | 9.09e-01 |
| GOMF SNRNA BINDING | 39 | 8.44e-01 | 1.82e-02 | 9.22e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 32 | 8.59e-01 | -1.82e-02 | 9.29e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 27 | 8.70e-01 | -1.82e-02 | 9.34e-01 |
| GOBP NEUROMUSCULAR PROCESS | 148 | 7.03e-01 | -1.82e-02 | 8.37e-01 |
| GOCC CONDENSED CHROMOSOME | 217 | 6.46e-01 | -1.81e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 35 | 8.53e-01 | -1.81e-02 | 9.26e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 36 | 8.51e-01 | -1.81e-02 | 9.25e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 66 | 7.99e-01 | -1.81e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 72 | 7.91e-01 | -1.81e-02 | 8.91e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 182 | 6.74e-01 | 1.81e-02 | 8.22e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 22 | 8.83e-01 | 1.81e-02 | 9.41e-01 |
| GOBP RETINA LAYER FORMATION | 14 | 9.07e-01 | -1.81e-02 | 9.55e-01 |
| GOBP REPRODUCTIVE PROCESS | 892 | 3.65e-01 | -1.81e-02 | 5.92e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 62 | 8.07e-01 | -1.79e-02 | 9.01e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 35 | 8.55e-01 | 1.78e-02 | 9.27e-01 |
| GOCC NUCLEAR PERIPHERY | 128 | 7.28e-01 | -1.78e-02 | 8.52e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 72 | 7.94e-01 | -1.78e-02 | 8.93e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 75 | 7.90e-01 | -1.78e-02 | 8.90e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 44 | 8.39e-01 | -1.78e-02 | 9.18e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 60 | 8.13e-01 | -1.77e-02 | 9.05e-01 |
| GOBP CELL FATE COMMITMENT | 179 | 6.84e-01 | -1.76e-02 | 8.28e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 26 | 8.76e-01 | 1.76e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 39 | 8.49e-01 | -1.76e-02 | 9.24e-01 |
| GOBP HEME METABOLIC PROCESS | 33 | 8.61e-01 | -1.76e-02 | 9.31e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 52 | 8.27e-01 | -1.75e-02 | 9.12e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 59 | 8.16e-01 | -1.75e-02 | 9.06e-01 |
| GOBP STEM CELL PROLIFERATION | 105 | 7.57e-01 | 1.75e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 16 | 9.04e-01 | 1.74e-02 | 9.54e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 11 | 9.21e-01 | 1.74e-02 | 9.62e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 13 | 9.14e-01 | -1.73e-02 | 9.60e-01 |
| GOCC METHYLOSOME | 12 | 9.18e-01 | -1.72e-02 | 9.61e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 12 | 9.18e-01 | -1.72e-02 | 9.61e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 11 | 9.21e-01 | -1.72e-02 | 9.62e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 9.25e-01 | -1.72e-02 | 9.63e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 11 | 9.22e-01 | -1.71e-02 | 9.62e-01 |
| GOCC NUCLEAR MATRIX | 102 | 7.66e-01 | 1.71e-02 | 8.76e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 638 | 4.68e-01 | -1.70e-02 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 73 | 8.03e-01 | 1.69e-02 | 8.98e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 9.14e-01 | 1.67e-02 | 9.60e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 62 | 8.20e-01 | -1.67e-02 | 9.08e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 9.24e-01 | 1.67e-02 | 9.63e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 9.27e-01 | 1.66e-02 | 9.65e-01 |
| GOCC TRANSPORTER COMPLEX | 271 | 6.39e-01 | 1.66e-02 | 7.98e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 15 | 9.12e-01 | -1.66e-02 | 9.58e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 23 | 8.91e-01 | 1.65e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF MRNA CATABOLIC PROCESS | 54 | 8.34e-01 | 1.65e-02 | 9.15e-01 |
| GOBP ACID SECRETION | 27 | 8.82e-01 | 1.65e-02 | 9.41e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 151 | 7.27e-01 | 1.65e-02 | 8.52e-01 |
| GOMF GLYCOLIPID BINDING | 23 | 8.91e-01 | -1.64e-02 | 9.46e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 12 | 9.22e-01 | -1.64e-02 | 9.62e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 533 | 5.20e-01 | -1.64e-02 | 7.18e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 28 | 8.81e-01 | -1.63e-02 | 9.41e-01 |
| GOBP NUCLEOSOME ASSEMBLY | 48 | 8.45e-01 | 1.63e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 50 | 8.42e-01 | 1.63e-02 | 9.21e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 14 | 9.16e-01 | -1.62e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 48 | 8.46e-01 | -1.62e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 169 | 7.19e-01 | 1.61e-02 | 8.47e-01 |
| GOBP EMBRYO DEVELOPMENT | 996 | 3.96e-01 | -1.60e-02 | 6.19e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 18 | 9.06e-01 | 1.60e-02 | 9.55e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 28 | 8.83e-01 | 1.60e-02 | 9.41e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1107 | 3.74e-01 | 1.60e-02 | 6.01e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 14 | 9.18e-01 | 1.59e-02 | 9.61e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 22 | 8.98e-01 | 1.59e-02 | 9.49e-01 |
| GOBP REGULATION OF BONE RESORPTION | 38 | 8.66e-01 | -1.58e-02 | 9.32e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 87 | 7.99e-01 | -1.58e-02 | 8.96e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 11 | 9.28e-01 | 1.58e-02 | 9.65e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 221 | 6.87e-01 | -1.58e-02 | 8.29e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 218 | 6.91e-01 | -1.57e-02 | 8.30e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 10 | 9.33e-01 | 1.54e-02 | 9.68e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 488 | 5.63e-01 | 1.54e-02 | 7.45e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 10 | 9.33e-01 | -1.54e-02 | 9.68e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 12 | 9.27e-01 | 1.53e-02 | 9.64e-01 |
| GOMF SUMO BINDING | 16 | 9.16e-01 | -1.53e-02 | 9.60e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 42 | 8.64e-01 | 1.53e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 13 | 9.24e-01 | 1.53e-02 | 9.63e-01 |
| GOBP COPPER ION TRANSPORT | 15 | 9.19e-01 | -1.51e-02 | 9.62e-01 |
| GOCC NUCLEAR BODY | 654 | 5.13e-01 | 1.51e-02 | 7.13e-01 |
| GOCC SUMO LIGASE COMPLEX | 11 | 9.31e-01 | -1.51e-02 | 9.67e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 9.22e-01 | -1.50e-02 | 9.63e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 44 | 8.63e-01 | 1.50e-02 | 9.32e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 31 | 8.86e-01 | -1.48e-02 | 9.43e-01 |
| GOBP MIRNA METABOLIC PROCESS | 87 | 8.11e-01 | 1.48e-02 | 9.04e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 167 | 7.42e-01 | 1.48e-02 | 8.63e-01 |
| GOBP CIRCADIAN RHYTHM | 176 | 7.38e-01 | -1.46e-02 | 8.60e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 9.33e-01 | -1.46e-02 | 9.68e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 21 | 9.08e-01 | -1.46e-02 | 9.56e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 35 | 8.81e-01 | 1.46e-02 | 9.41e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 47 | 8.63e-01 | -1.46e-02 | 9.31e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 60 | 8.46e-01 | -1.45e-02 | 9.22e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 18 | 9.15e-01 | 1.45e-02 | 9.60e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 14 | 9.25e-01 | 1.45e-02 | 9.63e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 14 | 9.25e-01 | -1.45e-02 | 9.63e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 76 | 8.27e-01 | 1.45e-02 | 9.12e-01 |
| GOBP COLLATERAL SPROUTING | 28 | 8.95e-01 | -1.45e-02 | 9.47e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 12 | 9.31e-01 | 1.44e-02 | 9.67e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 29 | 8.93e-01 | 1.44e-02 | 9.46e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 209 | 7.21e-01 | 1.44e-02 | 8.48e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 16 | 9.21e-01 | 1.43e-02 | 9.62e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 85 | 8.20e-01 | -1.43e-02 | 9.08e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 53 | 8.57e-01 | -1.43e-02 | 9.28e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 31 | 8.91e-01 | 1.43e-02 | 9.46e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 15 | 9.24e-01 | -1.42e-02 | 9.63e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 34 | 8.86e-01 | 1.42e-02 | 9.43e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 29 | 8.95e-01 | 1.42e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 19 | 9.15e-01 | 1.42e-02 | 9.60e-01 |
| GOCC MKS COMPLEX | 14 | 9.27e-01 | -1.42e-02 | 9.64e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 125 | 7.86e-01 | 1.41e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 114 | 7.95e-01 | -1.41e-02 | 8.93e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 69 | 8.40e-01 | 1.41e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 22 | 9.09e-01 | 1.41e-02 | 9.56e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 15 | 9.25e-01 | -1.41e-02 | 9.63e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 17 | 9.20e-01 | 1.41e-02 | 9.62e-01 |
| GOBP SENSORY PERCEPTION | 263 | 6.97e-01 | -1.40e-02 | 8.34e-01 |
| GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY | 44 | 8.74e-01 | -1.38e-02 | 9.36e-01 |
| GOCC AXOLEMMA | 17 | 9.21e-01 | -1.38e-02 | 9.62e-01 |
| GOMF VITAMIN BINDING | 101 | 8.12e-01 | 1.37e-02 | 9.04e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 20 | 9.15e-01 | 1.37e-02 | 9.60e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 11 | 9.37e-01 | 1.37e-02 | 9.70e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 272 | 6.98e-01 | -1.37e-02 | 8.34e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 31 | 8.95e-01 | -1.37e-02 | 9.47e-01 |
| GOCC MOTILE CILIUM | 130 | 7.88e-01 | 1.37e-02 | 8.90e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 19 | 9.18e-01 | -1.36e-02 | 9.61e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 92 | 8.23e-01 | 1.35e-02 | 9.09e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 9.28e-01 | 1.35e-02 | 9.65e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 117 | 8.02e-01 | 1.35e-02 | 8.98e-01 |
| GOBP EXIT FROM MITOSIS | 23 | 9.11e-01 | 1.34e-02 | 9.58e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 17 | 9.24e-01 | -1.34e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 19 | 9.20e-01 | 1.34e-02 | 9.62e-01 |
| GOCC SAGA COMPLEX | 22 | 9.14e-01 | -1.34e-02 | 9.60e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 244 | 7.20e-01 | 1.34e-02 | 8.47e-01 |
| GOMF RNA BINDING | 977 | 4.85e-01 | -1.33e-02 | 6.92e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 67 | 8.51e-01 | 1.33e-02 | 9.25e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 14 | 9.31e-01 | -1.33e-02 | 9.67e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 27 | 9.05e-01 | -1.33e-02 | 9.55e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 280 | 7.05e-01 | -1.32e-02 | 8.39e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 23 | 9.13e-01 | -1.32e-02 | 9.59e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 224 | 7.35e-01 | -1.32e-02 | 8.58e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 212 | 7.43e-01 | -1.31e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 55 | 8.67e-01 | -1.30e-02 | 9.33e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 34 | 8.96e-01 | 1.30e-02 | 9.48e-01 |
| GOBP THYMUS DEVELOPMENT | 43 | 8.83e-01 | 1.30e-02 | 9.41e-01 |
| GOBP TORC1 SIGNALING | 91 | 8.31e-01 | 1.30e-02 | 9.14e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 13 | 9.36e-01 | -1.30e-02 | 9.69e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC DENSITY | 11 | 9.41e-01 | -1.29e-02 | 9.72e-01 |
| GOBP HEART GROWTH | 110 | 8.16e-01 | -1.29e-02 | 9.06e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 38 | 8.91e-01 | 1.28e-02 | 9.46e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 11 | 9.42e-01 | 1.28e-02 | 9.72e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 18 | 9.26e-01 | -1.27e-02 | 9.64e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 474 | 6.37e-01 | -1.27e-02 | 7.97e-01 |
| GOBP MELANIN METABOLIC PROCESS | 15 | 9.32e-01 | -1.27e-02 | 9.68e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 14 | 9.35e-01 | -1.26e-02 | 9.69e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 8.98e-01 | -1.26e-02 | 9.49e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 14 | 9.35e-01 | -1.26e-02 | 9.69e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 62 | 8.64e-01 | 1.25e-02 | 9.32e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 104 | 8.25e-01 | -1.25e-02 | 9.11e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 29 | 9.07e-01 | -1.25e-02 | 9.55e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 38 | 8.94e-01 | -1.24e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 139 | 8.00e-01 | -1.24e-02 | 8.97e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 13 | 9.38e-01 | -1.24e-02 | 9.71e-01 |
| GOBP EXOCYTIC PROCESS | 73 | 8.56e-01 | -1.23e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 21 | 9.22e-01 | -1.23e-02 | 9.63e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 80 | 8.51e-01 | -1.22e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 720 | 5.81e-01 | 1.22e-02 | 7.60e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 25 | 9.17e-01 | -1.21e-02 | 9.61e-01 |
| GOBP BEHAVIOR | 547 | 6.36e-01 | -1.19e-02 | 7.97e-01 |
| GOBP APPENDAGE DEVELOPMENT | 150 | 8.03e-01 | -1.18e-02 | 8.98e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 9.49e-01 | 1.18e-02 | 9.76e-01 |
| GOBP DETECTION OF EXTERNAL STIMULUS | 73 | 8.62e-01 | -1.18e-02 | 9.31e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 158 | 7.99e-01 | 1.18e-02 | 8.96e-01 |
| GOBP LUNG VASCULATURE DEVELOPMENT | 10 | 9.49e-01 | -1.17e-02 | 9.76e-01 |
| GOBP CELL RECOGNITION | 95 | 8.44e-01 | -1.17e-02 | 9.22e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 17 | 9.34e-01 | 1.17e-02 | 9.68e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 21 | 9.26e-01 | -1.17e-02 | 9.64e-01 |
| GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT | 10 | 9.49e-01 | 1.17e-02 | 9.76e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 9.20e-01 | 1.16e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 66 | 8.71e-01 | -1.15e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 68 | 8.69e-01 | -1.15e-02 | 9.34e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 55 | 8.82e-01 | 1.15e-02 | 9.41e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 63 | 8.75e-01 | 1.15e-02 | 9.37e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 169 | 7.98e-01 | -1.14e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 28 | 9.17e-01 | 1.14e-02 | 9.61e-01 |
| GOBP SEX DIFFERENTIATION | 193 | 7.86e-01 | -1.14e-02 | 8.89e-01 |
| GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS | 558 | 6.48e-01 | 1.14e-02 | 8.04e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 9.48e-01 | 1.13e-02 | 9.76e-01 |
| GOMF TELOMERIC DNA BINDING | 35 | 9.08e-01 | -1.13e-02 | 9.56e-01 |
| GOCC NUCLEAR SPECK | 301 | 7.38e-01 | 1.12e-02 | 8.60e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 81 | 8.61e-01 | 1.12e-02 | 9.31e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 12 | 9.46e-01 | -1.12e-02 | 9.75e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 73 | 8.69e-01 | 1.12e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 83 | 8.61e-01 | -1.11e-02 | 9.31e-01 |
| GOMF HSP70 PROTEIN BINDING | 49 | 8.93e-01 | -1.11e-02 | 9.46e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 72 | 8.71e-01 | -1.11e-02 | 9.34e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 26 | 9.22e-01 | 1.11e-02 | 9.63e-01 |
| GOBP LIPID IMPORT INTO CELL | 19 | 9.33e-01 | 1.11e-02 | 9.68e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 13 | 9.45e-01 | 1.11e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 21 | 9.30e-01 | 1.11e-02 | 9.66e-01 |
| GOCC CILIUM | 440 | 6.94e-01 | 1.10e-02 | 8.31e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 65 | 8.79e-01 | -1.10e-02 | 9.39e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 20 | 9.33e-01 | 1.09e-02 | 9.68e-01 |
| GOCC SYNAPTIC MEMBRANE | 366 | 7.22e-01 | -1.09e-02 | 8.48e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 16 | 9.40e-01 | -1.09e-02 | 9.71e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 37 | 9.09e-01 | 1.09e-02 | 9.56e-01 |
| GOMF DIOXYGENASE ACTIVITY | 76 | 8.71e-01 | -1.08e-02 | 9.34e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 9.53e-01 | -1.08e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 16 | 9.41e-01 | -1.07e-02 | 9.72e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 113 | 8.45e-01 | -1.06e-02 | 9.22e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 71 | 8.77e-01 | -1.06e-02 | 9.38e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 137 | 8.30e-01 | 1.06e-02 | 9.13e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 11 | 9.51e-01 | -1.06e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 32 | 9.18e-01 | 1.05e-02 | 9.61e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 58 | 8.90e-01 | -1.05e-02 | 9.46e-01 |
| GOCC DENDRITE MEMBRANE | 28 | 9.24e-01 | -1.05e-02 | 9.63e-01 |
| GOBP CELL FATE DETERMINATION | 20 | 9.35e-01 | -1.05e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT | 12 | 9.50e-01 | -1.05e-02 | 9.77e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 19 | 9.37e-01 | 1.04e-02 | 9.70e-01 |
| GOBP ATP METABOLIC PROCESS | 180 | 8.10e-01 | -1.04e-02 | 9.02e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 53 | 8.96e-01 | -1.04e-02 | 9.48e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 54 | 8.95e-01 | 1.04e-02 | 9.47e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 293 | 7.62e-01 | 1.03e-02 | 8.75e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 193 | 8.05e-01 | 1.03e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1526 | 5.10e-01 | -1.03e-02 | 7.12e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 11 | 9.53e-01 | -1.02e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 32 | 9.20e-01 | -1.02e-02 | 9.62e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 15 | 9.46e-01 | -1.01e-02 | 9.75e-01 |
| GOBP REGULATION OF DNA REPLICATION | 108 | 8.56e-01 | -1.01e-02 | 9.27e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 13 | 9.50e-01 | 1.01e-02 | 9.77e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 26 | 9.29e-01 | -1.01e-02 | 9.66e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 57 | 8.96e-01 | -9.99e-03 | 9.48e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 11 | 9.54e-01 | -9.98e-03 | 9.79e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 138 | 8.40e-01 | -9.95e-03 | 9.19e-01 |
| GOBP MACROMOLECULE DEACYLATION | 54 | 8.99e-01 | 9.94e-03 | 9.50e-01 |
| GOBP VITAMIN TRANSPORT | 36 | 9.18e-01 | 9.94e-03 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 18 | 9.43e-01 | 9.81e-03 | 9.73e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 67 | 8.90e-01 | 9.75e-03 | 9.46e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 20 | 9.40e-01 | -9.75e-03 | 9.71e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 413 | 7.35e-01 | 9.74e-03 | 8.59e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 89 | 8.74e-01 | 9.72e-03 | 9.37e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 250 | 7.92e-01 | 9.70e-03 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 941 | 6.18e-01 | -9.70e-03 | 7.83e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 97 | 8.70e-01 | 9.65e-03 | 9.34e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 13 | 9.52e-01 | -9.64e-03 | 9.78e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 50 | 9.07e-01 | 9.58e-03 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 20 | 9.42e-01 | -9.48e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 22 | 9.39e-01 | 9.47e-03 | 9.71e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 125 | 8.55e-01 | -9.45e-03 | 9.27e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 37 | 9.21e-01 | -9.43e-03 | 9.62e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 365 | 7.59e-01 | -9.39e-03 | 8.73e-01 |
| GOBP CENTROSOME DUPLICATION | 71 | 8.92e-01 | 9.31e-03 | 9.46e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 23 | 9.39e-01 | 9.26e-03 | 9.71e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 15 | 9.51e-01 | 9.24e-03 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 21 | 9.42e-01 | -9.22e-03 | 9.72e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 44 | 9.16e-01 | -9.19e-03 | 9.61e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 22 | 9.41e-01 | 9.18e-03 | 9.72e-01 |
| GOBP NADPH REGENERATION | 23 | 9.39e-01 | 9.17e-03 | 9.71e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 12 | 9.56e-01 | 9.16e-03 | 9.80e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 9.58e-01 | 9.13e-03 | 9.81e-01 |
| GOBP TRNA METABOLIC PROCESS | 160 | 8.44e-01 | -9.01e-03 | 9.22e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 26 | 9.38e-01 | 8.88e-03 | 9.70e-01 |
| GOBP DENDRITE EXTENSION | 33 | 9.30e-01 | -8.88e-03 | 9.66e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 10 | 9.61e-01 | -8.87e-03 | 9.82e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 12 | 9.58e-01 | 8.85e-03 | 9.81e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 123 | 8.66e-01 | -8.82e-03 | 9.32e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 15 | 9.53e-01 | 8.82e-03 | 9.79e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 789 | 6.77e-01 | 8.79e-03 | 8.24e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 57 | 9.09e-01 | -8.79e-03 | 9.56e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 19 | 9.48e-01 | -8.70e-03 | 9.76e-01 |
| GOBP REGULATION OF DNA REPAIR | 189 | 8.37e-01 | 8.68e-03 | 9.17e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 31 | 9.33e-01 | -8.67e-03 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1346 | 5.99e-01 | -8.66e-03 | 7.72e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 65 | 9.04e-01 | 8.65e-03 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 26 | 9.40e-01 | -8.59e-03 | 9.71e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 40 | 9.25e-01 | -8.58e-03 | 9.63e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 11 | 9.61e-01 | -8.57e-03 | 9.82e-01 |
| GOCC SYNAPTIC CLEFT | 14 | 9.56e-01 | 8.55e-03 | 9.80e-01 |
| GOBP REGULATION OF APPETITE | 11 | 9.61e-01 | 8.53e-03 | 9.82e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 65 | 9.06e-01 | -8.49e-03 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 43 | 9.24e-01 | 8.46e-03 | 9.63e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 21 | 9.47e-01 | 8.45e-03 | 9.75e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 147 | 8.60e-01 | -8.45e-03 | 9.30e-01 |
| GOMF ALPHA ACTININ BINDING | 27 | 9.40e-01 | 8.44e-03 | 9.71e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 9.45e-01 | 8.43e-03 | 9.75e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 22 | 9.46e-01 | 8.34e-03 | 9.75e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 49 | 9.21e-01 | -8.24e-03 | 9.62e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 11 | 9.62e-01 | -8.21e-03 | 9.82e-01 |
| GOCC CATALYTIC COMPLEX | 1444 | 6.08e-01 | -8.18e-03 | 7.78e-01 |
| GOBP DNA CATABOLIC PROCESS | 23 | 9.46e-01 | -8.14e-03 | 9.75e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 23 | 9.46e-01 | 8.11e-03 | 9.75e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 53 | 9.19e-01 | -8.10e-03 | 9.62e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 15 | 9.57e-01 | 8.09e-03 | 9.80e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 173 | 8.55e-01 | 8.05e-03 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 50 | 9.22e-01 | -7.96e-03 | 9.63e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 15 | 9.58e-01 | 7.94e-03 | 9.81e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 9.43e-01 | -7.92e-03 | 9.73e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 74 | 9.06e-01 | 7.91e-03 | 9.55e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 163 | 8.65e-01 | -7.74e-03 | 9.32e-01 |
| GOBP TUBE FORMATION | 148 | 8.71e-01 | 7.72e-03 | 9.34e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 151 | 8.72e-01 | 7.60e-03 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 18 | 9.56e-01 | 7.58e-03 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 139 | 8.81e-01 | -7.36e-03 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 10 | 9.68e-01 | 7.22e-03 | 9.86e-01 |
| GOBP ORGAN GROWTH | 180 | 8.69e-01 | -7.16e-03 | 9.34e-01 |
| GOMF PDZ DOMAIN BINDING | 96 | 9.04e-01 | -7.14e-03 | 9.54e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 54 | 9.28e-01 | -7.12e-03 | 9.65e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 67 | 9.21e-01 | 7.05e-03 | 9.62e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 24 | 9.52e-01 | 7.05e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 9.62e-01 | -7.04e-03 | 9.82e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 139 | 8.87e-01 | 7.01e-03 | 9.43e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 23 | 9.54e-01 | -6.99e-03 | 9.79e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 16 | 9.62e-01 | 6.94e-03 | 9.82e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 19 | 9.59e-01 | 6.88e-03 | 9.81e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 9.66e-01 | 6.78e-03 | 9.85e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 15 | 9.65e-01 | -6.61e-03 | 9.84e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 52 | 9.35e-01 | 6.59e-03 | 9.69e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 10 | 9.72e-01 | -6.52e-03 | 9.87e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 20 | 9.60e-01 | -6.51e-03 | 9.81e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 39 | 9.44e-01 | 6.47e-03 | 9.74e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 94 | 9.14e-01 | -6.43e-03 | 9.60e-01 |
| GOCC CAVEOLA | 87 | 9.18e-01 | 6.39e-03 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 20 | 9.61e-01 | -6.25e-03 | 9.82e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 110 | 9.11e-01 | 6.18e-03 | 9.58e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 9.72e-01 | -6.17e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 74 | 9.27e-01 | 6.17e-03 | 9.64e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 53 | 9.38e-01 | 6.15e-03 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 12 | 9.71e-01 | -6.15e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1128 | 7.35e-01 | -6.04e-03 | 8.59e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 107 | 9.15e-01 | -6.00e-03 | 9.60e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 17 | 9.66e-01 | -6.00e-03 | 9.85e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 18 | 9.65e-01 | 5.99e-03 | 9.84e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 199 | 8.86e-01 | -5.89e-03 | 9.43e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 165 | 8.98e-01 | 5.82e-03 | 9.49e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 64 | 9.36e-01 | 5.81e-03 | 9.69e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 19 | 9.65e-01 | -5.78e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 26 | 9.60e-01 | 5.74e-03 | 9.81e-01 |
| GOBP GABAERGIC NEURON DIFFERENTIATION | 14 | 9.70e-01 | 5.74e-03 | 9.87e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 72 | 9.33e-01 | 5.71e-03 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 44 | 9.48e-01 | 5.68e-03 | 9.76e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 11 | 9.74e-01 | 5.68e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 14 | 9.71e-01 | -5.58e-03 | 9.87e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 16 | 9.70e-01 | -5.50e-03 | 9.87e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 10 | 9.76e-01 | 5.45e-03 | 9.90e-01 |
| GOBP HEAD MORPHOGENESIS | 38 | 9.54e-01 | 5.39e-03 | 9.79e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 14 | 9.73e-01 | -5.30e-03 | 9.88e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 28 | 9.62e-01 | 5.27e-03 | 9.82e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 61 | 9.44e-01 | 5.25e-03 | 9.73e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 9.77e-01 | 5.24e-03 | 9.90e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 12 | 9.75e-01 | -5.22e-03 | 9.89e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 69 | 9.40e-01 | 5.21e-03 | 9.72e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 33 | 9.59e-01 | -5.16e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATION | 102 | 9.29e-01 | 5.12e-03 | 9.66e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 120 | 9.24e-01 | -5.07e-03 | 9.63e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT INTO CELL | 17 | 9.72e-01 | -4.96e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 40 | 9.57e-01 | -4.95e-03 | 9.80e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 316 | 8.81e-01 | -4.92e-03 | 9.41e-01 |
| GOMF INSULIN RECEPTOR BINDING | 24 | 9.68e-01 | 4.80e-03 | 9.85e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 33 | 9.62e-01 | 4.75e-03 | 9.82e-01 |
| GOCC CENTRIOLAR SATELLITE | 98 | 9.35e-01 | 4.75e-03 | 9.69e-01 |
| GOMF PHOSPHATASE ACTIVITY | 213 | 9.07e-01 | 4.66e-03 | 9.55e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 13 | 9.77e-01 | -4.66e-03 | 9.90e-01 |
| GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY | 12 | 9.78e-01 | 4.63e-03 | 9.91e-01 |
| GOMF AMINO ACID BINDING | 41 | 9.59e-01 | -4.62e-03 | 9.81e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 145 | 9.24e-01 | -4.62e-03 | 9.63e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 11 | 9.79e-01 | -4.61e-03 | 9.91e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 27 | 9.67e-01 | 4.53e-03 | 9.85e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 29 | 9.66e-01 | 4.52e-03 | 9.85e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 79 | 9.45e-01 | -4.51e-03 | 9.74e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 110 | 9.35e-01 | 4.49e-03 | 9.69e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 15 | 9.76e-01 | -4.47e-03 | 9.90e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 308 | 8.93e-01 | 4.46e-03 | 9.46e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 72 | 9.48e-01 | -4.44e-03 | 9.76e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 67 | 9.50e-01 | -4.43e-03 | 9.77e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 64 | 9.52e-01 | -4.38e-03 | 9.78e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 9.79e-01 | -4.37e-03 | 9.91e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 77 | 9.47e-01 | -4.36e-03 | 9.75e-01 |
| GOBP POSTSYNAPTIC DENSITY ORGANIZATION | 38 | 9.63e-01 | 4.35e-03 | 9.83e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 10 | 9.81e-01 | 4.35e-03 | 9.92e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 58 | 9.55e-01 | 4.26e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 16 | 9.77e-01 | -4.23e-03 | 9.90e-01 |
| GOMF BETA CATENIN BINDING | 88 | 9.47e-01 | 4.14e-03 | 9.75e-01 |
| GOMF LRR DOMAIN BINDING | 16 | 9.78e-01 | 4.06e-03 | 9.90e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 20 | 9.75e-01 | 4.05e-03 | 9.89e-01 |
| GOBP RECOMBINATIONAL REPAIR | 152 | 9.33e-01 | -3.98e-03 | 9.68e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 12 | 9.81e-01 | -3.96e-03 | 9.92e-01 |
| GOCC MAIN AXON | 65 | 9.56e-01 | 3.93e-03 | 9.80e-01 |
| GOBP DNA DAMAGE RESPONSE | 754 | 8.57e-01 | -3.89e-03 | 9.28e-01 |
| GOCC CHROMOSOME | 1070 | 8.32e-01 | 3.88e-03 | 9.14e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 32 | 9.70e-01 | -3.87e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 10 | 9.84e-01 | -3.77e-03 | 9.93e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 11 | 9.83e-01 | 3.72e-03 | 9.93e-01 |
| GOBP MRNA MODIFICATION | 21 | 9.76e-01 | -3.72e-03 | 9.90e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 16 | 9.80e-01 | 3.60e-03 | 9.92e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 612 | 8.80e-01 | 3.60e-03 | 9.41e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 37 | 9.70e-01 | -3.52e-03 | 9.87e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 63 | 9.62e-01 | 3.51e-03 | 9.82e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 70 | 9.60e-01 | 3.48e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 40 | 9.70e-01 | -3.47e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 277 | 9.21e-01 | 3.47e-03 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 31 | 9.74e-01 | 3.44e-03 | 9.88e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 12 | 9.84e-01 | -3.42e-03 | 9.93e-01 |
| GOBP HEART DEVELOPMENT | 563 | 8.91e-01 | -3.39e-03 | 9.46e-01 |
| GOMF HISTONE BINDING | 210 | 9.33e-01 | 3.37e-03 | 9.68e-01 |
| GOBP FACE DEVELOPMENT | 54 | 9.66e-01 | -3.32e-03 | 9.85e-01 |
| GOBP AMINE TRANSPORT | 69 | 9.63e-01 | -3.27e-03 | 9.82e-01 |
| GOBP HEME BIOSYNTHETIC PROCESS | 24 | 9.78e-01 | 3.21e-03 | 9.91e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 21 | 9.80e-01 | -3.20e-03 | 9.92e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 65 | 9.65e-01 | -3.11e-03 | 9.84e-01 |
| GOCC T TUBULE | 64 | 9.66e-01 | -3.10e-03 | 9.85e-01 |
| GOBP CELLULAR RESPONSE TO UV | 78 | 9.63e-01 | 3.08e-03 | 9.82e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 23 | 9.80e-01 | 3.07e-03 | 9.92e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 12 | 9.85e-01 | 3.03e-03 | 9.94e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 9.87e-01 | 2.92e-03 | 9.94e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 47 | 9.73e-01 | 2.89e-03 | 9.88e-01 |
| GOMF ISOMERASE ACTIVITY | 139 | 9.53e-01 | -2.88e-03 | 9.79e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 15 | 9.85e-01 | -2.83e-03 | 9.93e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 15 | 9.85e-01 | 2.81e-03 | 9.93e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 219 | 9.43e-01 | -2.80e-03 | 9.73e-01 |
| GOBP HORMONE METABOLIC PROCESS | 130 | 9.57e-01 | 2.76e-03 | 9.80e-01 |
| GOBP RESPONSE TO PAIN | 26 | 9.81e-01 | 2.73e-03 | 9.92e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 16 | 9.85e-01 | -2.71e-03 | 9.93e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 48 | 9.74e-01 | -2.69e-03 | 9.89e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 19 | 9.84e-01 | -2.64e-03 | 9.93e-01 |
| GOBP DNA METABOLIC PROCESS | 799 | 9.02e-01 | 2.60e-03 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 24 | 9.83e-01 | 2.55e-03 | 9.93e-01 |
| GOBP B CELL PROLIFERATION | 67 | 9.71e-01 | -2.54e-03 | 9.87e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 31 | 9.81e-01 | -2.51e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 33 | 9.80e-01 | -2.49e-03 | 9.92e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 63 | 9.73e-01 | -2.48e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 15 | 9.87e-01 | 2.45e-03 | 9.94e-01 |
| GOBP BODY FLUID SECRETION | 68 | 9.72e-01 | 2.45e-03 | 9.88e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 151 | 9.59e-01 | -2.44e-03 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 16 | 9.87e-01 | -2.43e-03 | 9.94e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 18 | 9.86e-01 | -2.39e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 37 | 9.80e-01 | 2.38e-03 | 9.92e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 10 | 9.90e-01 | -2.38e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 10 | 9.90e-01 | -2.35e-03 | 9.96e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 11 | 9.89e-01 | 2.34e-03 | 9.95e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 28 | 9.84e-01 | -2.24e-03 | 9.93e-01 |
| GOCC PRP19 COMPLEX | 14 | 9.89e-01 | -2.18e-03 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 14 | 9.89e-01 | -2.16e-03 | 9.95e-01 |
| GOBP NICOTINAMIDE NUCLEOTIDE BIOSYNTHETIC PROCESS | 10 | 9.91e-01 | -2.03e-03 | 9.96e-01 |
| GOBP SHORT TERM MEMORY | 16 | 9.89e-01 | -2.00e-03 | 9.95e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 16 | 9.89e-01 | -1.99e-03 | 9.95e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 268 | 9.57e-01 | 1.90e-03 | 9.81e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 11 | 9.91e-01 | 1.87e-03 | 9.97e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 38 | 9.84e-01 | 1.86e-03 | 9.93e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 98 | 9.76e-01 | 1.77e-03 | 9.90e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 17 | 9.90e-01 | 1.77e-03 | 9.96e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 157 | 9.70e-01 | -1.75e-03 | 9.87e-01 |
| GOBP LEARNING | 131 | 9.73e-01 | 1.74e-03 | 9.88e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 132 | 9.74e-01 | 1.64e-03 | 9.89e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 364 | 9.59e-01 | 1.58e-03 | 9.81e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 443 | 9.56e-01 | 1.55e-03 | 9.80e-01 |
| GOCC GERM CELL NUCLEUS | 61 | 9.84e-01 | 1.47e-03 | 9.93e-01 |
| GOBP DEMETHYLATION | 23 | 9.90e-01 | 1.47e-03 | 9.96e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 49 | 9.87e-01 | 1.38e-03 | 9.94e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 64 | 9.85e-01 | 1.37e-03 | 9.93e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 135 | 9.78e-01 | -1.36e-03 | 9.91e-01 |
| GOBP SEXUAL REPRODUCTION | 619 | 9.54e-01 | 1.36e-03 | 9.79e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 14 | 9.93e-01 | 1.34e-03 | 9.97e-01 |
| GOBP MALE SEX DIFFERENTIATION | 108 | 9.81e-01 | -1.34e-03 | 9.92e-01 |
| GOMF MRNA BINDING | 298 | 9.69e-01 | -1.33e-03 | 9.86e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 16 | 9.93e-01 | 1.30e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 19 | 9.92e-01 | -1.28e-03 | 9.97e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 104 | 9.82e-01 | -1.25e-03 | 9.93e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 15 | 9.93e-01 | 1.23e-03 | 9.97e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 29 | 9.91e-01 | 1.20e-03 | 9.96e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 19 | 9.93e-01 | 1.18e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 17 | 9.93e-01 | 1.16e-03 | 9.97e-01 |
| GOBP NUCLEIC ACID CATABOLIC PROCESS | 581 | 9.66e-01 | -1.04e-03 | 9.85e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 15 | 9.95e-01 | 1.02e-03 | 9.98e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 22 | 9.93e-01 | 1.02e-03 | 9.97e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 125 | 9.85e-01 | -9.58e-04 | 9.94e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 30 | 9.93e-01 | 9.33e-04 | 9.97e-01 |
| GOBP NEURAL TUBE FORMATION | 116 | 9.88e-01 | 7.90e-04 | 9.95e-01 |
| GOBP SODIUM ION TRANSPORT | 159 | 9.86e-01 | -7.85e-04 | 9.94e-01 |
| GOBP AMINE CATABOLIC PROCESS | 12 | 9.97e-01 | -7.11e-04 | 9.99e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 30 | 9.95e-01 | 7.05e-04 | 9.98e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 23 | 9.95e-01 | -6.86e-04 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 82 | 9.92e-01 | -6.66e-04 | 9.97e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 192 | 9.87e-01 | 6.58e-04 | 9.95e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 10 | 9.97e-01 | -6.30e-04 | 9.99e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 14 | 9.97e-01 | -6.28e-04 | 9.99e-01 |
| GOCC MALE GERM CELL NUCLEUS | 49 | 9.94e-01 | -6.20e-04 | 9.97e-01 |
| GOBP BODY MORPHOGENESIS | 52 | 9.94e-01 | -5.65e-04 | 9.98e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 17 | 9.97e-01 | -5.41e-04 | 9.99e-01 |
| GOBP POLYAMINE TRANSPORT | 10 | 9.98e-01 | -5.38e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 946 | 9.82e-01 | -4.45e-04 | 9.92e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 10 | 9.98e-01 | 4.20e-04 | 9.99e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 64 | 9.96e-01 | 4.03e-04 | 9.98e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 166 | 9.93e-01 | -3.68e-04 | 9.97e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 46 | 9.97e-01 | 2.95e-04 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO LITHIUM ION | 10 | 9.99e-01 | 2.89e-04 | 9.99e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 18 | 9.98e-01 | -2.85e-04 | 9.99e-01 |
| GOBP FERTILIZATION | 108 | 9.96e-01 | 2.73e-04 | 9.98e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 22 | 9.98e-01 | 2.63e-04 | 9.99e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 15 | 9.99e-01 | -1.93e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 64 | 9.98e-01 | 1.85e-04 | 9.99e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 487 | 9.96e-01 | -1.42e-04 | 9.98e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 41 | 9.99e-01 | 1.25e-04 | 9.99e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 89 | 9.99e-01 | 5.19e-05 | 9.99e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 81 | 1.00e+00 | 3.42e-05 | 1.00e+00 |
Detailed Gene set reports
GOMF MHC PROTEIN COMPLEX BINDING
| set | GOMF MHC PROTEIN COMPLEX BINDING |
| setSize | 11 |
| pANOVA | 4.96e-06 |
| s.dist | -0.795 |
| p.adjustANOVA | 0.000108 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-DMa | -6448.5 |
| Tapbpl | -6414.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| Pirb | -6115.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Cd4 | -4891.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-DMa | -6448.5 |
| Tapbpl | -6414.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| Pirb | -6115.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Cd4 | -4891.5 |
GOCC MHC PROTEIN COMPLEX
| set | GOCC MHC PROTEIN COMPLEX |
| setSize | 17 |
| pANOVA | 6.53e-07 |
| s.dist | -0.697 |
| p.adjustANOVA | 1.92e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-DMa | -6448.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| H2-Q7 | -5203.5 |
| H2-T10 | -2083.5 |
| Mr1 | 5844.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-DMa | -6448.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| H2-Q7 | -5203.5 |
| H2-T10 | -2083.5 |
| Mr1 | 5844.5 |
GOMF PLATELET DERIVED GROWTH FACTOR BINDING
| set | GOMF PLATELET DERIVED GROWTH FACTOR BINDING |
| setSize | 11 |
| pANOVA | 1e-04 |
| s.dist | -0.677 |
| p.adjustANOVA | 0.00151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pdgfb | -7307.5 |
| Col4a1 | -6405.5 |
| Col3a1 | -6278.5 |
| Col6a1 | -5925.5 |
| Col1a1 | -5503.5 |
| Col1a2 | -4728.5 |
| Col5a1 | -4525.5 |
| Pdgfrb | -4057.5 |
| Pdgfa | -4007.5 |
| Pdgfra | -3619.5 |
| Pdap1 | -3568.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Pdgfb | -7307.5 |
| Col4a1 | -6405.5 |
| Col3a1 | -6278.5 |
| Col6a1 | -5925.5 |
| Col1a1 | -5503.5 |
| Col1a2 | -4728.5 |
| Col5a1 | -4525.5 |
| Pdgfrb | -4057.5 |
| Pdgfa | -4007.5 |
| Pdgfra | -3619.5 |
| Pdap1 | -3568.5 |
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION
| set | GOBP POSITIVE REGULATION OF PLATELET ACTIVATION |
| setSize | 10 |
| pANOVA | 0.000216 |
| s.dist | -0.676 |
| p.adjustANOVA | 0.00275 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Svep1 | -7429.5 |
| Pla2g4a | -7001.5 |
| Selp | -6467.5 |
| Flna | -5690.5 |
| Ptprj | -4739.5 |
| Pear1 | -4260.5 |
| Jak2 | -4143.5 |
| Pdpn | -3898.5 |
| Plek | -3800.5 |
| Tlr4 | -3283.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Svep1 | -7429.5 |
| Pla2g4a | -7001.5 |
| Selp | -6467.5 |
| Flna | -5690.5 |
| Ptprj | -4739.5 |
| Pear1 | -4260.5 |
| Jak2 | -4143.5 |
| Pdpn | -3898.5 |
| Plek | -3800.5 |
| Tlr4 | -3283.5 |
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX
| set | GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX |
| setSize | 10 |
| pANOVA | 0.000302 |
| s.dist | -0.66 |
| p.adjustANOVA | 0.00366 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-DMa | -6448.5 |
| Tapbpl | -6414.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-DMb1 | -5846.5 |
| Calr | -1710.5 |
| Pdia3 | 1124.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-DMa | -6448.5 |
| Tapbpl | -6414.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-DMb1 | -5846.5 |
| Calr | -1710.5 |
| Pdia3 | 1124.5 |
GOCC GOLGI LUMEN
| set | GOCC GOLGI LUMEN |
| setSize | 14 |
| pANOVA | 2.16e-05 |
| s.dist | -0.656 |
| p.adjustANOVA | 0.000391 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sdc4 | -7387.5 |
| Rab33b | -6757.5 |
| Sdf4 | -6600.5 |
| Gpc4 | -6064.5 |
| Sod3 | -5954.5 |
| Agrn | -5940.5 |
| Sdc3 | -5505.5 |
| Gpc3 | -5345.5 |
| Gpc6 | -5130.5 |
| Vtn | -4954.5 |
| Sdc1 | -4854.5 |
| Hspg2 | -2612.5 |
| Sdc2 | -1162.5 |
| Gpc1 | -580.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Sdc4 | -7387.5 |
| Rab33b | -6757.5 |
| Sdf4 | -6600.5 |
| Gpc4 | -6064.5 |
| Sod3 | -5954.5 |
| Agrn | -5940.5 |
| Sdc3 | -5505.5 |
| Gpc3 | -5345.5 |
| Gpc6 | -5130.5 |
| Vtn | -4954.5 |
| Sdc1 | -4854.5 |
| Hspg2 | -2612.5 |
| Sdc2 | -1162.5 |
| Gpc1 | -580.5 |
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB |
| setSize | 18 |
| pANOVA | 1.6e-06 |
| s.dist | -0.653 |
| p.adjustANOVA | 4.02e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Hfe | -5594.5 |
| H2-Q7 | -5203.5 |
| H2-T24 | -4928.5 |
| Ap3d1 | -2928.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Cd1d1 | -1386.5 |
| Ap3b1 | -76.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Hfe | -5594.5 |
| H2-Q7 | -5203.5 |
| H2-T24 | -4928.5 |
| Ap3d1 | -2928.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Cd1d1 | -1386.5 |
| Ap3b1 | -76.5 |
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
| set | GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
| setSize | 12 |
| pANOVA | 0.000101 |
| s.dist | -0.648 |
| p.adjustANOVA | 0.00151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Spry4 | -7300.5 |
| Kank1 | -7050.5 |
| Bcar1 | -6911.5 |
| Dmtn | -6885.5 |
| Coro1c | -6813.5 |
| Actn4 | -6767.5 |
| Ap1ar | -6550.5 |
| Rcc2 | -5288.5 |
| Postn | -4151.5 |
| Itgb1bp1 | -2701.5 |
| Efna5 | 668.5 |
| Fbln1 | 1390.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Spry4 | -7300.5 |
| Kank1 | -7050.5 |
| Bcar1 | -6911.5 |
| Dmtn | -6885.5 |
| Coro1c | -6813.5 |
| Actn4 | -6767.5 |
| Ap1ar | -6550.5 |
| Rcc2 | -5288.5 |
| Postn | -4151.5 |
| Itgb1bp1 | -2701.5 |
| Efna5 | 668.5 |
| Fbln1 | 1390.5 |
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX
| set | GOCC MHC CLASS I PEPTIDE LOADING COMPLEX |
| setSize | 12 |
| pANOVA | 0.000105 |
| s.dist | -0.647 |
| p.adjustANOVA | 0.00156 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-Q4 | -6576.5 |
| Tapbpl | -6414.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Tap1 | -2689.5 |
| Calr | -1710.5 |
| Pdia3 | 1124.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-Q4 | -6576.5 |
| Tapbpl | -6414.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Tap1 | -2689.5 |
| Calr | -1710.5 |
| Pdia3 | 1124.5 |
GOMF PEPTIDE ANTIGEN BINDING
| set | GOMF PEPTIDE ANTIGEN BINDING |
| setSize | 21 |
| pANOVA | 5.76e-07 |
| s.dist | -0.63 |
| p.adjustANOVA | 1.73e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-DMa | -6448.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-DMb1 | -5846.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| H2-Q7 | -5203.5 |
| H2-T24 | -4928.5 |
| Tap1 | -2689.5 |
| H2-T10 | -2083.5 |
| Dhcr24 | 3899.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-DMa | -6448.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-DMb1 | -5846.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| H2-Q7 | -5203.5 |
| H2-T24 | -4928.5 |
| Tap1 | -2689.5 |
| H2-T10 | -2083.5 |
| Dhcr24 | 3899.5 |
| Maml1 | 5793.5 |
GOMF PROFILIN BINDING
| set | GOMF PROFILIN BINDING |
| setSize | 12 |
| pANOVA | 0.000174 |
| s.dist | -0.626 |
| p.adjustANOVA | 0.00234 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Diaph1 | -7432.5 |
| Cttn | -6958.5 |
| Vasp | -6586.5 |
| Dbn1 | -6493.5 |
| Cyfip1 | -5037.5 |
| Htt | -4820.5 |
| Fmnl1 | -4701.5 |
| Enah | -4266.5 |
| Actg1 | -3929.5 |
| Rhoq | -2852.5 |
| Evl | -2250.5 |
| Pclo | -973.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Diaph1 | -7432.5 |
| Cttn | -6958.5 |
| Vasp | -6586.5 |
| Dbn1 | -6493.5 |
| Cyfip1 | -5037.5 |
| Htt | -4820.5 |
| Fmnl1 | -4701.5 |
| Enah | -4266.5 |
| Actg1 | -3929.5 |
| Rhoq | -2852.5 |
| Evl | -2250.5 |
| Pclo | -973.5 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN |
| setSize | 20 |
| pANOVA | 1.28e-06 |
| s.dist | -0.626 |
| p.adjustANOVA | 3.38e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| Atg5 | -6760.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Hfe | -5594.5 |
| H2-Q7 | -5203.5 |
| H2-T24 | -4928.5 |
| Tap1 | -2689.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Cd1d1 | -1386.5 |
| Ide | 6789.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| Atg5 | -6760.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Hfe | -5594.5 |
| H2-Q7 | -5203.5 |
| H2-T24 | -4928.5 |
| Tap1 | -2689.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Cd1d1 | -1386.5 |
| Ide | 6789.5 |
GOCC MHC CLASS I PROTEIN COMPLEX
| set | GOCC MHC CLASS I PROTEIN COMPLEX |
| setSize | 10 |
| pANOVA | 0.000632 |
| s.dist | -0.624 |
| p.adjustANOVA | 0.00681 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| H2-T10 | -2083.5 |
| Mr1 | 5844.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| H2-T10 | -2083.5 |
| Mr1 | 5844.5 |
GOMF BETA 2 MICROGLOBULIN BINDING
| set | GOMF BETA 2 MICROGLOBULIN BINDING |
| setSize | 11 |
| pANOVA | 0.000367 |
| s.dist | -0.62 |
| p.adjustANOVA | 0.00428 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-D1 | -5798.5 |
| Hfe | -5594.5 |
| H2-Q7 | -5203.5 |
| Fcgrt | -4731.5 |
| H2-T10 | -2083.5 |
| Mr1 | 5844.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-D1 | -5798.5 |
| Hfe | -5594.5 |
| H2-Q7 | -5203.5 |
| Fcgrt | -4731.5 |
| H2-T10 | -2083.5 |
| Mr1 | 5844.5 |
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING
| set | GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING |
| setSize | 12 |
| pANOVA | 0.000369 |
| s.dist | -0.594 |
| p.adjustANOVA | 0.00429 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Ptpn6 | -4242.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Clec2d | 6126.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Ptpn6 | -4242.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Clec2d | 6126.5 |
GOMF MHC PROTEIN BINDING
| set | GOMF MHC PROTEIN BINDING |
| setSize | 22 |
| pANOVA | 2.26e-06 |
| s.dist | -0.582 |
| p.adjustANOVA | 5.43e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Vcp | -7293.5 |
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| Pirb | -6115.5 |
| Lag3 | -5994.5 |
| Cd74 | -5848.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Pilra | -5124.5 |
| Derl1 | -5010.5 |
| Cd4 | -4891.5 |
| Tap1 | -2689.5 |
| Tubb5 | -2335.5 |
| H2-T10 | -2083.5 |
| Cd81 | -1815.5 |
| Pdia3 | 1124.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Vcp | -7293.5 |
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| Pirb | -6115.5 |
| Lag3 | -5994.5 |
| Cd74 | -5848.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Pilra | -5124.5 |
| Derl1 | -5010.5 |
| Cd4 | -4891.5 |
| Tap1 | -2689.5 |
| Tubb5 | -2335.5 |
| H2-T10 | -2083.5 |
| Cd81 | -1815.5 |
| Pdia3 | 1124.5 |
| Bcap31 | 1451.5 |
| Mfsd6 | 1735.5 |
GOCC PROTEASOME ACCESSORY COMPLEX
| set | GOCC PROTEASOME ACCESSORY COMPLEX |
| setSize | 23 |
| pANOVA | 1.4e-06 |
| s.dist | -0.581 |
| p.adjustANOVA | 3.62e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc1 | -7288.5 |
| Adrm1 | -7272.5 |
| Psmd10 | -7064.5 |
| Psmc4 | -6549.5 |
| Psmd2 | -6327.5 |
| Psme1 | -6257.5 |
| Psmd1 | -6039.5 |
| Psmd11 | -5965.5 |
| Psmd8 | -5359.5 |
| Psmd7 | -5325.5 |
| Psmc5 | -5161.5 |
| Psmd6 | -4829.5 |
| Psme3 | -4691.5 |
| Psmc2 | -4540.5 |
| Psmd13 | -3886.5 |
| Psmd3 | -3817.5 |
| Psmd4 | -3794.5 |
| Psmd12 | -3563.5 |
| Psmd14 | -2762.5 |
| Psmd5 | -1273.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Psmc1 | -7288.5 |
| Adrm1 | -7272.5 |
| Psmd10 | -7064.5 |
| Psmc4 | -6549.5 |
| Psmd2 | -6327.5 |
| Psme1 | -6257.5 |
| Psmd1 | -6039.5 |
| Psmd11 | -5965.5 |
| Psmd8 | -5359.5 |
| Psmd7 | -5325.5 |
| Psmc5 | -5161.5 |
| Psmd6 | -4829.5 |
| Psme3 | -4691.5 |
| Psmc2 | -4540.5 |
| Psmd13 | -3886.5 |
| Psmd3 | -3817.5 |
| Psmd4 | -3794.5 |
| Psmd12 | -3563.5 |
| Psmd14 | -2762.5 |
| Psmd5 | -1273.5 |
| Psmc3 | -9.5 |
| Psmc6 | 483.5 |
| Psmd9 | 1293.5 |
GOMF MHC CLASS I PROTEIN BINDING
| set | GOMF MHC CLASS I PROTEIN BINDING |
| setSize | 18 |
| pANOVA | 2.48e-05 |
| s.dist | -0.574 |
| p.adjustANOVA | 0.000438 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Vcp | -7293.5 |
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| Pirb | -6115.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Pilra | -5124.5 |
| Derl1 | -5010.5 |
| Tap1 | -2689.5 |
| Tubb5 | -2335.5 |
| H2-T10 | -2083.5 |
| Pdia3 | 1124.5 |
| Bcap31 | 1451.5 |
| Mfsd6 | 1735.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Vcp | -7293.5 |
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| Pirb | -6115.5 |
| H2-D1 | -5798.5 |
| H2-Q7 | -5203.5 |
| Pilra | -5124.5 |
| Derl1 | -5010.5 |
| Tap1 | -2689.5 |
| Tubb5 | -2335.5 |
| H2-T10 | -2083.5 |
| Pdia3 | 1124.5 |
| Bcap31 | 1451.5 |
| Mfsd6 | 1735.5 |
GOBP REGULATION OF PROTEIN DEUBIQUITINATION
| set | GOBP REGULATION OF PROTEIN DEUBIQUITINATION |
| setSize | 10 |
| pANOVA | 0.00276 |
| s.dist | -0.547 |
| p.adjustANOVA | 0.022 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Vcp | -7293.5 |
| Tnip1 | -6764.5 |
| Trim21 | -6580.5 |
| Park7 | -6569.5 |
| Zc3h12a | -5844.5 |
| Ubxn1 | -5237.5 |
| Itch | -4528.5 |
| Dnajb2 | -2027.5 |
| Tank | 545.5 |
| Otud4 | 3409.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Vcp | -7293.5 |
| Tnip1 | -6764.5 |
| Trim21 | -6580.5 |
| Park7 | -6569.5 |
| Zc3h12a | -5844.5 |
| Ubxn1 | -5237.5 |
| Itch | -4528.5 |
| Dnajb2 | -2027.5 |
| Tank | 545.5 |
| Otud4 | 3409.5 |
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION
| set | GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
| setSize | 10 |
| pANOVA | 0.00285 |
| s.dist | -0.545 |
| p.adjustANOVA | 0.0226 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkcz | -7451.5 |
| Anxa1 | -7074.5 |
| Nlrp3 | -6943.5 |
| Il4ra | -6861.5 |
| Hlx | -5826.5 |
| Irf1 | -4990.5 |
| Socs5 | -4608.5 |
| Bcl6 | -2557.5 |
| Rara | 2047.5 |
| Zfp35 | 3513.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Prkcz | -7451.5 |
| Anxa1 | -7074.5 |
| Nlrp3 | -6943.5 |
| Il4ra | -6861.5 |
| Hlx | -5826.5 |
| Irf1 | -4990.5 |
| Socs5 | -4608.5 |
| Bcl6 | -2557.5 |
| Rara | 2047.5 |
| Zfp35 | 3513.5 |
GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY
| set | GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY |
| setSize | 10 |
| pANOVA | 0.003 |
| s.dist | 0.542 |
| p.adjustANOVA | 0.0234 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Igf2bp2 | 7579.5 |
| Ythdc1 | 6917.5 |
| Hnrnpc | 5988.5 |
| Ythdf3 | 5242.5 |
| Fmr1 | 4871.5 |
| Rbm33 | 4663.5 |
| Ythdc2 | 4644.5 |
| Ythdf2 | 3209.5 |
| Ythdf1 | -459.5 |
| Hnrnpa2b1 | -622.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Igf2bp2 | 7579.5 |
| Ythdc1 | 6917.5 |
| Hnrnpc | 5988.5 |
| Ythdf3 | 5242.5 |
| Fmr1 | 4871.5 |
| Rbm33 | 4663.5 |
| Ythdc2 | 4644.5 |
| Ythdf2 | 3209.5 |
| Ythdf1 | -459.5 |
| Hnrnpa2b1 | -622.5 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN |
| setSize | 23 |
| pANOVA | 6.87e-06 |
| s.dist | -0.542 |
| p.adjustANOVA | 0.000144 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fcgr1 | -6509.5 |
| H2-DMa | -6448.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Ctss | -5693.5 |
| H2-M3 | -5646.5 |
| Ifi30 | -5477.5 |
| Mpeg1 | -5224.5 |
| Fcgr3 | -5006.5 |
| Fcgr2b | -2911.5 |
| Unc93b1 | -2879.5 |
| Fcer1g | -2756.5 |
| Lgmn | -613.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Fcgr1 | -6509.5 |
| H2-DMa | -6448.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Ctss | -5693.5 |
| H2-M3 | -5646.5 |
| Ifi30 | -5477.5 |
| Mpeg1 | -5224.5 |
| Fcgr3 | -5006.5 |
| Fcgr2b | -2911.5 |
| Unc93b1 | -2879.5 |
| Fcer1g | -2756.5 |
| Lgmn | -613.5 |
| Mfsd6 | 1735.5 |
| Pikfyve | 4276.5 |
| Traf6 | 4702.5 |
GOMF MAP KINASE PHOSPHATASE ACTIVITY
| set | GOMF MAP KINASE PHOSPHATASE ACTIVITY |
| setSize | 11 |
| pANOVA | 0.00197 |
| s.dist | -0.539 |
| p.adjustANOVA | 0.0168 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Dusp3 | -7494.5 |
| Dusp7 | -7360.5 |
| Dusp18 | -7294.5 |
| Dusp6 | -7226.5 |
| Dusp5 | -5500.5 |
| Dusp4 | -5033.5 |
| Dusp8 | -4358.5 |
| Dusp2 | -2553.5 |
| Dusp1 | -2074.5 |
| Dusp16 | 2154.5 |
| Dusp10 | 2416.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Dusp3 | -7494.5 |
| Dusp7 | -7360.5 |
| Dusp18 | -7294.5 |
| Dusp6 | -7226.5 |
| Dusp5 | -5500.5 |
| Dusp4 | -5033.5 |
| Dusp8 | -4358.5 |
| Dusp2 | -2553.5 |
| Dusp1 | -2074.5 |
| Dusp16 | 2154.5 |
| Dusp10 | 2416.5 |
GOBP GOLGI RIBBON FORMATION
| set | GOBP GOLGI RIBBON FORMATION |
| setSize | 11 |
| pANOVA | 0.00255 |
| s.dist | -0.525 |
| p.adjustANOVA | 0.0207 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prmt5 | -7539.5 |
| Gorasp1 | -6898.5 |
| Optn | -6121.5 |
| Golga2 | -4927.5 |
| Tmed5 | -4788.5 |
| Myo18a | -4331.5 |
| Golph3 | -3079.5 |
| Fhdc1 | -2432.5 |
| Trip11 | -1807.5 |
| Vamp4 | -972.5 |
| Gcc2 | -306.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Prmt5 | -7539.5 |
| Gorasp1 | -6898.5 |
| Optn | -6121.5 |
| Golga2 | -4927.5 |
| Tmed5 | -4788.5 |
| Myo18a | -4331.5 |
| Golph3 | -3079.5 |
| Fhdc1 | -2432.5 |
| Trip11 | -1807.5 |
| Vamp4 | -972.5 |
| Gcc2 | -306.5 |
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
| set | GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY |
| setSize | 10 |
| pANOVA | 0.00407 |
| s.dist | -0.525 |
| p.adjustANOVA | 0.0294 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Dab2ip | -6354.5 |
| Nr1d1 | -6328.5 |
| Trem2 | -6196.5 |
| Rab7b | -6186.5 |
| Sqstm1 | -5056.5 |
| Ticam2 | -4803.5 |
| Tax1bp1 | -2615.5 |
| Mfhas1 | -2299.5 |
| Lyn | -2030.5 |
| Trim32 | 2651.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Dab2ip | -6354.5 |
| Nr1d1 | -6328.5 |
| Trem2 | -6196.5 |
| Rab7b | -6186.5 |
| Sqstm1 | -5056.5 |
| Ticam2 | -4803.5 |
| Tax1bp1 | -2615.5 |
| Mfhas1 | -2299.5 |
| Lyn | -2030.5 |
| Trim32 | 2651.5 |
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX
| set | GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX |
| setSize | 12 |
| pANOVA | 0.00197 |
| s.dist | -0.516 |
| p.adjustANOVA | 0.0168 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psmc1 | -7288.5 |
| Psmd10 | -7064.5 |
| Psmc4 | -6549.5 |
| Psmd2 | -6327.5 |
| Psmd1 | -6039.5 |
| Psmc5 | -5161.5 |
| Psmc2 | -4540.5 |
| Psmd4 | -3794.5 |
| Psmd5 | -1273.5 |
| Psmc3 | -9.5 |
| Psmc6 | 483.5 |
| Psmd9 | 1293.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Psmc1 | -7288.5 |
| Psmd10 | -7064.5 |
| Psmc4 | -6549.5 |
| Psmd2 | -6327.5 |
| Psmd1 | -6039.5 |
| Psmc5 | -5161.5 |
| Psmc2 | -4540.5 |
| Psmd4 | -3794.5 |
| Psmd5 | -1273.5 |
| Psmc3 | -9.5 |
| Psmc6 | 483.5 |
| Psmd9 | 1293.5 |
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
| set | GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS |
| setSize | 10 |
| pANOVA | 0.00492 |
| s.dist | -0.514 |
| p.adjustANOVA | 0.0341 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pla2g2d | -7426.5 |
| Park7 | -6569.5 |
| Fcgr1 | -6509.5 |
| Fcgr3 | -5006.5 |
| C3 | -4366.5 |
| Spn | -4204.5 |
| Fcgr2b | -2911.5 |
| Fcer1g | -2756.5 |
| Btk | -1539.5 |
| Il20rb | 2911.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Pla2g2d | -7426.5 |
| Park7 | -6569.5 |
| Fcgr1 | -6509.5 |
| Fcgr3 | -5006.5 |
| C3 | -4366.5 |
| Spn | -4204.5 |
| Fcgr2b | -2911.5 |
| Fcer1g | -2756.5 |
| Btk | -1539.5 |
| Il20rb | 2911.5 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I |
| setSize | 29 |
| pANOVA | 1.7e-06 |
| s.dist | -0.513 |
| p.adjustANOVA | 4.25e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Fcgr1 | -6509.5 |
| Tapbpl | -6414.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Hfe | -5594.5 |
| Ifi30 | -5477.5 |
| Mpeg1 | -5224.5 |
| H2-Q7 | -5203.5 |
| Fcgr3 | -5006.5 |
| H2-T24 | -4928.5 |
| Fcer1g | -2756.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| H2-Q4 | -6576.5 |
| Fcgr1 | -6509.5 |
| Tapbpl | -6414.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Mill2 | -6340.5 |
| H2-Q6 | -6315.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Hfe | -5594.5 |
| Ifi30 | -5477.5 |
| Mpeg1 | -5224.5 |
| H2-Q7 | -5203.5 |
| Fcgr3 | -5006.5 |
| H2-T24 | -4928.5 |
| Fcer1g | -2756.5 |
| Tap1 | -2689.5 |
| Ulbp1 | -2244.5 |
| H2-T10 | -2083.5 |
| Calr | -1710.5 |
| Bag6 | -1130.5 |
| Pdia3 | 1124.5 |
| Mfsd6 | 1735.5 |
| Mr1 | 5844.5 |
| Ide | 6789.5 |
GOBP FAT CELL PROLIFERATION
| set | GOBP FAT CELL PROLIFERATION |
| setSize | 12 |
| pANOVA | 0.00207 |
| s.dist | -0.513 |
| p.adjustANOVA | 0.0176 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pid1 | -6220.5 |
| Trem2 | -6196.5 |
| Col6a1 | -5925.5 |
| E2f3 | -5209.5 |
| E2f1 | -5122.5 |
| Sqstm1 | -5056.5 |
| Tfdp1 | -4314.5 |
| Ppard | -4277.5 |
| Lipa | -3406.5 |
| Fgf16 | -3192.5 |
| Per2 | -2273.5 |
| Fto | 5161.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Pid1 | -6220.5 |
| Trem2 | -6196.5 |
| Col6a1 | -5925.5 |
| E2f3 | -5209.5 |
| E2f1 | -5122.5 |
| Sqstm1 | -5056.5 |
| Tfdp1 | -4314.5 |
| Ppard | -4277.5 |
| Lipa | -3406.5 |
| Fgf16 | -3192.5 |
| Per2 | -2273.5 |
| Fto | 5161.5 |
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE
| set | GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
| setSize | 16 |
| pANOVA | 0.000395 |
| s.dist | -0.512 |
| p.adjustANOVA | 0.00455 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Park7 | -6569.5 |
| Fcgr1 | -6509.5 |
| Ptgs2 | -6099.5 |
| Ccr5 | -5512.5 |
| Alox5ap | -5423.5 |
| Adam8 | -5266.5 |
| Fcgr3 | -5006.5 |
| Ptger3 | -4911.5 |
| C3 | -4366.5 |
| Aoc3 | -4029.5 |
| Fcer1g | -2756.5 |
| Pik3cg | -1965.5 |
| Btk | -1539.5 |
| Tnf | -774.5 |
| Tnfrsf11a | -540.5 |
| Il1b | 126.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Park7 | -6569.5 |
| Fcgr1 | -6509.5 |
| Ptgs2 | -6099.5 |
| Ccr5 | -5512.5 |
| Alox5ap | -5423.5 |
| Adam8 | -5266.5 |
| Fcgr3 | -5006.5 |
| Ptger3 | -4911.5 |
| C3 | -4366.5 |
| Aoc3 | -4029.5 |
| Fcer1g | -2756.5 |
| Pik3cg | -1965.5 |
| Btk | -1539.5 |
| Tnf | -774.5 |
| Tnfrsf11a | -540.5 |
| Il1b | 126.5 |
GOMF MYOSIN HEAVY CHAIN BINDING
| set | GOMF MYOSIN HEAVY CHAIN BINDING |
| setSize | 12 |
| pANOVA | 0.00215 |
| s.dist | -0.512 |
| p.adjustANOVA | 0.0182 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mybpc3 | -7278.5 |
| Coro1a | -6513.5 |
| Myl12b | -6301.5 |
| Limch1 | -5478.5 |
| Axl | -4994.5 |
| Calml4 | -4712.5 |
| Stx1a | -4125.5 |
| Nkd2 | -3892.5 |
| Myl9 | -3585.5 |
| Pdlim2 | -2644.5 |
| Ush1c | -510.5 |
| Sptbn5 | 4166.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Mybpc3 | -7278.5 |
| Coro1a | -6513.5 |
| Myl12b | -6301.5 |
| Limch1 | -5478.5 |
| Axl | -4994.5 |
| Calml4 | -4712.5 |
| Stx1a | -4125.5 |
| Nkd2 | -3892.5 |
| Myl9 | -3585.5 |
| Pdlim2 | -2644.5 |
| Ush1c | -510.5 |
| Sptbn5 | 4166.5 |
GOBP PEPTIDE CROSS LINKING
| set | GOBP PEPTIDE CROSS LINKING |
| setSize | 11 |
| pANOVA | 0.00341 |
| s.dist | -0.51 |
| p.adjustANOVA | 0.0257 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tgm2 | -7376.5 |
| Anxa1 | -7074.5 |
| Dsp | -6769.5 |
| Col3a1 | -6278.5 |
| Epb42 | -5952.5 |
| Fn1 | -4709.5 |
| Thbs1 | -3222.5 |
| F13a1 | -2815.5 |
| Krt10 | -1586.5 |
| Evpl | -803.5 |
| Abca7 | 4687.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Tgm2 | -7376.5 |
| Anxa1 | -7074.5 |
| Dsp | -6769.5 |
| Col3a1 | -6278.5 |
| Epb42 | -5952.5 |
| Fn1 | -4709.5 |
| Thbs1 | -3222.5 |
| F13a1 | -2815.5 |
| Krt10 | -1586.5 |
| Evpl | -803.5 |
| Abca7 | 4687.5 |
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY
| set | GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY |
| setSize | 17 |
| pANOVA | 0.000294 |
| s.dist | -0.507 |
| p.adjustANOVA | 0.00359 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Svep1 | -7429.5 |
| Ighg2c | -6965.5 |
| C1qa | -6889.5 |
| C1qb | -6515.5 |
| Trem2 | -6196.5 |
| C1s1 | -5561.5 |
| C8g | -5437.5 |
| Serping1 | -5183.5 |
| C3 | -4366.5 |
| C1qc | -4208.5 |
| C1ra | -3172.5 |
| C1rl | -2864.5 |
| C1qbp | -2643.5 |
| Ighm | -2348.5 |
| Cd55 | -1174.5 |
| Cr1l | 1069.5 |
| Cd46 | 5498.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Svep1 | -7429.5 |
| Ighg2c | -6965.5 |
| C1qa | -6889.5 |
| C1qb | -6515.5 |
| Trem2 | -6196.5 |
| C1s1 | -5561.5 |
| C8g | -5437.5 |
| Serping1 | -5183.5 |
| C3 | -4366.5 |
| C1qc | -4208.5 |
| C1ra | -3172.5 |
| C1rl | -2864.5 |
| C1qbp | -2643.5 |
| Ighm | -2348.5 |
| Cd55 | -1174.5 |
| Cr1l | 1069.5 |
| Cd46 | 5498.5 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION
| set | GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION |
| setSize | 12 |
| pANOVA | 0.00235 |
| s.dist | -0.507 |
| p.adjustANOVA | 0.0196 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prnp | -7505.5 |
| Tusc2 | -7475.5 |
| Il27ra | -7328.5 |
| Tlr2 | -6950.5 |
| Parp1 | -6754.5 |
| Ubr5 | -6360.5 |
| Vsir | -4700.5 |
| Nckap1l | -3786.5 |
| Tlr4 | -3283.5 |
| Tgfb1 | -683.5 |
| Ddit3 | 3949.5 |
| Otud5 | 5413.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Prnp | -7505.5 |
| Tusc2 | -7475.5 |
| Il27ra | -7328.5 |
| Tlr2 | -6950.5 |
| Parp1 | -6754.5 |
| Ubr5 | -6360.5 |
| Vsir | -4700.5 |
| Nckap1l | -3786.5 |
| Tlr4 | -3283.5 |
| Tgfb1 | -683.5 |
| Ddit3 | 3949.5 |
| Otud5 | 5413.5 |
GOBP ENDOTHELIAL CELL MORPHOGENESIS
| set | GOBP ENDOTHELIAL CELL MORPHOGENESIS |
| setSize | 13 |
| pANOVA | 0.00174 |
| s.dist | -0.502 |
| p.adjustANOVA | 0.0154 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stc1 | -7410.5 |
| Pecam1 | -7344.5 |
| Id1 | -7336.5 |
| Plod3 | -7202.5 |
| Heg1 | -6919.5 |
| Col18a1 | -6067.5 |
| Tnmd | -4388.5 |
| Notch4 | -3685.5 |
| Met | -3101.5 |
| Ift88 | -2567.5 |
| Clic4 | 183.5 |
| Arhgef26 | 1207.5 |
| Col27a1 | 5926.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Stc1 | -7410.5 |
| Pecam1 | -7344.5 |
| Id1 | -7336.5 |
| Plod3 | -7202.5 |
| Heg1 | -6919.5 |
| Col18a1 | -6067.5 |
| Tnmd | -4388.5 |
| Notch4 | -3685.5 |
| Met | -3101.5 |
| Ift88 | -2567.5 |
| Clic4 | 183.5 |
| Arhgef26 | 1207.5 |
| Col27a1 | 5926.5 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION
| set | GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION |
| setSize | 11 |
| pANOVA | 0.00427 |
| s.dist | -0.498 |
| p.adjustANOVA | 0.0307 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pdgfb | -7307.5 |
| Nf1 | -6955.5 |
| Myh9 | -6792.5 |
| Prkg1 | -6076.5 |
| Rhoa | -5815.5 |
| Gna12 | -5294.5 |
| Nfe2l2 | -4630.5 |
| Mef2c | -3013.5 |
| Myocd | -2223.5 |
| Gna13 | 1477.5 |
| Tpm1 | 5765.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Pdgfb | -7307.5 |
| Nf1 | -6955.5 |
| Myh9 | -6792.5 |
| Prkg1 | -6076.5 |
| Rhoa | -5815.5 |
| Gna12 | -5294.5 |
| Nfe2l2 | -4630.5 |
| Mef2c | -3013.5 |
| Myocd | -2223.5 |
| Gna13 | 1477.5 |
| Tpm1 | 5765.5 |
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS
| set | GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS |
| setSize | 10 |
| pANOVA | 0.00673 |
| s.dist | -0.495 |
| p.adjustANOVA | 0.043 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nup35 | -6581.5 |
| Kpna2 | -6238.5 |
| Kpnb1 | -5760.5 |
| Kpna3 | -4058.5 |
| Nup54 | -3465.5 |
| Ipo5 | -3024.5 |
| Kpna1 | -2203.5 |
| Kpna4 | -2142.5 |
| Ranbp2 | -2109.5 |
| Kpna6 | -1368.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Nup35 | -6581.5 |
| Kpna2 | -6238.5 |
| Kpnb1 | -5760.5 |
| Kpna3 | -4058.5 |
| Nup54 | -3465.5 |
| Ipo5 | -3024.5 |
| Kpna1 | -2203.5 |
| Kpna4 | -2142.5 |
| Ranbp2 | -2109.5 |
| Kpna6 | -1368.5 |
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY
| set | GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY |
| setSize | 10 |
| pANOVA | 0.00691 |
| s.dist | -0.493 |
| p.adjustANOVA | 0.0436 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Dusp7 | -7360.5 |
| Dusp18 | -7294.5 |
| Dusp6 | -7226.5 |
| Dusp5 | -5500.5 |
| Dusp4 | -5033.5 |
| Dusp8 | -4358.5 |
| Dusp2 | -2553.5 |
| Dusp1 | -2074.5 |
| Dusp16 | 2154.5 |
| Dusp10 | 2416.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Dusp7 | -7360.5 |
| Dusp18 | -7294.5 |
| Dusp6 | -7226.5 |
| Dusp5 | -5500.5 |
| Dusp4 | -5033.5 |
| Dusp8 | -4358.5 |
| Dusp2 | -2553.5 |
| Dusp1 | -2074.5 |
| Dusp16 | 2154.5 |
| Dusp10 | 2416.5 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN
| set | GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN |
| setSize | 15 |
| pANOVA | 0.00108 |
| s.dist | 0.487 |
| p.adjustANOVA | 0.0106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cox7a2 | 6943.5 |
| Cox6a1 | 6639.5 |
| Cox7c | 6517.5 |
| Cox6a2 | 6445.5 |
| Cox8b | 5821.5 |
| Cox8a | 5767.5 |
| Cox7b | 5727.5 |
| Cox5b | 5346.5 |
| Cox4i1 | 4003.5 |
| Cycs | 3494.5 |
| mt-Co1 | 3401.5 |
| Cox5a | 2217.5 |
| Cox7a1 | 1712.5 |
| Cox4i2 | -1032.5 |
| Cox7a2l | -6219.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Cox7a2 | 6943.5 |
| Cox6a1 | 6639.5 |
| Cox7c | 6517.5 |
| Cox6a2 | 6445.5 |
| Cox8b | 5821.5 |
| Cox8a | 5767.5 |
| Cox7b | 5727.5 |
| Cox5b | 5346.5 |
| Cox4i1 | 4003.5 |
| Cycs | 3494.5 |
| mt-Co1 | 3401.5 |
| Cox5a | 2217.5 |
| Cox7a1 | 1712.5 |
| Cox4i2 | -1032.5 |
| Cox7a2l | -6219.5 |
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION
| set | GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION |
| setSize | 13 |
| pANOVA | 0.00239 |
| s.dist | -0.486 |
| p.adjustANOVA | 0.0197 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Wdr1 | -7203.5 |
| Nes | -7137.5 |
| Trpv4 | -7093.5 |
| Cfl1 | -6812.5 |
| Stmn2 | -6698.5 |
| F2rl1 | -6017.5 |
| Plek | -3800.5 |
| Katnb1 | -3235.5 |
| Actn2 | -2561.5 |
| Vil1 | 63.5 |
| Dstn | 184.5 |
| Cfl2 | 206.5 |
| Sema5a | 2913.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Wdr1 | -7203.5 |
| Nes | -7137.5 |
| Trpv4 | -7093.5 |
| Cfl1 | -6812.5 |
| Stmn2 | -6698.5 |
| F2rl1 | -6017.5 |
| Plek | -3800.5 |
| Katnb1 | -3235.5 |
| Actn2 | -2561.5 |
| Vil1 | 63.5 |
| Dstn | 184.5 |
| Cfl2 | 206.5 |
| Sema5a | 2913.5 |
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT
| set | GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT |
| setSize | 11 |
| pANOVA | 0.00522 |
| s.dist | 0.486 |
| p.adjustANOVA | 0.0357 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Atp2b2 | 7165.5 |
| Mdk | 6821.5 |
| Serpine2 | 6389.5 |
| Ulk1 | 5817.5 |
| Cend1 | 5127.5 |
| Prox1 | 4820.5 |
| Ttbk2 | 4115.5 |
| Ophn1 | 4100.5 |
| Nfix | 3098.5 |
| Nrxn1 | -1458.5 |
| Kif14 | -4422.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Atp2b2 | 7165.5 |
| Mdk | 6821.5 |
| Serpine2 | 6389.5 |
| Ulk1 | 5817.5 |
| Cend1 | 5127.5 |
| Prox1 | 4820.5 |
| Ttbk2 | 4115.5 |
| Ophn1 | 4100.5 |
| Nfix | 3098.5 |
| Nrxn1 | -1458.5 |
| Kif14 | -4422.5 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN |
| setSize | 29 |
| pANOVA | 6.03e-06 |
| s.dist | -0.486 |
| p.adjustANOVA | 0.000129 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psme2 | -7040.5 |
| Fcgr1 | -6509.5 |
| H2-DMa | -6448.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Psme1 | -6257.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Ctss | -5693.5 |
| H2-M3 | -5646.5 |
| Ifi30 | -5477.5 |
| Mpeg1 | -5224.5 |
| Fcgr3 | -5006.5 |
| Ap3d1 | -2928.5 |
| Fcgr2b | -2911.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Psme2 | -7040.5 |
| Fcgr1 | -6509.5 |
| H2-DMa | -6448.5 |
| Tap2 | -6388.5 |
| H2-K1 | -6356.5 |
| Psme1 | -6257.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Tapbp | -5917.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Ctss | -5693.5 |
| H2-M3 | -5646.5 |
| Ifi30 | -5477.5 |
| Mpeg1 | -5224.5 |
| Fcgr3 | -5006.5 |
| Ap3d1 | -2928.5 |
| Fcgr2b | -2911.5 |
| Unc93b1 | -2879.5 |
| Fcer1g | -2756.5 |
| Cd1d1 | -1386.5 |
| Lgmn | -613.5 |
| Ap3b1 | -76.5 |
| Mfsd6 | 1735.5 |
| Pikfyve | 4276.5 |
| Traf6 | 4702.5 |
| Mr1 | 5844.5 |
GOMF T CELL RECEPTOR BINDING
| set | GOMF T CELL RECEPTOR BINDING |
| setSize | 16 |
| pANOVA | 0.000785 |
| s.dist | -0.485 |
| p.adjustANOVA | 0.00812 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| Fyn | -6707.5 |
| Add1 | -6589.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-Eb1 | -6179.5 |
| H2-D1 | -5798.5 |
| Dock2 | -5657.5 |
| H2-Q7 | -5203.5 |
| H2-T10 | -2083.5 |
| Cd1d1 | -1386.5 |
| Stoml2 | 3785.5 |
| Eps8l1 | 5680.5 |
| Mr1 | 5844.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T23 | -7213.5 |
| H2-T22 | -7126.5 |
| Fyn | -6707.5 |
| Add1 | -6589.5 |
| H2-Q4 | -6576.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-Eb1 | -6179.5 |
| H2-D1 | -5798.5 |
| Dock2 | -5657.5 |
| H2-Q7 | -5203.5 |
| H2-T10 | -2083.5 |
| Cd1d1 | -1386.5 |
| Stoml2 | 3785.5 |
| Eps8l1 | 5680.5 |
| Mr1 | 5844.5 |
GOCC TRAPPIII PROTEIN COMPLEX
| set | GOCC TRAPPIII PROTEIN COMPLEX |
| setSize | 11 |
| pANOVA | 0.00561 |
| s.dist | -0.482 |
| p.adjustANOVA | 0.0374 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Trappc4 | -7346.5 |
| Trappc3 | -6634.5 |
| Trappc5 | -6144.5 |
| Trappc11 | -5996.5 |
| Trappc12 | -5667.5 |
| Trappc6a | -4982.5 |
| Trappc13 | -4922.5 |
| Trappc2 | -4060.5 |
| Trappc2l | -2158.5 |
| Trappc8 | 1681.5 |
| Trappc1 | 6640.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Trappc4 | -7346.5 |
| Trappc3 | -6634.5 |
| Trappc5 | -6144.5 |
| Trappc11 | -5996.5 |
| Trappc12 | -5667.5 |
| Trappc6a | -4982.5 |
| Trappc13 | -4922.5 |
| Trappc2 | -4060.5 |
| Trappc2l | -2158.5 |
| Trappc8 | 1681.5 |
| Trappc1 | 6640.5 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II |
| setSize | 15 |
| pANOVA | 0.00126 |
| s.dist | -0.481 |
| p.adjustANOVA | 0.012 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-DMa | -6448.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Ctss | -5693.5 |
| Ifi30 | -5477.5 |
| Fcgr2b | -2911.5 |
| Unc93b1 | -2879.5 |
| Fcer1g | -2756.5 |
| Lgmn | -613.5 |
| Pikfyve | 4276.5 |
| Traf6 | 4702.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-DMa | -6448.5 |
| H2-Ab1 | -6190.5 |
| H2-Eb1 | -6179.5 |
| H2-Aa | -5973.5 |
| B2m | -5962.5 |
| Cd74 | -5848.5 |
| H2-DMb1 | -5846.5 |
| Ctss | -5693.5 |
| Ifi30 | -5477.5 |
| Fcgr2b | -2911.5 |
| Unc93b1 | -2879.5 |
| Fcer1g | -2756.5 |
| Lgmn | -613.5 |
| Pikfyve | 4276.5 |
| Traf6 | 4702.5 |
GOCC CIS GOLGI NETWORK MEMBRANE
| set | GOCC CIS GOLGI NETWORK MEMBRANE |
| setSize | 13 |
| pANOVA | 0.0027 |
| s.dist | -0.481 |
| p.adjustANOVA | 0.0217 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2-T22 | -7126.5 |
| Trappc3 | -6634.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Bok | -5387.5 |
| H2-Q7 | -5203.5 |
| Tmem165 | -2789.5 |
| Phtf1 | -1365.5 |
| Gpr108 | -374.5 |
| Vps13b | 1650.5 |
| Atp2c1 | 4738.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2-T22 | -7126.5 |
| Trappc3 | -6634.5 |
| H2-K1 | -6356.5 |
| H2-Q6 | -6315.5 |
| H2-D1 | -5798.5 |
| H2-M3 | -5646.5 |
| Bok | -5387.5 |
| H2-Q7 | -5203.5 |
| Tmem165 | -2789.5 |
| Phtf1 | -1365.5 |
| Gpr108 | -374.5 |
| Vps13b | 1650.5 |
| Atp2c1 | 4738.5 |
GOBP T HELPER 2 CELL DIFFERENTIATION
| set | GOBP T HELPER 2 CELL DIFFERENTIATION |
| setSize | 13 |
| pANOVA | 0.00272 |
| s.dist | -0.48 |
| p.adjustANOVA | 0.0218 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkcz | -7451.5 |
| Anxa1 | -7074.5 |
| Nlrp3 | -6943.5 |
| Il4ra | -6861.5 |
| Hlx | -5826.5 |
| Irf1 | -4990.5 |
| Socs5 | -4608.5 |
| Bcl3 | -3838.5 |
| Men1 | -2912.5 |
| Bcl6 | -2557.5 |
| Kmt2a | 925.5 |
| Rara | 2047.5 |
| Zfp35 | 3513.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Prkcz | -7451.5 |
| Anxa1 | -7074.5 |
| Nlrp3 | -6943.5 |
| Il4ra | -6861.5 |
| Hlx | -5826.5 |
| Irf1 | -4990.5 |
| Socs5 | -4608.5 |
| Bcl3 | -3838.5 |
| Men1 | -2912.5 |
| Bcl6 | -2557.5 |
| Kmt2a | 925.5 |
| Rara | 2047.5 |
| Zfp35 | 3513.5 |
GOBP REGULATION OF MONOCYTE CHEMOTAXIS
| set | GOBP REGULATION OF MONOCYTE CHEMOTAXIS |
| setSize | 20 |
| pANOVA | 0.000208 |
| s.dist | -0.479 |
| p.adjustANOVA | 0.00267 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ninj1 | -6828.5 |
| Creb3 | -6806.5 |
| Pla2g7 | -6666.5 |
| Cxcl12 | -6639.5 |
| Ccl2 | -5836.5 |
| Cx3cr1 | -5691.5 |
| Slit2 | -5612.5 |
| Cxcl10 | -5223.5 |
| Serpine1 | -4895.5 |
| Aif1 | -4248.5 |
| Ccr1 | -3485.5 |
| App | -3352.5 |
| Dusp1 | -2074.5 |
| Lyn | -2030.5 |
| Nbl1 | -1516.5 |
| Ano6 | -1432.5 |
| Lgmn | -613.5 |
| Ccr2 | -96.5 |
| Mospd2 | 618.5 |
| Hmgb1 | 979.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Ninj1 | -6828.5 |
| Creb3 | -6806.5 |
| Pla2g7 | -6666.5 |
| Cxcl12 | -6639.5 |
| Ccl2 | -5836.5 |
| Cx3cr1 | -5691.5 |
| Slit2 | -5612.5 |
| Cxcl10 | -5223.5 |
| Serpine1 | -4895.5 |
| Aif1 | -4248.5 |
| Ccr1 | -3485.5 |
| App | -3352.5 |
| Dusp1 | -2074.5 |
| Lyn | -2030.5 |
| Nbl1 | -1516.5 |
| Ano6 | -1432.5 |
| Lgmn | -613.5 |
| Ccr2 | -96.5 |
| Mospd2 | 618.5 |
| Hmgb1 | 979.5 |
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION
| set | GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION |
| setSize | 15 |
| pANOVA | 0.00133 |
| s.dist | 0.479 |
| p.adjustANOVA | 0.0125 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Agtpbp1 | 7565.5 |
| Foxp2 | 7397.5 |
| Atp2b2 | 7165.5 |
| Whrn | 6848.5 |
| Ldb1 | 6403.5 |
| Rora | 5193.5 |
| Cend1 | 5127.5 |
| Ttll1 | 5113.5 |
| Slc25a46 | 3435.5 |
| Herc1 | 2677.5 |
| Cacna1a | 1425.5 |
| Atxn2 | 1217.5 |
| Ttc21b | 857.5 |
| Atp7a | -2173.5 |
| Psap | -2452.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Agtpbp1 | 7565.5 |
| Foxp2 | 7397.5 |
| Atp2b2 | 7165.5 |
| Whrn | 6848.5 |
| Ldb1 | 6403.5 |
| Rora | 5193.5 |
| Cend1 | 5127.5 |
| Ttll1 | 5113.5 |
| Slc25a46 | 3435.5 |
| Herc1 | 2677.5 |
| Cacna1a | 1425.5 |
| Atxn2 | 1217.5 |
| Ttc21b | 857.5 |
| Atp7a | -2173.5 |
| Psap | -2452.5 |
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS
| set | GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS |
| setSize | 15 |
| pANOVA | 0.00138 |
| s.dist | -0.477 |
| p.adjustANOVA | 0.0128 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Creb3 | -6806.5 |
| Pla2g7 | -6666.5 |
| Cxcl12 | -6639.5 |
| Ccl2 | -5836.5 |
| Cx3cr1 | -5691.5 |
| Cxcl10 | -5223.5 |
| Serpine1 | -4895.5 |
| Aif1 | -4248.5 |
| Ccr1 | -3485.5 |
| App | -3352.5 |
| Ano6 | -1432.5 |
| Lgmn | -613.5 |
| Ccr2 | -96.5 |
| Mospd2 | 618.5 |
| Hmgb1 | 979.5 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| Creb3 | -6806.5 |
| Pla2g7 | -6666.5 |
| Cxcl12 | -6639.5 |
| Ccl2 | -5836.5 |
| Cx3cr1 | -5691.5 |
| Cxcl10 | -5223.5 |
| Serpine1 | -4895.5 |
| Aif1 | -4248.5 |
| Ccr1 | -3485.5 |
| App | -3352.5 |
| Ano6 | -1432.5 |
| Lgmn | -613.5 |
| Ccr2 | -96.5 |
| Mospd2 | 618.5 |
| Hmgb1 | 979.5 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats graphics grDevices utils datasets methods base
##
## other attached packages:
## [1] kableExtra_1.4.0 pkgload_1.4.0 GGally_2.2.1 ggplot2_3.5.1
## [5] reshape2_1.4.4 beeswarm_0.4.0 gplots_3.2.0 gtools_3.9.5
## [9] tibble_3.2.1 dplyr_1.1.4 echarts4r_0.4.5 mitch_1.17.4
##
## loaded via a namespace (and not attached):
## [1] sass_0.4.9 utf8_1.2.4 generics_0.1.3 tidyr_1.3.1
## [5] bitops_1.0-9 xml2_1.3.6 KernSmooth_2.23-24 stringi_1.8.4
## [9] caTools_1.18.3 digest_0.6.37 magrittr_2.0.3 evaluate_1.0.1
## [13] grid_4.4.1 RColorBrewer_1.1-3 fastmap_1.2.0 plyr_1.8.9
## [17] jsonlite_1.8.9 gridExtra_2.3 promises_1.3.0 purrr_1.0.2
## [21] fansi_1.0.6 viridisLite_0.4.2 scales_1.3.0 jquerylib_0.1.4
## [25] cli_3.6.3 shiny_1.9.1 rlang_1.1.4 munsell_0.5.1
## [29] withr_3.0.1 cachem_1.1.0 yaml_2.3.10 parallel_4.4.1
## [33] tools_4.4.1 colorspace_2.1-1 httpuv_1.6.15 ggstats_0.7.0
## [37] vctrs_0.6.5 R6_2.5.1 mime_0.12 lifecycle_1.0.4
## [41] stringr_1.5.1 htmlwidgets_1.6.4 MASS_7.3-61 pkgconfig_2.0.3
## [45] pillar_1.9.0 bslib_0.8.0 later_1.3.2 gtable_0.3.5
## [49] glue_1.8.0 Rcpp_1.0.13 systemfonts_1.1.0 highr_0.11
## [53] xfun_0.48 tidyselect_1.2.1 rstudioapi_0.17.1 knitr_1.48
## [57] xtable_1.8-4 htmltools_0.5.8.1 rmarkdown_2.28 svglite_2.1.3
## [61] compiler_4.4.1END of report